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SUMMARY
A method of analysis was developed for the measurement of 
total extractable N-nitroso compounds in biological fluids.
The method was based on the selective chemical reduction of 
N-nitroso compounds to nitric oxide which was subsequently 
determined with a chemiluminescence analyser.
The availability of nitrosatable precursors and nitrosating 
agents for in vivo N-nitrosation and the occurrence of 
N-nitroso compounds in vivo were investigated. Nitrosatable 
precursors were shown to be present in high concentrations in 
the diet and in biological fluids. The nitrosating agent, 
nitrite, was shown to be formed from nitrate in the mouth, the 
amount formed varying considerably between individuals.
Raised gastric concentrations of nitrite were shown to be 
associated with high gastric pH and bacterial colonisation of 
the stomach. It was demonstrated that nitrite could be 
transported in the blood, despite its coupled oxidation with 
oxyhaemoglobin.
Total extractable N-nitroso compounds were measured in fasting 
gastric juice, and were found to be positively correlated with 
gastric pH. A significant relationship was also demonstrated 
between raised gastric N-nitroso compound and nitrite 
concentrations and the growth of nitrate reducing bacteria. 
Treatment with high doses of vitamin C (4g/day) was found to 
reduce these gastric N-nitroso compound concentrations. 
Treatment with the H^ receptor antagonists Cimetidine and
2
Ranitidine was associated with raised gastric N-nitroso 
compound concentrations and urinary
N-nitrosothiazolidine-4-carboxylic acid concentrations 
respectively.
The N-nitroso compounds present in nitrosated gastric juice 
were tentatively identified as dipeptide derivatives. Mass 
spectrometry demonstrated that a major component of nitrosated 
alanylalanine was N-nitrosoiminodiisopropanoic acid. However, 
although nitrosated alanylalanine was found to be mutagenic, 
synthesis of the pure N-nitrosodialkanoic acid demonstrated 
that this was non-mutagenic.
The interrelationships between N-nitroso compound 
concentration, pH, nitrite concentration, and growth of 
nitrate reducing bacteria were discussed in relation to the 
aetiology of human cancer.
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1.1 THE CHEMISTRY OF FORMATION OF N-NITROSO COMPOUNDS
1.1.1 General Chemistry
N-nitroso compounds all contain the group N-N=0, and are 
formed by the reaction of a nitrosating agent on the 
corresponding nucleophile (Fig. 1.1).
Nitrosating agents are compounds that can generate a
+
nitrosonium ion (NO ) or, less often, nitric oxide (NO).
Free nitrosonium ion can be obtained only in strong acids or
in solid salts such as nitrosonium tetrafluoroborate 
-f* .
(NO BF^). However, it can readily be generated from 
labile nitrosating agents formed in nitrite solutions and 
gaseous nitrogen oxides with the general formula NOX where 
X is a nucleophilic group.
N-nitroso compounds are most easily formed from amino or amido 
compounds containing a secondary nitrogen atom. However, they 
can under certain conditions be formed from compounds, 
containing primary, tertiary and quaternary nitrogens, 
although the reactions are usually far slower with much lower 
yields.
Secondary aliphatic amines and amides yield stable N-nitroso 
derivatives and the reaction goes no further.
R2NH + NOX — ^ r2nhno + x“ — ^ r2nno + HX
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Fig. 1.1 General formulae for various classes of N-nitroso
compounds
N-Nitrosamines
R»
vN-N=0
B."'
N-Nitrosamides
N=0
R !-N-C-RM
6
N-Nitrosamino acids N-Nitrosoureas
y=o ^=0
ri_N-CH -R” 
COOH
R 1 ~N-C-RH0i 2 
0
N-Nitrosourethanes N-Nitrosoguanidines
(N-Ni tros ocarbamates)
N=0 N=0
R ’-N-^-OR" R ’-N-g-NHp 
NH
N-Nitrososulphonamides N-Nitrosothioamides
0 N=0
R 1-S-N-N==0 R'-C-S-N-R**
0 R"
Where R' and R" may be substituted or unsubstituted
aryl, alkyl or heterocyclic groups
However the N-nitroso derivatives of secondary aromatic amines 
undergo the Fisher-Hepp rearrangement under acidic conditions 
to give a salt of the p-nitroso derivative. For example, 
N-nitrosomethylaniline can rearrange to give p-nitroso-N- 
methylaniline. This reaction is now known to be 
intermolecular, with hydrolysis liberating nitrous acid which 
subsequently reacts at the para position (Smith, 1966).
15
CH3 HC1 H2C1“
N=0 25°C CH3
Primary aromatic amines form unstable N-nitroso derivatives 
which tautomerise to the corresponding diazohydroxide and 
hydrolysis produces a relatively stable diazonium salt (Ridd, 
1961).
( 3 - N H 2  + N0X — > <^~~^>-NHNO + HX — > ^^)-N=N-OH
+ HX — » N] X~ + H20
Whereas, with aliphatic primary amines the diazonium salt is 
unstable and loses nitrogen to form a carbonium ion (Ridd, 
1961).
R - N+=5 N — > R+ + N2
This carbonium ion can then undergo addition, elimination, and 
rearrangement reactions to give a variety of products. One of 
these pathways can result in alkylation of the primary amine
16
to give a secondary amine and subsequently a 
N-nitrosodialkylamine.
(RN+== N) X~ + RNH2 — > HX +N2 + R2NH
R2NH + NOX — > R2NN0 + HX
Four or five carbon primary diamines or diaminoacids can form 
secondary amines by cyclization to five or six membered 
heterocyclic compounds. The yields obtained on nitrosation of 
these amines are thus much higher than those from aliphatic 
primary monoamines as the proximity of another amine is not 
required. Thus nitrosation of putrescine gives 
N-nitrosopyrrolidine (Wartheson et al., 1975).
^ C H 2-CH2 M203^ ^  ch2 —  c»2
ch2 ch2 ch2 ch2
\  \  \  /
nh2 nh2 n
N=0
Tertiary amines yield nitrosamines via an imminium salt which 
undergoes hydrolysis to a secondary amine which can then be 
nitrosated (Smith & Loeppky, 1967).
NO
R2NCH2R’ + NOX ^  [R2N - CH2R’] +X“ — > R2N+=CHR’ + [HNO] + X'
R2N = CHR’ + H20 — > R2NH + RCHO + IT 
R2NH + NOX — > R2NNO + HX
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Tertiary amides do not react except at high temperatures when 
they give nitrosamines and sometimes nitrosamides. 
Trialkylureas usually yield the corresponding nitrosourea, 
whereas dialkyl and trialkyl-thioureas, 1f1-dialky1-3- 
phenylureas and tetraalkylurea's yield nitrosamines (Eisenbrand 
et al., 1974; Elespuru & Lijinsky, 1973; Lijinsky et al,, 
1972).
1.1.2 N-Nitrosation by Aqueous Nitrous Acid
The best known nitrosating agents are produced in aqueous 
solutions of nitrous acid at pH less than 5 and their 
reactions have been extensively studied (Challis, 1981; Ridd, 
1961). The effective nitrosating agent is neither nitrous 
acid nor nitrite ion but the NOX formed from the protonated 
nitrous acid and a nucleophilic catalyst X (e.g. N02>
Cl , SCN ) as below.
N0“ + KjO+ HN02 + H20
HN02 + H^0+ H20+-N0 + H20
H20+ - NO + X" NOX + H20
N-nitrosation can be considered as a nucleophilic attack by an 
amine or amide on the electron deficient nitrogen of the 
nitrosating agent NOX.
Only the unprotonated amino substrate which is in equilibrium 
with its conjugate acid reacts with NOX.
R2N%2 + h2° ^  r2nh + h30+
R2NH + NOX ^  R2I@INO + X" ^  R2NNO + HX
It follows, therefore, that reaction rates are dependant on 
pH, the basicity of the amine/amide, and the presence of 
catalytic ions (X ) in addition to the concentrations of the 
reactants themselves.
In the absence of other nucleophiles, nitrite ion acts as the 
catalyst, X , forming the reactive species dinitrogen 
trioxide (nitrous anhydride), which is in equilibrium with 
nitrous acid.
H20+ - NO + N02 N203 + H20
N203 + H20 2HN02
The counteracting effects of acidity on the concentrations of 
dinitrogen trioxide and unprotonated amine result in an 
optimum pH for nitrosation which for the basic secondary 
amines (pKa^ 5) is normally between pH 2 and pH 3.4. The
19
rates of reaction (k^) calculated on the amounts of amine 
and nitrite salt added are extremely dependant on amine 
basicity.
2
Rate = k^[amine][nitrite]
Thus the weakly basic piperazine (pKa = 5.57) nitrosates at a 
rate (k^) about 2 x 10  ^times greater than the strongly 
basic piperdine (pKa = 11.2) at pH 3 (Mirvish, 1972). This is 
because a far greater proportion of the weakly basic 
piperazine is present in the unprotonated form. Thus, when 
the rate coefficient (k2) is calculated from the actual 
concentrations of nitrous acid and unprotonated amine in
solution, the rates are approximately the same being 1.4 x
5 - 2 - 1  5 - 2 - 110 M sec and 0.62 x 10 M sec respectively.
Rate = k2 [R (R»)NH][HN02]2
Very weakly basic amino compounds such as amides, ureas, and
some aromatic amines are too unreactive to combine readily
with dinitrogen trioxide. However, at pH 2 or lower they
undergo nitrosation via another pathway in which either
+ +
hydrated or unhydrated nitrosonium ion (H20N0 or NO )
is the nitrosating agent (Challis, 1981; Mirvish, 1975; Ridd,
1961).
hno2 + h3o+ h2ono+ + h2o 
r2nh2 + h2o <*=* r2nh + h3o+ 
r2nh + h2ono+ ^  r2n+nho + h2o
R2N+NH0 + H20 ^  R2NN0 + H30+
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Therefore, the rate of reaction of N-alkylureas,
N-aIky1carbamates, simple amides, and some weakly basic 
aromatic amines is proportional to the nitrite and hydrogen 
ion concentrations.
Rate = k3 [R (Rf) NH] [HNC>2] [H30+]
The reactions are slow at pH ^  3 but become progressively
faster with decreasing pH and do not show an optimum pH. The
rate of reaction is also strongly dependant on structure with
the fastest reaction rates applying to the most basic
compounds. Thus at pH 2 and 25°C, 1,3,-dimethylurea has a
-2 -1
reaction rate coefficient k3 = 200M sec ,
-2 -1N-Methylurea k3 = 8M sec , and N-Ethylurea k3 =
3M  ^sec  ^(Mirvish, 1975).
Thus in general weakly basic secondary amines, N-alkylureas 
and N-alkylcarbamates are most readily N-nitrosated, whereas 
strongly basic secondary amines, simple N-alkylamides and 
guanidines are nitrosated more slowly. Slower still is the 
nitrosation of most primary and tertiary amines and quaternary 
ammonium compounds.
1.1.3 Catalysis of N-nitrosation in aqueous nitrous acid
In the previous section the active nitrosating agent 
considered was dinitrogen trioxide which is formed by the 
nucleophilic attack of a nitrite ion on the electrophilic 
nitrosonium ion. However, other nucleophiles can combine with
21
the nitrosonium ion and give more reactive nitrosating agents 
than dinitrogen trioxide. Such nucleophiles are catalysts of 
nitrosation, and can be anions (X ) or nucleophilic entities 
(HX).
In the presence of such catalysts the rate of nitrosation is 
proportional to the nitrite concentration and not to the 
square of the nitrite concentration (Fan & Tannenbaum, 1973).
Rate = k4 [R (R1) NH][HNQ2][H30+][X~]
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1.1.3.1 Anionic Catalysis
Fan and Tannenbaum (1973), studied the effect of several 
anions on the nitrosation of morpholine and found that their 
catalytic effect diminished in the series - 
scn" - » >  Br Cl y  SO^ = C10~ = H2PO" = RCC>2
To this series can be added I which has a greater effect 
than SCN (Boyland et al., 1971). Fan and Tannenbaum 
(1973), proposed the following reaction mechanism for anion 
catalysed nitrosations after Turney and Wright (1959).
mon + h_o + x 
2 3
NOX + R2NH + H20
NOX + 2H20
RoNN0 + H_0+ + X" 
2 3
However, they recognised that the nitrosation of amines in the 
presence of anionic catalysts proceeded via the catalysed and 
uncatalysed mechanisms simultaneously and thus combined the 
two rate equations to give -
R*
RM,,>NNO
dt
= k, [hno ]§t' (R")UH] + k . (imo ] [r (r > )uh] [h,o+][x ]
This can be rearranged to give -
dt
3 = M  [h o+] [r2nh] k, [hno j + k4jx“jm
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At pH values below 2,
k4[x-]>k1 [ m q J
m
therefore the anion catalysed mechanism is predominant. As 
the pH increases so does [NO^] and both nitrosating
mechanisms become operative. Therefore conditions may exist 
when the overall reaction rate is between first and second 
order for nitrite and less than first order for X .
The reason for the difference in effectiveness between the 
anions is not completely understood. At first sight their 
effectiveness would appear to be related to their relative 
nucleophilicity, thus for SCN : Br : Cl their 
nucleophilicity constants would predict a ratio of 54:7:1 for 
their relative catalytic effectiveness (Hine, 1956). However, 
Fan and Tannenbaum (1973) showed that their catalytic effect 
was in the ratio 15,000:30:1. The rates of formation of NOX 
for the different anions is approximately the same (Dahn et 
al., 1960) the equilibrium constants, however, are different 
(Turney & Wright, 1959) and this might contribute to the 
difference.
The catalytic effect of these anions is far greater for the 
weakly basic amines than for the strongly basic amines (Fan & 
Tannenbaum, 1973; Boyland & Walker, 1974; Boyland et al., 
1971), no anionic catalytic effect being observed for amides 
(Berry & Challis, 1974), thioamides (Al-Mallah et al., 1974), 
ureas and urethanes (Hallet et al., 1980), and sulphonamides
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(Williams, 1976). A reason for the lack of catalytic effect 
of anions on the nitrosation of these compounds is suggested 
by the work of Hallet et al., (1980). They studied the effect 
of various nucleophiles on the denitrosation of 
N-methyl-N-nitrosoaniline and N-nitroso-p-toluenesulphon- 
amide. If one considers the implications of their results for 
the nitrosation reaction
-H+
R2NH + NOX 5==^  R2N+HN0 x=* r2nno 
(1) (2)
then anionic catalysis is only effective when (1) is the rate
limiting step. Hallet et al. (1980) suggest that the
introduction of a strong electron withdrawing substituent 
(e.g. >^C = 0, -SC^-) at the amino nitrogen atom results in
the deprotonation step (2) becoming rate limiting. Thus 
amides and sulphonamides, are not subject to anionic catalysis.
There have been several reports that chloride ion can either 
inhibit or enhance nitrosation depending on the pH. For 
example, Hildrum (1975) showed that chloride enhanced the 
nitrosation of proline at pH 0.5 and inhibited it at pH^>2.5. 
Similarly, (Mirvish et al., 1973) found that chloride 
inhibited the nitrosation of sarcosine at pH values of 2.5 and
3.5 by 34% and 55% respectively. Scanlan (1975), suggests 
that chloride ion inhibits nitrosation because of the effect 
of ionic strength on activity coefficients and/or 
dissociation, and because nitrosyl chloride is such a weak
catalyst, rate enhancement is only observed at high acidities 
(pH 2) where reaction via the nitrosyl chloride mechanism 
is predominant.
25
1.1.3.2 Non ionic nucleophilic catalysis
There are many nucleophilic compounds other than anions which 
react with nitrous acid to give NOX compounds, these include 
alcohols, thiols, phenols and carbohydrates. However, the NOX 
compounds formed are usually too stable or unstable to be 
useful as catalysts of N-nitrosation although they may 
participate in transnitrosation reactions under suitable 
conditions (Section 1.1.5.1). Thus in general these compounds 
act as nitrite scavengers and are therefore inhibitors of 
N-nitrosation. However, phenols and thiourea have been shown 
to be catalysts of N-nitrosation (Walker et al., 1979; Masui
Phenols provide an example of both the catalytic and 
inhibitory effect of such compounds. Phenol itself reacts 
readily with nitrous acid to give p-nitrosophenol which exists 
mainly as its stable tautomeric form quinone monoxime (Challis 
& Lawson, 1971), and thereby acts as an inhibitor of 
N-nitrosation.
However, with an excess of nitrite quinone monoxime has been 
shown to catalyse the nitrosation of pyrrolidine (Davies & 
McWeeny 1977) and diethylamine (Walker et al., 1979). It is 
suggested that the catalysis involves the rapid formation of 
an unstable O-nitroso derivative which acts as a powerful 
nitrosating agent. Under these circumstances nitrosamine
et al., 1979)
10
+ HX | J + HX
p-nitrosophenol quinone monoxime
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-  - 2  formation is proportional to [NC^ ] not [NO^ ] and
therefore the catalytic mechanism is only important at high
[nitrite]/[phenol] ratios.
0 0 0
+ N2O3 *=* HNO2
0
r2nh
* R2NN0 +
0
NOH NONO NOH
The assumption that it is the quinone form of the 
nitrosophenol that is involved is supported by the fact that 
m-nitrosophenol, which cannot exist in the quinone form does 
not enhance nitrosation. An interesting and important aspect 
of catalysis by p-nitroso phenol is that the formation of 
N-nitrosodiethylamine still proceeds effectively at relatively 
high pH; a condition which normally inhibits nitrosamine 
formation. Even at pH 6 where nitrosation is normally very 
slow, the rate still exceeds the optimum rate for the 
uncatalysed reaction (Walker et al. 1979). Similarly, 
(Pignatelli et al., 1980) polyhydroxyphenols can be either 
inhibitors or catalysts depending on the relative position of 
the hydroxyl groups. For example, 1,2- and 
1,4-dihydroxyphenols are inhibitors at pH 4 due to their 
oxidation to stable quinones, along with the reduction of the 
nitrosating agent to nitric oxide, which is a poor nitrosating 
agent in the absence of catalysts.
OH 0
+ 2 NOX + 2N0 + 2HX
On the other hand 1,3,dihydroxyphenols are catalysts of 
N-nitrosation due to the formation of a dinitroso derivative
27
which can tautomerise to the oxime form and thus form an 
O-nitroso derivative. Thus resorcinol forms 
2,4,dinitroso-resorcinol, which then tautomerises to the 
stable oxime
OH
4- 2N0X
OH
1 *
+ 2 HOX
07 it 0
The effect is also extended to the more complex naturally 
occuring polyhydroxyphenols in which those that contain a 
resorcinol structure are catalysts (quercitin, kaempferol, 
catechin, naringenin) whereas those without this structure 
show no catalytic activity (ferulic acid, caffeic acid, 
chlorogenic acid).
The only other report of catalysis of nitrosation by a 
nucleophile in aqueous nitrous acid involves thiourea (Masui 
et al., 1979). At pH 4 thiourea strongly catalyses the 
nitrosation of dimethylamine by the mechanism below.
(CH3)2NH
(NH2)2C=S + N203 ^  [(NH2)2C=S-NO]+ N02 »(CH3)2NNO
+
(NH2)2C=S
+
(HN02
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1.1.3.3 Other Catalysts
Surfactants which possess both hydrophobic and hydrophilic 
properties can form in aqueous media spherical molecular 
aggregates called micelles. Micelles formed by 
cetyltrimethylammonium bromide and lecithin have been shown to 
enhance the rate of nitrosation of di-n-hexylamine at pH 3.5 
by 800 times (Okun & Archer, 1977). This catalytic effect is 
only significant with long chain dialkyl nitrosamines, and is 
presumably due to the precursor amine being concentrated at 
the water/micelle interface with the hydrocarbon chains being 
buried in the hydrophobic micelle interiors. In addition, if 
the surfactant is cationic the surface of the micelle will be 
cationic or neutral if the surfactant is non-ionic, the 
location of the polar amino groups at the surface of the 
micelle will also give the micelle a cationic character. Thus 
nitrosation will be further enhanced by electrostatic attack 
of nitrite ion and destabilisation of the protonated amine 
relative to free base. Yang et al. (1977) demonstrated a 
non-enzymic acceleration of nitrosation by bacteria and yeast 
cells. They suggested that similar hydrophobic interactions 
between the precursor amines and cellular constituents, such 
as the lipid bilayer of cell membranes, accounted for the 
catalysis. Kim et al. (1980) demonstrated that bile acids, 
which are involved in the digestion of fat and the elimination 
of cholesterol by incorporation into micelles containing bile 
acid, lecithin and cholesterol, also catalyse the nitrosation 
of dihexylamine.
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Yamamoto et al. (1977), demonstrated that organic acids 
enhance the nitrosation of amides, the best catalysts having 
the greater number of carboxyl or hydroxy groups, thus in 
order of effectiveness -
The kinetics of the organic acid catalysed reaction are first 
order with respect to nitrite and organic acid. This would 
fit with the normally accepted nitrosating agent for amides 
namely the hydrated nitrosonium ion. However, no mechanism 
has been suggested for the catalytic effect.
1.1.4 Inhibition of nitrosation in aqueous nitrous acid
Inhibition of N-nitrosation can be effected by the addition of 
compounds (scavengers) which convert nitrosating agents to 
inactive products. In such cases nitrous acid is reduced to 
either nitrogen or nitric oxide, or nitrosonium ion may be 
bound irreversibly.
Inhibitors which reduce nitrous acid to nitrogen, such as 
ammonia, primary amines, hydrazine, urea, sulphamic acid and 
its salts, hydroxylamine and azides, have been used 
extensively experimentally, but have little significance to in 
vivo nitrosation. However, several compounds which reduce 
nitrous acid to nitric oxide under mildly acidic conditions 
have considerable relevance as they are found endogenously or 
in foods. These include, thiols, sulphur dioxide, bisulphite, 
ascorbic acid, tocopherols, phenols and other antioxidants.
malic acid tricarballylic 
acid ^  lactic acid dOz succinic acid ^  acetic acid
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Several workers (e.g:- Mirvish et al. 1972; Greenblatt 1973) 
have shown that ascorbic acid is an effective inhibitor of 
nitrosation reactions. It is effective over a wide range of 
pH because both the free acid and the ascorbate ion rapidly 
reduce NOX to nitric oxide. The nitrosating agent initially 
reacts with the 3-hydroxy group to form a nitrite ester, which 
decomposes to yield nitric oxide and the semiquinone. Further 
reaction of NOX with the 4-hydroxy group and subsequent 
decomposition of the ester completes the oxidation of 
ascorbate to dehydroascorbic acid.
Mirvish et al. (1972) demonstrated that ascorbate was an
effective inhibitor for the nitrosation of several secondary
amines, methylurea and oxytetracycline. Fan and Tannenbaum
(1973) confirmed that ascorbic acid inhibited the nitrosation
of morpholine and that when the ascorbic acid:nitrite ratio
was 2:1 at 25°C and pH 4 the inhibition was complete. The
inhibition probably results from direct competition by
ascorbic acid for the nitrosating agent. Mirvish (1972)
2
pointed out that ascorbate ion is 2.4 x 10 times more 
rapidly nitrosated than ascorbic acid, which explains why 
inhibition is more effective ,at pH 3 to 4 than at pH 1 to 2,
For lipophilic matrices, however, the lipid-soluble 
artocopherol may be a better inhibitor than ascorbic acid 
(Fiddler et al. 1978; Mergens et al. 1978). The a-tocopherol
HOCHi
CH20H
H0CH-
CH20H
I 0,
ch2oh
+ NOX — > HX +
HO OH 0 0 
+
2N0 + HX
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can compete for the nitrosating agent when emulsified in 
aqueous solution, as well as when dissolved in aprotic 
solvents, being oxidised to a quinoid product.
Other compounds that compete for nitrosating agents and thus 
can inhibit nitrosation include thiols, alcohols, 
carbohydrates and phenols.
Alcohols and carbohydrates reduce the initial rate of 
nitrosation by reacting rapidly with nitrous acid to form 
alkyl nitrites which are ineffectual nitrosating agents 
(Williams & Aldred, 1982).
HN02 + ROH RONO + H20
However, the final yield of nitrosamine remains the same 
because as nitrous acid is used for nitrosation it is replaced 
by decomposition of the alkyl nitrite.
Thiols are much better inhibitors of N-nitrosation, because 
S-nitrosation is virtually irreversible. Thus L-cysteine and 
N-acetylpenicillamine are both effective inhibitors of 
nitrosation (Williams and Aldred, 1982). However, to inhibit 
nitrosation completely a 20 fold excess of thiol over amine is 
required.
CH3 ch3
ch3
Ci6H33 + NOX — *
CH3
c16h33 + NO + X“
ch3
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The reduction of to nitric oxide by phenols has
already been mentioned (Section 1.1.3.2). Phenol itself
o 4reacts with nitrous acid at pH 1.5 and 25 C 10 times 
more rapidly than dimethylamine (Challis, 1973). This large 
difference should prevail for most alkylamines and be 
virtually independant of acidity up to pH 5. The difference 
should be even greater for polyhydroxylated and polycyclic 
aromatic compounds which are more reactive towards nitrous 
acid than phenol. Thus phenols are efficient nitrite 
scavengers and effective inhibitors of N-nitrosation.
However, it should be remembered that those phenols which can 
form quinone oxime derivatives catalyse N-nitrosation by way 
of the 0-nitroso derivative (Section 1.3.2). The complex 
mixtures of polyphenols which occur in foods and drinks have 
effects which are difficult to predict. For example Japanese 
green tea enhanced the nitrosation of secondary amines when 
added at low concentration. However, at higher concentrations 
inhibition occured (Nakamura and Kawabata, 1981).
Nitrous acid can react with unsaturated compounds to give a 
variety of products. For example alkenes yield 
pseudonitrosites on reaction with nitric oxide, which may be 
effective nitrosating agents in aprotic solvents (Walters et^  
al., 1979(a)). Sorbic acid reacts rapidly with nitrous acid 
to give a variety of products.
0N0 
1
CH3— CH CH = CH - C00H
n203
— > »
OH
ch3
fiH
CH
CHti
CH
C00H
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and and
ONO
CH3 - CH^ ^CH = CHCOOH CH3 - C = C - CH = CH - COOH 
O N
NN^-» 0
Sorbic acid is as effective as ascorbic acid at inhibiting the 
nitrosation of dimethylamine. However, it is a weaker 
inhibitor for the nitrosation of morpholine and has no 
inhibitory effect with N-methylaniline (Tanaka et al. 1978).
1.1.5 N-Nitrosation in Neutral and Alkaline Solutions
In recent years the possibility that N-nitrosation can occur 
under neutral and alkaline conditions has received increasing 
attention. This attention has been partly due to the 
discovery of N-nitroso compounds in neutral biological 
samples. Both nitrite salts, and nitrogen oxides can act as 
nitrosation agents in neutral and alkaline solution.
Nitrite ion being negatively charged encounters a barrier of 
electrostatic repulsive force as it approaches any other 
centre of negative charge, such as the electronegative 
nitrogen atom of a secondary amine. The nitrite ion per se 
cannot therefore nitrosate such electronegative compounds. As 
mentioned previously however double protonation in acidic 
media facilitates nitrosation via the hydrated nitrosonium 
ion, nitrogen trioxide or NOX nitrosation agents.
NOX
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Similarly amine-nitrite interactions are possible if a 
positively charged carbon atom is substituted on the amine 
nitrogen to overcome its electronegativity and allow the 
approach and reaction with the nitrite ion. Such reactions 
involving electronegative catalysts do not require hydrogen 
ion and can occur in neutral and alkaline solutions. Thus 
carbonyl compounds such as formaldehyde and benzaldehyde 
enable the nitrosation of various secondary amines in neutral 
and basic solution via the formation of an iminium ion thus:-
R2NH + R'CHO --» R2N+ = CHR’ + Off"
R2N+ = CHR’ + N02 ^  R2N - CHR’
'ONO
R2N-CHR’
i [  > R2NN0 + R’CHO
0=N-0
The iminimum ion/nitrite adduct rearranges to form a 
nitrosamine and regenerate the carbonyl catalyst (Keefer & 
Roller, 1973). Pyrrolidine, piperidine, dimethylamine, 
diethylaraine and di-n-propylamine can all be nitrosated under 
these conditions. However, diisopropylamine cannot be 
nitrosated, presumably because of steric crowding by the 
isopropyl group. Tertiary and quaternary nitrogen compounds 
cannot react by the above mechanism as they are incapable of 
forming iminium ions through reaction with aldehydes.
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Nitrogen dioxide, dinitrogen trioxide and nitric oxide can all 
act as nitrosating agents in neutral and basic aqueous media, 
although nitric oxide requires either oxidation to nitrogen 
dioxide or the presence of certain metal salts. The 
nitrosation reactions are usually faster and more extensive 
than in aqueous nitrous acid and occur despite the hydrolysis 
of the nitrogen oxides to nitrite ion. This is because the 
rate of nitrosation is much faster than the hydrolysis, twenty 
times faster for morpholine and 340 times faster for 
piperidine (Challis et al. 1980).
N203 + 20H~ --- * 2N02 + H20
N204 + 20H“ --- * N02 + NO3 + H20
Only unprotonated basic amines react, no reaction being 
observed for amides (Challis and Kyrtopulos, 1978, 1979).
These reactions are inhibited by acid, sodium azide, ascorbic 
acid, some phenols, simple alcohols and primary amines (Li, 
1981) whereas, they are catalysed by nucleophilic anions such 
as thiocyanate (Li, 1981) and by 1,2-alkanolamines and 1,2 
dihydroxy compounds including carbohydrates (Challis and 
Shuker, 1979, 1980; Challis et al. 1980). Although simple 
alcohols inhibit the nitrosation due to formation of the 
corresponding alkyl nitrite, addition of 1,2-diols catalyses 
the reaction. This is because the nitrite ester formed is an 
effective nitrosating agent as the (3-substituted-0H group is
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electron withdrawing and makes the alkoxide (XCH^CH^O ) 
a better leaving group.
R2NH
XCH2CH2OH + NOX HX + XCH2CH2ONO -- * R2NNO + XCH2CH2OH
where X = OH, R^N etc.
Similarly 1,2-alkanolamines and carbohydrates catalyse the 
reaction via their nitrite esters.
1.1.5.1 Transnitrosation
In addition to nitrous acid and nitrogen oxides many nitroso 
compounds and nitro compounds can act as nitrosating agents. 
Thus N-nitrosations can be effected by nitrite esters (RONO), 
thionitrite esters (RSNO) and by N-nitroso compounds (RR’NNO).
Nitrosamines and N-nitrosaminoacids can act as 
transnitrosating agents at pH ^  3 (Singer et al. 1980), 
probably via denitrosation and liberation of nitrous acid.
R2NN0 + HX -5=^ [R2NHN0]£- R2NH + XNO 
XNO + R2NH — > R2NN0 + HX
Thus transnitrosations, like nitrosations are catalysed by 
nucleophilic anions. The less basic the parent amine the more 
effective the transnitrosation agent. Thus
37
N-nitrosopiperazines are good transnitrosating agents but 
N-nitrosopiperidine is stable and will not act as a nitroso 
donor. Transnitrosation is also facilitated by weakening of 
the N-NO bond by electron withdrawing substituents such as the 
carboxyl group of N-nitrosamides as one would suspect.
The decomposition of simple nitrite esters to yield nitrous 
acid enabling the subsequent nitrosation of amines has already 
been mentioned (Section 1.1.4), as has the direct nitrosation 
by nitrite esters bearing electron withdrawing (3-substituents 
(Section 1.1.5), which can occur in alkaline solution.
RONO + HX ?=* [ROHNOjJ- ROH + NOX -- » R2NNO + HX
XCH2CH2ONO + R2NH --- > XCH2CH2OH + R2NNO
Nitrosophenols are unstable under aerobic conditions and are 
oxidised to the corresponding C-nitrophenol which do not 
nitrosate secondary amines. However, certain nitrosophenols 
can act as transnitrosation agents via their O-nitroso 
derivatives (Section 1.1.3.2).
Nitrosothiols are better nitrosating agents than nitrite 
esters because RS is a better leaving group than RO .
Thus S-nitrosocysteine can nitrosate N-methylaniline in acid, 
neutral and alkaline solutions (Davies et al., 1978). This 
transnitrosation reaction does not require activation by acids 
and therefore does not proceed via the release of nitrous acid.
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1.1.6 The Influence of Microorganisms on the formation of 
N-nitroso compounds
Several research groups have suggested that bacteria can 
assist N-nitrosation reactions at pH values around neutrality 
(Sander, 1968; Hawksworth & Hill, 1971; Klubes et al., 1972; 
Ayanaba and Alexander, 1973; Hashimoto et al., 1975; Kunisaki 
and Hayashi, 1979). Mechanisms suggested for their 
participation include (a) decrease of the pH of the system by 
bacterial metabolism (b) reduction of nitrate to nitrite (c) 
metabolic production of secondary amines (d) adsorption of 
amine onto the cell surface or cytoplasmic membrane (e) 
nitrosation by bacterial enzyme systems.
Growing cultures of bacteria generally reduce the pH of the 
culture medium to about pH 6.0. At this pH although chemical 
nitrosation is very slow it is still considerably faster than 
at neutrality (Ralt & Tannenbaum, 1981). Some bacteria can 
rapidly reduce nitrate to nitrite. Hill et al. (1972) found 
that over 40% of the non-sporing, strictly anaerobic bacteria 
which constitute 99% of the intestinal flora, possessed a 
nitrate reductase enzyme. Thus the presence of bacteria in 
systems containing nitrate can accelerate N-nitrosation by 
rapidly increasing the concentration of nitrosating agent. In 
addition, bacteria can increase the availability of secondary 
amines by metabolism of amino acids, and quaternary amino 
compounds. For example, bacteria can produce piperidine and 
pyrrolidine from lysine and arginine respectively and 
dimethylamine from choline (Hawksworth and Hill, 1972).
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Several workers (Klubes et al., 1972; Collins-Thompson et al., 
1972; Mills and Alexander, 1976) have demonstrated that boiled 
bacterial cells catalyse N-nitrosation at neutral pH. They 
proposed that this was due to non-enzymic catalysis by one or 
more unidentified metabolic products. Yang et al. (1977) also 
demonstrated non-enzymic bacterial catalysis at pH 3.5. They 
found that the rate enhancement depended on the alkyl chain 
length of the precursor amine, the relative rates being 
dihexylamine ^  dipentylamine ^  dibutylamine. These 
results were similar to those they obtained for micellar 
catalysis mentioned earlier (Section 1.1.3.3), and they
proposed that a similar catalytic mechanism was operative.
The evidence for enzymic catalysis of nitrosamine formation in 
the presence of microorganisms is far from clear, and there is 
some conflict in opinion about the existence of such an enzyme 
system. A recent reappraisal of the evidence led Ralt and 
Tannenbaum (1981) to conclude that the evidence for enzymic 
catalysis was poor due to the use of controls which did not 
adequately eliminate the other mechanisms mentioned above. 
Nevertheless, Hawksworth and Hill (1971) demonstrated the 
formation of N-nitrosopiperidine and N-nitrosopyrrolidine in 
systems containing E.coli at pH 6.5 whereas even the more 
weakly basic diphenylamine showed no detectable nitrosation in 
the nutrient broth above pH 5 in the absence of bacteria. 
Furthermore, many nitrate reducing strains of E.coli failed to 
produce detectable levels of nitrosamines. This indicates 
that the bacteria actively catalyse the nitrosation reaction
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and are not merely acting as a means of generating nitrite and 
acid conditions. Ayanaba and Alexander (1973) demonstrated 
the formation of N-nitrosodiphenylamine from diphenylamine and 
nitrite by 7 bacterial species, 2 yeasts and 1 fungus even 
though the pH was maintained at 7.5 + 0.1 although the pH may 
have been low locally. In addition they found enhanced 
nitrosation on addition of a crude enzyme extract from a 
bacterium (Pseudomonas sp.) and a yeast (Cryptococcus sp.). 
This catalytic activity disappeared on boiling of the extract, 
again suggesting enzymic catalysis. Kunisaki and Hayashi
(1979) showed that microbial formation of 
N-nitrosodimethylamine had an optimum pH of 8.0 and that 
disrupted or boiled cells were inactive. Hayashi et al.
(1982) studied 49 strains of anaerobic bacteria isolated from 
the stomach of monkeys. They found that 18 strains increased 
the rate of nitrosation of dimethylamine by 1.1 to 1.5 times 
at pH 6.0. Aerobic strains increased the rate of nitrosation 
more dramatically, but this enhancement may have been due to a 
change in pH which had decreased to about pH 5.5.
As well as assisting the formation of N-nitroso compounds 
bacteria have also been shown to degrade nitrosamines.
Rowland and Grasso (1975) showed that the majority of bacteria 
found in the human gut were active in degrading 
diphenylnitrosamine and dimethylnitrosamine to nitrite and 
parent amine. Thus in the presence of nitrate/nitrite 
bacteria may enhance nitrosamine formation whereas in the 
absence of sufficient nitrosating agent bacteria may decrease 
the concentration of nitrosamines.
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1.1.7 N-nitrosation in Lipophilic Media
In lipophilic systems amines are unprotonated and can be 
nitrosated by nitrogen oxides or transnitrosating agents. 
Nitrogen oxides can nitrosate both amines and amides in 
aprotic systems, whereas in aqueous systems no reaction is 
observed for amides. Secondary amines and amides react with 
dinitrogen trioxide to give high yields of their N-nitroso 
derivatives, (Challis and Kyrtopoulos, 1979; White, 1955) 
whereas dinitrogen tetroxide produces a mixture of N-nitro and 
N-nitroso derivatives, (Challis and Kyrtopoulos, 1978). 
Transnitrosation reactions can also occur in lipophilic media 
via release of nitrogen oxides. For example, alkyl nitrites 
are very soluble in lipophilic media and can decompose to 
generate alkoxyl radicals (RO ) and nitric oxide. The 
nitric oxide can then be oxidised to nitrogen dioxide and 
nitrosate lipid soluble amines (Forest et al., 1978).
Likewise other compounds that are lipid soluble and decompose 
to give nitrogen oxides could act as transnitrosating agents. 
Walters et al. (1979), suggest that the pseudonitrosites of 
unsaturated lipids could act in this way. The lipid soluble 
a-tocopherol is an effective inhibitor of such nitrosations 
(Fiddler et al., 1978). However, in two phase systems 
inhibitors which act via the production of nitric oxide (e.g. 
ascorbic acid) can enhance nitrosation. Thus Mottram et al. 
(1977), showed that the addition of sodium ascorbate to a 
two-phase system enhanced the nitrosation of pyrrolidine by 
between 5 and 25 times. This enhancement is due to the nitric
42
oxide migrating to the lipid phase where it can be oxidised to 
nitrogen dioxide, which is a powerful nitrosating agent. 
Similarly, Massey et al. (1979), demonstrated a 20 fold 
enhancement in the rate of formation of N-nitrosodihexylamine 
in aqueous sodium nitrite at pH 5.25 following the addition of 
n-decane 20% w/v. They attributed the increased formation to 
nitrosation in the lipid phase by oxides of nitrogen produced 
from the decomposition of nitrite in the aqueous phase. Thus 
the nitrosation of di-n-propylamine was not enhanced as it was 
present almost entirely in the aqueous phase (Partition 
coefficient ^  350).
1.1.8 Summary
N-nitroso compounds can be formed from primary, secondary, 
tertiary and quaternary nitrogen compounds, although the most 
facile reactions are those of secondary amines and amides.
The nitrosation reactions can occur in aqueous systems at all 
pH values as well as in lipophilic media. The active 
nitrosating agents are generally electronegative derivatives 
of nitrous acid in acid systems, and nitrogen oxides in 
alkaline and lipophilic systems. Transnitrosation of the 
nitroso group from one nitroso compound to another can occur 
under a wide variety of conditions.
Many compounds catalyse nitrosation reactions either by 
forming more reactive nitrosating agents as intermediates or 
by increasing the concentration of nitrosating agent. 
Conversely inhibitors of nitrosation act via reducing the
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availability of nitrosating agent by direct competition. 
Microorganisms have also been shown to enhance nitrosation 
although whether this involves bacterial enzymes is not yet 
clear.
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1.2. THE TOXICITY CARCINOGENICITY AND MUTAGENICITY OF 
N-NITROSO COMPOUNDS
1.2.1 Toxicity
The formation of N-nitroso compounds from secondary amines and 
nitrous acid was discovered by chemists more than 100 years 
ago, however, the first report of their toxicity was not made 
until 1937 when Freund (1937) described the hepatotoxic effect 
of N-nitrosodimethylamine in two chemists accidentally 
intoxicated by this chemical. However, the toxicity of 
N-nitroso compounds received little attention until Barnes and 
Magee (1954) demonstrated that a single lethal dose of 
dimethylnitrosamine given orally or by injection produced 
extensive liver necrosis in rats, rabbits, mice, guinea-pigs 
and dogs. In addition chronic poisoning was produced by 
feeding rats a diet containing 50, 100 and 200ppm 
N-nitrosodimethylamine. At the lowest dosage no rats died 
during the duration of the experiment but nevertheless they 
showed a significant loss in weight. At intermediate 
concentrations (100 ppm) all rats died within 62-95 days and 
at 200 ppm all rats were dead after 34-37 days on the diet.
Since this pioneer work, many other N-nitroso compounds have 
been shown to produce acute toxic effects. N-nitrosamines 
have proved to be mainly systemically acting agents with 
toxicities ranging from a LD^q of 18 mg/kg bodyweight for 
the highly toxic N-nitrosomethylbenzylamine to a LD^q of 
more than 7500 mg/kg for the practically non-toxic
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N-nitrosodiethanolamine. N-nitrosamides on the other hand 
react locally as well as systemically with toxicities ranging 
from a LD^q of 4mg/kg bw for N-methyl-N- nitrosourethane to 
a 1*Dj.q of 1200 mg/kg bw for N-butyl-N-nitrosourea (Druckrey 
et al., 1967; Magee and Barnes, 1972). The organs mainly 
affected by the nitrosamines are the liver and lungs, while 
nitrosamides generally damage bone marrow and lymphatic tissue 
(Druckrey et al., 1967).
1.2.2 Carcinogenicity
In addition to the acute toxic effects, Magee and Barnes 
(1956, 1959) demonstrated that rats fed on a diet containing 
low levels of dimethylnitrosamine (10, 20, 50 mg/kg) developed 
liver cancer, whereas higher dietary concentrations (100-200 
mg/kg) induced kidney tumours. These findings led to a 
widespread investigation into the carcinogenic effects of 
N-nitroso compounds. In 1967 Druckrey et al., listed 65 
N-nitroso compounds that had been shown to induce tumours in 
rats, and in 1973 Preussmann extended this list to over eighty 
compounds. By 1981 about 300 N-nitroso compounds had been 
tested, of which 85% of 209 N-nitrosamines and 92% of the 86 
N-nitrosamides had induced tumours in laboratory animals 
(N.R.C., 1981). Some of these N-nitroso compounds have been 
tested for carcinogenicity in a large number of animal 
species. One of the most thoroughly examined N-nitroso 
compounds is N-nitrosodiethylamine. Schmahl and Habs (1980) 
list the carcinogenic effect of N-nitrosodiethylamine in 22 
animal species, including mice, rats, hamsters, guinea-pigs,
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rabbits, cats, dogs, pigs, monkeys, fish, frogs and the grass 
parakeet. So far, no species has proved to be resistant to 
its action. The main target organ for the carcinogenic action 
of N-nitrosodiethylamine is the liver, although the 
cytotropism of the action can be different in different 
species. For example, dogs develop mainly leiomyosarcomas, 
whereas, pigs develop reticulosarcomas (Schmahl, 1980). In 
addition to the liver, the oesophagus, the stomach, the 
paranasal sinus, the trachaeobronchial system and the kidneys 
can be affected. N-nitroso compounds are therefore, very 
versatile multipotent group of carcinogens, inducing malignant 
tumours in almost all important organs with many being active 
in single dose.
Despite the variety of target organs that can be affected by 
any one N-nitroso compound, some generalisations can be made 
about their organotropism. N-nitroso compounds can be divided 
into two groups, one including the dialkyl, alkylaryl and 
diaryl and heterocyclic nitrosamines and the other the alkyl 
and aryl nitrosamides. These two groups differ in their 
biological actions because of their different chemical 
stabilities. N-nitrosamines are essentially stable under 
physiological conditions whereas N-nitrosamides are not. For 
example, the half-life of the nitrosamide N-nitrosomethylurea 
falls from 125 hours at pH 4 to only 1.2 hours at pH 7 
(Druckrey et al., 1967). Consequently, N-nitrosamines act 
systemically producing tumours in the organs that metabolise 
them to the active carcinogen, whereas, N-nitrosamides do not
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require metabolic activation and decompose spontaneously 
producing tissue damage and tumours locally or in some cases 
in organs with rapid cell turnover, e.g. bone marrow, 
lymphatics.
The necessity for metabolic activation explains why 
N-nitrosamines act primarily on the liver, since generally 
speaking, the enzymes responsible for the metabolism of 
foreign compounds are present in highest amounts in the 
liver. However, experiments with tissue slices from the rat 
have shown that other organs can also metabolise 
N-nitrosamines (Montesano and Magee, 1970). For example, in 
experiments concerning the metabolism of
N-nitrosodimethylamine and N-nitrosodiethylamine, rat liver 
was the most active in metabolising N-nitrosodimethylamine, 
followed by the kidney which showed appreciable activity and 
then by the lung and oesophagus which were also active, with 
the small intestine showing only very slight activity. A 
similar relationship was observed with N-nitrosodiethylamine 
except that the rate of metabolism was lower in the liver 
slices and rather higher in the lung. Interestingly, using 
tissue slices from the hamster, similar results were obtained 
for the metabolism of N-nitrosodimethylamine, but with 
N-nitrosodiethylamine the lung was more active than the 
liver. This correlates well with the powerful carcinogenic 
action of N-nitrosodiethylamine in the hamster lung and the 
lack of lung tumour induction with N-nitrosodimethylamine.
The hypothesis that the organotropic, toxic and carcinogenic 
effects of nitrosamines are not due to the preferential uptake
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of the unmetabolised carcinogen, but rather, to the
preferential metabolism by specific organs is supported by an
autoradiographic study of transected mice (Johansson and
Tjalve, 1978). They measured the distribution of 
14unmetabolised C labelled N-nitrosodimethylamine and its 
14bound C products, in normal mice and in mice whose
N-nitrosodimethylamine metabolism had been blocked by
pyrazole, ethanol or nialamide. Treated mice showed a uniform
distribution of unmetabolised N-nitrosodimethylamine
throughout the body 30 minutes after intravenous injection, no 
14
bound C was found. Normal mice concentrated unmetabolised 
N-nitrosodimethylamine in a variety of organs including the 
liver, pancreas, salivary gland, intestinal mucosa and bone 
marrow. However, only the liver and renal cortex contained 
bound N-nitrosodimethylamine. More recently, Hodgson et al.
(1980) measured the methylation of DNA caused by 
N-nitrosomethylbenzylamine in various organs, and discovered 
that this oesophageal carcinogen was predominantly metabolised 
in the oesophagus, which is the target organ for 
N-nitrosomethylbenzylamine.
The variation in metabolic activity of different organs 
towards a specific N-nitrosocompound may account for the 
strong structural dependence observed for the organotropism of 
nitrosamines. In an attempt to link structure with target 
organ Druckrey et al. (1967) found that in general simple 
symmetrical dialkylnitrosamines e.g. N-nitrosodimethylamine, 
produced liver cancers, whereas unsymmetrical
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dialkylnitrosamines e.g. N-nitrosomethylvinylamine produced 
oesophageal cancers. Cyclic nitrosamines e.g. 
N-nitrosomorpholine gave a mixed response, inducing tumours in 
either the liver or the oesophagus. The organotropism of 
N-nitroso compounds cannot however, be due only to differences 
in their metabolism as nitrosamides also show organ 
specificity. For example, alkylacylnitrosamides e.g. 
N-nitrosomethylurea, in addition to liver and oesophageal 
tumours gave rise to tumours of the forestomach, lung, brain, 
nervous system and spinal cord. Similarly, Odashima (1980) 
studying 1-methyl- to 1-amyl-l-nitrosoureas in the female 
Donyru rat, found that each nitrosourea induced tumours in 
different organs. For example, peripheral nervous system 
tumours were produced by 1-methyl-1-nitrosourea whereas
1-amyl-l-nitrosourea produced upper digestive tract tumours.
In addition to chemical structure, the organ specificity of 
N-nitroso compounds also depends on:-
a) The method, rate and dosage of application
b) The animal species or strain
Because N-nitrosamines require metabolic activation, they 
show similar action after transcutaneous, subcutaneous, 
intraperitoneal, rectal, oral, and intravenous application, in 
most cases the target organ being independent of the route of 
application. However, the organotropism of N-nitrosamides 
does depend on the method of application, due to their 
proximal action. For example, N-nitrosomethylurea and
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N-nitrosomethylurethane produce cancer of the BDII rat 
forestomach after oral application, however, when given 
intravenously, N-nitrosomethylurea causes brain tumours and 
N-nitrosomethylurethane produces lung tumours (Druckrey et 
al., 1967). This proximal effect is also extended to the 
unstable N-nitrosamines such as N-nitrosoacetoxymethyl 
methylamine which when given orally causes cancer of the 
forestomach (Habs et al., 1978).
The amount of the single or daily dose applied can also have a 
profound influence on the organ affected by 
N-nitrosocompounds. For example, a single subtoxic dose of 
diethylnitrosamine (50% of the LD^q) produces predominantly 
carcinomas of the kidney in rats. However, if the dose is 
reduced to about 2% of the LD,_q and given daily the rats 
develop liver cancers, and if the daily dose is further 
reduced to about 0.5% of the LD,-q oesophageal cancers 
develop in addition to liver tumours (Schmall, 1970). This 
different effect of the low dose may be a result of the 
protective action of the liver. N-nitrosamines absorbed from 
the gut enter the portal circulation and are carried directly 
to the liver which would act as a "first line of defence" by 
greatly reducing the concentration of nitrosamines in the 
systemic circulation and thus protecting the kidney and other 
organs. This hypothesis is supported by Pegg (1980) who 
compared the degree of alkylation of kidney and liver DNA 
following oral and intravenous administration of 
N-nitrosodimethylamine and showed that the liver/kidney ratio
51
for alkylated products was 4 to 7 times greater after 
ingestion than after intravenous injection.
The organotropism and potency of N-nitroso compounds can 
differ between species. For example, the cyclic nitrosamine
2-6-dimethylnitrosomorpholine induces oesophageal cancers in 
rats with a cumulative dose D,-q of 0.5g/kg, pancreatic 
tumours in Syrian hamsters D,-q = 1 g/kg, pancreatic tumours 
in European hamsters D^q = 8 g/kg and liver cancers in 
Guinea-pigs = 1 g/kg (Lijinsky, 1980). In rats the 
trans isomer is a much more potent carcinogen than the cis, 
whereas in the hamster and guinea-pig the reverse is true 
(Lijinsky and Reuber, 1980(a)). In addition carcinogenic 
potency in rats was reduced by deuteration of the alpha carbon 
atom, and increased by deuterium in the beta positions whereas 
in hamsters the reverse was true (Lijinsky et al., 1978). All 
these findings suggest that the metabolic pathways of 
activation to carcinogenic intermediates in the three species 
are quite different accounting for the differences in 
organotropism.
Such differences can also occur between different strains of 
the same species. For example, N-nitrosoethylurea produces 
leukemias and a few duodenal tumours in Donyru rats, but 
results in the development of duodenal tumours in 70% and 
leukemias in only 43% of Fischer rats (Odashima, 1980).
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1.2.2.1 Transplacental carcinogenicity, foetal toxicity and 
teratogenicity
Rats given single doses of N-nitrosomethylurea on the 13th and 
14th day of pregnancy either produced deformed offspring or 
the foetuses were killed and resorbed (Von Kreybig, 1965). 
Teratogenic effects have also been shown for high doses of 
N-nitrosomethylurea or N-nitrosoethylurea, which in the first 
half of pregnancy induce brain and bone malformations in the 
offspring of rats, Syrian golden hamsters and minipigs 
(Ivankovic, 1979). Druckrey (1973) noted that administration 
of some N-nitroso compounds early in the development of the 
foetus caused brain malformations. Treatment in the later 
stages of pregnancy produced carcinogenic rather than 
teratogenic effects.
The pattern of response of the developing foetus to N-nitroso 
compounds is very different from that of adults. As mentioned 
previously nitrosamines require metabolic activation to their 
carcinogenic form, whereas nitrosamides do not. The foetus 
and neonate however, differ from the adult in their metabolic 
capability. The rat liver for example does not achieve normal 
adult function until 3 to 5 days after birth. In addition at 
certain stages of development, the nervous system, the liver, 
and the bladder undergo rapid cell division in contrast to the 
absence or very low levels of cell division later in life.
These metabolic differences between adults and the foetus 
result in nitrosamides being far more effective carcinogens in 
the foetus than the adult whereas nitrosamines are less
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effective in the foetus. Thus N-nitroso ethylurea induces 
brain and spinal cord tumours in the offspring of treated 
mothers at one-fiftieth of the dose required to induce tumours 
in the adult (Ivankovic & Druckrey, 1968a). However, ten 
nitrosamines investigated for transplacental carcinogenicity 
gave similar tumour incidences in adults and offspring, with 
the mothers showing greater sensitivity to respiratory tract 
tumours (Althoff & Grandjean, 1979). Emura et al., (1980) 
have shown that the foetus does not develop tracheal tumours 
when N-nitrosodiethylamine is administered to the dam before 
the 12th day after mating. They associated the onset of 
sensitivity with mucopolysaccharide synthesis and 
differentiation of the rough endoplasmic reticulum to a longer 
flatter organelle with many attached ribosomes. They suggest 
that the endoplasmic reticulum is therefore involved in the 
synthesis of the N-nitrosodiethylamine-activating enzymes.
As would be expected the organotropism of N-nitroso compounds 
in the foetus also varies between species and strains as in 
adults (Schmahl & Habs, 1980).
1.2.2.2 Dose Response Studies
In experiments with BDII rats, Druckrey et al. (1963), studied 
the effect of 9 dose levels of N-nitrosodiethylamine 
(0.75-14.2 mg/kg bw), on liver tumour incidence and induction 
time. They concluded that the carcinogenic response to 
N-nitrosodiethylamine was irreversible leading to linear 
dose-effect and dose-time relationships with no indication of
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a no effect threshold. Small single doses were additive with 
a summation of carcinogenic effect. Recently, Crampton (1980) 
studied the effect of N-nitrosodimethylamine, 
N-nitrosodiethylamine, N-nitrosopiperidine and 
N-nitrosopyrrolidine at doses of about 2-1500 p.g/kg bw/day. 
Undoubted carcinogenic responses were obtained at levels of 8 
p,g/kg bw/day for N-nitrosodimethylamine and 
N-nitrosodiethylamine, at 23 jig/kg bw/day for 
N-nitrosopiperidine, and at 290 jig/kg bw/day for 
N-nitrosopyrrolidine. Hyperplastic nodules of the liver 
occurred with N-nitrosodimethylamine at 2 U-g/kg bw/day. Thus 
if hyperplastic nodules are considered to be preneoplastic and 
irreversible lesions then a positive effect was observed at 
the lowest dose tested. Thus Crampton also found no evidence 
for a no effect level.
1.2.3 Mutagenicity
Approximately 150 N-nitroso compounds have been examined for 
both carcinogenic activity in animals and mutagenicity in 
bacteria. Bacterial mutagenicity assays of N-nitrosamines 
require supplementation with animal derived enzymes as the 
bacteria themselves are not capable of activating these 
compounds. N-nitrosamides, on the other hand do not require 
enzyme activation. Most compounds tested were carcinogenic 
and mutagenic. Only a few N-nitroso compounds are mutagenic 
and not carcinogenic, many more being carcinogenic but not 
mutagenic, including some rat liver carcinogens which are not
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activated by rat liver microsomal preparations e.g. 
N-nitrosodiisopropylamine (Lijinsky, 1981). N-nitroso 
compounds have also been shown to be mutagenic in Drosophila 
melanogaster (Alderson, 1965), and mammalian cell cultures 
(Langenback et al., 1980). However, for a class of compounds 
containing most established carcinogens, qualitative 
prediction of carcinogenicity is less valuable than 
quantitative determinations of the relative potency of the 
various compounds. Unfortunately, there is no correlation 
between mutagenic potency in bacterial systems and 
carcinogenicity, however, quantitative correlations have been 
observed in mammalian systems. For example four nitrosamines 
were placed in order of carcinogenicity by a mutagenicity 
assay using mutable hamster lung cells co-cultivated with 
hamster liver cells for activation. The same four carcinogens 
showed no correlation of mutagenic and carcinogenic potency in 
the Ames test with S.typhimurium (Langenbach et al., 1980).
1.2.4 Metabolic activation of N-nitroso compounds
Nitrosamides do not require metabolic activation to exert 
their biological effects. This is because they rapidly 
degrade via the methyldiazonium intermediate to form methyl 
carbonium ions capable of alkylating DNA as below.
NO
CH3 - N - CO - NH2 — > CH3 - N = N - OH — ► CH$ + N2
Nitrosamines on the other hand require metabolic activation to 
exert their biological effects, and studies on
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N-nitrosodimethylamine have shown that the liver is the 
principal organ in the metabolism of this potent carcinogen 
(Magee, 1956; Heath, 1962; Magee & Vandekar, 1958). Magee and
Vandekar, using liver slices and subcellular fractions in
vitro demonstrated that N-nitrosodimethylamine metabolism was 
localised in the microsomes and cytosol, and that it required 
molecular oxygen and NADPH. The principal oxidative 
demethylation enzyme system involved has been shown to be a 
liver microsome cytochrome P-450 monooxygenase (Czygan et al.,
1973). This is supported by the demonstration that a
reconstituted enzyme system containing cytochrome P-450, 
NADPH-cytochrome P-450 reductase, and phosphatidylcholine also 
catalyses the demethylation of N-nitrosodimethylamine 
(Lotlikar et al., 1975).
The primary reaction required for the activation of 
N-nitrosamines is thus considered to involve an enzyme 
mediated a-hydroxylation requiring NADPH and oxygen. The 
a-hydroxynitrosamine so formed, spontaneously cleaves to yield 
an aldehyde fragment and an alkyldiazohydroxide. In this 
hypothetical scheme, the diazohydroxide loses water to produce 
an alkyl carbonium ion which may then react with water to form 
alcohols or with cellular nucleophiles to form alkylated 
products, as over (Fig. 1.2).
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Fig. 1.2 Demethylation via q-hydroxylatioa (After Michejda
et al., 1981)
R’ - N - CH2 - RT1
NO
  R’ - N - CH - R1 '
NADPH I <
Enzyme NO OH
R1'CHO
R1 - N = N - OH <-  R’NH - NO
-OH
Cellular
R'nJ ■ R* * - Nu + N2
nucleophiles
It was originally postulated that the diazohydroxide lost 
water to yield a diazoalkane as the major toxic derivative. 
However, Lijinsky et al. (1968), using fully deuterated 
N-nitrosodimethylaraine demonstrated that the methyl group of 
the alkylated hepatic nucleic acid derivative 7-methylguanine 
contained three deuterium atoms. If the diazomethane 
intermediate had caused the methylation, then only two of the 
three deuterium atoms from the deuterated 
N-nitrosodimethylamine would be expected to appear in the 
methyl group of 7-methylguanine.
In addition to a-hydroxylation it is thought that 
(3-hydroxylation prior to a-hydroxylation may be an important 
activation mechanism for dialkylnitrosamines with long side 
chains. Thus N-nitrosodi-n-propylamine yields N-nitroso 
N-propyl-N-( 2-oxo propyl )amine following (3 -hydroxyl at ion and 
oxidation. This can then be cleaved to
N-nitrosomethyl-n-propylamine, which then forms a methylating 
agent by the subsequent a-hydroxylation of the propyl moiety 
(Kruger & Bertrum, 1973) (Fig. 1.3).
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Fig. 1.3 Methylation by N-nitrosodi-n-propylamine (After
Kruger & Bertrum, 1973)
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Experiments with mixed function oxidase inducers such as 
phenobarbitone (McLean & Vershuuren, 1969) have given 
anomolous results, stimulating N-nitrosodimethylamine 
metabolism at high substrate concentrations and inhibiting 
metabolism at low concentrations. This has led to the 
hypothesis that at least two different forms of the 
N-demethylase with different substrate affinities are involved 
(Arcos et al., 1977), or that other enzyme systems are 
involved such as a microsomal monoamine oxidase (Gangolli,
1981).
Thus in common with a broad range of other carcinogens the 
ultimate toxic and carcinogenic agents resulting from the 
metabolism of N-nitrosamines are electrophiles which are 
capable of covalent reaction with cellular macromolecules 
including DNA, RNA, and proteins (Pegg, 1977). Although 
tumour induction takes place only in organs in which 
alkylation occurs (Magee & Barnes, 1967) the nature of the 
alkylating molecule for any given nitrosamine is not known.
It is generally considered that alkylation of DNA is central
14
to chemically induced carcinogenesis. Using C 
N-nitrosodimethylamine, Magee and Faber (1962) demonstrated 
methylation of rat liver proteins and nucleic acids. A large 
part of the radioactivity in the protein was present as 
methylated histidine and in the nucleic acids activity was in 
the form of 7-methylguanine. However, the formation of 
7-methylguanine does not account for the relative 
carcinogenicity of N-nitrosodimethylamine, N-nitrosomethylurea
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and methylmethane sulphonate for the kidney (Swann & Magee,
1968). Loveless (1969) demonstrated alkylation of the 0-6
position of guanine by N-nitrosomethylurea, but not by
methylmethane sulphonate, which alkylated only the N-7
position. It is now thought that it is this alkylation of DNA
oxygens that is crucial for mutagenesis and carcinogenesis
(Singer, 1976, 1979). Gerchman and Ludlum (1973), suggested
that methylated 0-6 guanine is misread as adenine causing a
mis-spelling to occur at a critical site in the DNA with a
subsequent carcinogenic response. The carcinogenicity of an
alkylating agent may be dependant therefore on the extent to
which it acts as an S„1 or S„2 reagent. S..2 reagentsN N N
(e.g. methylmethane sulphonate) would alkylate the major 
nucleophilic centre the N-7 position of guanine, whereas SN1 
reagents (e.g. methyldiazonium cation) are capable of reacting 
with the less nucleophilic oxygen sites (Pegg, 1977). This 
may explain the relationship obtained between carcinogenicity 
and the initial ratios of N-7-alkylguanine/0-6-alkylguanine 
formed using ten monofunctional alkylating agents including 
N-nitrosomethylurea, N-nitrosoethylurea,
N-nitrosomethylurethane, N-methyl-N’-nitro-N-nitrosoguanidine 
and methylmethane sulphonate (Bartsch et al., 1982).
In addition to 7-methylguanine and 0-6-methylguanine, 
additional adducts such as 0-4-alkylthymine, N-alkylureas and 
N-3-alkylpyrimidines have also been implicated in 
carcinogenesis (Kroger & Singer, 1979; Singer, 1979).
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1.2.5 Toxic and Carcinogenic effects of N-nitroso
compounds in humans
A few cases of acute human poisoning by N-nitrosodimethylaraine 
have been reported. Freund (1937) described the illness of 
two chemists accidently intoxicated by
N-nitrosodimethylamine. One of the workers, who developed an 
acute illness after dropping a flask of N-nitrosodimethylamine 
and cleaning it up died eight weeks later. The main pathology 
was confined to the liver. Cirrhosis of the liver was also 
noted in two men working with N-nitrosodimethylamine in a 
research laboratory (Barnes & Magee, 1954). In addition a 
woman died of hepatic failure after repeated criminal 
poisoning with N-nitrosodimethylamine (Fussgaenger & 
Ditschuneit, 1980). Also extensive liver damage and 
alkylation of liver DNA was observed in two patients after the 
suspected murderous administration of N-nitrosodimethylamine 
(Kimbrough, 1982). Thus N-nitrosodimethylamine is acutely 
toxic towards the human liver as would be expected from 
experiments with laboratory animals. There are, however, no 
reports of any other N-nitroso compound producing toxic 
effects in humans, but it is likely that they too would show 
similar effects as observed in laboratory animals.
Although N-nitrosodimethylamine caused extensive liver damage 
in the unfortunate people mentioned above, other than 
hyperplastic nodules of the liver, no definitive signs of a 
neoplastic process was evident in any of them. Nevertheless, 
N-nitroso compounds have induced tumours in 36 species of
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laboratory animal, which belong to 36 genera, 25 families, 17 
orders and 5 classes of animals (Bogovski & Bogovski, 1981). 
There appears to be no published report of any animal species 
that is resistant to carcinogenesis by these agents and no 
reason to believe that man is not susceptible.
If the somatic mutation hypothesis for chemical induction of 
cancer is valid, that is, DNA damage is causally related to 
the initiation of cancer, then if N-nitroso compounds can be 
activated to DNA methylating agents in man, they would be 
expected to be potential human carcinogens. Montesano and 
Magee (1970) reported the formation of 7-methylguanine in 
human liver slices incubated with N-nitrosodimethylamine. The 
amount of methylation observed in human liver slices is 
similar to that produced in rat liver (Montesano et al.,
1982). Also as the ratio of the rate of methylation observed 
in vitro between rat and hamster liver, closely corresponds to 
the ratio observed in vivo (Margison et al., 1976)^ it seems 
likely that human liver would be methylated to a similar 
extent as rat liver after in vivo exposure to 
N-nitrosodimethylamine. In support of this conclusion is the 
recent report by Shank and Herron (1982) of 7-methylguanine 
and 0-6-methylguanine in the liver of a male victim of 
probable N-nitrosodimethylamine poisoning. The fact that such 
transformations could lead to cancer has been demonstrated by 
Parsa and Butt (1982), who succeeded in transforming cultured 
human pancreatic cells into biologically malignant cells with 
N-nitrosodimethylamine. Metabolism of N-nitrosamines by human
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cells leading to alkylation of DNA is not limited to 
N-nitrosodimethylamine, or to the liver. For example Harris 
et al. (1982), demonstrated DNA alkylation associated with the 
metabolism of several aliphatic and cyclic nitrosamines by 
cultured cells from the human bronchus, colon, oesophagus, 
pancreatic duct and bladder.
Thus human tissues are able to metabolise N-nitroso compounds 
to electrophilic intermediates capable of alkylating DNA.
There is no reason therefore to suppose that man should be 
resistant to the toxic and carcinogenic effects of N-nitroso 
compounds.
6 4
1.3 SOURCES OF NITROSATABLE NITROGEN
1.3.1 Introduction
As indicated previously many types of nitrogenous substrate 
can act as precursor to N-nitroso compounds (Table 1.1).
Table 1.1
A List of Nitrogeneous Precursors to N-nitroso compounds
Amides (including peptides)
Amines
Ammonium compounds 
Carbamates 
Cyanamides 
Guanidines 
Hydrazines 
Hydroxylamines 
Ureas
It is not possible here to examine the source and occurrence 
of every nitrosatable compound that can be found in the 
environment due to their ubiquity, and only a brief review of 
the major amino compounds present is given below to illustrate 
their universal occurrence in the environment.
Sources of nitrosatable substrate for in vivo nitrosation 
include
a) Food and drink
b) Drugs
c) The atmosphere
Primary
Secondary
Tertiary
or
Quaternary
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1.3.2 Food and Drink
Food and drink are major sources of nitrosatable nitrogen to 
the body. Due to the ease of analysis the majority of studies 
have concentrated on volatile dietary amines, although some 
work has been done on non-volatile nitrogen compounds 
particularly free amino acids. The various types of amino 
compounds found in food and drink are discussed below.
1.3.2.1 Alky1-amines
Due to their volatility and therefore ease of separation and 
analysis, simple alkyl amines have been looked for in most 
types of food. These amines are commonly formed by 
decarboxylation of amino acids or by amination of aldehydes. 
Due to the involvement of bacteria in these reactions 
(Golovnya, 1976), alkyl amines are plentiful in foods produced 
by microbial action e.g. wine, cheese, beer and fermented 
sausage. For example, Cheddar cheese, contains methyl-, 
ethyl-, n- and isopropyl-, n- and isobutyl-, dimethyl, 
diethyl-, dipropyl, and dibutyl-amines (Ney & Wirotama,
1971). Similarly, Golovnya (1976) identified six primary, six 
secondary and three tertiary alkyl amines in Rossiysky 
cheese. Unfortunately little quantitative work has been 
carried out. Nevertheless, where quantification has been 
attempted, concentrations rarely exceed a few parts per 
million (Neurath & Schreiber, 1974; Neurath et al., 1977). 
Wines and beers also contain a wide variety of alkyl amines. 
Beer contains methyl-, dimethyl-, ethyl- and butyl-amines,
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while N-ethylacetamide, isoamylamine, N-isoamylacetamide and 
dimethylamine are found in wines (Kahn, 1969). Singer and 
Lijinsky (1976) quantified various amines in beer and wine, 
dimethylamine being present at concentrations of less than 
lmg/kg. Neurath et al., (1977) found isopentylamine at 2mg/kg 
and phenethylamine at 2mg/kg in white wine, and methyl-, 
ethyl-, dimethyl, methylethyl-, diethyl- and isopentyl-amine 
in hops and malt.
Fish have been shown by many researchers to be rich in alkyl 
amines. Trimethylamine is formed in all salt water fish and 
crustacea by post-mortem reduction of the nitrogenous 
excretion compound, trimethylamine-N-oxide. Dimethylamine is 
also produced from trimethylamine-N-oxide but by an endogenous 
enzyme and not by bacterial action (Visek, 1974; Kostuch & 
Sikorski, 1977). Concentrations of dimethylamine in fish can 
be high even in fish sold for human consumption. For example, 
Singer and Lijinsky (1976) found 740mg/kg dimethylamine in 
frozen cod, and llOmg/kg in a fresh bass. Alkylamines have 
also been found in most fish products. Wick et al. (1967) 
found di- and trimethyl-, ethyl-, diethyl-, n-propyl- and 
butyl-amines in a fish protein concentrate, and Golovnya 
(1976) identified seven primary, six secondary and three 
tertiary alkylamines in sturgeon and salmon caviar.
Primary, secondary and tertiary alkylamines are also found in 
meats. Methyl-, dimethyl-, trimethyl-, ethyl-, diethyl-, 
n-propyl- and isopropy1-amines were identified in cured and
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uncured pork (Patterson & Edwards, 1975; Patterson & Mottram, 
1974). Again, the concentrations are low, for example only 
2mg/kg of dimethylamine was found in baked ham and 
frankfurters (Singer & Lijinsky, 1976).
Higher concentrations of alkylamines have been found in fresh 
fruit and vegetables. For example, radishes can contain 
42mg/kg methylamine, 40mg/kg ethylamine, and 6.9mg/kg 
n-pentylamine, and celery was found to contain 5.1mg/kg 
dimethylamine (Neurath et al., 1977).
Alkylamines have also been found in cereals, bread, tea, 
coffee, milk (dried, whole, evaporated), and pickles (Neurath 
et al., 1977; Neurath & Schreiber, 1974; Lijinsky & Epstein, 
1970; Singer & Lijinsky, 1976). In fact it is probable that 
all foods contain at least low levels of primary, secondary 
and tertiary alkylamines.
1.3.2.2 Cyclic Amines
Many foods contain cyclic amines, which may be derived from 
plant alkaloids, of from the products of non-enzymic browning 
and thermal processing. Singer and Lijinsky (1976) found 
morpholine in all the meat, fish and drink samples they 
analysed, generally at concentrations of less than lmg/kg, 
although frozen ocean perch was found to contain lOmg/kg. In 
addition many of the samples contained traces of pyrrolidine 
and piperidine. Neurath et al. (1977) found that the most 
prevalent secondary cyclic amines present in foods were 
pyrrolidine, piperidine, N-methylbenzylamine, N-*methylaniline
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and N-methylphenethylamine, the latter being the most 
widespread in foods of plant origin. The concentrations found 
in fresh vegetables can be quite high, for example red radish 
was shown to contain 38ppm of pyrrolidine and carrots 
contained 16.5ppm N-methylbenzylamine.
Spices have been shown to contain precursors to cyclic 
nitrosamines. For example, treatment of black pepper and 
paprika with sodium nitrite gave N-nitrosopiperidine and 
N-nitrosopyrrolidine (Sen et al., 1973). However, the amine 
precursors were not identified.
1.3.2.3 Amino Acids
Free amino acids are found in various types of foods.
Arginine and proline have been found in potatoes and their 
concentrations increase on storage (Sweeney, 1969). Free 
arginine, proline, hydroxyproline, tryptophan and sarcosine, 
which all contain secondary amino groups were found in fresh 
pork. The concentrations of these amino acids, especially 
that of proline, also increase on storage (Bowers, 1969; 
Lakritz et al., 1976).
1.3.2.4 Polyamines
The diamines putrescine and cadaverine and the polyamines 
spermidine and spermine, probably occur universally in animals 
and plants. These amines are important in the regulation of 
nucleic acid function and protein synthesis, and may also be 
involved in the stabilisation of membranes. In all organisms
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spermidine and spermine are formed from putrescine by 
successive donation of one or two aminopropyl groups 
respectively, from decarboxylated S-adenosylmethionine (Smith, 
1981). These polyamines have been found in cereals (Moruzzi & 
Caldarera, 1964), and in pork and ham (Lakritz et al., 1975). 
On heating putrescine and cadaverine yield pyrrolidine and 
piperidine respectively and have therefore been implicated in 
the formation of these secondary amines during the cooking of 
foods (Lijinsky & Epstein, 1970). However, Courts (1970) 
suggests that this would constitute only a very minor source 
of secondary amines. Cadaverine, putrescine, spermidine and 
spermine have also been detected in fresh milk (Sanguansermi 
et al., 1974).
1.3.2.5 Aromatic amines
Catecholamines, indoleamines, and histamine are metabolically 
active in man especially in the nervous system and in 
regulation of blood pressure. These amines are frequently 
found in food especially after deliberate or accidental 
bacterial contamination. Their occurrence in food has been 
extensively studied due to their toxic effects, particularly 
in people taking mono-amine oxidase inhibitor drugs. The 
majority of these amines contain only primary amino groups and 
thus it is debatable whether they are important precursors for 
in vivo nitrosation. They can however, occur in very high 
concentrations. For example Cheddar cheese can contain up to 
1500mg/kg tyramine (Sen, 1969), 1300mg/kg histamine and 
300mg/kg tryptamine (Voigt et al., 1974). Tyramine and
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histamine are also found in beer and wine at up to 12mg/kg 
(Sen, 1969; Ough, 1971). These amines may also accumulate in 
meat products due to bacterial activity. For example Salami 
was found to contain 263mg/kg tyramine and 68mg/kg 
phenethylamine (Koehler & Eitenmiller, 1978). Concentrations 
of histamine high enough to cause food poisoning (over 
lOOOmg/kg) can occur in fish from the family Scombridae e.g. 
tuna and mackerel, due to bacterial decarboxylation of the 
amino acid histidine which is a major component of muscle in 
these fish (Kim & Bjeldanes, 1979).
Many aromatic amines including some containing secondary amino 
groups occur in plants (see review by Smith, 1981). Notable 
inclusions are the secondary amines synephrine that occurs in 
tangerines at up to 280mg/kg, and epinephrine in broad beans 
at up to 600mg/kg. Gramine and hordenine are aromatic 
tertiary amines which could undergo nitrosative cleavage to 
yield N-nitrosodimethylamine. They occur in malt, malt 
extract as a result of their biosynthesis in germinating 
barley from tyrosine and tryptophan respectively. As a result 
hordenine is found in beer at concentrations in excess of 
2mg/kg (Drews et al., 1957).
1.3.2.6 Amido compounds
Until recently no suitable method existed for the measurement 
of N-alkylureas in foods. However, recently Kawabata et al.
(1980) developed such a method and analysed a range of food 
products. No alkylureas were detected and thus it seems
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unlikely that foods contain significant amounts of these 
precursors. Nevertheless creatine occurs in relatively large 
amounts in the tissues of vertebrates especially in the muscle 
where creatine phosphate plays an important physiological 
role. Creatine can be dehydrated to creatinine during the 
frying of bacon, beef hamburgers, and during the drying of 
beef and fish (Mirvish et al., 1982). The creatinine formed 
can be present in large amounts, e.g. 3300ppm in fried bacon, 
and on nitrosation can yield N-nitrosomethylurea.
Tea contains the secondary amide a-glutamylethylaraide 
(theanine) formed by the condensation of ethylamine with 
glutamic acid and accounting for more than 1% of the dry 
weight of the leaves (Wickremasinghe, 1978).
However, by far the largest source of nitrosatable amido 
compounds in the diet is likely to be proteins and peptides.
In addition to the nitrosatable amino groups on the prolyl, 
tryptophyl, histidyl and arginyl residues, every peptide bond 
is a potentially nitrosatable secondary amido group. This has 
been confirmed by Pollock (1982) who demonstrated the 
formation of N-nitroso compounds from 23 dipeptides containing 
no other N-nitrosatable group except the peptide bond.
1.3.3 Drugs as Nitrosatable Precursors
Comparatively high concentrations of nitrosatable amines may 
occur transiently in vivo after the ingestion of drugs 
containing nitrosatable secondary or tertiary amino groups.
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In general drugs could act as precursors of four groups of 
N-nitroso compounds (Rao, 1980).
(a) N-nitrosodialkylamines by nitrosative cleavage of 
tertiary amino groups.
e.g.
C CH.
CH.
Aminopyrene
CH3
^  NNO
ch3
(Lijinsky & Greenblatt, 1972)
(b) N-nitrosocyclicamines by nitrosative cleavage of 
tertiary amino groups.
e.g.
(CH2)3NHCH3
Desipramine (Ziebarth & Teichman, 1980)
(c) N-nitroso derivatives of N-dealkylated drugs
e.g.
CH2C6H5
1
NCH2CH2N(CH3)2
ch2c6h5 
I
.N. ,NCH2CH2NCH3
I
NO
Tripelennamine (Eisenbrand, 1981)
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(d) N-nitroso derivatives of drugs containing secondary 
amino groups
e.g.
NOH
Phenmetrazine (Greenblatt et al., 1972)
Scheunig and Zeibarth (1976) list 23 secondary amino- and 34 
tertiary amino- drugs produced in the German Democratic 
Republic. Rao (1980) lists 49 drugs known to yield N-nitroso 
compounds on reaction with nitrite. Although most researchers 
have employed high nitrite concentrations when testing drugs 
for nitrosatability, some secondary amines, e.g. piperazine, 
ethambutol; and some tertiary amines, e.g. aminopyrene, 
aminophenazone; have been demonstrated to be nitrosatable 
under physiological conditions (Ziebarth & Teichmann, 1980).
1.3.4 Other Environmental Sources of Nitrosatable Nitrogen
1.3.4.1 Cosmetics
Many cosmetics contain N-nitrosodiethanolamine due to the 
presence of triethanolamine added as an antiallergenic, which 
is nitrosated by the preservative bronopol (Fan et al.,
1977). Other nitrosatable ingredients include stearalkonium 
chloride, lauramine oxide, dimethylstearamine and
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triisopropanolamine (NRC, 1981). Nevertheless the relevance 
of cosmetics to in vivo nitrosation is probably only slight.
1.3.4.2 Agricultural Chemicals
Traces of agricultural chemicals in food represent another 
source of nitrosatable nitrogen available for in vivo 
nitrosation.
Nitrosatable agricultural chemicals include a large group of 
insecticides which are esters of N-methylcarbamic acid e.g. 
Baygon and Carbaryl; the triazine herbicides e.g. Atrazine and 
Simazine, and piperazine fungicides e.g. Triforine. The 
N-nitroso derivatives of many of these chemicals have proved 
to be mutagenic and/or carcinogenic, for example 
N-nitrosocarbaryl has been found to be more potent even than 
N-nitrosomethylnitroguanidine in Haemophilus influenzae and 
Escherichia coli (Elespura et al., 1974), and in addition it 
has been shown to be a potent carcinogen producing cancer of 
the forestomach in Sprague-Dawley rats (Preussman et al., 
1976).
The relevance of agricultural chemicals to in vivo nitrosation 
is in dispute. Some researchers believe that the high 
toxicities of the N-nitroso derivatives of the compounds mean 
that in vivo nitrosation of such pesticides eaten with food 
should be taken into account especially in establishing 
acceptable daily intakes (Preussman et al., 1976). Others 
such as Oliver (1981) believe that the low levels of pesticide 
consumed and the low (less than 1%) nitrosation yields, mean 
that any in vivo nitrosation of these chemicals is negligible.
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1.3.4.3 Atmosphere
Information regarding the occurence of nitrosatable precursors 
in air is lacking as researchers have concentrated on the 
detection of volatile nitrosamines. Nevertheless, it seems 
likely that amines produced during sewage treatment and 
industrial processes would be present in the atmosphere.
A large amount of research has been done on the amine content 
of tobacco smoke - an atmospheric pollutant. Precursor amines 
for volatile, non-volatile and tobacco specific nitrosamines 
have been identified, e.g. Nicotine, nornicotine and 
dimethylamine. Schmeltz and Hoffmann (1977) identified more 
than 600 nitrogen compounds in tobacco smoke. Apart from the 
specific case of tobacco smoke, and certain industrial 
environments, atmospheric amine contents are probably 
insignificant compared with those in foods.
1.3.5 Endogenous Amines
In addition to the nitrosatable nitrogen from exogenous 
sources such as the diet, nitrosatable amines can be produced 
by nitrogen metabolism or by the gut flora. For example, the 
gut flora can produce secondary amines from amino acid 
precursors, e.g. lysine — * piperidine and dimethylamine from 
the nitrogenous alcohol, choline (Johnson, 1977). The 
nitrogen metabolism waste products, urea, creatinine and uric 
acid are examples of endogenous nitrosatable amido compounds. 
Due to the endogenous formation of nitrosatable compounds, the 
amounts excreted in the urine, are large compared with the
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estimated dietary intake and include secondary amines 
(20-40mg/day), urea and alkylureas (15-35g/day) and 
miscellaneous compounds such as spermine, spermidine, indican 
and porphyrins (Bartholomew & Hill, 1984).
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1.4. SOURCES OF NITROSATING AGENT FOR IN VIVO NITROSATION
1.4.1 Introduction
The principal nitrosating agents likely to be involved in in 
vivo nitrosation would be acidic solutions of nitrite in 
aqueous systems and nitrogen oxides in lipophilic systems. In 
addition nitrate can act as a source of nitrosating agent via 
its reduction to nitrite in vivo (Section 1.4.6). Oxides of 
nitrogen such as nitric oxide and nitrogen dioxide occur in 
polluted atmospheres whereas nitrite and nitrate are present 
in the diet. The occurrence of these precursors is reviewed 
below.
1.4.2 Dietary Sources of Nitrate
1.4.2.1 Vegetables
It has been estimated that about 200 billion tons of carbon 
are fixed annually by photosynthetic processes. As nitrogen 
constitutes about 2% and carbon about 40% of the dry weight of 
plants, this means that approximately 10 billion tons of 
nitrogen are incorporated into plants every year. Apart from 
those species that have a symbiotic association with nitrogen 
fixing bacteria the bulk of the plant nitrogen arises from the 
reduction of nitrate taken up from the soil. (Beeves & 
Hageman, 1969). It is therefore not suprising that all plants 
contain measureable amounts of nitrate and that some contain 
quite high concentrations.
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Nitrate accumulation in vegetables occurs when nitrate uptake 
is in excess of its reduction and subsequent assimilation.
This reduction of nitrate to the useable (ammoniacal) form 
requires the donation of 8 electrons from NADPH, which in turn 
is produced by the photoreduction of NADP. Consequently, the 
nitrate content of vegetables as well as depending on the 
availability of nitrate in the soil, is affected by factors 
which cause variations in photosynthetic rate or interfere 
with electron transport. Thus nitrate tends to accumulate as 
daytime temperatures drop, in plants grown in the shade or at 
high latitudes, during drought and in plants grown in mineral 
deficient soils.
A number of reviews of the nitrate content of vegetables have 
been published (White, 1975; Picks ton et al., 1980; Walker, 
1975; Richardson, 1907; Jackson et al., 1967; Siciliano et 
al., 1975; Corre & Breimer, 1979; Ashton, 1970; NRC, 1981). 
Despite wide variations in the nitrate content of particular 
types of vegetable e.g. Beet 100 to 8,100 mg/kg (Corre & 
Breimer, 1979), they can be classified into five categories 
according to nitrate accumulation (NRC, 1981).
Table 1.2
Classification of Vegetables According to Nitrate Content 
(After NRC, 1981)
Class 1 Concentrations frequently greater than 2,500 mg/kg
Turnip Greens 
Spinach
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Radish
Class 2
Class 3
Class 4
Lettuce
Beet
Most concentrations lower than 2,500 mg/kg
Rhubarb
Parsley
Leek
Endive
Most concentrations lower than 1000 mg/kg
Pumpkin
Kale
Carrot
Cabbage
Beans
Most concentrations lower than 500 mg/kg
Turnip
Onion
Melon
Aubergine
Cucumber
Cauliflower
Broccoli
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Class 5 Most concentrations lower than 200 mg/kg
Tomato
Potato
Sweet Peppers 
Peas
Mushroom
Asparagus
Estimates of the total consumption of vegetables have varied 
between 82 g/person/day (FDA, 1979) and 330 g/person/day 
(Hoyem, 1974). The majority of estimates have however been 
about 200 g/person/day (Walker, 1975; NRC, 1981; USDA, 1980).
The average daily intake of vegetables in Britain during 1984
was 335 g/person (MAFF, 1985). Therefore assuming a median
nitrate content of between 200 and 500 mg/kg, we can estimate
the daily nitrate intake from vegetables to be
200 + 500 x 0.335 = 117 mg/day, this value being higher than 
2
those reported previously (White, 1975) and 62 mg (Hartman,
1981).
1.4.2.2 Fruits and Fruit Juices
The nitrate content of fruit and fruit juices is typically 
very low, usually less than 10 mg/kg (Walker, 1975; White, 
1975; Pickston et al., 1980). Thus with a consumption of 
fruit and fruit juices of 115 g/person/day (MAFF, 1985), the 
nitrate intake from fruit would be 0.115 x 10 = 1.2 mg/person/ 
day. This compares with other estimates, 1.4 mg
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(White, 1975), 1.2 mg (Hartman, 1981), 4.3 mg (NRC). The 
estimate given by the NRC is higher as they allow for the 
occasionally high nitrate content of some fruits, particularly 
strawberries.
1.4.2.3 Cereals and Cereal Products
The accumulation of nitrate in cereals is dependant on the 
same factors as for vegetables, although the content is 
usually less in the grains than in the leaves and stems. 
Reported nitrate concentrations in wheat have been 
0.4 to 11 mg/kg (McNamara et al., 1971), 9 to 15 mg/kg (Wu & 
McDonald, 1976). Flour has been found to contain similar 
concentrations of nitrate e.g. 4 to 14 mg/kg (Wu & McDonald, 
1976). White (1975) estimated the nitrite content of bread to 
be 22 mg/kg. As the majority of cereal intake would be as 
bread an estimate of between 10 and 20 mg/kg for the nitrate 
content would seem reasonable. The consumption of cereals and 
baked products in the USA was estimated by White (1975) to be 
90 g/person/day and by the NRC (1982) to be 100 g/person/day. 
However, these estimates which represent less than 3 slices of 
bread are low for the average British person. The average 
consumption of cereals and baked products for 1984 was 
estimated at 220 g/day (MAFF, 1985) representing a nitrate 
intake of 3.3 mg/person/day.
1.4.2.4 Cured Meats
The origin of the use of nitrate in curing meats is unknown, 
although it may have started as late as the 14th century along
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with the use of salpetre in gunpowder. Today it is known that 
nitrite is the active curing agent. However, nitrate is still 
added to the curing mixture to maintain a low level of nitrite 
in the meat through its slow reduction during storage.
Many surveys have been made of the nitrate content of meats. 
Fudge and Truman (1973), analysed over 200 cured meat products 
from different parts of the world and found mean nitrate 
concentrations of 230, 129 and 171 mg/kg in canned, vacuum 
packed and fresh products respectively. Panalaks et al.
(1973) analysed 197 samples of cured meat products and found a 
mean nitrate content of 132 mg/kg. Recently, however, 
measures have been taken to reduce the nitrate content of 
meats and there are indications that these measures are 
proving effective. For example, in Canada the average 
concentration of nitrate in cured meats was 181 mg/kg in 1971, 
95 mg/kg in 1973, and 38 mg/kg in 1978 (Hartman, 1981). 
Consequently White's (1975) estimate of 216 mg/kg seems high 
and the estimate given by the NRC of 40 mg/kg appears more 
realistic. Nevertheless this may not apply worldwide as a 
survey of 2,115 Polish meat products between 1976 and 1978 
found nitrate levels of less than 220 mg/kg in 67.7%, of 
between 220 and 730 mg/kg in 26.3%, of between 730 and 
1,460 mg/kg in 5.6% and over 1,460 mg/kg in 0.4% 
(Lemieszek-Chodorowska, 1980).
Using the MAFF (1985) estimate of a consumption of 19g of 
cured meats per person per day in 1984, and a nitrate content 
of 40 mg/kg this represents 0.76 mg N0^/person/day.
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1.4.2.5 Fresh Meats
There is little information about the nitrate content of fresh 
meats. However, Whelan (1935) found nitrate concentrations of 
6 mg/kg and 33 mg/kg in the tissues of dogs fed with moderate 
and high concentrations of nitrate respectively. Similarly, 
in an experiment involving the feeding of hay containing near 
lethal doses of nitrate to dairy cows, Wright and Davison 
(1964) found 0.9 mg/kg nitrate in meat from control cows, and 
11 mg/kg in treated cows.
A review of the concentration of nitrate in meat blanks 
(without added nitrite or nitrate) in curing experiments found 
that nitrate concentrations varied from 0 to 49 mg/kg (Usher & 
Telling, 1975).
The NRC (1981) estimate an average nitrate content of 
10 mg/kg, therefore using an average consumption of 
80 g/person/day (MAFF, 1985) the average daily nitrate intake 
from fresh meats would be 0.8 mg/person/day.
1.4.2.6 Dairy Products
White (1975) quoted three studies where the nitrate content of 
fresh milk was less than 1 mg/kg, and as a result estimated 
the average content to be 0.5 mg/kg. Walker (1975) reviewed 
three different studies which reported higher levels of 
nitrate in the range 20 to 40 mg/kg. In a recent study 
Pederson et al. (1980) reported that the nitrate content of 
Danish milk ranged from 2 to 15 mg/1 with a mean content of
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7 mg/1. An estimate of 14 mg/kg nitrate for fresh milk would 
therefore represent an average of these seven studies.
Nitrates have been used extensively in Europe for the 
prevention of "blowing" or gas holes in cheese caused by the 
growth of coli-aerogenes bacteria. However, this practice has 
been abandoned in some countries due to the formation of 
adverse colours. Pederson et al. (1980) reported that the 
nitrate content of cheese dropped during storage. For 
example, 24 hour old cheese to which no nitrate had been added 
contained an average of 5 mg/kg which dropped to 1 mg/kg after 
16 weeks. Cheese that had been treated with 200 mg/kg nitrate 
was found to contain 56 mg/kg after 24 hours and only 6 mg/kg 
after 16 weeks. Most cheeses by the time they are eaten would 
therefore contain less than 5 mg/kg.
Assuming, therefore that the consumption of milk and other 
dairy products is about 390 g/person/day (MAFF, 1985) and the 
average nitrate content is 7 mg/kg, then the average daily per 
capita nitrate intake from dairy products would be 2.7 mg.
1.4.2.7 Water
During the last 20 years there has been a gradual increase in 
the nitrate concentration of many surface and underground 
water supplies in England and Wales (HMSO, 1979). The nitrate 
concentration is dependant upon geochemical conditions, 
agricultural run off of agricultural fertilisers and manure, 
and the increased recycling of sewage effluent in lowland 
rivers. The current World Health Organisation European
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Standards for Drinking Water recommends levels of less than 
50 mg/1 nitrate ion, nitrate concentrations ranging from 
50 mg/1 to 100 mg/1 are regarded as acceptable, but 
concentrations above 100 mg/1 are not recommended (WHO,
1970). The European Economic Community has proposed a maximum 
admissible concentration of 50 mg/1 for all water supplied for 
human consumption.
The concentration of nitrate ion in British water supplies is 
very variable. Taylor (1958) examined well waters, stream and 
river waters, lakes and reservoirs, spring waters, wells, 
chalk waters and gravel beds, and found that the nitrate 
concentration varied from 0.0 to 210 mg/1. In 1976 over 100 
water sources in England continuously or intermittently 
exceeded 50 mg/1 (HMS0, 1979). Walker (1975) quotes data 
accumulated between 1962 and 1974 showing UK nitrate 
concentrations of 1 to 57 mg/1, with London Water usually 
containing 30 to 35 mg/1. An estimated average concentration 
of 30 mg/1 would therefore appear reasonable, although this is 
much higher than the estimate of White (1975) of 0.71 mg/1, 
and than the 1.3 mg/1 estimated by the NRC (1981) for the 
American Consumer. Assuming an average daily water 
consumption of 1.6 litres/person, a nitrate concentration of 
30 mg/1, represents on average nitrate intake of 
48 mg/person/day.
86
1.4.3 Endogenous Synthesis of Nitrate
As well as dietary sources of nitrate, long term metabolic 
balance studies have demonstrated the biosynthesis of nitrate 
in healthy adults on low nitrate diets (Wagner & Tannenbaum,
1982). Excretion of nitrate in the urine is three to four 
fold greater than the dietary intake of nitrate (Green et al., 
1981).
It was originally proposed that the nitrate was produced by 
"heterotrophic nitrification" of ammonia or organic nitrogen 
compounds by micro organisms in the gastrointestinal tract 
(Tannenbaum et al., 1978). Experiments with germ free rats, 
however, demonstrated that microorganisms were not involved, 
on the contrary, the intestinal flora can decrease the urinary 
output of nitrate (Witter et al., 1981; Green et al.,
1981(b)). It has also been proposed that the excess nitrate 
comes from a large body pool of nitrate, which is gradually 
washed from the body (Witter et al., 1971a), or from nitrogen 
oxides inhaled from the atmosphere (Witter et al., 1979b). 
However, Green et al. (1981(a)) discount these two hypotheses 
by measurement of atmospheric nitrogen oxides and by the use 
of labelled nitrate. It appears therefore that the 
synthesis of nitrate is a mammalian process. It is currently 
thought that the reduced nitrogen compounds are oxidised by 
oxygen radicals generated within the body. Thus activation of 
the reticulo endothelial system by bacterial induced fever 
significantly increases nitrate biosynthesis, as the 
lymphocytes released produce superoxide to combat the 
infection (Wagner et al., 1981).
Long term metabolic studies of six men eating a diet 
containing 9.3 mg NO^/day demonstrated an average nitrate 
biosynthesis of 0.62 mg/kg bodyweight/day. Therefore a 70 kg 
man would produce 43.4 mg of nitrate endogenously each day.
1.4.4 Total Daily Nitrate Exposure
Table 1.3
An Estimate of Average per capita Daily Nitrate Exposure
Source
Dietary nitrate intake 
White (1975) Walker (1975)
(mg)
NRC (1981)
Cured Meats 0.8 9.4 16.1 1.2
Fresh Meats 0.8 - - 0.6
Vegetables 117 86 43.2 65
Fruits 1.2 1.4 - 4.3
Baked Goods 
& Cereals 3.3 2.0 1.2
Dairy Products 2.7 0.2 - 0.2
Water 48 0.7 57.0 2
Total Dietary
Content 173.8 mg 99.7 mg 116.3 mg 74.5 mg
Endogenous
Formation 43.4 mg
Total Nitrate
Exposure 217.2 mg
Table 1.3, lists the estimates made above of the average per 
capita intake of nitrate from various sources. For comparison 
the estimates of White (1975), Walker (1975) and the NRC
(1981) are also given. The estimate made is similar to that 
of the NRC (1981) except for the far higher contribution from 
drinking water, reflecting the higher levels found in the UK. 
The total estimated intake is higher than the daily intake 
measured by Stephany and Schuller (1980). They analysed 201
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different 24 hour samples of food and drink, and found an 
average daily nitrate intake of 110 mg. It should be noted 
that the vast majority of the nitrate consumed is present 
either in vegetables or drinking water. In addition, a 
significant proportion of the daily exposure to nitrate is 
caused by its endogenous formation.
1.4.5 Dietary Sources of Nitrite
Nitrite is rarely found in substantial concentrations in the 
environment, as it is highly reactive and easily oxidised to 
nitrate, or lost through reaction with phenols, amines, thiols 
and other biochemicals. Nevertheless, nitrite does occur in 
some foods and its occurrence is reviewed below.
1.4.5.1 Cured Meats
One of the principal sources of nitrite in the diet arises 
from its use as a curing agent particularly in meats. Sodium 
nitrite is added to meats to produce three effects. Firstly 
it produces the characteristic red-pink colour of cured meats 
by forming the stable pigment nitrosyl myoglobin from 
myoglobin. Secondly, it produces the characteristic cured 
flavour of the product, and thirdly it acts as an 
antibacterial agent which is particularly effective at 
inhibiting the growth of Clostridium botulinum. Much of the 
nitrite added is lost during processing and storage due to its 
reaction with meat components. For example, Birdsall (1981) 
reported a 70% reduction in residual nitrite between 
processing and consumption, whereas Buege et al. (1978) found
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a loss of 70% and Cassens et al. (1979) a loss of 85 to 98%. 
The fate of the added nitrite is not completely understood, 
although amongst the breakdown products detected or suggested 
are, nitric oxide, nitrous oxide, and nitrogen (Walters & 
Casselden, 1973), C-nitroso, C-nitro and S-nitroso compounds 
(Woolford & Cassens, 1977; Davies et al., 1978), and 
pseudonitrosites of unsaturated lipids (Walters et al.,
1979). The importance of these breakdown products to in vivo 
nitrosation is unclear as S-nitroso compounds and 
pseudonitrosites could participate in transnitrosation 
reactions (Section 1.5.1). The residual nitrite level in 
cured meats at the time of consumption is about 10 mg/kg as 
nitrite ion (Birdsall, 1981; NRC, 1981). Using the MAFF 
(1985) estimate of cured meat consumption for 1984 of 
19 g/person/day, this would represent a daily per capita 
nitrite intake of 0.19 mg.
1.4.5.2 Fresh Meats
Using very sensitive analytical procedures, evidence has been 
obtained for nitrite contents of up to 50 {ig/kg in fresh meat 
(Walters, 1980). Assuming a daily consumption of 80 g this 
would represent a nitrite intake of only 4 p.g.
1.4.5.3 Vegetables
Nitrite concentrations in fresh vegetables usually do not 
exceed 2 mg/kg (Corre & Breimer, 1979; White, 1975; Pickston 
et al., 1980) with the exception of a sample of Puka (a green 
vegetable eaten by Maoris) which was found to contain 40 mg/kg
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(Pickston et al., 1980). However, nitrate may be converted to 
nitrite during storage as a result of bacterial action or 
plant nitrate reductase activity (Lin & Yen, 1980). The 
accumulation of nitrite during storage is therefore dependant 
on storage conditions. For example, Lin and Yen (1980) found 
practically no increase in nitrite concentrations at storage 
temperatures of -10°, 2° and 15°C, but at 26°C the 
concentration was increased as much as 10 and 600 fold after 2 
and 3 days respectively. This suggests that the nitrite was 
produced by contaminating bacteria. Similarly Phillips (1968) 
found that nitrite accumulated in spinach but not when 
frozen. In addition cooking vegetables lowers the nitrite 
content as it is extracted into the cooking water (Pickston et 
al., 1980). Nevertheless, the nitrite content of processed 
and frozen vegetables can be 2 to 3 times higher than fresh 
vegetables (Siciliano et al., 1975).
With an average nitrite content of 1 mg/kg and a daily 
consumption of 335 g/day the average daily nitrite intake in 
vegetables would be 0.34 mg.
1.4.5.4 Fruit
The nitrite content of fruit has generally been considered as 
negligible. Harada et al. (1972) detected nitrite in fruits 
in the range 0.02 to 0.41 mg/kg. Pickston et al. (1980) did 
not detect nitrite in fruit eaten in New Zealand, however 
their detection limit was 0.2 mg/kg. Nevertheless it seems 
likely that the average nitrite content of fruit is very low
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probably not exceeding 0.1 mg/kg which represents a daily per 
capita nitrite intake from fruit of 0.01 mg.
1.4.5.5 Dairy Products
The nitrite content of dairy products has also been thought to 
be negligible (White, 1975; NRC, 1982). However, Pederson et 
al. (1980) found nitrite concentrations in cheese varied 
between 0 and 0.9 mg/kg. Similarly, Harada et al. (1972) 
found nitrite concentrations in cheese ranging from 0.21 to 
1.26 mg/kg. Fresh milk on the other hand has been reported to 
contain no nitrite (Sander, 1967). It seems reasonable to 
assume that the average nitrite concentration of dairy 
products would not exceed 0.2 mg/kg representing an average 
daily intake of 0.08 mg.
1.4.5.6 Cereals
Bread and flours have been shown to contain nitrite at low 
concentrations. For example, Harada et al. (1972) found 
nitrite concentrations between 2 and 4 mg/kg in flours and 
between 10 and 16 mg/kg in bread crumbs. The estimates made
by the NRC (1981) and White (1975) were lower being 2.6 mg/kg
and 0.17 mg/kg respectively. Taking a slightly higher 
estimate of nitrite content of 3 mg/kg, a daily consumption of 
220 g/day represents an average daily nitrite intake of 
0.66 mg.
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1.4.5.7 Water
Nitrite is not normally found in drinking water. However, 
poor storage conditions can lead to the formation of nitrite 
in waters containing high concentrations of nitrate (Li et_ 
al., 1980).
1.4.6 Endogenous Formation of Nitrite
1.4.6.1 Oral Nitrite Formation
Nitrite occurs normally in the saliva in a wide range of 
concentrations. For example, Okabe (1973) found 
concentrations between 0.06 and 133 mg/1, while Spiegelhalder 
et al. (1976) found 0.006 mg/1 to 19.7 mg/1. Saliva sampled 
directly from the salivary ducts, however, contains nitrate 
but not nitrite (Goaz & Biswell, 1961; Tannenbaum et al., 
1974). In addition ductal saliva shows no nitrate reducing 
capacity (Tannenbaum, 1974). This indicates that the salivary 
nitrite is produced by reduction of nitrate in the mouth by 
either
(a) The action of oral microflora.
(b) The action of non-enzymic reducing substances in
the salivary secretions or formed as bacterial 
metabolites.
(c) The action of food derived enzymes present in the 
saliva.
(d) The action of a mammalian tissue enzyme.
The majority of researchers consider that the reduction is 
carried out by the oral microflora, and both aerobic and
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anaerobic nitrate reducing bacteria have been found in saliva 
(Ishiwata et_al., 1975(a); Sasaki & Matano, 1980; Tannenbaum 
et al., 1974). On the other hand Sasaki and Matano (1979,
1980) found that the nitrate reducing activity was localised 
at the dorsum linguae; no nitrite formation being detected 
elsewhere in the mouth. They attributed this reduction to a 
tissue enzyme, as the estimated nitrate reducing activity of 
indigenous bacteria in the saliva was insufficient to account 
for the rate of nitrite production observed.
Several studies have demonstrated an increase in salivary 
nitrite concentrations following the consumption of nitrate 
rich vegetables, vegetable juices or sodium nitrate 
(Tannenbaum et al., 1976; Spiegelhalder et al., 1976; Harada 
et al., 1975; Ishiwata et al., 1975(a)). The maximal nitrite 
concentrations were found to occur between 1 and 2 hours after 
ingestion of nitrate and were accompanied by corresponding 
increases in salivary nitrate levels. It is generally assumed 
that nitrate is absorbed in the upper gastro intestinal tract 
and concentrated from the plasma into the saliva by the 
salivary glands. It appears that nitrate is concentrated by 
the same active transport system as thiocyanate and iodide, 
and competes with these other ions for uptake from the 
circulatory system. Relative affinities for the transport 
system are I ^  SCN ^  N0^ (Burgen & Emmelin,
1961). Spiegelhalder et al. (1976) demonstrated that with 
nitrate consumptions of less than 54mg,salivary nitrate 
concentrations did not increase. Therefore, below this
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"threshold dose" of nitrate, iodide and thiocyanate may be 
inhibiting the transport of nitrate. Above the threshold 
level, about 25% of the ingested nitrate recirculated to the 
saliva and about 20% of this was reduced to nitrite. This 
resulted in an average increase of nitrite concentration of 
20 [J-g/ml per lOOmg nitrate ingested. Stephany and Schuller 
(1980) compared their results with those of Spiegelhalder 
(1976), Harada (1975) and Ishiwata et al. (1975, a, b, c) and 
estimated an average conversion of 6.3 mol %/24 hours.
Thus with an average daily nitrate load of 217.2 mg (Table 
1.3), salivary reduction would produce about llmg of nitrite.
1,4.6.2 Gastric Nitrite Formation
Another source of nitrite is the reduction of nitrate by 
bacteria present in the achlorhydric stomach. At a gastric pH 
of greater than 4.5 to 5, bacterial colonisation of the 
stomach occurs, resulting in reduction of nitrate to nitrite. 
The fact that the reduction is microbiological is indicated by 
the correlation between nitrate-reducing bacteria and the 
percentage conversion of nitrate to nitrite (Bartholomew et 
al., 1980). Ruddell et al. (1976) showed that the nitrite 
concentration of fasting gastric juice above pH 5 
(30.4 p.mol/1) was significantly higher than juice with a 
pH <2.5 ( 1.7 p.mol/1). In addition the total number of 
organisms as well as the total number of nitrate reductase 
positive organisms were significantly higher in the high pH 
samples.
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Gastric anacidity is relatively commonplace particularly in
older people and therefore nitrite production in the stomach
cannot be considered a special case. In addition even people
with normal gastric secretion have a gastric pH of greater
than 5 immediately following a meal due to the buffering
capacity of the food (Walters et al., 1979(b)). Sander (1969)
demonstrated that measureable nitrite formation occurred in
those people whose gastric pH remained above 5 for at least
half an hour. The nitrite was not found in the non-viscous
fresh secretions, but exclusively in gastric mucus. This is
presumably because within these mucilagenous deposits the
nitrate reducing bacteria are protected from the acid
secretions for sufficient time for nitrate reduction to
occur. Nevertheless, Witter et al. (1979(c)) demonstrated
13
that gavage of Sprague-Dawley rats, with NO^ resulted in 
essentially all of the nitrate passing into the upper 
intestine, therefore for the purposes of this estimate nitrite 
production in the normal stomach will be considered to be 
negligible.
1.4.6.3 Intestinal Nitrite Formation
Tannenbaum et al. (1978) reported concentrations of nitrite of 
up to 1540 p.mol/kg in ileostomy effluents and up to 
407 (imol/kg in faecal samples. He suggested that the nitrite 
was produced by heterotrophic nitrification of ammonia or 
organic nitrogen compounds. Witter et al. (1979(a,b)) thought 
that this was unlikely as the intestinal tract is 
predominantly anaerobic and in addition the oxidation would
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require vast numbers of microorganisms, whereas the upper 
intestine contains few bacteria. As mentioned earlier 
(Section 1.4.3), experiments with germ free rats have 
demonstrated that nitrate in the intestinal tract is probably 
synthesised by mammalian and not by microbial processes (Green 
etal., 1981). Thus an alternative explanation for the ileal 
nitrite levels reported by Tannenbaum et al. (1978) would be 
bacterial reduction of nitrate present in the intestinal 
tract. A contradiction of this theory is the absence of 
nitrate in the ileostomy effluents reported by Tannenbaum et 
al. (1978). Saul et al. (1981), however, did detect nitrate 
in ileostomy fluids although they found much lower nitrite 
levels (0 to 15 p.mol/kg).
It is difficult to determine what the above findings mean in
terms of nitrite exposure. Witter and Balish (1979) and
Witter et al. (1979c) studied the in vivo distribution of 
13NC>2 in rats, and demonstrated that very little was
absorbed from the stomach whereas nearly all was absorbed from
the upper small intestine. Nevertheless up to 24% of the 
13 -NO^ given by gavage could reach the ileum within one 
hour. Fritsch et al. (1975, 1976) demonstrated that the 
isolated rat small intestine and caecum when placed in glucose 
solution and treated with 500mg of potassium nitrate could 
reduce nearly 50% of the nitrate to which they were exposed. 
Their evidence suggested that the reduction was effected by 
the intestinal mucosa rather than by the ileo-caecal
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microflora, whereas Witter and Balish (1979) showed that 
nitrate reduction was apparently caused by bacterial nitrate 
reductases rather than mammalian host enzymes.
A consideration of the above evidence suggests that whatever 
the mechanism of reduction it would be reasonable to assume 
that at least 10% of the nitrate reaching the intestinal tract 
would be reduced to nitrite, representing a nitrite exposure 
of about 17.4 mg/person/day.
1.4.7 Total Daily Nitrite Exposure
Table 1.4 lists the estimates made above of the average per 
capita exposure to nitrite from dietary and endogenous 
sources. For comparison the estimates of White (1975, 1976) 
and the NRC (1981) are also given. It should be noted that 
cereals are the principal source of nitrite in the diet and 
not cured meats and this reflects the higher consumption of 
cereal products.
Nevertheless, dietary sources may be insignificant compared to 
the endogenous formation of nitrite which could account for 
over 90% of the daily exposure to nitrite.
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Table 1.4
An Estimate of Average per capita Daily Nitrite Exposure
Dietary Nitrite Intake (mg)
Source
Cured Meats 0.19
Fresh Meats ^0.01
Vegetables 0.34
Fruit 0.01
Dairy Products 0.08
Cereals 0.66
Water -
Total Dietary Intake 1.28
Oral Nitrite Formation 11
Intestinal Nitrite
Formation 17.4
Total Endogenous Nitrite
Formation 28.4
NRC (1981) White 
(1975, 
1976)
0.30
0.06
0.12
0.01
0.01
0.26
0.01
0.77
3.5
2.38
0.2
0.02
2.60
8.62
Total Nitrite Exposure 29.68 4.27 11.22
1.4.8 Sources of Nitrogen Oxides
Pollution of the atmosphere by nitrogen oxides could represent 
a significant source of nitrosating agent for in vivo 
nitrosation. The major sources of nitrogen oxide pollution 
include industrial effluents particularly from nitric acid 
plants, automobile exhaust gases, the uncontrolled flares used 
in the oil and gas industries, and other combustion sources 
such as forest fires. The highest atmospheric concentrations 
of nitrogen oxides are therefore usually found in urban 
areas. Not suprisingly the concentrations found vary
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considerably throughout the day being influenced by for
example, the heavy traffic during rush hours, with the terrain
and the weather combining to amplify or reduce these
variations. The NRC (1981) summarise the available data on
atmospheric nitrogen oxide pollution and estimate an average
3
concentration of 0.058 mg/m .
In addition to nitrogen oxide pollution of outdoor air, indoor 
air can be heavily polluted by poorly vented gas space and 
water heaters, and by gas cookers. In poorly ventilated
3
kitchens concentrations can be as high as 1.88 mg/m (NRC,
1981).
Another pollutant of indoor airs is cigarette smoke, which can 
contain as much as 1000 mg/kg nitric oxide (Norman & Keith, 
1965) in the mainstream smoke. What exposure this represents 
to the passive smoker is uncertain. Nevertheless the smoker 
himself inhales large amounts of nitric oxide. Jenkins and 
Gill (1980) measured the nitrogen oxides delivered from nine 
different sorts of cigarettes. They found that each cigarette 
delivered from 3.2 to 47 p.mols of oxides of nitrogen 
predominantly as nitric oxide. The mean nitric oxide delivery 
was 0.51 mg/cigarette, which represents an intake of 10.2 mg 
for a smoker on twenty cigarettes a day.
A reasonable average nitric oxide concentration for an urban
3
dweller would be 0.1 mg/m (Archer (discussion), 1982). The 
resting tidal volume of air breathed is 673 ml/min with an 
average of 14 breaths a minute (Haldane & Priestley, 1905).
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However, about 167 ml of each breath resides in the oesophagus 
trachae and other dead space where no respiratory exchange can 
take place (Bell et al., 1965)
Thus at rest about 7 litres of air is swept per minute, this
volume can increase to about 70 litres per minute during
exercise (Bell et al., 1965). Therefore a reasonable estimate
3
of the average daily volume of air breathed would be 15m
3
which with a concentration of nitric oxide of 0.1 mg/ra 
represents a daily nitric oxide intake for a non smoker of
1.5 mg. A smoker, smoking twenty cigarettes a day would on 
the other hand have a daily nitric oxide intake of 11.7 mg.
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1.5. IN VIVO N-NITROSATION
1.5.1 Introduction
In the previous sections the availability of precursor 
compounds and the chemical conditions required for the in vivo 
formation of the highly toxic mutagenic and carcinogenic 
N-nitroso compounds have been discussed. Evidence that in 
vivo N-nitrosation actually occurs in man has been obtained by 
several different approaches:
(i) In vitro nitrosations using simulated in vivo 
conditions,
(ii) administration of nitrosating agents and/or amines 
to laboratory animals,
(iii) analysis of human body fluids, secretions and 
excretions for N-nitroso compounds,
(iv) in vivo N-nitrosation experiments in man.
1.5.2 Simulated in vivo N-nitrosation Experiments
It is unlikely that N-nitroso compounds can be formed in vivo 
which cannot be formed in the laboratory. Conversely, 
however, the formation of an N-nitroso derivative under 
laboratory conditions does not necessarily mean that it will 
be formed in vivo. Nevertheless, simulated in vivo 
nitrosations represent a simple and useful indicator of what 
could be formed.
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There have been many chemical investigations of nitrosamine 
formation which have a bearing on nitrosamine formation in 
vivo. The kinetics of formation, the influence of catalysts 
and inhibitors and the wide range of possible precursor 
compounds have been extensively studied and are reviewed 
earlier (Section 1.1). Such chemical investigations have 
usually employed unrealistically high concentrations of 
reactants, and cannot therefore be classed as simulated in 
vivo experiments. Nevertheless in some cases attempts have 
been made to simulate in vivo conditions usually by 
controlling the temperature, pH, and the concentration of 
reactants within physiological limits and sometimes by 
carrying out the reaction in an authentic physiological fluid.
Simulated in vivo nitrosations have been carried out mainly on 
amines known to be components of the diet and in particular of 
drugs, although in some cases whole foods have been 
nitrosated. Such experiments are reviewed below.
In 1968 Sander et al. studied the nitrosation of amines of 
varying basicity in vitro in human gastric juice. The 
nitrosation of diphenylamine, a weakly basic amine, was 
extremely rapid, whereas the strongly basic amines were 
nitrosated less readily. Sen et al. (1969) reported the 
formation of N-nitrosodiethylamine in vitro when the parent 
amine and nitrite were incubated in the gastric juices from 
rats, rabbits, cats, dogs and man. Human and rabbit juices 
(pH 1-2) were more effective as nitrosation media than rat 
gastric juice (pH 4-5). This finding agrees with the
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observation that the optimum pH for nitrosation is around pH
2.5 to 3.5 (Section 1.2) and has important consequences when 
interpreting the results of in vivo nitrosation experiments in 
laboratory animals.
Scheunig and Ziebarth (1976) demonstrated the nitrosation of 
the drugs aminopyrine, analgine and piperazine under simulated 
gastric conditions even when at a nitrite concentration as low 
as 16 |imol/l. In addition they demonstrated (Ziebarth & 
Scheunig, 1976) that the addition of various nitrite 
scavengers lowered the extent of the nitrosation under 
simulated in vivo conditions of piperazine and 
aminophenazone. Effective inhibitors potentially suitable for 
food use were sodium sulphite and ascorbic acid. Roper and 
Heyns (1978) nitrosated a variety of tetracycline drugs under 
simulated stomach conditions and found that 
N-nitrosodimethylamine was formed from minocycline, 
doxycycline, oxytetracycline and anhydrochlorotetracycline, 
the highest yields being obtained from minocycline. Ascorbic 
acid was again shown to inhibit the production of 
N-nitrosodimethylamine, for example, during the nitrosation of 
minocycline addition of ascorbic acid in molar ratios to 
nitrite of 1:1 and 2:1 blocked N-nitrosodimethylamine 
formation by 97% and 100% respectively. Ziebarth and Teichman 
(1980) studied the in vitro nitrosation of 61 drugs used in 
the German Democratic Republic under simulated in vivo 
conditions. They employed a nitrite concentration of 
0.64 mmol/1 in pentagastrin-simulated human gastric juice. As
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an added refinement, they simulated the gastric pH changes 
that occur after a meal by gradually adjusting the pH from 7 
to 2 over a period of 60 minutes. Only seven of the tested 
drugs yielded detectable amounts of N-nitroso compounds under 
these conditions, with two of these, analgine and 
piperazineadipate, giving 100% yields based on the nitrite 
added. Under these conditions ascorbic acid was an effective 
inhibitor of the nitrosation of these drugs, the extent of 
inhibition varying between 80 and 90%. In contrast to the 
preceding experiments, Mergens et al. (1980) carried out in 
vitro nitrosations of aminopyrine and dimethylamine at around 
neutrality, to simulate the conditions found in the upper part 
of the intestinal tract. They used a nitrite concentration of
4.3 mmol/1 and a pH of between 6 and 8 with the nitrosation 
being carried out in a phosphate buffer containing oil with 
either bile acids or a commercial emulsifying agent. The 
system thus simulated the lipid filled micelles known to be 
present during fat digestion. Both of the amines tested 
produced N-nitrosodimethylamine under these conditions with 
the nitrosation of aminopyrine and to a greater extent of 
dimethylamine being enhanced by bile acids. Vitamin C and 
cir-tocopherol were found to inhibit nitrosation substantially 
whereas dl-a-tocopherol acetate was found to be ineffective.
Walters et al. (1974) demonstrated that normal foods contained 
potential precursors to N-nitroso compounds. They nitrosated 
a variety of foods using a nitrite concentration of about lOOx 
greater than the maximum likely to be encountered in the human
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stomach. The majority of the N-nitroso compounds formed were 
not steam volatile. Even at more realistic nitrite 
concentrations (1.45 mmol/1 and 0.145 mmol/1), cheese and milk 
yielded detectable levels of non-volatile N-nitroso 
compounds. Walters et al. (1979) extended these findings by 
incubating a slurry of luncheon meat, egg and milk at pH 2.0 
with human gastric juice containing thiocyanate. No nitrite 
was added to the incubation other than that already present in 
the luncheon meat (30mg NO^/kg) resulting in an overall 
nitrite concentration of 0.45mM. On analysis of the 
incubations they detected N-nitrosopiperidine (59 p.mol/1) and 
N-nitrosopyrrolidine (2-3 (j.mol/1), adding further weight to 
the hypothesis that foods can be nitrosated in vivo.
Groenen et al. (1980, 1982) in a similar set of experiments, 
studied the formation of N-nitroso compounds from a wide range 
of constituents of the Western diet including vegetables, 
fruit, cereals, meat, fish, dairy products, dressings, spices 
and beverages. The samples were prepared for consumption as 
usual and then incubated in simulated gastric juice containing 
0.145 mmol/1 nitrite. These incubations were subsequently 
analysed for a number of volatile nitrosamines and N-nitroso 
aminoacids. Surprisingly, they found that despite the vast 
number of products investigated only fish and fish products 
yielded volatile nitrosamines, and then only 
N-nitrosodimethylamine was detected, with the amounts formed 
being highly variable and unpredictable. The obvious 
precursor compounds for N-nitrosodimethylamine in fish would
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be, dimethylamine, trimethylamine and trimethylamine-oxide as 
mentioned earlier (Section 1.3.2.1)*however, no correlation 
was found between the concentrations of these and the amount 
of N-nitrosodimethylamine formed. Nevertheless a serving of 
fish was found to be capable of producing up to 44 pg of 
N-nitrosodimethylamine under simulated gastric conditions. 
Formation of N-nitrosoamino acids followed a different 
pattern. Most fish products did not give rise to substantial 
amounts whereas many other products and in particular fried 
products did. As would be expected from the study of Walters 
et al. (1976) these non-volatile N-nitroso compounds were 
found in higher concentrations than the volatile nitrosamines 
with fried eggs yielding up to 148 pg per portion.
Marquardt et al. (1977) nitrosated beef, hot dogs and Japanese 
raw fish under simulated gastric conditions albeit using a 
high nitrite concentration (80 mmol/1). Interestingly, they 
also found that fish gave different results compared with the 
other foods. On testing the products for mutagenic activity 
using the Ames test which would be sensitive to N-nitrosamides 
they found that only the fish extract was mutagenic. 
Furthermore addition of 160 mmol/1 of ascorbic acid to the 
nitrosations prevented the formation of mutagens from fish, 
suggesting that the mutagen was an N-nitroso compound.
Endo and Takahashi (1973) nitrosated under strong acidic 
conditions, in real and simulated gastric juice 
methylguanidine which is found in fresh beef, cod, ray, 
sardines and especially in shark and produced a mutagenic
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product, which they later identified (Endo et al., 1977) as 
N-nitrosomethylcyanamide. They also nitrosated 14 other 
naturally occuring guanidines but none of the others produced 
any mutagenic activity.
Masuda et al. (1978) demonstrated that the rate of formation 
of N-nitrosomethylcyanamide from methylguanidine at pH 1.2 and 
pH 2.3 was proportional to the concentration of 
methylguanidine and to the square of the nitrite 
concentration. Thus even the highest levels reported for 
methylguanidine in foods and nitrite in saliva would result in 
very low concentrations of N-nitrosomethylcyanamide being 
formed in the stomach (17 ng/ml). However, these workers 
speculated that local concentration effects may conceivably 
produce sufficiently high concentrations to cause cancer in 
the stomach.
The use of in vitro studies such as those cited above to 
estimate the extent to which nitrosation could occur in vivo 
can be criticised on several counts. Most importantly the 
concentrations of reactants are often unrealistically high, 
and when low they are not replenished. Additionally, the test 
tube cannot imitate the life processes of the animal, that is 
there is no absorption or secretion of reactants and/or 
products, and no transport of reactants and products to other 
regions of the gut. Nevertheless, the results of many of the 
in vitro experiments have been confirmed by experiments 
carried out in vivo in laboratory animals. These in vivo 
experiments are reviewed below.
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1.5.3 Animal Experiments
The in vivo formation of N-nitroso compounds in laboratory 
animals has been well investigated and documented (Mirvish, 
1975; WHO, 1977; Lijinsky, 1980). Several long term animal 
experiments involving the chronic coadministration of nitrite 
plus amines or amides have been carried out. Any subsequent 
N-nitrosation has been detected either indirectly by noting 
the appearance of characteristic toxic and carcinogenic 
effects, or directly by chemical analysis. Experiments such 
as these began as long ago as 1963 when Druckrey et al. 
suggested that carcinogenic compounds could be formed from 
precursor amino compounds and nitrite present in the acid 
stomach. They carried out an experiment with rats adding 
nitrite and diethylamine to their diet for three generations, 
but found that none of the animals developed cancer. 
Subsequently it became clear that this negative result was due 
to several factors, the most important being that diethylamine 
is strongly basic (pK = 10.93) and does not nitrosate very
ii
rapidly at low concentration. In addition the mild acidity of 
the rats stomach (pH never below 4) was unfavourable for 
nitrosation. Sander (1968) performed a similar experiment 
except that the rat diet was buffered to give a gastric pH of 
between 1.5 and 2.5 to provide a more favourable environment 
for N-nitrosation. Nevertheless even though nitrite and 
diethylamine were given at a concentration of 0.3% in the 
diet, formation of N-nitroso diethylamine could not be 
detected either chemically or indirectly by tumour induction.
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Weakly basic amines such as N-methylaniline (pK^ = 4.85) and 
diphenylamine (pK^ = 0.9) did undergo in vivo 
N-nitrosation. Similarly the amines of intermediate basicity 
morpholine (p&A = 8.7) and N-methylbenzylamine (pK^ = 9.54) 
induced tumours in the rat liver and oesophagus when 
coadministered with nitrite (Sander & Burkle, 1969). In 1969, 
Sen et al. demonstrated that even the strongly basic 
diethylamine could be nitrosated in vivo when administered 
with nitrite to the dog or cat at sufficiently high 
concentration (400 mg amine, 300 mg NO^).
Since these early experiments other researchers have 
demonstrated the in vivo N-nitrosation of a wide range of 
amines and amides that are found in drugs and medicines, 
agricultural chemicals, and as food components. The resulting 
N-nitroso compounds have usually been detected chemically 
rather than indirectly l>y tumour induction. For example, 
Friedman and McClanahan (1973) showed the in vivo synthesis of 
N-nitroso sarcosine after mice had been injected with 
sarcosine and nitrite through the stomach wall, and Braunberg 
and Dailey (1973) similarly measured the in vivo nitrosation 
of proline. Sander et al. (1973) demonstrated the production 
of 1,4,dinitroso piperazine "in vivo" in dogs by detecting it 
in their urine after treatment with nitrate and piperazine. 
Greenblatt et al. (1972) detected the nitrosated product of 
the appetite suppressant phenmatrazine after rabbits or rats 
had received intragastric injections of aqueous solutions of 
nitrite and phenmetrazine. Lijinsky and Greenblatt (1972) fed
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rats the analgesic drug aminopyrene along with sodium nitrite 
and 68 hours later detected severe cetrilobular necrosis of 
the rat liver. Such necrosis is typical of the effect of 
N-nitrosodimethylamine and thus the results suggested the in 
vivo production of N-nitrosodimethylamine following the 
nitrosative cleavage of the tertiary amine aminopyrene 
(Section 3.3). Mysliwy et al. (1974) demonstrated the intra 
gastric formation of N-nitrosopyrrolidine in dogs given 
pyrrolidine and nitrite via a gastric fistula. Ivankovic and 
Preussman (1970) found neurogenic tumours in the offspring of 
female rats fed on ethylurea and nitrite during pregnancy.
Mice fed on nitrite and ethylurea developed tumours similar to 
those previously induced by N-nitrosoureas (Mirvish et al., 
1972). It was therefore assumed that these tumours were 
induced by the in vivo formation of N-nitrosoureas. This 
assumption was confirmed by Mirvish and Chu (1973) who used 
thin layer chromatography to demonstrate the formation of 
N-nitrosoureas in the stomach of starved rats gavaged with 
methyl or ethylureas and nitrite. The formation of 
N-nitrosomethylurea could be inhibited by the addition of 
sodium ascorbate to the diet (Mirvish et al., 1980). Alam et 
al. (1971a) demonstrated the formation of N-nitroso piperidine 
in the stomach and isolated intestinal loop of the rat 
following the introduction of nitrite (10.25 mg) and 
piperidine (125-1250 mg) via catheters. Eisenbrand et al. 
(1974) demonstrated that the fungicide Ziram could be 
nitrosated in vivo to form N-nitrosodimethylamine in rats.
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Similarly Rickard and Dorough (1978) showed that carbaryl, a 
carbamate pesticide, was nitrosated in the rat stomach, 
however only trace levels were produced because the pH of the 
rat stomach (pH 3-5) was not favourable for nitrosation. 
Administration of carbaryl and nitrite to the guinea pig, 
however, gave much higher yields of the N-nitroso derivative 
as the stomach contents are more acid (pH 1.5). Moreover, by 
using a very sensitive radiotracer analytical technique 
Rickard and Dorough were able to detect in vivo N-nitrosation 
after administering realistic amounts of nitrite (7.25 p,moles) 
and carbaryl (0.25 pmoles). Iqbal et al. (1980) using 
sensitive analytical procedures involving HPLC/TEA and GC/TEA 
were also able to use more realistic concentrations of 
precursors. They demonstrated in vivo nitrosation of 
dimethylamine and morpholine in mice gavaged with only 250 pg 
of amine and 250 pg of nitrite. The yield from the less basic 
morpholine (pK^ = 8.7) was as expected much higher (about 10 
times) than that from dimethylamine (pK^ = 10.72). In vivo 
nitrosation could also be detected after administration of as 
little as 5 pg morpholine and 100 pg NC^. In addition 
they found that thiocyanate catalysed in vivo nitrosation 
which was consistent with the in vitro findings of Boyland and 
Walker (1974) and that ascorbate inhibited in vivo nitrosation 
which correlated well with reports of inhibition of tumour 
induction and toxicity in animals fed amines and nitrite 
(Archer et al., 1975; Cardesa et al., 1974; Mirvish et al., 
1975, 1976; Shank & Newberne, 1976). These additional 
findings are of considerable importance as thiocyanate ion is 
a normal constituent of saliva which is found at higher'
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concentrations in smokers (Densen et al., 1967; Walters et 
al., 1979), and ascorbate is a permitted food additive which 
could therefore be potentially useful as an in vivo 
nitrosation inhibitor.
The majority of researchers have studied intragastric 
nitrosation using nitrite as the nitrosating agent.
Hawksworth and Hill (1974) on the other hand demonstrated that 
nitrosation can occur in the infected rat bladder with nitrate 
as one of the precursors, presumably following its bacterial 
reduction to nitrite. Alam et al. (1971a) described the, 
synthesis of N-nitrosopiperidine in the gastro-intestinal 
tract of the rat following the administration of sodium 
nitrate and piperidine. The yields were, however, lower than 
in similar experiments where amine and nitrite were used (Alam 
et al., 1971b). Iqbal et al. (1980) observed the synthesis of 
N-nitrosomorpholine in mice fed with morpholine and exposed to 
atmospheric nitrogen dioxide. Mirvish et al. (1981) confirmed 
these results but further research indicated that the 
nitrosamine may have been produced as an artifact of the 
analysis. Nevertheless, inhalation of nitric oxide does lead 
to the appearance of nitrate and nitrite in the blood (Oda et 
al., 1981), indicating that nitrogen oxides may be effective 
nitrosating agents in vivo. Van Broekhoven and Stephany 
(1978) also demonstrated the in vivo reduction of nitrate and 
subsequent synthesis of nitrosamines in the rumen of cows.
They detected N-nitrosodimethylamine, N-nitrosodiethylamine 
and N-nitrosopyrrolidine in the rumen fluid after the direct
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introduction of 260 mg/kg of potassium nitrate. The amount of 
nitrosamine formed correlated well with the nitrite formation 
as a function of time after nitrate administration. This 
experiment not only demonstrated the action of nitrate as an 
in vivo nitrosating agent but also the availability of amine 
precursors in the diet as no amines were administered. 
Hashimoto et al. (1976) demonstrated that 
N-nitrosodimethylamine was formed in the stomach, small 
intestine and caecum of rats fed a diet containing 0.1% 
dimethylamine and 0.4% potassium nitrate only when the rats 
were infected with certain bacteria.
Thus animal experiments have suggested that in vivo 
nitrosation of a wide variety of amines and amides could occur 
in man. The most important site for in vivo N-nitrosation is 
likely to be the acidic stomach although other sites may also 
be involved. Moreover, nitrate can be an effective 
nitrosating agent at sites colonised by nitrate reducing 
bacteria. Further evidence for in vivo nitrosation in man has 
been obtained by the detection of N-nitroso compounds in human 
tissues and body fluids. A review of the reports of N-nitroso 
compounds in human fluids and tissues is given below.
1.5.4 The Occurrence of N-nitroso compounds in vivo
Over the past ten or so years there have been many reports of 
N-nitroso compounds (particularly the volatile nitrosamines) 
in human samples. As will be discussed later many of these 
reports have recently fallen under suspicion because
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insufficient provisions had been made to prevent the 
artifactual formation of N-nitroso compounds during the 
analysis. Nevertheless they will be reviewed as reported 
below.
1.5.4.1 N-nitroso Compounds in Human Blood
In 1977, Fine et al. reported that both N-nitrosodimethylamine 
and N-nitrosodiethylamine were present in human blood. They 
found a wide range of concentrations with
N-nitrosodimethylamine ranging from 2.1 to 10.4 nmol/1 and 
N-nitrosodiethylamine from 0 to 4.5 nmol/1. The highest 
concentrations were found after consumption of a meal 
containing 1.6 ^g of N-nitrosodimethylamine. Yamamoto et al. 
(1980) also detected N-nitrosodimethylamine in human blood at 
concentrations ranging from less than 6.7 to 17.6 nmol/1; 
however, consumption of a meal high in nitrates and secondary 
amines had no effect on these conditions. Kowalski et al. 
(1980) found N-nitrosodimethylamine (0.9 to 3.5 nmol/1) in 
only 7 out of 20 blood samples analysed.
N-nitrosodiethylamine (0.9 to 1.2 nmol/1) was found in only 4 
samples and N-nitrosopiperidine (6.1 nmol/1) in one. After 
eating a meal only two of the volunteers showed an increase in 
blood nitrosamine concentration. Nevertheless, assuming a 
blood volume of 5640 ml the total amounts of nitrosamine 
formed in a few cases appeared to be greater than that 
consumed in the meals indicating in vivo formation. Lakritz 
et al. (1980) analysed blood from 38 people and found 
N-nitrosodimethylamine in 97% of the samples (0 to 20 nmol/1)
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but showed no significant effects from meals or smoking. The
variation in the results of the experiments outlined above
were thought by Eisenbrand et al. (1981) to be due to the
artifactual formation of nitrosamines during the analysis.
They tried two methods for the analysis of blood samples,
either vacuum distillation followed by extraction into
dichloromethane, or by column extraction on a cellulose
adsorption column. Using these methods they detected
N-nitrosodimethylamine in water blanks. Analysis of 36 blood
samples produced peaks which were indiscernible in size from
the blanks and thus no conclusive evidence for the presence of
volatile nitrosamines was obtained. Nevertheless they did
detect N-nitrosodimethylamine (3 to 7 nmol/1) in blood after
the donors had drunk 500ml of beer containing 60 jig/kg of this
nitrosamine. Lakritz et al. (1982) subsequently extended
their study to 161 samples and modified their method to allow
for artifactual formation, by subtracting a blank value in
their calculations and by adding ascorbate to the steam
distillation. With these procedural modifications they still
found N-nitrosodimethylamine but at lower concentration (0 to
11 nmol/1). In 1982 Garland et al. reported on the
development of a very sensitive high resolution mass
spectrometry assay for N-nitrosodimethylamine in human
plasma. However, they detected its presence in only 9 out of
128 samples and then at only very low concentrations
( 10 ^  g/ml). Analysis of negative samples ( ^31 x
-1210 g/ml) by the GC/TEA method used by other researchers 
produced positive results with a mean N-nitrosodimethylamine
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concentrations of 448 pg/ml indicating that artifactual 
formation occurs during GC/TEA analysis.
Thus the more recent studies where adequate precautions have 
been taken against artifact formation, suggest that human 
blood does not normally contain volatile N-nitroso compounds, 
although on occasion very low concentrations may be present. 
Whether the low concentrations of nitrosamines found in blood 
are formed in vivo or are preformed dietary components is as 
yet uncertain.
1.5.4.2 N-nitroso Compounds in Human Urine
Secondary amines especially dimethylamine, piperidine and 
pyrrolidine are excreted in normal urine in amounts as high as 
60 mg/day (Draser & Hill, 1974). Thus in the presence of a 
nitrosating agent such as the nitrite produced by bacterial 
infection, substantial amounts of nitrosamine could be formed 
in the urinary tract. This possibility was confirmed by Hicks 
et al. (1978) who found N-nitroso compounds in urines from 
patients with chronic infections of the urinary tract, but not 
in urine from healthy subjects although deliberate nitrosation 
of this urine in vitro produced large amounts of N-nitroso 
compounds demonstrating the presence of an adequate supply of 
amine precursors. The infected urines contained 
N-nitrosodimethylamine and other volatile nitrosamines at 
concentrations of up to 780 p.g/1 and the more complex 
non-volatile N-nitroso compounds at concentrations of up to 
9100 p.g/1. Similarly, Brooks et al. (1972) found
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N-nitrosodimethylamine in the urines of two women with Proteus 
mirabilis infection of the bladder, and Eisenbrand et al.
(1976) confirmed by mass spectrometry the presence of 
N-nitrosodimethylamine in the urine of 2 out of 8 patients 
with urinary tract infections. Radomski and Hearn (1976) 
demonstrated the role bacteria play in urinary nitrosamine 
formation by showing that the N-nitrosodimethylamine found 
during urinary tract infection decreased after therapy with 
oxytetracycline, despite the fact that this drug is itself 
capable of nitrosation to yield N-nitrosodimethylamine.
N-nitrosodimethylamine has however, also been found in trace 
amounts in the urine of healthy individuals, typically at 
concentrations of 0.1 fig/1 although 0.7 p.g/1 was found in one 
individual (Lakritz et al., 1982). The concentrations found 
were not significantly affected by ingestion of an ordinary 
diet containing preformed nitrosamine and/or potential 
nitrosamine precursors, although the possibility that 
nitrosamines had been formed and metabolised could not be 
ruled out. Ellen et al. (1982) also found 
N-nitrosodimethylamine in the urine of healthy volunteers 
albeit at low concentration ( ^ 0.1 fig/1), surprisingly however 
intake of large quantities of nitrate which led to the 
appearance of detectable amounts of nitrite in the urine had 
no significant effect on the concentration of urinary 
nitrosamines. Nevertheless, all 8 samples of urine from one 
individual contained detectable amounts of 
N-nitrosodimethylamine, suggesting that important 
interindividual variations may exist.
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Eisenbrand et al. (1981) after taking adequate precautions to 
prevent artifactual formation of nitrosamines could not detect 
any nitrosamine in the urine of 25 randomly selected 
volunteers (detection limit 0.1 pg/1) even after they had 
drunk orange juice containing 13.26 pg of
N-nitrosodimethylamine. Unfortunately these researchers did 
not apply their method of analysis to urines from people with 
urinary tract infections. They did, however, show that if 
N-nitrosodimethylamine (13.26 pg) was drunk in beer or in 
orange juice containing 6% ethanol, up to 2.4% of the 
N-nitrosodimethylamine was recovered in the urine. This was 
presumably due to ethanol reducing the activity of the 
N-nitrosodimethylamine metabolising enzymes (Spiegelhalder et^  
al., 1982).
The experiments above are inconclusive, although in vivo 
N-nitrosation has been indicated in infected urinary tracts, 
proper artifact controls were not carried out and the data 
therefore remains ambiguous, whereas, the experiments of 
Spiegelhalder et al. (1982) demonstrate that 
N-nitrosodimethylamine formed elsewhere in the body would be 
metabolised before appearing in the urine, unless sufficient 
alcohol is consumed to prevent its metabolism. The 
N-nitrosodimethylamine found in healthy subjects by Lakritz et 
al. (1982) and Ellen et al. (1982) may therefore have been 
artificially produced during the analysis, and that found by 
Spiegelhalder et al. (1982) was probably preformed in the 
diet. Thus no hard evidence for in vivo nitrosation can be
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drawn from these experiments. Recently however, Ohshima and 
Bartsch (1981) have measured N-nitroso proline in the urine 
which was undoubtedly produced in vivo, this experiment will 
be discussed later (Section 1.5.5).
1.5.4.3 N-nitroso Compounds in Human Gastric Juice
In 1978 Lakrtiz et al. analysed the gastric contents of 35 
patients for volatile nitrosamines. N-nitrosodiethylamine (5 
to 30 pg/kg) was present in four samples, 
N-nitrosodimethylamine (2 pg/kg) in two samples and 
N-nitrosopyrrolidine (6 pg/kg) in one sample. Again, however, 
as in most early experiments the methods used for the 
prevention of artifact formation were suspect. Eisenbrand et^  
al. (1981) using similar methods failed to find any 
nitrosamines in 25 samples of gastric juice although some of 
the samples contained nitrite.
Walker et al. (1980) analysed fasting and post prandial 
gastric juice samples from 13 normal subjects and from 35 
patients with chronic atrophic gastritis for volatile and 
total N-nitroso compounds. N-nitrosodimethylamine was found 
in 35 of the patients (0 to 14.5 pg/1) and in 6 of the normal 
subjects (0 to 2.5 pg/1) whereas N-nitrosodiethylamine was 
found in 20 of the patients (0 to 14.3 pg/1) but was absent in 
controls. No significant difference was observed between the 
post prandial and fasting samples. Although no significant 
differences were found with the non-volatile nitrosamines 
their concentration tended to be higher in the
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post prandial than in the fasting gastric juice. There were 
strong indications that the volatile nitrosamines detected 
were formed in vivo as analysis of three random samples of the 
standard meal consumed, revealed only one that contained a 
trace of N-nitrosodimethylamine ( 1 pg/kg), and no
N-nitrosodiethylamine was found. However, the possibility of 
artifactual formation cannot be ruled out in these experiments 
as freezing was the only method of preservation employed.
The analysis of N-nitroso compounds present in human gastric 
juice and the factors influencing their formation constitutes 
the bulk of the experimental work in this thesis. The method 
developed for their determination has been adapted in a 
modified form by others (Bavin et al., 1982) and has resulted 
in conflicting results which will be discussed later (Chapter 
8).
1.5.4.4 N-nitroso Compounds in Human Faeces
In 1978 Wang et al. reported that volatile nitrosamines were 
present in human faeces. The results from 12 faecal samples 
demonstrated that most faeces contain N-nitrosodimethylamine 
at concentrations of 0.3 to 1.5 pg/kg. N-nitrosodiethylamine 
was found in higher concentrations (0.2 to 13 pg/kg), and some 
samples also contained traces of N-nitrosodibutylamine, 
N-nitrosopyrrolidine and N-nitrosomorpholine. It was 
considered likely that these nitrosamines were produced in the 
lower gastrointestinal tract by bacterial action on nitrites 
(formed by reduction of nitrate by oral or intestinal
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bacteria) and secondary amines (produced by degradation of 
amino acids or by bacterial metabolism). Archer et al. (1982) 
re-examined the nitrosamine concentrations in human faeces 
using methods to avoid the artifactual formation of 
nitrosamines. They used fresh faeces to avoid storage 
problems, spiked samples with N-nitrosodipropylamine to 
determine recovery, and added 2,6-dimethylmorpholine to detect 
artefactual nitrosamine synthesis. They also thoroughly 
washed all their glassware with dichloromethane to remove all 
traces of adsorbed N-nitrosomorpholine. Analysis of 12 human 
faecal samples produced no evidence for the presence of any 
volatile nitrosamines despite a recovery of better than 75% 
for the N-nitrosodipropylamine standard. Archer et al. (1982) 
also repeated the method used by Wang et al. and showed that 
it was subject to artefact formation.
Suzuki and Mitsuoka (1981) carried out an experiment to 
determine the effects of different diets on faecal nitrosamine 
concentrations. The authors claimed that their methods 
produced no artefactual formation of nitrosamine during 
analysis or storage. This claim was based on control 
experiments which demonstrated that the reagents and glassware 
were not sources of contamination and that nitrosamine yield 
was not affected by the addition to the samples of 1 mol/1 
sulphamic acid, 50 mmol/1 ascorbic acid or 0.1 mmol/1 sodium 
nitrite. In contrast to Archer et al. (1982) they found 
N-nitrosodimethylamine, N-nitrosodibutylamine, 
N-nitrosopiperidine, and N-nitrosopyrrolidine at a maximum
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total mean concentration of 26.6 |_ig/kg with
N-nitrosopiperidine reaching a maximum mean concentration of
13.3 jig/kg. Changing from a typical Japanese diet to a 
western style diet produced marked increases in nitrosamine 
levels, and the authors considered that this was due to 
differences in the quantities of dietary nitrate and amino 
acids or lipids in the western diet.
The doubts surrounding the methods for the determination of 
faecal nitrosamines make it impossible to judge the 
significance of the findings of Suzuki and Mitsuoka.
Inclusion of a marker amine during the analysis would have
removed much of the ambiguity surrounding these results. One
fundamental difference between the method of Suzuki and 
Mitsuoka and that of Archer et al. was that the former
attempted to improve the distribution ratio for
dichioromethane extraction by salting out and alkalisation of 
the faecal samples. This may help to extract nitrosamines 
contained in undigested foods or bound chemically or 
physically to some compounds. However, extraction of 
nitrosamines under the alkaline conditions employed can lead 
to their artificial formation (Suzuki & Mitsuoka, 1982) thus 
their data may require correction.
Eisenbrand et al. (1981) used similar methods to Archer et al. 
to eliminate artefactual formation of N-nitroso compounds, and 
analysed 29 faecal samples. No volatile nitrosamines were 
found except in one sample from a healthy 18 month old child 
which contained a trace (0.5 jig/kg) of N-nitrosodimethylamine.
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1.5.4.5 N-nitroso Compounds in Other Human Samples
Other human samples which have been analysed for N-nitroso 
compounds include saliva (Ellen et al., 1982; Wishnok & 
Tannenbaum, 1976), vaginal secretions (Harrington et al.,
1973), and human nipple aspirates (Melkian et al., 1981).
As mentioned earlier saliva contains endogenously formed 
nitrite and is therefore a potential site for in vivo 
nitrosation. Ishiwata et al. (1975) and Wishnock and 
Tannenbaum (1976) incubated human saliva with added secondary 
amines at 37°C and observed the formation of nitrosamine, 
however, they did not publish data concerning nitrosamine in 
normal saliva. Ellen et al. (1982) carried out volatile 
nitrosamine determinations on saliva samples from 24 healthy 
volunteers before and after the intravenous administration of
9.5 g NaNO^ or oral administration of 0.15 g NH^NO^/kg 
bodyweight. Volatile nitrosamines with the exception of 
N-nitrosodimethylamine were not found. N-nitrosodimethylamine 
was occasionally found in trace amounts, with all the saliva 
samples from one individual containing appreciable amounts 
(0.1 - 8.9 jig/1) indicating that personal factors are 
involved. Nitrate intake had no effect on salivary 
nitrosamine levels.
Harrington et al. (1973) reported the presence of 
N-nitrosodimethylamine in a pooled vaginal discharge sample 
obtained from 100 patients with various genital tract 
infections. Identification of the nitrosamine was carried out
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by low resolution mass spectrometry of the parent ion at M/Z 
+
75 and the NO ion at M/Z 30, a technique which Gough et al.
(1977) has since shown to be ambiguous. In addition artifact 
controls were not carried out making the results even more 
unreliable. Nevertheless, the same group went on to analyse 
further pooled vaginal discharge samples (Allsobrook et al.,
1974), from patients with and without trichomoniasis. The low 
resolution mass spectrometry was made more specific by 
monitoring 13 mass numbers which produce significant peaks in 
the mass spectra of low molecular weight dialkylnitrosamines.
A simultaneous rise in intensity of at least six of these 
peaks was taken as an indication of the highly probable 
presence of a nitrosamine. No evidence was obtained for the 
presence of volatile nitrosamine in trichomonas-negative 
samples. In the samples that proved positive for Trichomonas 
vaginalis, however, evidence for trace amounts of N-nitroso- 
dimethylamine, N-nitrodiethylamine, N-nitrosomethylpropyl­
amine, N-nitrosodipropylamine and N-nitrosoethylpropylamine 
was obtained. Even if this experiment does not conclusively 
demonstrate in vivo nitrosamine formation, as artefactual 
formation cannot be ruled out, the difference between the 
Trichomonas-negative and Trichomonas-positive samples does 
show that infection has at least produced the necessary 
precursors for that nitrosation to take place.
Finally, Melkian et al. (1981) attempted to determine volatile 
nitrosamines in the breast fluid of non-lactating women. Due 
to the small size of the samples obtained (4 to 50 p.1) the
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detection limits were high (12.5 ng/ml to 1 ng/ml) and 
nitrosamines were absent from all samples.
Despite the volume of work carried out on the occurrence of 
endogenous N-nitroso compounds in humans the majority of the 
studies have not incorporated appropriate controls of artefact 
formation. The data, therefore, remains ambiguous. Despite 
numerous indications that in vivo nitrosation does occur in 
humans, such experiments are very unlikely to produce 
conclusive evidence. Nevertheless, a different approach has 
produced far more substantial evidence and is discussed in the 
next section.
1.5.5 In vivo N-nitrosation Experiments in Man
Conclusive evidence that N-nitrosation occurs in man has to 
come from experiments performed on man himself. Due to the 
inherent hazards of such experiments, they have necessarily 
been limited to two types of experiment. Firstly attempts 
have been made to detect the in vivo nitrosation of dietary 
components, after eating typical meals, and secondly 
experiments have been carried out where amines have been 
co-administered with nitrate and their subsequent nitrosation 
has been monitored. In the latter type of experiment, only 
amines known to yield non-hazardous products can be used for 
obvious reasons.
In 1969, Sander and Seif administered a drink containing 
100 mg sodium bicarbonate, 300 mg sodium nitrate, 1000 mg 
glucose and 10 mg diphenylamine to 31 people with gastric
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hypoacidity. Nitrite was present in the fasting gastric juice 
of 8 of the volunteers whose initial gastric pH was above 4. 
N-nitrosodiphenylamine (2 to 10 pg) was subsequently detected 
in 11 of the volunteers who showed substantial nitrite 
formation and a gradual decrease of gastric pH from the 
elevated level produced by the drink to pH 3. In 5 patients 
in whom the sodium bicarbonate did not counteract gastric 
acidity nitrosamine amounts of less than 1 p.g were detected. 
Thus Sander and Seif with a relatively simple experiment 
demonstrated that in vivo nitrosation can occur in man, 
however, they used relatively massive amounts of diphenylamine 
and therefore did not prove that it is a significant reaction 
under normal circumstances.
In 1977, Fine et al. purported to demonstrate conclusively the 
formation of N-nitrosamines in vivo in man following the 
consumption of a midday meal consisting of bacon, spinach and 
tomato sandwich and beer. The volatile nitrosamines detected 
were measured in blood samples taken at various intervals 
after the meal. The analytical procedures used, however, had 
only been rigorously evaluated down to concentrations of about 
1 pg/kg whereas the levels measured were between 0.1 and 
0.8 pg/kg. As has already been discussed (Section 1.5.4.1) 
subsequent experiments on the occurrence of volatile 
nitrosamines in blood have demonstrated the necessity for 
proper precautions to prevent the formation of artefacts, and 
therefore the data from the above experiment remains ambiguous 
and cannot be considered proof of in vivo nitrosation.
Similarly Walters et al. (1976, 1979) using an oral tube, 
introduced into the stomach of a smoker and a non-smoker, a 
homogenised meal containing egg, milk, and luncheon meat with 
an overall nitrite concentrations of 0.46 mmol/1. Fifteen 
minutes later the stomach contents were recovered and analysed 
for volatile nitrosamines by gas chromatography linked with 
high resolution mass spectrometry, no nitrosamines were 
detected. Nevertheless when a similar homogenised meal 
containing an overall nitrite concentration of 0.5 mmol/1 was 
retained in the stomach for 30 minutes before analysis, 
N-nitrosopiperidine was detected three times in samples from 
the smoker and once in those from the non-smoker at 
concentrations of 0.27 to 0.54 p.g/kg. In addition 
non-volatile nitrosamines which were dichloromethane 
extractable were detected in one sample (0.4 p.mol/kg) and that 
were water soluble in all samples (7 to 20 (imol/kg). In this 
experiment as in so many others, no precautions were taken to 
prevent artefactual formation of nitrosamines and therefore 
the data, especially that for the extremely low concentrations 
of N-nitrosopiperidine, may not represent in vivo nitrosation.
Recently Ohshima and Bartsch (1981) have developed a technique 
which appears to demonstrate conclusively that N-nitrosation 
does occur in man. Their method was developed for the 
quantitative estimation of in vivo nitrosation in rats 
(Ohshima et al., 1982), and is based on the fact that 
N-nitrosoproline is not carcinogenic in animals and is not 
readily metabolised. Thus more than 95% of a dose of
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N-nitrosoproline administered per os to rats was excreted 
unchanged into urine within 24 hours. In addition sequential 
administration of aqueous solutions of proline and sodium 
nitrite resulted in a drastic increase in the urinary 
excretion of N-nitrosoproline. Ohshima and Bartsch (1981) 
then used this method to investigate in vivo nitrosation in a 
male volunteer. As nitrite is not normally present in the 
diet at high concentration (Section 1.4.5), the volunteer 
ingested nitrate rich vegetable juice (to provide nitrite via 
its in vivo reduction), together with proline, and 
N-nitrosoproline excretion was quantitatively monitored. 
Following ingestion of the precursors, urinary concentrations 
of N-nitrosoproline increased rapidly to a maximum after 6 to 
8 hours, returning to the baseline level after 24 hours. 
Neither nitrate nor proline when taken alone led to detectable 
increases in urinary N-nitrosoproline concentrations. In 
addition the vegetable juice and proline used contained no 
detectable concentrations of preformed N-nitrosoproline. 
Therefore, the N-nitrosoproline excreted in the urine was most 
probably formed in the human body through the in vivo 
nitrosation of proline, ingestion of 325 mg of nitrate and 250 
mg of proline producing a 5 to 7.5 fold increase in 
N-nitrosoproline excretion (14 to 15.9 pg/24 hr). 
Interestingly, the in vivo nitrosation of proline was 
completely inhibited by the intake of 1 g of vitamin C and 
reduced by 50% by 500mg of vitamin E.
The experiments of Ohshima and Bartsch therefore demonstrate 
the actuality of in vivo N-nitrosation in man, following the
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intake of nitrate and precursor amine. Nevertheless, the 
amount of nitrate given in one dose is two to three times the 
normal daily intake of nitrate (Section 1.4.2), and moreover a 
marked increase in N-nitrosoproline excretion did not occur 
until the nitrate dose was about 200mg NO^ which should 
be compared with the estimated normal daily dose of 173.8 mg. 
The experiments do not therefore demonstrate that the intake 
of a normal diet would lead to a significant production of 
N-nitrosocompounds, although the background levels of 
N-nitrosoproline observed may be the products of such a 
process.
1.5.6 Conclusions and Present Work
It is evident from the literature reviewed here that a vast 
amount of work has been carried out on the possible synthesis 
of N-nitroso compounds in vivo from their precursors. The 
potentially serious consequences of in vivo nitrosation have 
been demonstrated by the appearance of tumours in laboratory 
animals after administration of either N-nitroso compounds 
themselves or their precursors. Nevertheless, although the 
occurrence of nitrosatable precursors and nitrosating agents 
in human diet is not in doubt it is still a matter of debate 
whether the concentrations found would enable in vivo 
N-nitrosation to occur to any significant extent. Moreover, 
knowledge of the occurrence of N-nitroso compounds in man is 
limited almost exclusively to the simple volatile 
N-nitrosamines despite the fact that the majority of 
nitrogenous precursors would yield more complex non-volatile
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N-nitroso compounds. Because of this deficiency of data on 
the occurrence of N-nitroso compounds and the extent of iri 
vivo nitrosation it is still only a matter of speculation 
whether or not N-nitroso compounds have a role in the etiology 
of human cancer.
In this study therefore, a method has been devised to measure 
all types of N-nitroso compounds as a group and to 
differentiate them from other compounds potentially derived 
from nitrite. Using this novel method, measurements have been 
made of the occurrence of N-nitroso compounds in physiological 
secretions from groups of people with different risks of 
developing cancer. These measurements along with measurements 
of other physiochemical parameters have been used to isolate 
significant factors leading to in vivo nitrosation and to 
relate them with cancer "risk".
Finally preliminary investigations have been made on the 
identity of the non-volatile compounds usually formed in vivo 
in man.
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CHAPTER 2 
Methods
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2. METHODS
2.1 Sample Preservation
2.1.1 Introduction
As the majority of human samples used in the experiments 
reported in this thesis were obtained from hospitals, they 
often had to be stored in a deep freeze (~20°C) for 
considerable periods before extraction and analysis. A 
reliable method was therefore required which ideally would 
preserve any N-nitroso compounds present, and prevent 
artifactual formation of N-nitroso compounds during storage. 
The latter of these requirements was considered to be the most 
important, in order to avoid false positive results, although 
the possibility of instability producing false negative 
results must be considered in the interpretation of the 
results.
2.1.2 Method
Methods for the effective inhibition of the formation of 
N-nitroso compounds have been reviewed in Chapter 1 (Section 
1.1.4). The reduction of nitrous acid (the nitrosating agent) 
to nitrogen was the most suitable method of inhibition. For 
the experiments described in this thesis it was therefore 
decided to use sulphamic acid, although it has been reported 
to be ineffective above pH 2 (Mirvish, 1975) and some studies 
suggest that it may even enhance nitrosamine formation above 
pH 4 (Ziebarth & Teichmann, 1980). These problems were
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overcome by adding sulphamic acid to the samples at a 
concentration of 0.5% w/v which not only provided a vast 
excess of sulphamic acid over the nitrite but also lowered the 
pH of even neutral gastric juices to pH 1.5. Thus samples 
were collected directly into clean sample bottles containing 
sufficient solid sulphamic acid to give a final concentration 
of at least 0.5% w/v. The samples were then shaken thoroughly 
to dissolve the sulphamic acid and immediately placed in a 
deep freeze at -20°C and stored frozen until required for 
extraction and analysis. As a further safeguard, samples were 
discarded if they produced detectable amounts of nitric oxide 
on addition of glacial acetic acid during the analysis for 
total N-nitroso compounds (Section 2.4.1), indicating the 
presence of nitrite and hence failure of the sulphamic acid 
treatment.
2.1.3 The Stability of N-nitroso Compounds in Preserved 
Samples
The stability of a nitrosamide (N-nitroso methylurea) and a 
nitrosamine (N-nitroso sarcosine) was investigated under the 
storage conditions described above.
Samples of gastric juice adjusted to pH 2 were spiked with 
N-nitroso sarcosine and N-nitrosomethylurea at a concentration 
of about 10 pg/ml. Sulphamic acid and sodium nitrite were 
then added simultaneously at concentrations of 0.5% w/v and 
0.3 mM respectively to simulate what might occur during sample 
collection. The samples were then frozen and stored at
-20°C. Aliquots were taken and analysed for total N-nitroso 
compound content by the Luminox method (Section 2.4.1) after 
0, 14, 21 and 28 days storage.
The results (Table 2.1) show that the representative 
nitrosamine, N-nitroso sarcosine, was stable under the 
proposed sample storage conditions. On the other hand the 
nitrosamide, N-methyl-N-nitroso urea, gradually decomposed 
over long storage periods.
Table 2.1
Number of days storage 
0 14 21 28
% recovery of N-nitroso sarcosine 103% 104% 108% 94%
% recovery of N-nitroso methylurea 138% 56% 52% 16%
2.1.4 The Artefactual Formation of N-nitrosamines during 
Sample Storage
Because sulphamic acid has been shown to enhance nitrosamine 
formation above pH 4 (Ziebarth & Teichmann, 1980), it was 
decided to test whether the use of sulphamic acid could cause 
the artefactual formation of nitrosamines under the conditions 
of sample storage used for the experiments in this thesis.
The effect of adding sulphamic acid at 0.5% w/v was 
investigated in solutions containing 1 mmol/1 morpholine and 
either 0.1 mmol/1 or 10 mmol/1 sodium nitrite at pH 7 and 
pH 3. As some of the morpholine was nitrosated in the 
solutions at pH 3 before the addition of sulphamic acid, the
extent to which nitrosation occurred was compared with the 
amount of nitrosation occurring in control solutions in which 
nitrosation had been stopped by adjusting their pH to 7 rather 
than by the addition of sulphamic acid. N-nitroso morpholine 
present in the solutions was analysed by GC/TEA (Section 
2.4.2) after extraction into dichloromethane and concentration 
using a Kuderna-Danish evaporator.
No evidence was obtained for the artefactual formation of 
N-nitrosomorpholine either immediately after the addition of 
sulphamic acid or after one weeks storage at -20°C.
Addition of sulphamic acid at 0.5% w/v and storage at -20°C 
was thus considered suitable for the stabilisation and storage 
of samples suspected of containing nitrosamines and nitrite.
2.2 Sample Extraction
The methods used in the work described in this thesis for the 
determination of N-nitroso compounds require them to be in 
solution in non-aqueous solvents. Therefore in preparation 
for analysis a liquid-liquid extraction method had to be 
developed. As the N-nitroso compounds expected to be found in 
biological samples could be either polar (e.g.
N-nitrosoproline) or non-polar (e.g. N-nitrosodialkylamines), 
a solvent of intermediate polarity had to be chosen. Other 
requirements were that the solvent should be readily and 
inexpensively obtainable at high purity, and that it should 
have a reasonably low boiling point to allow easy reduction in 
volume.
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The solvent chosen was ethyl acetate with which good 
extractions could be made of both polar and non-polar 
nitrosamines. For example, extraction of aqueous solutions of 
N-nitrosoproline and N-nitroso dibutylamine with three 
consecutive volumes of solvent equal to the aqueous volume 
produced recoveries of 93% and 91% respectively. The ethyl 
acetate used for the extraction was pre-treated with a 0.5% 
aqueous solution of sulphamic acid, which was found to remove 
a blank response found in some batches of ethyl acetate. The 
following extraction method was therefore used for all aqueous 
samples.
To an aqueous sample of not more than 30ml which had been 
preserved by the addition of sulphamic acid (0.5% w/v) was 
added sodium chloride (10% w/v), the sample was then shaken 
vigorously with 30ml of ethyl acetate treated with sulphamic 
acid (see above) for at least one minute. Often an emulsion 
formed which was broken by centrifugation. The ethyl acetate 
extract was then collected in a 100ml volumetric flask and the 
extraction repeated with a further two 30ml volumes of ethyl 
acetate. Finally the volume was made up to 100ml and the 
extracts stored at -20°C until analysis.
Extracts destined for analysis for total N-nitroso compounds 
by the Luminox method (Section 2.4.1) required no further 
preparation. Sample extracts destined for analysis by GC/TEA 
(Section 2.4.2) were dried over anhydrous sodium sulphate, 
filtered, reduced in volume to about 0.2ml using a rotary 
evaporator, and methylated by the addition of an ethereal 
solution of diazomethane (Section 2.4.2.2).
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When samples were being extracted for the analysis of the 
simple steam volatile nitrosamines, it was desirable that a 
solvent with a low boiling point was used. Therefore 
depending on the nature of the sample either dichloromethane 
or ethyl formate were used. The extract could then be reduced 
in volume using a Kuderna Danish evaporator.
2.3 N-nitrosation of Biological Samples
In some experiments it was necessary to nitrosate biological 
samples. These nitrosations were carried out using either 
simulated gastric conditions or very severe ("exhaustive") 
conditions. After the nitrosations were complete, excess 
nitrite was removed by the addition of sulphamic acid prior to 
extraction of any N-nitroso compounds formed. The conditions 
used for these nitrosations are given below in Table 2.2.
Table 2.2
Conditions for "exhaustive" and "simulated gastric" 
N-nitrosation
Exhaustive
N-nitrosation
Simulated Gastric 
N-nitrosation
Medium 
Nitrite 
Thiocyanate 
Temperature 
Reaction Time
pH2 HC1/KC1 buffer pH2 HC1/KC1 buffer
0.14 mol/1 
3.0 mmol/1
0.3 mmol/1
1.5 mmol/1
370C 
3 hours
370C 
3 hours
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2.4 Sample Analysis for N-nitroso Compounds
2.4.1 The Luminox Method of Analysis for Total N-nitroso 
Compounds
A reliable method was required for the analysis of N-nitroso 
compounds present in the various physiological secretions 
studied. Since the majority of N-nitroso compounds present 
were likely to be non-volatile a novel method was required for 
their determination. A procedure was developed in which 
nitrite, N-nitroso compounds and nitrate on a biological 
matrix could be denitrosated selectively to nitric oxide. The 
nitric oxide released was simultaneously removed in a stream 
of nitrogen and determined with great sensitivity using a 
chemiluminescence analyser (Walters et al., 1978).
The apparatus used is illustrated in Figure 2.1. 50 ml of
sample extract was contained in a 250 ml three-necked round 
bottomed flask. One neck of the flask was connected to a 
reservoir of oxygen-free nitrogen of a pressure of one 
atmosphere and another to an efficient water condensor whilst 
the third neck provided a septum through which the reactants 
could be injected. Connection was made from the top of the 
condensor through two traps containing approximately 5M NaOH 
to a British Oxygen Luminox 101A chemiluminescence analyser. 
This analyser included a photomultiplier refrigerated for 
maximum stability at the lower concentrations of nitric 
oxide. The ranges of the instrument covered the values from 
0-0.3, 0-1.0, 0-3.0, 0-10, 0-30 and 0-100 vpm ( p. 1/1). As a
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result of reduced pressure maintained in the analyser reaction 
chamber by a vacuum pump, the gaseous products were drawn out 
of the three-necked flask in a stream of nitrogen. The nitric 
oxide responses were calculated from the integrated areas 
under the recorder peaks in combination with the relevant 
range factor.
After equilibration of the sample under study in the refluxing 
solvent, 2.0 ml glacial acetic acid was injected into the 
system through the septum and the nitric oxide evolution 
determined. The subsequent addition of 3.0 ml 15% w/v HBr in 
glacial acetic acid (prepared by bubbling HBr gas into A.R. 
glacial acetic acid) caused a further evolution of nitric 
oxide if any N-nitroso compound was present.
Using this procedure a rectilinear relationship was obtained 
between the amount of N-nitroso sarcosine and that of the 
nitric oxide produced up to at least 200 p.g of the 
nitrosamine. The limit of detection of N-nitrososarcosine, 
estimated at five times the signal noise, was approximately 
0.1 (ig. The coefficients of variation obtained by two 
independent operators in analysing nominal additions of 2.0 p.g 
N-nitrososarcosine to lOg powdered cornflakes were 9.7% and 
13.8%. The difference observed between the mean values 
obtained by the two operators (1.75 p.g and 2.07 jig) was not 
significant.
Nitric oxide was obtained similarly from the denitrosation 
with hydrogen bromide of all other N-nitroso compounds
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examined, which included the nitrosamine of both weakly basic 
(e.g. diphenylamine) and strongly basic (e.g. dimethylamine) 
amines, nitrosamides, and N-nitrososulphonamides.
For the differentiation of N-nitroso compounds from pther 
compounds potentially formed from nitrite in a biological 
matrix (Table 2.3), the above method relies on the different 
conditions required for their denitrosation. Some compounds 
such as pseudonitrosites decompose to nitric oxide in the 
refluxing solvents alone. For example, the pseudonitrosite of 
the unsaturated glyceride palmitodiolein, as well as that of 
cyclohexene decomposed to nitric oxide in refluxing ethyl 
acetate. No further nitric oxide response occurred following 
the subsequent addition of either acetic acid or hydrogen 
bromide in the same solvent. Similarly, the pseudonitrole, 
2-nitro-2-nitrosopropane, and the thionitrite, 
2-methyl-5-nitrosopropane-2-thiol, decomposed to nitric oxide 
in the refluxing solvents and did not give any further 
response under the conditions employed either for the 
determination of nitrite or for N-nitroso compounds.
The addition of glacial acetic acid produces nitric oxide from 
inorganic and alkyl nitrites. In addition to N-nitroso 
compounds, two other types of nitrogenous compounds, namely 
nitrolic acids and S-nitrothiols, are stable in acetic acid 
under the conditions of the test procedure but release nitric 
oxide upon addition of hydrogen bromide. Thus they could not 
be differentiated from N-nitroso compound by this procedure.
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The majority of other compounds potentially formed from 
nitrite in a biological matrix do not yield nitric oxide 
either in acetic acid or hydrogen bromide. This is 
essentially true of aromatic C-nitroso compounds, although 
nitric oxide equivalent to 0.02% and 0.01% of theoretical was 
released in acetic acid and hydrogen bromide respectively from
4-nitrosodiphenylamine. The evolution of nitric oxide from 
the aliphatic C-nitroso compound, 2-methyl-2-nitrosopropane 
under the various conditions relevant to the assay of 
nitrosamines and nitrosamides has been found to be dependent 
on the atmosphere above the solvent system. After refluxing 
in air in ethyl acetate with and without added acetic acid for 
various periods of time, nitric oxide equivalent to 
considerable proportions of that contained in the molecule was 
released following the addition of hydrogen bromide. Under an 
atmosphere of nitrogen, however, even after refluxing for 105 
minutes only up to 0.1% of the nitrogen content of the 
molecule was released as nitric oxide following treatment with 
hydrogen bromide. Thus it is essential to maintain an 
atmosphere of nitrogen during the differentiation of N-nitroso 
compounds.
Other compounds potentially derived from nitrite which have 
proved to be stable so far as breakdown to nitric oxide is 
concerned throughout the determination of N-nitroso compounds 
include nitrones, oximes, amine oxides, alkyl nitrates,
C-nitro and azoxy compounds.
The method is represented schematically in Fig. 2.2.
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Table 2.3
Compounds other than nitrosamines and nitrosamides potentially 
formed from nitrite
NO
/
^N-NO^ nitramine R2N0 nitroxide ^C pseudonitrate
(aminoxyl) / \
NO2
v *»*
-C-ONO alkyl nitrite -CONHOH hydroxamic -N=N- azoxy compound
 ^ acid |
0"
-C-N0 C-nitroso -SN0 thionitrite C—G pseudonitrosite 
/ compound | |x
NO N02
NOH NO
// i
-C nitrolic acid -SO^-N- nitroso- -CH=N0H oxime
\ sulphonamide
N0„
x + X \ /
.CsNR nitrone N-N0o nitramide C-C oxazetidine
i / 2 / | i v
0“ -CO N-0
/
\ v
/C-NR isonitrone -C-ONO^ alkyl nitrate -CN0 nitrile oxide 
\ / (oxaziridine)
0
\  X,
C=N0oH nitronic acid -C-N0o C-nitro -S-N0o thionitrate 
/  2. /  2 . . 2
compound
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Fig 2.2
Scheme Representing the Sequential Determination of Compounds 
Formed from Nitrite
Sample --- > Refluxing Ethyl
Acetate
i
Nitric oxide
Addition of ■ 
Glacial 
Acetic acid
I
Nitric oxide
-> Addition 
of
Hydrogen 
Bromide 
Nitric oxide
from
pseudonitrosites
thionitrites
pseudonitroles
from from
inorganic nitrites N-nitroso 
organic nitrites compounds
S-nitrothiols 
nitrolic acids
2.4.2 Gas Chromatographic Determination of N-nitroso 
Compounds
The Luminox method (Section 2.4.1) was devised in order to 
provide a measure of total N-nitroso compounds including those 
too involatile to be determined by gas chromatography, and as 
such it cannot characterise individual N-nitroso compounds. 
However, a nitrosamine specific gas chromatograph detector, 
the thermal energy analyser (TEA), is commercially available. 
The detection system is very similar to the Luminox method, in 
that the N-nitroso compounds are cleaved to give nitric oxide 
which is subsequently determined by a chemiluminescence 
analyser. The difference is that while the Luminox method 
uses chemical denitrosation, the TEA uses a flash catalytic 
heater to rupture the N-NO bond. It is because the TEA is a 
gas phase technique with the essential chemical sequences 
occurring in the gas phase and/or at the solid gas interface, 
that the TEA can be used as a gas chromatograph detector. The 
gas chromatograph column effluent is simply passed into the
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catalytic furnace where the N-NO bonds of any N-nitroso 
compounds are ruptured. The products then pass out of the 
furnace in the carrier gas stream to a cold trap which removes 
all except gaseous products. Finally the gaseous products are 
carried into the chemiluminescence analyser where any nitrosyl 
radicals produced from N-nitroso compounds are determined 
(Fine et al., 1975).
GC/TEA can in principle be used for the quantification and 
determination of any N-nitroso compound which is sufficiently 
volatile either with or without derivatisation for gas 
chromatography. Notable exceptions are the N-nitrosamides to 
which the TEA responds erratically with poor yields of the 
nitrosyl radical (Mirvish et al., 1979). This is thought to 
be because the N-nitrosamides undergo irreversible thermal 
rearrangement in the catalytic furnace of the TEA, to give 
diazo esters. These diazo esters would decompose to give 
nitrogen which would not be detected by the TEA (Chow, 1979).
0 0
1 'I 1r' c r ‘ 0
\  II
R1 C
R1OCOR
N0 + RCOOH
\
0
Recently, however, a modification of the TEA catalytic furnace 
has been described which enables the analysis of 
N-nitrosamides (Fine et al., 1983).
GC/TEA has been employed in the experiments included in this 
thesis for the analysis of the steam volatile dialkyl 
nitrosamines and simple heterocyclic nitrosamines, N-nitroso 
amino acids, and N-nitrosoiminodialkanoic acids. N-nitroso 
amino acids and N-nitrosoiminodialkanoic acids are not 
sufficiently volatile for successful gas chromatographic 
analysis, and were therefore methylated with diazomethane to 
give volatile derivatives before analysis (Sections 2.4.2.1,
2.4.2.2).
2.4.2.1 PREPARATION OF DIAZOMETHANE
Methylation was carried out using a freshly distilled solution 
of diazomethane prepared in the apparatus illustrated in Fig. 
2.3. The use of ground glass joints was avoided as these can 
cause the explosive decomposition of diazomethane.
2.14g of N-methyl-N-nitroso-p-toluenesulphonamide (Diazald) 
were dissolved in 30ml of diethylether in a 150ml round 
bottomed flask with a long neck and cooled in ice. To this 
solution was added a solution of 0.4g KOH in 10ml of 96% 
ethanol. If a precipitate formed more ethanol was added until 
the precipitate just dissolved. After 5 minutes, an ethereal 
solution of diazomethane was distilled from the reaction 
mixture using a hot water bath, a water condensor and a 
conical flask cooled in an ice bath as a receiver.
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Fig. 2.3
Apparatus for the Preparation of Diazomethane
Water condenser
Rubber
bungs
Joint made from a 
sleeve of rubber tubing
Diazald/ether 
KOH /ethanol
Hot water
Ice bath
Diethylether
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2.4.2.2 METHYLATION
After dehydration over anhydrous sodium sulphate, (Section 
2.2) the extract to be methylated was placed in a pear shaped 
flask. The solution was then cooled in ice and an ethereal 
solution of diazomethane was added dropwise with a glass 
pasteur pipette until the solution acquired a pale yellow 
colour. If the extract to be methylated was coloured, the 
presence of excess diazomethane was tested for by removing a 
few drops into a test tube, and introducing a glass rod 
moistened with glacial acetic acid. Immediate evolution of 
nitrogen indicated the presence of excess diazomethane and 
hence completion of the methylation reaction. The methylated 
solution was then left to stand for ten minutes following 
which time ether was removed using a stream of nitrogen, until 
the solution was almost but not completely dry. The products 
were then redissolved in 0.2ml of a suitable solvent for 
GC/TEA analysis.
2.4.2.3 GC/TEA CONDITIONS FOR THE ANALYSIS OF N-NITROSAMINES
Typical conditions for the analysis of N-nitrosamines by 
GC/TEA are given in Table 2.4. Typical chromatograms of 
mixtures of steam volatile nitrosamines, N-nitroso amino acids 
and N-nitrosoiminodialkanoic acids are given in Figs. 2.4,
2.5, 2.6.
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Fig. 2.4
GC/TEA of Steam Volatile N-nitrosamines
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Fig. 2.5
GC/TEA of N-nitroso Amino Acid Methyl Esters
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Fig. 2.6
GC/TEA of Nitrosated Dipeptide Methyl Esters
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2.5 Sample Analysis for Nitrite and Nitrate
2.5.1 Nitrite Test Tape
A semiquantitative nitrite determination was carried out on 
the majority of the gastric juice samples examined in order to 
obtain an instant assessment of the nitrite concentration in 
the samples before their stabilisation with sulphamic acid. 
This was an important consideration as the volumes of the 
samples were low and thus separate aliquots could not be 
retained for nitrite analysis.
The method employed Ames MN-Labstix" test tape which has a 
colour code indicating either an absence of nitrite or 
concentrations which were either low (greater than 0.01 
mmol/1) or high (greater than or equal to 0.2 mmol/1). In 
addition the test tape indicated the pH of the sample.
2.5.2 Nitrite Determination by the Modified Greiss Procedure
In some samples nitrite was assayed using the official AOAC 
method (Horwitz, 1975) as modified by Fiddler (1977).
Detailed experimental details will be given in the relevant 
sections.
2.5.3 Chemiluminescence Method of Nitrite/Nitrate 
Determination
The chemiluminescence method for the group determination of 
N-nitroso compounds described earlier (Section 2.4.1) can also 
be used to determine N0  ^and NO^ the reduction of
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NC>2 and NOg to nitrogen oxide being achieved by the 
addition of glacial acetic acid or a mixture of TiCl^ (3% 
w/v), and HBr (15% w/v) in glacial acetic acid respectively. 
Thus a sample can be analysed for NO^ , N-nitroso 
compounds and NO^ by the sequential addition of glacial 
acetic acid, HBr and TiCl^/HBr reagents. However, as 
previously mentioned the presence of water seriously affects 
the denitrosation reactions and thus this method is not 
suitable for the analysis of aqueous solutions of nitrite and 
nitrate.
Aqueous solutions can be analysed using different reducing 
agents as described by Cox (1980) who used a solution of 
sodium iodide in glacial acetic acid for nitrite reduction and 
a solution of ammonium molybdate and ferrous ammonium sulphate 
in sulphuric acid for nitrite plus nitrate reduction.
Where chemiluminescence has been used for the determination of 
nitrite and nitrate, the method of Cox has been adapted as 
follows
2.5.4 Nitrite Determination by Chemiluminescence
To the three necked flask (Fig. 2.1) was added 75ml of glacial 
acetic acid and 25ml of 0.2mol/l sodium iodide. When the 
reagents were refluxing and a steady baseline output had been 
obtained from the chemiluminescence analyser, a small aliquot 
of the aqueous sample for analysis was injected via the 
septum. Any nitric oxide evolved was determined, and nitrite 
was estimated by reference to a standard curve. As soon as
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nitric oxide evolution had ceased (3-5 mins) a further sample 
aliquot could be added, enabling the rapid determination of 
many samples. The reagents only required changing when a 
significant broadening of the nitric oxide response peaks 
occurred.
2.5.5 Nitrate Determination by Chemiluminescence
For determination of nitrate a similar procedure to that for 
nitrite determination was used except that the three necked 
flask contained 100ml of 50% v/v sulphuric acid containing 
0.5g ammonium molybdate and lg of ferrous ammonium sulphate. 
This reagent reduced both nitrite and nitrate to nitric oxide, 
therefore the nitrate concentration was calculated after 
subtraction of the nitrite concentration.
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CHAPTER 3
The Availibility of Nitrosatable Substrate 
for in vivo Nitrosation
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3. THE AVAILABILITY OF NITROSATABLE SUBSTRATE FOR IN VIVO
NITROSATION
3.1 Introduction
As discussed in Section 1.3, many types of substrate can act 
as precursor to N-nitroso compound. Due tb the ubiquity of 
these precursors in the diet it seems unlikely that the 
availability of nitrosatable nitrogen precursors is a limiting 
factor in the formation of N-nitroso compounds in vivo. 
However, earlier work has largely been limited to 
investigating precursors of simple steam-volatile 
N-nitrosamines and it was considered important to extend these 
studies to include precursors of non-volatile N-nitroso 
compounds. The Luminox method (Section 2.4.1) which allows 
the determination of total volatile and involatile N-nitroso 
compounds, was therefore applied to an investigation of the 
availability of nitrosatable compounds in some components of 
the diet and other exogenous sources, and in body fluids.
3.2 Methods
The nitrosatable substrates chosen for investigation to 
represent exogenous sources were boiled frozen codfish, Edam 
cheese, tobacco smoke condensate, and the tricyclic 
antidepressant nortriptylene. To represent endogenous 
sources, the human body fluids, gastric juice (pentagastrin 
stimulated and bile contaminated juices), bile, prostatic 
fluid, saliva and urine (normal and bacterially infected) were 
chosen. All the chosen substrates were nitrosated under the
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"exhaustive" conditions and in addition the exogenous 
substrates were nitrosated under the simulated gastric 
conditions described in Section 2.3.
After three hours the nitrosations were stopped by the 
addition of sulphamic acid and the products extracted into 
dichloromethane. The concentration of total N-nitroso 
compounds in the extracts was then determined by the Luminox 
method (Section 2.4.1). In addition after extraction, the 
aqueous fractions of the nitrosation mixtures of cod and 
cheese were freeze dried and portions of the freeze dried 
powder were analysed for N-nitroso compounds non-extractable 
into dichloromethane. Portions of the extracts of the 
nitrosation of saliva and gastric juice were concentrated 
using a Kuderna Danish evaporator and analysed by GC/TEA 
(Section 2.4.2). The nitrosated body fluids were also 
analysed by the Luminox method and GC/TEA before nitrosation.
Finally in the case of nitrosation of nortriptylene under 
simulated gastric conditions the effect of including vitamin C 
at a concentration of 5.0 mmol/1 (equivalent to the ingestion 
of 0.5 - 1 g vitamin C) was studied.
3.3 Results
3.3.1 Total N-nitroso Compound Determinations
The results of the total N-nitroso compound determinations are 
summarised in Tables 3.1 and 3.2.
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Table 3.2
Total N-nitroso Compounds Present in Physiological Fluids 
Before and After "Exhaustive" N-nitrosation
Physiological Fluid Amount of Total N-nitroso compounds
Before N-nitrosation After "Exhaustive" N-nitrosation
GASTRIC JUICE
(a) Pentagastrin stimulated
(b) With bile reflux
None detected 
0.45 {Jmol/1
65.1 [Jmol/1 
287 [I mol/1
Bile 0.5{j,mol/l 101 jj.mol/1
URINE
(a) Normal
(b) With bacterial infection
0.1111 mol/1 
3.59 [jmol/1
38.2 (jmol/1
62.2 (jmol/1
Saliva 0.01 j. mol/1 45 iimol/1
Prostatic fluid None detected 143 (imol/1
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3.3.2 The Effect of Vitamin C on the Nitrosation of
Nortriptylene
N-nitroso compounds were formed in the presence and absence of 
nortriptylene hydrochloride due to the presence of 
nitrosatable precursor in the gastric juice. The additional 
extractable N-nitroso compounds attributed to the drug 
amounted to 31 pg as N-nitrosonortriptylene, only a small 
proportion of the total dose. The inclusion of ascorbic acid 
at a concentration of 5.0 mmol/1 in the incubations reduced 
the additional nitrosation by 75%.
3.3.3 GC/TEA Determinations
3.3.3.1 N-NITROSO COMPOUNDS PRESENT IN NITROSATED GASTRIC 
JUICE
Only a small percentage (5.2%) of the N-nitroso compounds 
formed from the bile reflux gastric juice were found to be 
volatile without derivatisation, with N-nitrosodimethylamine 
(3.02 pmol/1) and N-nitroso-pyrrollidine (0.87 pmol/1) being 
identified. In addition five minor (total of 0.86 pmol/1) and 
two major (total of 14.12 pmol/1) unidentified peaks were 
obtained. No simple volatile N-nitroso compounds were 
produced from the pentagastrin stimulated gastric juice.
After derivatisation with diazomethane, again marked 
differences were apparent between the two samples of gastric 
juice. Methylation of the bile reflux gastric juice resulted 
in over 30% (88.3 pmol/l) of the total concentration of
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Fig. 3.1
GC/TEA of Nitrosated Gastric Juice after Methylation
6. 06
8. 03
9. 47
10. 45
12. 52
2.2. -47
32.88
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N-nitroso compounds being made amenable to gas chromatography 
(Fig. 3.1). The major compound present was identified as 
N-nitrosoproline (32.0 pmol/l), with at least 16 other 
unidentified compounds being present. In contrast methylation 
of the pentagastrin stimulated gastric juice only made 4.3% 
(2.83 jimol/1) of the N-nitroso compounds present sufficiently 
volatile for GC/TEA, with only two peaks being present in the 
chromatogram one of which corresponded to N-nitrosoproline 
(2.32 jjjmol/1).
3.3.3.2 N-NITROSO COMPOUNDS PRESENT IN NITROSATED SALIVA
Only a small percentage (7.75%) of the N-nitroso compounds 
formed from the precursors in saliva were found to be volatile 
without derivatisation, with N-nitrosodimethylamine 
(2.12 (imol/1), N-nitrosodiethylamine (0.06 umol/l) and 
N-nitrosopyrrollidine (2.19 pjnol/1) being identified. In 
addition a further unidentified peak was obtained in the 
GC/TEA chromatogram (0.12 |imol/l).
After derivatisation with diazomethane, however, 49.6% of the 
total N-nitroso compounds were made amenable to gas 
chromatography (Fig. 3.2). The major compound present was 
identified as N-nitrosoproline (20.8 (j.mol/1), with 
N-nitrososarcosine (1.2 pmol/l), and N-nitrosopipecolic acid 
(0.3 (imol/l) also being identified. Thus a total 
concentration of N-nitroso compounds of 25.7 umol/l could be 
found by GC/TEA, which represented 57% of the total 
N-nitrosocompound concentration found using the Luminox method.
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Saliva
3.4 Discussion
The results demonstrate the expected vast excess of 
nitrosatable precursors available in foods over that likely to 
be nitrosated in vivo. In addition they demonstrate the 
potential hazard of tobacco smoke, which is rich in 
nitrosatable nitrogen and of pharmaceuticals containing 
nitrosatable nitrogen atoms. For example a 50 mg dose of 
nortriptylene could yield 0.1 pinole of its N-nitroso 
derivative (Fig. 3.3).
Fig. 3.4
N-nitrosonortriptylene
NO
It is noteworthy that the inclusion of ascorbic acid to a 
concentration of 5.0 mmol/1 to the simulated gastric 
nitrosation reduced the nitrosation of nortriptylene by 75%.
Both cod and cheese were also shown to contain large amounts 
of precursors to complex non-extractable N-nitroso compounds. 
It is possible that after breakdown in the gut these may also 
form precursors of extractable N-nitroso compounds.
The body fluids analysed also contained large amounts of 
nitrosatable nitrogen available for in vivo N-nitrosation.
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Moreover, the amounts of N-nitroso compounds formed after 
exhaustive nitrosation were in vast excess to the preformed 
N-nitroso compounds present in the body fluids, indicating 
that it is the nitrosating agent and not the nitrosatable 
substrate that is the limiting factor governing the formation 
of N-nitroso compounds in these fluids.
The marked differences between the compounds present in the 
nitrosated gastric juice obtained from patients with 
gastro-intestinal reflux when compared with the "clean" 
gastric juice obtained by pentagastrin stimulation of fasting 
volunteers, suggest that the fluid entering the stomach is 
rich in nitrosatable nitrogen. The nitrosation of bile itself 
demonstrated that it does not contain sufficient precursors to 
explain the increased nitrosatability of reflux contaminated 
gastric juice. The observation of N-nitrosamino acids and the 
presence of compounds with similar chromatographic properties 
but longer retention times suggested that the precursors 
present in the reflux may be the peptides and amino acids 
resulting from protein digestion in the intestine.
It is interesting that the bacterially contaminated urine 
sample not only contained more preformed N-nitroso compounds 
but also more nitrosatable precursors than urine from a 
healthy person. The preformed N-nitroso compounds may be due 
to the role of bacteria in in vivo N-nitrosation and the 
increase in nitrosatable nitrogen may be due to the presence 
of bacterial metabolites (Section 1.1.6).
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CHAPTER 4
The Availability of Nitrosating Agent 
for in vivo N-nitrosation
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4. THE AVAILABILITY OF NITROSATING AGENT FOR IN VIVO
N-NITROSATION
4.1 Introduction
4.1.1 Salivary Nitrite
The estimate of the average per capita daily nitrite exposure 
discussed earlier was 29.7mg (Table 1.4). Of this estimate 
96% was deemed to be formed endogenously from nitrate, and in 
turn nearly 40% of this endogenous nitrite formation was 
estimated to have arisen from the oral reduction of dietary 
nitrate. It is probable that drinking water contributes 
nearly 30% of the total dietary intake of nitrate (Table 1.3) 
and therefore it was decided to study the effect of water 
borne nitrate on salivary nitrite concentrations.
Until recently, the main concern about nitrate in water 
supplies centred on its reduction to nitrite by bacteria 
within the colonised achlorhydric stomach of the young infant, 
to produce methaemoglobinaemia a condition hardly ever seen in 
the United Kingdom (Fraser & Chivers, 1981). Foetal 
haemoglobin is particularly susceptible to oxidation by 
absorbed nitrite, with the production of methaemoglobin, which 
cannot transport oxygen from the lungs to the tissues. In 
addition, the erythrocytes of the young infant can be 
deficient in methaemoglobin reductase, an enzyme which reduces 
the oxidised haem pigment to its active ferrous form. 
Furthermore, the young infant consumes a large proportion of 
its food in liquid form in water and thus the intake of
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nitrate from this source may be high in relation to blood 
volume. Unfortunately, methaemoglobinaemia has caused 
fatalities in young infants living in areas of high nitrate 
drinking water and in consequence the World Health 
Organisation has recommended a limit on its concentration for 
continuous use of 11.3mg/l as nitrate nitrogen (WHO, 1977). 
However, this limit is based on the hazards of infantile 
methaemoglobinoemia and does not take into consideration the 
potential risk of nitrite derived from nitrate in drinking 
water participating in the in vivo formation of N-nitroso 
compounds. Consequently a study has been made of the effects 
on salivary nitrite concentrations of ingestion of nitrate in 
water at concentrations up to and in excess of the WHO 
recommended limit.
4.1.2 Gastric Juice Nitrite
Nitrite produced in the saliva passes directly on swallowing 
into the acidic media of the stomach. The nitrite 
concentration in the stomach is usually much lower than that 
of the saliva due presumably to the dilution effect of the 
gastric contents, its disproportionation in the acid 
environment, and its reaction with phenolic, amine, sulphydryl 
and other compounds. As discussed earlier (Section 1.4.6.2) 
however, stomachs colonised by bacteria can contain much 
higher nitrite concentrations due to microbial reduction of 
dietary nitrate present in the stomach contents. The role of 
this microbial reduction of nitrate in the production of 
N-nitroso compounds in the stomachs of people with 
achlorhydria has been studied.
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4.1.3 Blood Nitrite
Nitrite produced in vivo can only participate in N-nitrosation 
reactions at its site of formation unless a transport 
mechanism exists to carry it to other sites. Thus the nitrite 
produced in the saliva can participate in nitrosation 
reactions in the stomach after swallowing. If nitrite could 
be transported by the blood, however, it could be involved in 
N-nitrosation reactions elsewhere in the body.
Although nitrite readily undergoes a coupled oxidation with 
oxyhaemoglobin to form nitrate and methaemoglobin (Fig. 4.1)> 
the initial reaction, which is dependant on the nitrite ion 
and hydrogen ion concentrations, is slow (Rodkey, 1976). Once 
methaemoglobin is formed, however, a second faster reaction 
ensues between oxyhaemoglobin and the nitrite salt of 
methaemoglobin which is directly dependant on the 
concentration of oxyhaemoglobin and on the square of that of 
methaemoglobin. Methaemoglobinaemia can result in this manner 
from nitrite produced microbiologically from nitrate in the 
colonised achlorhydric stomach of the young infant.
Nevertheless this second autocatalytic reaction only occurs 
after methaemoglobin concentrations of about 7% have been 
reached which is higher than that normally found in human 
blood of less than 5%.
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It was therefore decided to investigate the stability of 
nitrite in blood in vitro, and to measure its occurrence and 
transport in vivo.
FIGURE 4.1
The Reaction of oxyhaemoglobin with nitrite
4.1.4 Urinary Nitrite
The presence of nitrite in urine is used as a diagnostic test 
for the presence of bacterial infection of the urinary tract 
or bladder. The presence of high nitrite concentrations in 
the urine has been associated with high concentrations of 
N-nitroso compounds (Hicks et al., 1978; Brooks et al., 1972; 
Eisenbrand et al., 1976). Nitrite can be detected in the 
urine of healthy volunteers after the intake of large 
quantities of nitrate (Ellen et al., 1982), and concentrations 
of N-nitroso compounds are also found (Lakritz et al., 1982; 
Ohshima & Bartsch, 1981). It was therefore decided to measure 
the nitrite concentration in the urine of healthy individuals.
Fe3+Hb + NCL + H_0
3+ -
2Fe HbN09
_  34- , , „ - ,
02Fe2+Hb + N0~ + 2H+ + e 
2Fe3+Hb + 2N0' 
0„Fe2+Hb + 2Fe3+HbNO'
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4.2 Methods
4.2.1 Salivary Nitrite
A group of eight volunteers all of whom were non-smokers 
restricted their nitrate intake overnight by using distilled 
water for drinks, and by avoiding foods known to contain high 
concentrations of nitrate. During the following morning 3-4ml 
samples of saliva were collected every 30-45 minutes. 
Immediately after the third sample had been collected, 250ml 
of distilled water containing either 0, 5.6, 8.5, 11.3, 22.6 
or 45.2mg/l nitrate nitrogen (0 , 0.5, 0.75, 1, 2, 4 times the 
WHO limit) was drunk by the volunteers. The experiment was 
terminated after six samples had been collected so that the 
results would not be affected by the nitrate content of the 
volunteer's mid-day meal. Each nitrate concentration was 
studied in each volunteer on at least three occasions. Thus a 
typical timetable for each occasion was:-
Table 4.1 A Timetable of salivary sampling times during the 
nitrate drink experiment
9.00 am Saliva sample 1
9.30 am Saliva sample 2
10.00 am Saliva sample 3
NITRATE DRINK
10.30 am Saliva sample 4
11.00 am Saliva sample 5
11.45 am Saliva sample 6
EXPERIMENT TERMINATED
In addition the salivary concentration of nitrite was 
monitored throughout the day in six volunteers (Nos. 1, 2, 4,
6, 7, 8), who consumed their normal diets. The nitrate 
content of their mid-day meals was measured colorimetrically
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as nitrite (Section 2.5.2) following homogenisation, 
deproteinisation, and reduction to nitrite by shaking with 
spongy cadmium.
Immediately after collection the saliva samples were 
stabilised by the addition of a single pellet of sodium 
hydroxide A.R. (O.lg). Nitrite determinations were carried 
out on the saliva samples by the modified Greiss prodecure 
(Section 2.4.2), as follows:
lml of saliva was mixed with 4ml of deionised water and 
centrifuged at ca. 30,000 g for 15 minutes. Two 2ml aliquots 
(Test, Blank) of the supernatant were transferred to 5ml 
volumetric flasks. To one of the flasks (Blank) 25ml of 
sulphamic acid were added, and the solution made acidic (pH 
less than 2) if necessary with hydrochloric acid. This flask 
was then incubated at 65°C for 10 minutes to destroy any 
nitrite present, and cooled: After incubation of the blank,
lml of sulphanilamide/HCl reagent (0.5% in ca. 2.5 N HC1) was 
added to both the test and blank samples, and allowed to react 
for 5 minutes. Following this time lml of 1-Napthylethylene- 
diamine-dihydrochloride reagent (0.1% in 1^0) was added to 
both samples which were subsequently made up to 5ml with 
deionised water and left in the dark for 15 minutes to allow 
the colour to develop. The absorbance of the test sample at 
538nm was then measured using the sample blank as a 
reference. The nitrite concentration in the saliva was then 
calculated by reference to a standard curve, prepared by 
treating a range of standard nitrite solutions in the same way 
as the saliva samples.
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4.2.2 Gastric Juice Nitrite
During an extensive study of the occurrence of N-nitroso 
compounds in the human stomach (Section 5.1), the gastric 
juices were also tested for pH, NC^ concentration, and 
the presence of micro organisms. Unfortunately due to the low 
volumes of gastric juice obtained, and because the primary 
objective was to measure N-nitroso compounds a 
semi-quantitative method of nitrite analysis (Ames "N-Labstix" 
test tape) which did not require a separate sample had to be 
used (Section 2.5.1).
In all, 517 specimens of gastric juice were obtained via the 
aspiration channel of an endoscope from 320 patients with 
various gastro intestinal disorders and from 50 healthy 
volunteers acting as controls. Before each endoscopic 
examination the endoscope and its aspiration channel and 
polythene tubing were sterilised with activated glutaraldehyde 
and then rinsed with water. Every effort was made to avoid 
contamination of the gastric juice sample with saliva. 
Immediately after collection part of the sample was cultured 
for aerobic and anaerobic micro organisms by the hospital 
bacteriology laboratory using the method of Drasar and 
Crowther (1971) and its nitrate reducing activity was assessed 
by the method of Cowan and Steel (1974). The pH of the rest 
of the sample was then measured using either narrow range pH 
paper (Whatman), or a pH meter, and the presence of nitrite 
was tested for with nitrite test tape. The data was 
subsequently analysed using the Royal Statistical Society’s 
GLIM package: London 1977.
4.2.3 Blood Nitrite
To ascertain the stability of nitrite in whole blood 25ml 
samples of citrated pigs blood were "spiked" with sodium 
nitrite to a concentration of 60 (J.mol/1 and then incubated at 
37°C for either 0, 2, 5, 10, 15, 25, 30, 40, 50, 60 or 
120mins. After incubation each blood sample was immediately 
deproteinised by the addition of 100ml of absolute alcohol.
The precipitated protein was then removed by centrifugation, 
and the alcoholic supernatant filtered through a glass fibre 
filter paper. This filtrate was then evaporated to dryness on 
a rotary evaporator at 30°C, and the residue taken up in 
10ml of deionised water. Any remaining protein was then 
precipitated by the addition of 1ml of Carrez I solution 
followed by 1ml of Carrez II solution. The resulting 
deproteinised solution was filtered through a glass fibre 
filter paper into a 10ml measuring cylinder and the volume of 
the filtrate was recorded. The nitrite content of the 
filtrate was measured without delay using the modified Griess 
procedure (Section 2.5.2) by the addition of 1ml of 
sulphanilamide (0.5% in ca. 2.5M HC1) followed three minutes 
later by 1ml of 0.1% N-l-napthylethylenediamine 
dihydrochloride and diluting to 10ml. The absorbance at 538nm 
was measured after 15 minutes, and the nitrite concentration 
calculated by reference to a standard curve. This method was 
shown to give an 80% recovery of a nitrite spike added to the 
alcohol after the deproteinisation step, and this recovery 
figure was included in all calculations.
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The occurrence of nitrite was investigated in pig and human 
blood. After slaughter by exsanguination, pig blood was 
immediately deproteinised by draining directly into absolute 
alcohol. A further sample was collected, citrated and stored 
at room temperature for two hours before deproteinisation.
The experiment was carried out in triplicate on two different 
pigs. The nitrite concentrations were subsequently measured 
by the modified Griess procedure as above.
Two 25ml samples of human blood were obtained from blood bank 
stocks deproteinised with 100ml of absolute alcohol and their 
nitrite content was determined colorimetrically as described 
for pigs blood above.
Because, the nitrite concentrations in human blood were 
expected to be low, and because large samples as used above 
were difficult to obtain it was decided that a more sensitive 
method of nitrite analysis was required. A chemiluminesence 
detection method was chosen (Section 2.5.3) which had the 
following advantages:
(i) Increased sensitivity
(ii) Rapidity
(iii) No sample preparation was required thus minimising 
the possibility of sample contamination.
Two millilitres of blood were taken from the forearm of 
fifteen volunteers and centrifuged immediately. 0.5ml 
aliquots were then analysed by the chemiluminescence detection 
of the nitric oxide evolved after treatment with sodium iodide 
in glacial acetic acid (Section 2.5.4).
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In addition the transport of nitrite in blood was investigated 
in a volunteer who donated samples of blood and saliva at 
10.00 am, 10.55 am, 11.40 am, and 12.40 am.
In order to ensure an adequate supply of salivary nitrite to 
the blood, the volunteer drank a lemon drink containing 200mg 
(2.35 mmol) of sodium nitrate at 10.12am.
Aliquots of the whole blood were analysed by the 
chemiluminescence method (Section 2.5.3) for nitrite and 
nitrite plus nitrate within five minutes of collection by 
direct injection into the respective refluxing reducing 
reagents. The remaining sample was centrifuged immediately at 
1000 g to prepare a serum sample which was analysed for 
nitrite and nitrate by the same method as soon as possible.
The saliva samples were preserved with a pellet of sodium 
hydroxide and analysed the colorimetric method (Section 2.5.2) 
on completion of the rest of the experiment.
4.2.4 Urinary Nitrite
Owing to the low concentration of NO^ expected in normal 
urine the chemiluminescence method of analysis was used 
(Section 2.5.3). Urine samples from fifteen healthy 
individuals were stabilised by the addition of sodium 
hydroxide to about 0.5%. Nitrite was then determined by the 
direct injection of 0.5ml aliquots of urine into the sodium 
iodide/glacial acetic acid reducing system and measuring the 
nitric oxide evolved.
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4.3 Results
4.3.1 Salivary Nitrite
4.3.1.1 VARIATION IN SALIVARY NITRITE CONCENTRATION 
FOLLOWING THE INTAKE OF NITRATE IN DRINKING WATER
In general salivary nitrite concentrations increased 
immediately after consumption of the nitrate drink reaching a 
peak about one hour later (Fig. 4.2).
Fig. 4.3 illustrates the mean salivary nitrite concentrations 
for each volunteer before and after consumption of each 
nitrate drink.
The post drink salivary nitrite concentrations increased along 
with increasing nitrate concentration in the nitrate drink, 
although the scale of the increase varied from individual to 
individual, the largest increases being observed in volunteers 
from Group B. The most noticeable increases occurred when the 
nitrate drink contained more than 11.3mg NOg(N)/l, that 
is at concentrations higher than the WHO recommended limit.
Fig. 4.4 illustrates the mean increase in salivary nitrite 
concentration in all eight volunteers one hour after the 
consumption of the nitrate drink. Again with one exception 
(volunteer 2) significant increases in salivary nitrite 
concentrations were not found until the drink contained 
nitrate at concentrations greater than or equal to the WHO 
recommended limit.
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It was noted that not only did the two groups of volunteers A 
and B differ in their response to water borne nitrate, but 
that they also differed in the behaviour of their salivary 
nitrite concentrations before the drink. Members of group A 
showed relatively stable morning salivary nitrite 
concentrations with only small increases occurring after the 
consumption of a nitrate drink. Members of group B, however, 
had high and rapidly decreasing morning salivary nitrite 
concentrations which showed greater increases after 
consumption of nitrate. Thus a relationship has been shown 
between the rate of change in salivary nitrite concentration 
over the hour prior to the nitrate drink, and the increase in 
salivary nitrite concentration over the hour following the 
nitrate drink, Fig. 4.5. There was a linear relationship with 
a coefficient of correlation of 0.89. The values for the 
volunteers in group A form a cluster while those for the 
volunteers in group B are far more dispersed.
4.3.1.2 VARIATION IN SALIVARY NITRITE CONCENTRATION DURING 
THE DAY
Considerable individual differences were observed between the 
salivary nitrite concentrations of the volunteers during the 
morning before consumption of the nitrate drink (Figs. 4.6 and
4.7). The volunteers appeared to fall into two groups, those 
who had low (less than lOppm) and relatively constant salivary 
nitrite concentrations (Group A) (Fig. 4.6) and those who had 
higher and more variable initial nitrite concentrations
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RLg 4.5 Relationship of the increase in salivary nitrite concentration 
over 1 hour produced by the consumption of 11.3 mg NO, (N) 
to the fall in resting salivary nitrite concentration before 
consumption of nitrate. Volunteers who were less efficient at 
donverting nitrate to nitrite (+). Volunteers who were more 
efficient (©).
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fig A.6 Die salivary nitrite concentration of volunteers from
Group A during the morning before consumption of the
nitrate drink
Volunteer No 5 
Sample No
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Ilg b.7 Ihe salivary nitrite concentration of volunteers from
group B during the morning before consumption of the
nitrate drink
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showing a general fall during the morning (Group B) (Fig.
4.7). One of the volunteers arguably fell into a third group 
as his initial nitrite concentrations were consistently far 
higher than any of the other volunteers. The difference 
between these groups is also illustrated in Table 4.2 which 
gives the percentage of the morning readings over lOppm for 
each volunteer, calculated from at least 54 readings.
Table 4.2 The percentage of pre-nitrate drink saliva samples 
containing greater than 10 ppm NaN02 in each 
volunteer
Salivary NaN0£ Concentration ppm 
Group Volunteer % greater than Mean + SEM Range 
10 ppm
r l 85 26 + 2.4 81-3.5
r 2 60 12 4- 0.8 27-0.7
B f 3 35 11 + 1.9 64-2.3
( 4 42 9.0 + 0.7 20-0.3
r 5 13 5.9 + 0.5 11-1.0
A f 6 17 7.1 + 0.4 18-0
? 7 3 4.6 + 0.3 18-2.3
( 8 2 4.5 + 0.2 11-1.8
The salivary concentration of nitrite of the six volunteers 
Nos. 1, 2, 4, 6, 7, 8 who were monitored through the day are 
shown in Fig. 4.8. Again as expected volunteers (6, 7, 8) 
showed relatively constant and low salivary nitrite 
concentrations which generally fell during the morning whereas 
the other volunteers (Group B) had a higher initial salivary 
nitrite concentration which showed a general fall during the 
morning and a subsequent rise in the afternoon probably as a 
result of nitrate consumed at lunchtime. Table 4.3 lists the 
results of the nitrate analyses carried out on typical meals 
available in the staff canteen.
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Table 4.3
Nitrate Contents of Typical Mid-day Meals Available to 
Volunteers in Staff Canteen
Meal Weight
(g)
Main Course
Ham vol au vents, potatoes, 324
beans
Chicken and ham pie, 317
potatoes, mixed 
vegetables
Plaice, chipped potatoes, 305
peas
Steak and kidney pie, 310
potatoes, carrots
Sliced beef, potatoes, 301
mixed vegetables,
Yorkshire pudding
Beef cutlet, chipped 234
potatoes
Dessert
Ice Cream Roll 98
Plum crumble and custard 291
Apple Turnover 188
Nitrate Total Nitrate
Concentration mg NO3 (N) 
mg NO3 (N) kg"1
22
8.8
11
8.8
11
22
7.2
4.1
9.0
7.1
2.8
3.4
2.7 
3.3
5.1
0.7
1.2
1.7
4.3.2 Gastric juice nitrite
The semi quantitative method employed for the nitrite 
determination could give one of three different results, that 
is zero, low and high. Despite the limitations of the method 
a highly significant relationship between gastric pH and 
nitrite concentration was obtained (p less than 10 ). The
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presence of low but detectable levels of nitrite 
( 0.01 mmol/1) was associated with an increase of 2.5pH units
above the normal gastric pH (2.9), while a high level 
(>0.2 mmol/1) was associated with an increase of 2.9pH units 
above normal.
No significant difference in nitrite concentrations were 
observed between the sexes after taking into account all of 
the analysable factors. However, detectable nitrite levels 
were more common in the gastric juice of non-smokers than 
smokers (p = 0.047).
Raised nitrite concentrations as well as being associated with 
achlorhydria were accompanied by an increased growth of total 
and nitrate reducing bacteria although this was not 
statistically significant. Nevertheless, a highly significant 
relationship was established between the culturing of nitrate 
reductase organisms and elevation of pH (p = 0.0057), and 
therefore it seems likely that if a more accurate method of 
nitrite determination had been used the expected relationship 
would have been obtained.
4.3.3 Blood Nitrite
4.3.3.1 THE STABILITY OF NITRITE IN WHOLE BLOOD
The results are illustrated in Fig. 4.9. Of an initial 
concentration of 60|imol/l, 50% of the nitrite could still be 
recovered after between 10 and 15 minutes which is equivalent 
to about 25 complete circulations of the vascular system, and
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lower concentrations survived until the end of the 
experiment. Moreover, no attempt was made to prevent the 
oxidation of the haemoglobin by atmospheric oxygen and 
therefore methaemoglobin concentrations may have been 
unrealistically high and consequently the rate of nitrite 
oxidation faster than that in vivo.
4.3.3.2 THE OCCURRENCE OF NITRITE IN PIGS BLOOD
The results are given in Table 4.4, and illustrate the 
presence and stability of nitrite at low concentrations in 
pigs blood.
Table 4.4 The Nitrate content of pigs blood at slaughter and 
after 2 hours storage
Blood Nitrite Concentration mol/1
at slaughter after 2 hrs storage
1.1 0.52
Pig No. 1 0.75 0.40
0.95 0.62
Mean 0.93 0.51
1.2 0.87
Pig No.2 1.5 0.77
1.4 0.87
Mean 1.37 0.84
4.3.3.3 THE OCCURRENCE OF NITRITE IN HUMAN BLOOD
Low concentrations of nitrite were detected in some of the 
samples of human blood by both the colorimetric and 
chemiluminescence determinations.
Table 4.5 The Nitrite content of human blood
Nitrite content of human blood jj.mol/1
Volunteer Method
1 Colorimetric 0.16
2 " 0.08
3 Chemiluminesence none detected
4
5 "
6 
7 
8
9 .. ..
10 
11 
12
13
14
15 " 1.15
16 " 0.64
17 " none detected
4.3.3.4 THE TRANSPORT OF NITRITE IN HUMAN BLOOD
The results are summarised in Table 4.6.
Table 4.6 The Nitrite and Nitrate content of human blood 
before and after a Nitrate (2.35 mmol) drink
Time Saliva
[NO2] mmol/1
Blood
Serum
[N02](J-niol/l 
Whole Blood
Blood
Serum
[NO3] mmol/1 
Whole Blood
10.00am 0.27 ND ND 0.05 0.05
Nitrate Drink
10.55am 1.9 1.2 0.4 0.42 0.18
11.40am 1.1 1.2 0.4 0.42 0.15
12.40am 0.45 3.6 0.2 0.25 0.28
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The nitrate drink produced an increase in blood nitrate 
concentrations which in turn produced the expected increase in 
salivary nitrite concentration. Although initially nitrite 
was not detected in the blood, it became detectable, following 
this nitrate induced increase in salivary nitrite 
concentrations.
4.3.4 Urinary Nitrite
The results of the determinations are listed in Table 4.7.
Low concentrations of nitrite were found in all samples at 
concentrations ranging from 0.2 to 10.9 [imol/1. The 
significance of such low concentrations of nitrite in the 
nearly neutral environment of the urine and in the absence of 
bacterial catalysts is unknown.
Table 4.7
The concentration of nitrite in the urine of healthy volunteers 
Volunteer No. Nitrite concentration p. mol/1
1 2.93
2 1.02
3 1.07
4 2.53
5 4.44
6 1.40
7 2.65
8 2.49
9 1.40
10 2.17
11 0.20
12 0.47
13 10.9
14 2.17
15 1.44
Mean + S.E.M. = 2.485 + 0.685
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4.4 Discussion
In spite of its ready oxidation by oxyhaemoglobin, the 
experiments above demonstrate that nitrite can survive in 
blood for periods greatly in excess of the time required for 
circulation within the vascular system of about 30 seconds.
The discovery of low concentrations of nitrite in some samples 
of human blood further emphasised the possibility that low 
concentrations of nitrite could be transported throughout the 
vascular system. Futhermore, the appearance of nitrite in the 
blood could occur in a healthy human on a normal diet. If one 
assumes that the nitrite observed is at the same concentration 
in the whole blood volume then at the peak nitrite 
concentration measured (3.6 (imol/1 @ 12.40 am), the blood 
would contain approximately 20 moles of nitrite which is 
equivalent to only about 10ml of saliva at the peak nitrite 
concentration measured (1.9 mmol/1). It may be however, that 
blood nitrite concentrations represent the concentration in 
the total body water (60-70 litres) in which case the 
concentration of 3.6 p.mol/1 represents a very much larger 
reservoir of nitrite of 216 to 252 p.moles. Thus the body 
water may represent a pool of nitrite which is being 
continually replenished by microbial nitrate reduction and 
depleted by reaction to produce among other things N-nitroso 
compounds.
Nitrite was also found at similar concentrations in the urine 
of healthy volunteers and this again may be a reflection of a 
body pool of nitrite.
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Considerable individual differences were observed in salivary 
and urine nitrite concentrations and it may be that these 
represent simple diagnostic tools for the prediction of groups 
with a high risk from the in vivo formation of N-nitroso 
compounds. Certainly the volunteers from Group A appeared to 
produce a far greater amount of nitrosating agent destined for 
the acidic stomach than did the volunteers from Group B. Of 
the two females included in the salivary nitrite study 
(Volunteers No. 3 and 7) one showed a large increase in 
salivary nitrite concentration with increasing levels of 
nitrate in the drinking water whereas the other showed a far 
more gradual increase. On the basis of the small number of 
volunteers involved, therefore, it is unlikely that sex 
contributed to the considerable variations in nitrate reducing 
ability observed.
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CHAPTER 5
The Occurrence and Formation of 
N-nitroso Compounds in vivo
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5. THE OCCURRENCE AND FORMATION OF N-NITROSO COMPOUNDS IN
VIVO
5.1 Introduction
The experiments reviewed in Chapter 1 and undertaken in 
Chapters 3 and 4 support the hypothesis that supplies of 
nitrosatable nitrogen and nitrosating agent are available to 
allow in vivo N-nitrosation to occur. Comparisons between 
"exhaustive" and "simulated gastric" N-nitrosations of body 
fluids (Section 3.3) indicate that the supply of nitrosatable 
precursor particularly to the more complex non-volatile 
N-nitroso compounds is in vast excess to the estimated supply 
of nitrosating agent. It is therefore likely that one of the 
main factors governing in vivo N-nitrosation is the supply of 
nitrosating agent.
If in vivo nitrosation does occur these experiments suggest 
that the majority of the N-nitroso compounds formed would be 
fairly complex non-volatile molecules. In addition one would 
expect the total amount of N-nitroso compound found to be 
directly related to the supply of nitrosating agent, but 
reasonably independant of additional sources of nitrosatable 
nitrogen although obviously the amounts of any particular 
compound formed must be proportional to the supply of its 
precursors and relative ease of nitrosation.
To test these hypotheses, studies have been made of the 
occurrence of N-nitroso compounds in physiological fluids 
particularly in the gastric contents. In addition attempts
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have been made to discover the factors governing their 
concentration.
5.1.1 N-nitroso compounds in human gastric juice
A major experiment was undertaken to determine the 
concentration of N-nitroso compounds found in human fasting 
gastric juice and the factors influencing their formation. 
Fasting gastric juice was used in the experiments as the 
subjects studied were patients attending an endoscopy unit 
(Wexham Park Hospital, Slough) for endoscopic examination for 
a variety of gastrointestinal complaints, and such patients 
are routinely fasted for at least twelve hours prior to 
examination. In practice fasting facilitated sampling and 
ensured that the samples obtained from different patients were 
more comparable.
It became apparent from this study that factors affecting 
gastric pH and nitrite concentration such as certain 
medications and surgical procedures could have a commensurate 
effect on the intragastrie concentration of N-nitroso 
compounds. Further studies were made therefore of the 
concentration of N-nitroso compounds in the gastric juice of
1. patients treated with the H^-receptor antagonist, 
Cimetidine, which reduces gastric acid output.
2. patients who had undergone partial gastrectomy or 
vagotomy to reduce gastric acid secretion.
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3. patients taking large doses of vitamin C in an attempt to 
reduce gastric nitrite concentration.
5.1.2 N-nitroso compounds in bile
Many of the gastric juice samples which were found to be high 
in N-nitroso compounds in the above experiments obviously 
contained bile presumably resulting from the enterogastric 
reflux associated with many gastrointestinal disorders.
In addition high concentrations of N-nitroso compounds were 
associated with partial gastrectomy, a surgical procedure 
which results in the loss of the pyloric reflux barrier and 
consequently allows enterogastric reflux. It was decided 
therefore to determine whether the bile contained sufficient 
concentrations of N-nitroso compounds to account for the 
increased gastric juice concentrations apparently associated 
with enterogastric reflux.
5.1.3 N-nitroso compound in urine
The nearly neutral conditions found in the healthy urinary 
tract are not suitable for N-nitrosation by aqueous nitrous 
acid (Section 1.1.2) however, samples of urine from healthy 
individuals contain low concentrations of nitrite (Section 
4.3.4) and therefore it may be possible for N-nitrosation to 
occur by other mechanisms (Section 1.1.5). In addition not 
all of the N-nitroso compounds found in the gastrointestinal 
tract are metabolised, and these can be recovered unchanged in
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the urine (Ohshima & Bartsch, 1981). One such compound, 
N-nitroso proline has been used as a measure of the extent of 
in vivo N-nitrosation (Section 1.5.5).
Two studies have therefore been carried out. Firstly urines 
from normal healthy individuals have been analysed for total 
extractable N-nitroso compounds. Secondly, urinary excretion 
of N-nitroso proline has been monitored in individuals before 
during and after receptor blockade.
5.2 Methods
5.2.1 N-nitroso compounds in human gastric juice
301 specimens of gastric juice were obtained from 267 
untreated subjects (Table 5.1) including 50 healthy volunteers 
without any history of gastrointestinal symptoms and who were 
not taking drugs which might affect the conditions within the 
s tomach.
Table 5.1
The sex and age distribution of the patients who donated 
gastric juice samples for study
Number of Patients Age Range (yr) Number of Specimens
Male
Patients
Female
136 18-81 162
81 18-87 89
Male
Controls
Female
24 16-60
50
26 18-52
267 301
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The 217 patients suffering from gastrointestinal disorders 
were drawn from those attending Wexham Park Hospital, Slough 
for routine endoscopy. After examination they were placed in 
the diagnostic groups listed in Table 5.2.
The gastric juice samples were taken after an overnight fast 
of at least 12 hours via the aspiration channel of an 
endoscope, which had been treated as in Section 2.2 to prevent 
contamination of the samples.
Great care was also taken to avoid contamination of the 
gastric juice with saliva. Immediately after collection part 
of the sample was cultured for aerobic and anaerobic 
microorganisms, and its nitrate reducing activity was 
assessed. The pH of the rest of the sample was measured with 
pH paper (Whatman) or a pH meter and the presence or absence 
of nitrite tested for with Ames "N-Labstix" test tape (Section 
2.5.1). Sulphamic acid (50mg/10ml juice) was added and the 
specimens were immediately placed in a deep freeze at 
-20°C. In this way both acidic and hypochlorhydric gastric 
juices were stored frozen at below pH 2. The samples were 
then extracted as soon as practicable with ethyl acetate and 
analysed for total N-nitroso compounds using the Luminox 
method (Section 2.4.1). Owing to insufficient sample volumes 
91 of the specimens were not cultured for microorganisms.
The data obtained was analysed using the Royal Statistical 
Society's GLIM package: London 1977. The variables examined 
included age, sex, smoking habit, presence of nitrite, pH,
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N-nitroso compound concentration and bacteriology. To 
eliminate the risk of false associations owing to the small 
numbers in some groups, only first order and a few genuine 
second order interactions were examined. Exploration of the 
residuals from the fit indicated that a natural logarithmic 
transformation of N-nitrosamine concentration was appropriate 
to obtain an approximately normal distribution, and this was 
used throughout the analysis.
Table 5.2
The Diagnostic Groups of Patients who Donated Gastric Juice 
Samples for Study
Group Number of Patients Number of Specimens
Duodenal Ulcer 70 77
Vagotomy 24 26
Partial Gastrectomy 14 16
Atrophic Gastritis 13 14
Gastric Ulcer 33 52
Pernicious Anaemia 16 17
Carcinoma of the Stomach 23 23
Reflux Oesophagitis 
Miscellaneous Dyspepsia
10 12
with Normal Endoscopy 14 14
Controls 50 50
Total 267 301
5.2.1.1 THE EFFECT OF CIMETIDINE ON INTRAGASTRIC
CONCENTRATIONS OF N-NITR0S0 COMPOUNDS
216 specimens of gastric juice were obtained as above from 140 
patients with various gastroduodenal conditions (Table 5.3) 
and who had been treated with cimetidine in daily doses of 0.2 
to 1.6g for periods of 1 week to 45 months.
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Table 5.3
The diagnostic groups from which samples were obtained for the
study of the effect of cimetidine on the intragastric
concentration of N-nitroso compounds
Group Patients Samples
n = 140 n = 216
Post Vagotomy 15 22
Post Partial Gastrectomy 4 5
Duodenal Ulcer 74 122
Atrophic Gastritis 5 5
Gastric Ulcer 24 40
Reflux Oesophagitis 7 8
Miscellaneous dyspepsia/ 11 14
normal mucosa on endoscopy
In addition serial studies were carried out in 53 patients 
undergoing cimetidine treatment. In 30 patients gastric juice 
samples were taken before, and after treatment for 3 to 9 
weeks (mean 6 weeks), with daily doses of 0.8 to 1.6g (usually 
lg) of cimetidine. In 23 patients a sample was taken during 
the treatment period which ranged between 1 and 48 weeks and 
again to 1 to 40 weeks after cimetidine treatment had been 
discontinued.
All the gastric juice samples were processed for pH, nitrite, 
bacterial culture with special reference to nitrate-reducing 
bacteria and measurement of total extractable N-nitroso 
compounds as described in section 5.2.1. One to four hours 
prior to endoscopy the patients were asked to take one 200mg 
tablet of cimetidine.
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The data were analysed using the GLIM package (Royal 
Statistical Society, London: 1977) and compared with the 
results obtained for untreated patients (Section 5.2.1).
5.2.1.2 THE EFFECT OF GASTRIC SURGERY ON INTRAGASTRIC 
N-NITROSO COMPOUND CONCENTRATION
Fasting gastric juice samples were obtained at endoscopy from 
patients who had undergone partial gastrectomy or vagotomy 1 
to 40 years previously. Details of the patient groups are 
given in Table 5.4. The samples were cultured for total and 
nitrate reducing bacteria and analysed for pH, nitrite 
concentration, and total extractable N-nitroso compound 
concentration as in Section 5.2.1. The data obtained were 
compared with that from 20 gastric carcinoma cases and 50 
healthy endoscopically normal controls, using the Royal 
Statistical Society's GLIM package, London 1977.
5.2.1.3 THE EFFECT OF ASCORBIC ACID TREATMENT ON THE 
CONCENTRATION OF N-NITROSO COMPOUNDS IN THE GASTRIC 
JUICE OF ACHLORHYDRIC SUBJECTS
A total of 229 fasting gastric juice samples were obtained 
from 51 patients with hypochlorhydria before, during and 4 
weeks after treatment with Vitamin C (Table 5.5). During the 
treatment period the patients took lg of Vitamin C four times 
per day for four weeks. Where possible each patient gave two 
samples, one week apart before treatment, two samples after 2
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Table 5.4
Details of patients who underwent gastric surgery and provided 
samples for the study of the effect of gastric surgery on 
intragastric N-nitroso compound concentration
Patients Age
Total M F Range Mean
Controls 50 24 26 16-60 29.5
Partial Gastrectomy 
i) Bilroth 1 16 9 7 57-74 65.3
ii) Bilroth 2 34 25 9 40-88 64.0
iii) Stomach 
Cancer 20 12 8 54-89 73.2
Vagotomy 
i) Proximal 
Gastric 17 11 6 19-62 46.8
ii) Truncal with 
pyloroplasty 26 20 6 27-78 48.7
Table 5.5
The diagnostic groups from which samples were obtained for the 
study of the effect of Vitamin C on the intragastric 
concentration of N-nitroso compounds
Diagnosis Treatment period
Before During After
Patients Samples Patients Samples Patients Samples
Pernicious Anaemia 16 29 16 30 9 11
Partial Gastrectomy 21 41 20 33 10 11
Atrophic Gastritis 14 25 14 25 9 10
Vagotomy 4 6 4 8 0 0
Totals 55 101 54 96 28 32
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and 4 weeks treatment with Vitamin C and a further two samples 
4 and 5 weeks after treatment had been discontinued. In all 
cases at least one sample was obtained during each period 
except for the vagotomy patients where no samples were 
obtained after treatment.
The samples obtained were analysed for pH and total 
extractable N-nitroso compounds (Section 5.2.1) and the data 
analysed using the Wilkoxen-matched pairs test.
5.2.2 N-nitroso compounds in human bile
Bile samples were obtained from patients being treated at 
Whipp's Cross Hospital for gall stones or malignant disease of 
the pancreas or colon with no gall stones. The samples were 
collected via a T-tube or by drainage of the surgically 
removed gall bladder. Unfortunately control samples of bile 
from healthy individuals were unobtainable due to the invasive 
sampling technique. The samples were stabilised by the 
addition of sulphamic acid to a concentration of 0.5% w/v and 
stored frozen (Section 2.1). Ethyl acetate extracts of the 
samples were prepared (Section 2.2) and analysed for total 
extractable N-nitroso compounds by the Luminox method (Section
2.4.1).
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5.2.3 N-nitroso compounds in human urine
5.2.3.1 TOTAL N-NITROSO COMPOUNDS AND N-NITROSAMINO ACIDS
Six 24 hour samples of urine were collected from six healthy
individuals without urinary tract infection while consuming
their normal diets. The samples were stabilised with
sulphamic acid (Section 2.1) and after noting the total volume
of the 24 hour sample a portion was extracted with ethyl
acetate (Section 2.2). Total extractable N-nitroso compound
concentration was subsequently measured in this extract by the
Luminox method (Section 2.4.1). In addition a further 25ml
aliquot of each 24 hour urine sample was mixed with 5ml of
H^SO^ (3 mol/1) containing 1.0% w/v sulphamic acid. 20 ml
TMof this mixture were placed on a Preptube 2020 extraction 
column (Thermo Electron Co Ltd) and allowed to equilibrate for 
5 minutes. N-nitrosoamino acids were then eluted with 4 x 
20ml of ethyl acetate waiting 2 to 3 minutes between each 
addition. The eluate was dried over anhydrous sodium 
sulphate, filtered and reduced in volume to c 0.5ml using a 
rotary evaporator. N-nitroso amino acids were then determined 
by GC/TEA following derivatisation with diazomethane (Section 
2.4.2). Recoveries of N-nitroso proline from spiked samples 
were found to be better than 90% with a detection limit of 
3pg/l.
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5.2.3.2 EXCRETION OF URINARY N-NITROSOPROLINE BEFORE,
DURING AND AFTER ^  RECEPTOR BLOCKADE
Eight healthy male volunteers (age range 28 - 45 years) were 
studied over a 6 day period. On every day shortly after 
arising each subject drank 200ml of fresh chilled beetroot 
juice (nitrate concentration 1.09mg N0^ ml to 
provide an intake of nitrate of 218mg N0^. Thirty 
minutes after the beetroot juice, one capsule containing 50mg 
proline was swallowed and the subject then continued to eat a 
normal diet throughout the day with restriction only on intake 
of cured meat such as hamburgers, bacon or smoked ham, in an 
attempt to standardise the daily nitrate intake and minimise 
intake of preformed N-nitroso compounds. Advice was given 
that beer and spirits were best avoided throughout the study, 
but if the volunteers preferred they could have these drinks 
providing that approximately the same quantity was ingested on 
each of the six days of the study. Each subject emptied his 
bladder before drinking the beetroot juice and 24 hour urine 
collections were made for each of the six days of the study. 
The urine was stabilised by the addition of lOg of sodium 
hydroxide to each 24 hour container, at the start of each 
collection period. On the third and fourth days of the study 
a 150mg tablet of the powerful H^-receptor blocker,
Ranitidine, was taken prior to drinking the beetroot juice and 
again 12 hours later. On days five and six each subject 
omitted the ranitidine but continued to ingest the beetroot 
juice and proline as before.
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After noting the total volume of each 24 hour urine sample, 
25ml aliquots were extracted as in Section 5.2.3.1 and 
analysed for the presence of N-nitrosamino acids by GC/TEA 
following derivatisation with diazomethane (Section 2.4.2).
5.3 Results
5.3.1 N-nitroso compounds in human gastric juice
5.3.1.1 THE EFFECT OF AGE
N-nitroso compound concentrations rose progressively with age,
even after taking into account the influence of pH. In the
samples obtained from patients this rise was statistically
significant with the concentration ranging from 0.01 to
40p.mol/l (Table 5.5). The regression coefficient of
N-nitrosamine on age being 0.02p.mol/l per year (p = 0.56 x 
-4 .10 ) (Fig. 5.1). In the control samples the N-nitroso
compound concentration ranged from 0.02 to 1.1 p.mol but the 
increase failed to reach significance.
The patients also showed a significant rise in gastric pH with 
age. The pH in these samples varied from 1.0 to 9.0 with the 
regression coefficient of pH on age being 0.031 units per year
(p < 10-6).
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Table 5.5
The range of age, pH and intragastric N-nitroso compound 
concentration in the volunteers studied
Group Age Range pH Range N-N=0 Range
Control 18-60 1 to 7 0.02- 1.1 jimol/l
Patients 18-87 1 to 9 0.01-40 {J.raol/1
5.3.1.2 THE EFFECT OF SEX AND CIGARETTE SMOKING
No significant differences in the concentration of N-nitroso 
compounds or nitrite were observed between smokers and 
non-smokers after taking into account all other analysable 
factors. However, N-nitroso compounds were significantly 
higher in the gastric juice of males being an average 
1.55 [imol/l higher than females (p = 0.0036).
5.3.1.3 THE EFFECT OF GASTRIC pH
There was a highly significant relationship between gastric 
N-nitroso compound concentration and pH even after taking into 
account all other factors and their interactions.
The concentration of N-nitroso compounds rose progressively 
with pH (Fig. 5.2) from a geometric mean of 0.10 p.mol/1 at pH 
1 to 1.5 to a mean of 1.20 p.mol/1 at pH 6.5-9.0, with a 1.5 
fold increase in N-nitroso compound concentration per pH unit, 
the regression coefficient (b) of N-nitroso compound on pH 
being 0.44 (p < 10 )^ (Fig. 5.3).
This significant correlation between pH and the concentration 
of N-nitroso compounds was also seen in several of the
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diagnostic groups when they were considered individually.
These groups were duodenal ulcer (b = 0.51; p = 0.91 x
- 6 -4
10 ), post-vagotomy (b = 0.61; p = 0.4 x 10 ), gastric
ulcer (b = 0.54; p = 0.0061), and pernicious anaemia (b =
0.62; p = 0.0052). In addition those conditions known to be
associated with reduced gastric acidity and thus raised pH
such as pernicious anaemia, gastric carcinoma, and partial
gastrectomy showed the highest mean concentrations of
N-nitroso compounds (Fig. 5.4).
5.3.1.4 THE EFFECT OF GASTRIC NITRITE CONCENTRATION
The relationship between gastric nitrite concentration and 
achlorhydria has already been discussed in Section 4.3.2. The 
semi-quantitive method of nitrite analysis used (Section
2.5.1) gave one of three results either zero (< 0.01 mmol/1), 
low (0.01 mmol/1 > <0.2 mmol/1), high (> 0.2 mmol/1). Mean 
concentrations of N-nitroso compounds were higher at both 
"low" and "high" nitrite concentrations than at "zero" nitrite 
concentration. "Low" nitrite concentrations were associated 
with a 1.7 fold increase in the concentration of N-nitroso 
compounds (p = 0.043); and "high" nitrite concentrations were 
associated with a 2.4 fold increase (p = 0.021).
5.3.1.5 THE EFFECT OF GASTRIC MICROORGANISMS
There was a significant association between nitrate 
reductase-positive organisms and raised gastric pH (p =
0.028). In addition although it was not possible to carry out 
quantitative microbiology on these samples, a highly
215
M
ean 
pH
KLg 5-^ Ihe relationship between gastrointestinal condition, intragastric 
pH and the concentration of total N-nitroso compounds in the 
gastric juice.
Geometric mean N-Nitrosamine concentration (pm o lM )
LTI o  LTI
“1----------------- 1----------------- r
CZ in
m  ©ro
UJ
S  ©
C*
Cl ^
Cl •r->
D
“ 3n
ui
ON
oo
“a
>
N = Normal Oes = Reflux Oesophagitis Gas = Atrophic Gastritis 
DU = Duodenal Ulcer V = Vagotomy GU = Gastric Ulcer 
PG = Partial gastrectomy Care = Carcinoma of the stomach 
PA = Pernicious anaemia
216
significant relationship was established between the culturing 
of nitrate reductase-positive organisms and the concentration 
of N-nitroso compounds (p = 0.31 x 10 "*).
5.3.1.6 THE EFFECT OF CIMETIDINE TREATMENT
An equally strong correlation was demonstrated between pH and 
N-nitrosamine concentration in the stomachs of 
cimetidine-treated patients as in the untreated patients (Fig.
5.5). The concentration of N-nitroso compounds rose 
progressively from a mean of 0.11 p.raol/1 at pH 1 to 1.5 to a 
mean of 1.66 p.mol/1 at pH 6.5 to 9 (p < 10 in treated 
patients compared with 0.10 .^mol/1 to 1.2 (imol/1 in untreated 
patients.
The slopes for the regression (b) of the natural logarithm of 
N-nitroso compound concentration on pH in the treated and 
untreated patients were 0.49 and 0.47 respectively. The 
difference between these two slopes was not significant 
indicating that cimetidine treatment did not directly 
influence intragastric N-nitroso compound concentrations.
Nevertheless, as expected, gastric pH levels were 
significantly increased during cimetidine treatment being on 
average 0.5pH units higher (p = 0.0025). This increase in pH 
was accompanied by an overall 1.5 fold increase in the mean 
concentration of N-nitroso compounds (p = 0.021) in cimetidine 
treated patients when compared untreated patients in the same 
diagnostic groups with higher mean concentrations seen in the
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cimetidine treated individuals in each of these groups (Fig.
5.6). Thus although the concentrations of N-nitroso compounds 
were not directly affected by cimetidine treatment, increased 
intragastric concentrations of these compounds were observed 
during cimetidine treatment in association with an increased 
gastric pH.
The large number of samples (n = 122) from duodenal ulcer 
patients enabled a significant correlation to be observed 
between cimetidine induced pH elevation and gastric N-nitroso 
compound concentration in this diagnostic group alone, with 
the concentration of N-nitroso compounds being on average 2.8 
times higher during cimetidine treatment (p = 0.0083).
Curiously, in duodenal ulcer patients treated with cimetidine 
(n = 41) smoking reduced gastric N-nitroso compound 
concentrations by 63% (p = 0.031), whereas in patients who had 
had vagotomies, the concentrations of N-nitroso compounds were
10.7 fold higher (p = 0.031) in smokers.
Gastric nitrite concentrations rose and the growth of 
nitrate-reducing bacteria increased more often in cimetidine 
takers compared with untreated patients. Again this could be 
attributed to the pH change produced by cimetidine, the trends 
being no different to those expected in patients with other 
causes of hypochlorhydria.
No significant differences in the concentrations of N-nitroso 
compounds were seen between the sexes during cimetidine 
treatment.
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The results of the serial studies are illustrated in Figs. 5.7
and 5.8. Cimetidine treatment resulted in higher gastric pH
levels in 73% of patients and increased the concentration of
N-nitroso compounds in 86% of patients. Both of these
increases reached significance, the mean pH rose from pH 2.3
to pH 4.1 (p = 0.00048) and the geometric mean concentration
of N-nitroso compounds rose from 0.08 to 0.47 jjmol/1 (p =1.9 
-6
x 10 ) with the increases being independent of diagnostic
group. Discontinuation of cimetidine treatment on the other 
hand reduced gastric pH in 74% of patients with the mean fall 
from pH 3.4 to 2.3 being significant (p = 0.0082), However, 
although gastric concentrations of N-nitroso compounds fell in 
70% of the patients with a geometric mean reduction from 0.30 
to 0.16 pmol/l this reduction was not significant.
5.3.1.7 THE EFFECT OF GASTRIC SURGERY
The results are summarised in Table 5.6. As expected a highly
significant relationship was demonstrated between gastric pH
“6
and concentration of N-nitroso compounds (p < 10 ).
Partial gastrectomy, which led to significant increases in 
gastric pH, nitrite concentration and nitrate reducing 
bacteria, produced concentrations of N-nitroso compounds very 
similar to those found in gastric cancer patients. Proximal 
gastric vagotomy did not produce any significant changes 
within the stomach whereas truncal vagotomy and pyloroplasty 
produced marked rises in gastric pH in some patients enabling 
growth of nitrate reducing bacteria in over half of the 
samples and leading to high concentrations of N-nitroso 
compounds.
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Fig 5.7 Intragastric pH and total N-nitroso compound concentrations
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Table 5.6
The effect of gastric surgery on the intragastric 
concentrations of nitrite and N-nitroso compounds, gastric pH, 
and the growth of nitrate reducing bacteria
Gastric Juice Specimens
Diagnostic Group Subject Sample Mean % %N03 Geometr
n n pH N02 reducing mean NNi
Normal controls 50 50 2.9 6
bacteria
cultures
6
concent: 
p. mo 1/1
0.14
Partial Gastrectomy
i) Billroth 1 16 19 5.7 47 53 0.86
ii) Billroth 2 34 60 4.9 50 66 1.31
Stomach Carcinoma 20 26 4.1 59 56 1.04
Vagotomy 
i) Proximal 
Gastric 17 18 1.8 0 12 0.16
ii) Truncal with
pyloroplasty 26 26 2.9 21 57 0.94
5.3.1.8 THE EFFECT OF VITAMIN C
The results are summarised in Table 5.7. No significant 
change in gastric pH was observed during Vitamin C treatment 
in any group. When the results from all the patients were 
taken as a whole, the mean concentration of N-nitroso 
compounds was significantly reduced during Vitamin C treatment 
(p = 0.02) whereas no difference was noted between the levels 
before and after treatment (p = 0.47). This significant 
reduction in the concentration of N-nitroso compounds was also 
noted in the partial gastrectomy group (the largest group 
studied) on its own (p = 0.027) but not in the other groups.
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Table 5.7
Results of N-NO compound analysis and pH determinations on
gastric juice samples from patients before during and after
Vitamin C treatment
Group Treatment Period
Before During After
Mean + SEM Mean + SEM Mean + SEM
pH [NN0] (j.mol/1 pH [NN0] pi mol/1 pH [NN0J ptmol/1
Pernicious Anaemia 6.2 + 0.1 7.41 + 2.62 6.0 + 0.1 9.06 + 4.14 6.1+ 0.2 12.5 + 4.92
Partial Gastectomy 5.4 + 0.3 5.00 + 1.41 5.4 + 0.3 1.98 + 0.52 5.3 + 0.2 9.76 + 5.78
Atrophic Gastritis 5.4 + 0.2 7.30 + 3.19 5.3 + 0.3 3.40 + 1.44 4.8 + 0.6 4.33 + 3.17
Vagotomy 4.9 + 1.0 3.97 + 1.80 4.9 + 0.4 2.89 + 1.21 —  —
Totals 5.6 +0.1 6.21 + 1.22 5.5 + 0.1 4.51 + 1.34 5.4 + 0.2 8.88 + 2.77
5.3.2 N-Nitroso compounds in bile
The concentrations of N-nitroso compounds found (Table 5.8),
were similar to those found in normal gastric juice. Using an
unpaired students T-test, there was no significant difference
between the two patient groups.
Table 5.8
Total N-nitroso compounds concentrations in bile samples from
patients with gall stones or pancreatic cancer
Concentration of N-nitroso compounds (p, mol/1)
Patients No of Samples Mean Median Range
Gall Stone Patients 25 0.12 0.10 0 - 0.5
Pancreatic Cancer
Patients 11 0.05 0.04 0 - 0.22
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5.3.3 N-nitroso compounds in urine
5.3.3.1 TOTAL N-NITROSO COMPOUNDS
The results of the determinations of total extractable 
N-nitroso compounds in the urines of healthy individuals are 
given in Table 5.9. The amounts of N-nitroso compounds 
excreted over the 24 hour sampling period varied widely, 
ranging from 0.068 {imoles to 0.653 (imoles with a mean value of 
0.272 pmoles. The lowest concentrations of N-nitroso 
compounds were excreted by volunteer 1 who excreted 
significantly less N-nitroso compound than volunteers 2, 3 and 
6. Thus the volunteers could be split into two significantly 
different groups with volunteers 1, 4 and 5 (group A) 
excreting less than 0.2 p.moles/24 hours and volunteers 2, 3 
and 6 (group B) excreting more than 0.3 p.moles/24 hours.
5.3.3.2 N-NITR0S0 AMINO ACIDS
The results of the determinations of N-nitrosamino acids in 
the urines of healthy individuals consuming their normal diets 
are given in Table 5.10. Only three N-nitrosoamino acids were 
identified, namely N-nitrososarcosine (NSAR), N-nitrosoproline 
(NPR0) and N-nitrosothiazolidine-4-carboxylic acid (NTCA).
The amounts of N-nitrosoamino acid excreted over the 24 hour 
sampling period ranged from none detected (less than 1 nmole) 
to 152 nmole which represented only 17.4% of the mean 
concentration of total N-nitroso compounds excreted. Again, 
the lowest concentrations of N-nitroso compounds were excreted 
by Volunteer 1 who excreted significantly less N-nitroso
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compound than volunteers 2, 3 and 6. Thus the volunteers 
could again be split into the same two significantly different 
groups with Group A excreting less than 40 nmoles/24 hours and 
group B excreting more than 60 nraoles/24 hours. The 
difference between the two groups was due to differences in 
the excretion of NPRO and NTCA, with NSAR excretion being 
similar in both groups.
Table 5.9
Total N-nitroso compound excretion in urines from healthy 
individuals on normal diets
Volunteer N-nitroso compound excreted/24 hours moles x 10“^
No of sample Mean + SEM Range
1 6 0.172+0.034 0.068-0.293
2 6 0.432+0.072 0.253-0.653
3 6 0.318+0.073 0.117-0.540
4 6 0.194 + 0.040 0.049 - 0.306
5 6 0.182 + 0.031 0.128 - 0.318
6 6 0.336 + 0.065 0.170 - 0.565
Total 36 0.272 + 0.025 0.049 - 0.653
Group A
( 1 + 4 + 5 )  18 0.183 + 0.019* 0.049 - 0.318
Group B
( 2 + 3 + 6 )  18 0.362 + 0.040* 0.117 - 0.653
* Group B excreted significantly more N-nitroso compounds 
than Group A p < 0.005. Students T-test
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Table 5.10
N-nitrosamino acid excretion in urines from healthy 
individuals on normal diets
N-nitrosamino acid excreted/24 hour
Mean moles x 10"9
Volunteer No of samples NSAR NPRO NTCA Total % of Total
1 6 9.4 2.4 1.0 12.8 + 5.5 7.4
2 6 9.5 38.5 30.1 78.1 + 21.2 18.1
3 6 5.7 19.0 41.9 66.6 + 28.6 21.0
4 6 4.4 11.0 23.0 38.4 + 14.3 19.8
5 6 5.1 12.6 6.5 24.2 + 8.4 13.3
6 6 4.3 28.9 30.1 63.3 + 24.2 18.8
Total 36 6.4 18.7 22.1 47.2 + 7.8 17.4
Group A 
(1 + 4 + 5) 18 6.3 8.7 10.2 25.2 + 5.93* 13.8
Group A 
(2 + 3 + 6) 18 6.5 28.8 34.0 69.3 + 12.8* 19.1
* Group B excreted significantly more N-nitrosoamino acids than Group A 
p < 0.0025. Students T-test
5.3.3.3 URINARY N-NITR0S0PR0LINE, BEFORE, DURING AND AFTER 
h2 RECEPTOR BLOCKADE
The samples contained TEA positive compounds with coincident 
retention times to N-nitroso proline and N-nitroso 
thiazolidine-4-carboxylic acid and the individual results for 
each volunteer are shown in Table 5.11. As the data were not 
normally distributed they were evaluated by a ranking method 
using the Wilcoxon Rank Sum test for individual comparisons.
^-receptor blockade had previously been shown to result in 
higher intragastric concentrations of N-nitroso compound
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(Section 5.3.1.6). However, Ranitidine did not significantly 
increase the 24 hour urinary output of N-nitrosoproline, in 
fact if anything the output decreased. In contrast to the 
N-nitroso proline results, ^ “blockade significantly 
increased the urinary output of N-nitrosothiazolidine- 
4-carboxylic acid. This increase in output was due largely to 
an increased urinary concentration of NTCA (Table 5.12) rather 
than any effect on urinary volume.
Table 5.11
N-nitrosoproline (NPRO) and N-nitrosothiazolidine-4-carboxylic 
acid (NTCA) 24 hour urinary outputs (nmoles)
Subject Days
1 2 3 4 5 6
1 NPRO 69 ND ND ND ND ND
NTCA ND 59 ND 21 45 ND
2 NPRO 49 43 52 ND 35 60
NTCA 43 ND 190 140 ND ND
3 NPRO 59 58 55 46 ND 125
NTCA ND ND 68 ND 120 160
4 NPRO 40 41 22 46 ND 50
NTCA 26 31 80 62 ND 28
5 NPRO 3500 1100 2100 580 560 300
NTCA ND ND ND 200 ND ND
6 NPRO 900 230 390 97 100 100
NTCA ND ND 148 390 ND ND
7 NPRO 54 26 ND ND ND ND
NTCA 57 34 140 150 ND ND
8 NPRO 130 250 ND ND 240 120
NTCA ND ND 120 61 ND ND
continued..../
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Subject
1 2
Days
3 4 5 6
NPRO MEDIAN
RANGE
64.0
0-3500
50.5 37.0 23.0 
0-1100 0-2100 0-580
17.5
0-560
80.0
0-300
NTCA MEDIAN
RANGE
0
0-57
0
0-59
100* 102* 
0-190 0-200
0
0-120
0
0-160
* p < 0.05 (two tailed test) ND = Not detected
Table 5.12
Urine concentration of NTCA in eight volunteers nmoles/1
1 2
Day
3 (a) 4 (a) 5 6
Mean
SE
14.2
8.0
14.2
6.8
54.3
15.4
73.5 13.6
21.6 9.3
13.6
9.3
(a) Subject ingested 300 mg/day ranitidine
(b) p < 0.05 (day 2 vs day 3)
(c) p < 0.02 (day 2 vs day 4)
5.4 Discussion
N-nitroso compounds have thus been detected at low 
concentrations in human gastric juice, urine and bile. Unlike 
some previous studies (Section 1.5.4) the samples analysed 
were adequately protected against artefactual production of 
N-nitroso compounds by collection over sulphamic acid. In 
fact due to the destruction of N-nitrosamides by this 
preservation method (Section 2.1), the actual concentrations 
present in these fluids may be higher than reported.
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Considerable variation was observed in the concentrations of 
N-nitroso compounds observed even in the healthy control 
subjects. This variation prevented the identification of the 
factors influencing the formation of N-nitroso compounds in 
groups of patients from whom only small numbers of samples 
were obtained. The extent of these variations highlight the 
danger of drawing conclusions from studies carried out on 
small groups of people.
The in vitro N-nitrosation experiments described in Chapter 3 
suggested that the limiting factor for in vivo N-nitrosation 
would be the supply of nitrosating agent. This conclusion is 
supported by the finding that the concentration of N-nitroso 
compounds found in the stomach was related to the intragastric 
nitrite concentration and to factors conducive to colonisation 
by nitrate reducing bacteria such as high pH and enterogastric 
reflux.
It is apparent that if the samples of bile analysed were 
representative of bile samples in general, the N-nitroso 
compound in bile cannot account for the increased 
concentrations found in gastric juices contaminated with 
bile. Thus although the origins of the N-nitroso compounds in 
the urine and bile samples are unknown, it seems likely that 
the N-nitroso compounds found in the gastric juices were the 
result of intragastric N-nitrosation.
The factors influencing the intragastric formation of 
N-nitroso compounds, when considered in conjunction with the 
experiments described in Chapters 3, 4, 6 and 7 enable the
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description of a major pathway whereby factors leading to 
reduced gastric acidity could increase the risk of gastric 
cancer in man, and therefore they are discussed fully in 
Chapter 8.
The origin of the N-nitroso compounds detected in the urine 
could be endogenous or exogenous. However, the mean amount of 
NPRO excreted each day by healthy individuals on normal diets 
was only 18.7 nmoles (Section 5.3.3.2) whereas the mean daily 
excretion of NPRO by healthy individuals consuming diets 
supplemented with proline and nitrate (Section 5.3.3.3) was 
257 nmoles. This indicates that at least some of the NPRO 
present in human urine is the result of in vivo N-nitrosation 
as proposed by Ohshima and Bartsch (1981). Similarly as only 
small amounts of NCTA were present in the urine of subjects 
before administration of ^  blocker (Section 5.3.3.3), the 
increase noted during ranitidine administration also suggests 
an endogenous source.
The results (Section 5.3.3.3) also indicate that the 24 hour 
urinary output on NPRO was not increased during the 48 hour 
period of blockage (Days 3 and 4); if anything it tended 
to decrease. This finding is in contrast to the marked 
elevation in the intragastric concentration of N-nitroso 
compounds produced by H2 receptor blockade (Section 5.3.1.6), 
also found by Stockbrugger et al., (1982). This discrepancy 
may be explained by the fact that the duration of exposure to 
the blocker in the present study was only 48 hours which 
was probably insufficient time for gastric bacterial
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colonisation to occur. Similarly Milton Thompson et al., 
(1982) did not find an increase in the intragastric 
concentration of N-nitroso compounds during receptor 
blockade with Cimetidine in 8 healthy sailors, presumably 
because although 24 hour hydrogen ion concentrations were 
decreased the gastric pH was rarely above pH 4 and as a result 
bacterial counts of > lO^ml  ^were only rarely observed.
In contrast to the results obtained with NPRO, an increase in 
NTCA output occurred during inhibition of gastric hydrochloric 
acid secretion, suggesting that these conditions favoured the 
production of NTCA or inhibited its metabolism. It is 
noteworthy that although urinary NPRO excretion was greatly 
increased by the supplementation of the diet with proline and 
nitrate (see above), the excretion of NTCA was not affected by 
nitrate supplementation in the absence of H2 receptor 
blockade, the mean daily output of NTCA being only 18.8 
nmoles/24 hours. This suggests that the NTCA excreted by 
subjects with acidic stomach is of dietary rather than 
endogenous origin.
Considerable variations in the urinary output of N-nitrosamino 
acids and total N-nitroso compounds were noted between 
individuals, although the volunteers appeared to fall into the 
category of a low (Group A) or a high excretor (Group B). The 
reasons for this variation is unknown but could be due to 
differences in; dietary intake of preformed N-nitroso 
compounds; dietary intake of nitrosating agent (principally 
nitrate); capacity for in vivo nitrate reduction; capacity for
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in vivo N-nitrosation. It is noteworthy in this context that 
three of the volunteers (1, 2 and 5) had previously 
participated in the salivary nitrate reduction experiments as 
volunteers 8, 4 and 6 respectively (Section 4.3). Volunteers 
1 and 5 who excreted comparatively small amounts of N-nitroso 
compounds also were comparatively poor at reducing nitrate to 
nitrite in the saliva. On the other hand, volunteer 2 who 
excreted large amounts of N-nitroso compound in the urine was 
an efficient salivary nitrate reducer. Moreover, volunteer 1 
excreted the least N-nitroso compound, and had the lowest 
salivary nitrite concentration before and after ingestion of 
nitrate (volunteer 8, section 4.3). This clearly suggests 
that the differences in urinary output of N-nitroso compounds 
may reflect genuine differences in the amount of in vivo 
N-nitrosation occuring in individuals due to differences in 
dietary nitrate intake and in vivo nitrate reduction.
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CHAPTER 6
The Identity of N-Nitroso 
Compounds Formed in vivo
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6. THE IDENTITY OF N-NITROSO COMPOUNDS FORMED IN VIVO
6.1 Introduction
Having established that N-nitroso compounds were present in 
physiological fluids in concentrations that were influenced by 
known factors it was considered important to discover whether 
they represented a significant human health hazard.
The toxicity, mutagenicity and carcinogenicity of N-nitroso 
compounds has been discussed (Section 1.1.2) with the general 
conclusions that they are far more likely to be hazardous than 
not. Nevertheless, the identities of the N-nitroso compounds 
found in the biological fluids analysed above are unknown and 
their structures may be complex. Therefore, before any risk 
they impose can be estimated they have to be identified.
It was decided to study the N-nitroso compounds present in 
exhaustively nitrosated gastric juice (Section 3.2). This 
would give an indication of the type of compounds which can be 
produced from the precursors present in gastric juice.
The fact that the majority of the N-nitroso compounds present 
in the nitrosated juice were not sufficiently volatile for gas 
chromatography unless they were methylated with diazomethane 
(Section 3.3.1) suggested that they may contain carboxylic 
acid groups. In addition the spread of retention times from 
less than 10 to greater than 30 minutes indicated a mixture of 
compounds of widely differing molecular weight. A 
consideration of the precursors likely to be available
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suggested that the low molecular weight compounds could be the 
methyl esters of compounds such as N-nitroso sarcosine and 
N-nitrosoproline, and that the higher molecular weight 
compounds could be the methyl esters of nitrosated peptides.
To investigate the hypothesis that the compounds present in 
nitrosated gastric juice were the derivatives of peptides and 
amino acids a nitrosated protein (egg albumen) digest was 
prepared for comparison. In addition a number of nitrosated 
dipeptides were prepared and their gas chromatographic 
properties studied. The product of nitrosation of alanyl 
alanine was also studied by mass spectrometry, and identified 
as N-nitroso iminodiisopropanoic acid by comparison with 
synthetic preparation of the same compound. Finally the 
nitrosated gastric juice was re-examined by gas chromatography 
and peak coincidences with nitrosated dipeptides were noted.
6.2 Methods
6.2.1 Preparation of an egg albumen digest
0.1 g of two times recrystallised ovalbumen was dissolved in 
9 ml of distilled water, and denatured by the addition of 1 ml 
of 0.1 M NaOH and heating for 15 minutes in a boiling water 
bath. After the denatured protein had cooled 2 mg of papain 
dissolved in 1 ml of distilled water were added. The pH of 
the mixture was adjusted to pH 7 using 0.1 M HC1 and hydrogen 
sulphide was bubbled through the mixture for 10 minutes to 
activate the papain. The mixture was then sealed under 
nitrogen and incubated for 3 hours at 65°C. The proteolysis 
was then stopped by boiling the mixture for 5 minutes. The
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digest was then filtered and nitrosated using the conditions 
described in Section 2.3. After three hours the nitrosation 
was "stopped" with sulpharaic acid, the products were extracted 
into ethyl formate (Section 2.2), dried over anhydrous sodium 
sulphate and reduced in volume to about 2 ml with a 
Kuderna-Danish evaporator. The extract was then methylated 
(Section 2.4.22) and analysed by GC/TEA (Section 2.4.2).
6.2.2 N-nitrosation of dipeptides
0.5 mmoles of each of the dipeptides listed in Table 6.1 were 
dissolved in 100 ml of HC1/KC1 buffer, pH 2, containing 
4 mmoles of sodium nitrite and incubated for three hours at 
37°C. The nitrosations were "stopped" by the addition of 
sulphamic acid, extracted with 4 x 50 ml of ethyl acetate and 
dried over anhydrous sodium sulphate. Each extract was 
filtered and made up to 250 ml and analysed by the Luminox 
method (Secion 2.4.1) and the percentage yields calculated.
Table 6.1
Dipeptides tested for N-nitrosatability
Dipeptide Abbreviation
L-ALANYL-L-ALANINE ALA-ALA
L-ALANYL-L-ASPARTIC ACID ALA-ASP
L-ALANYL-GLYCINE ALA-GLY
L-ALANYL-L-HISTIDINE ALA-HIS
L-ALANYL-L-LEUCINE ALA-LEU
L-ALANYL-L-LYSINE ALA-LYS
L-ALANYL-L-METHIONINE ALA-MET
L-ALANYL-L-PHENYLALANINE ALA-PHE
L-ALANYL-L-PROLINE ALA-PRO
L-ALANYL-L-SE RINE ALA-SER
l-alanyl-l-threonine ALA-THR
L-ALANYL-L-TRYPTOPHAN ALA-TRY
GLYCYL-L-PHENYLALANINE GLY-PHE
L-PHENYLALANYL-GLYCINE PHE-GLY
L-PROLYL-L-ALANINE PRO-ALA
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The remaining extract was concentrated using a rotary 
evaporator, methylated with diazomethane (Section 2.4.2.2) and 
analysed by GC/TEA (Section 2.4.2).
6.2.3 GC/MS Analysis of Nitrosated Alany1-alanine
The GC/MS analysis was carried out using a Hewlett Packard 599 
2A low resolution mass spectrometer and the following GC 
conditions.
Column: Glass SCOT (24m x 0.5mm)
Stationary Phase: SP2100
Carrier Gas: Helium 10 ml/min
o
Oven Temperature: 100 C for 3 minutes then
programmed to 230°C at
-i C°n •16 C m m
Injection Port Temperature: 250°C
The nitrosated product of alanylalanine was methylated by 
treatment with diazomethane to make it sufficiently volatile 
for gas chromatography.
The accurate masses of some of the ions were obtained by high 
resolution mass spectrometry. Due to a fault, the mass 
spectrometer could not run an entire spectrum at high 
resolution. Nevertheless accurate masses could be obtained of 
particular ions by a peak matching procedure using an internal 
standard (perfluorokerosene). Thus five ions were selected 
for determination at a resolution of 7000-8000.
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6.2.4 Synthesis of N-nitrosoiminodiisopropanoic acid
The parent amine was prepared from alanine and chloropropionic 
acid and subsequently nitrosated with an acid solution of 
sodium nitrite as follows.
L-alanine, chloropropionic acid and sodium hydroxide were 
dissolved in distilled water in molar ratios of 1:1:3. The 
mixture was then boiled under reflux for 3 hours to form the 
parent amine.
NH -CH-COOH + CH0-CH-COOH + 3NaOH — » NaOOC-CH-NH-CH-COONa + NaCl + 3Ho0
2 I 3 I I I  2
CH3 Cl CH3 CH3
The parent amine was then nitrosated without purification by 
the addition of an excess of sodium nitrite, adjusting to pH 2 
with hydrochloric acid and standing at room temperature for 
four hours. The N-nitroso compound was then extracted into 
diethylether, concentrated by removal of the ether with a 
stream of nitrogen and left to crystallise. Recrystallisation 
was carried out from ethyl acetate.
A methanolic solution of the compound was methylated by 
addition of an ethereal solution of diazomethane and a mass 
spectrum prepared.
6.2.5 Re-examination of nitrosated gastric juice
A sample of nitrosated gastric juice (Section 3.2) was 
methylated with diazomethane (Section 2.4.2.2) and analysed by 
gas chromatography (Section 2.4.2) for the presence of
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N-nitrosamino acids and N-nitrosoiminodialkanoic acids. The 
chromatogram obtained was compared with those obtained from a 
mixture of methylated amino acids and from a mixture of 
methylated nitrosated dipeptides.
6.3 Results
6.3.1 Analysis of nitrosated egg albumen digest
The gas chromatogram obtained (Fig. 6.1) illustrated that the 
compounds eluted had similar properties to those obtained from 
nitrosated gastric juice (Fig. 6.2). Several peak 
coincidences were noted at retention times of 6.76 cf 6.76, 
8.10 cf 8.03, 9.55 cf 9.47, 10.44 cf 10.45, 17.61 cf 17.59, 
18.67 cf 18.82 and 25.51 cf 25.96 minutes, the chromatograms 
being very similar in appearance.
6.3.2 N-nitrosation of dipeptides
The total yield of N-nitroso compound obtained from each of 
the dipeptides was estimated assuming the formation of a 
mono-N-nitroso compound with the general formula given in Fig.
6.3 and are listed in Table 6.2. These structures are 
consistent with nitrosation of the primary amino groups 
resulting in deamination of the N-terminal end, coincident 
with nitrosation of the nitrogen of the peptide bond to give a 
nitrosamide.
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Fig. 6.1 GC/TEA of Nitrosated Egg Albumen Digest after
Methylation
6.76
9.09
9.55
11.29
15.32
17.61
18.76
25.51
29.37
33.29
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Fig. 6.2
GC/TEA of Nitrosated Gastric Juice after Methylation
6. 06
8. 03
9 . 47
10. 45
12. 52
18. 52
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243
Fig. 6.3 General formula used in calculation of nitrosation 
yields of dipeptides
0
II H
R1 — CH— C— N— -CH—  R"
NH2 COOH
V
0 NO
II I
R1 — CH— C— N— CH— R"
OH COOH
All of the dipeptides produced N-nitroso compounds although 
the yields varied considerably. Suprisingly all of the 
dipeptides except for ALA-HIS and ALA-TRY produced compounds 
which gave good TEA positive responses. This was unexpected 
as N-nitrosamides do not usually undergo thermolysis to nitric 
oxide in the TEA pyrolyser (Section 2.4.2). Although ALA-HIS, 
and ALA-TRY did not give GC/TEA peaks this was thought to be 
due to lack of volatility of the product of nitrosation even 
after methylation rather than being due to a difference in the 
nature of their products.
This was supported by evidence of a long retention time peak 
obtained in the analysis of ALA-TRY which was observed as a 
small hump in the background signal. Although the GC/TEA 
evidence suggested that the products were not nitrosamides,
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Table 6.2
The Results of the Lumlnox and GC/TEA analyses of nitrosated 
dipeptides
Peptide % yield Luminox % yield GC/TEA Retention t
ALA-ALA 6.4 5.3
GC/TEA
min
7.79
ALA-ASP 8.0 2.2 17.07
ALA-GLY 10.3 6.8 7.27
ALA-HIS 0.09 - -
ALA-LEU 7.8 5.1 10.05
ALA-LYS 0.77 0.1 12.02
ALA-MET 12.8 5.0 20.85
ALA-PHE 9.4 4.7 23.77
ALA-PRO 0.11 two 0.01 7.06 (NPRO)
ALA-SER 10.4
peaks 0.01
4.1
22.33
15.09
ALA-THR 9.6 3.1 12.91
ALA-TRY 8.6 - -
GLY-PHE 1.5 1.5 23.73
PHE-GLY 8.3 7.4 23.93
PRO-ALA 1.0 0.3 23.07
the yields calculated by GC/TEA were often lower than those 
calculated by the Luminox method suggesting that more than one 
product may be formed. ALA-PRO gave rise to two GC/TEA peaks 
one of which was identified as N-nitrosoproline produced 
presumably after acid hydrolysis of the dipeptide during the 
nitrosation. The peak observed with the longer retention time 
being the nitrosated dipeptide.
6.3.3 GC/MS analysis of Nitrosated Alanylalanine
The mass spectrum of nitrosated alanylalanine following 
methylation (Fig. 6.4) contained the expected molecular ion 
for the structure proposed in Fig. 6.5. The molecular ion had 
a mass to charge ratio (m/z) of 218. This was somewhat
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Fig. 6.4 Mass Spectrum of Methylated Nitrosated
Alanylalanine
50
100
M/Z
150 —
200 —
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unexpected as it indicated that both the alcoholic and 
carboxylic acid groups had been methylated (Fig. 6.5), whereas 
diazomethane was not expected to nitrosate alcoholic groups.
Fig. 6.5
CHo— CH—  C— NH—  CH—  COOH
I l
NH2 CH3
Nitrosation
0 
I
CH3— CH— C— N— CH— COOH
I I I
OH NO CH3
Methylation 
CH3— CH--C— N—  CH— COOH
l II l I
OCH3 0 NO CH3
Although the majority of the fragment ions present in the 
spectrum could be easily explained as in the scheme
illustrated in Fig. 6.6. The ions at m/z 114, 100 and 70 were
however, harder to explain, therefore it was decided to 
confirm the molecular formula by high resolution mass 
spectrometry.
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Fig. 6.6 Proposed Fragmentation of Methylated Nitrosated
Alanylalanine
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Fig. 6.7 Mass Spectrum of N-nitrosodiisopropanoic acid 
dimethylester
0 .
50
100
M/Z
150
200
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6.3.4 Analysis of nitrosated alanylalanine by high 
resolution mass spectrometry
The masses of the five selected ions for high resolution 
analysis are listed in Table 6.3 along with the molecular 
formulae giving the nearest fits to these masses.
The results for the ions m/z 218, 188 and 159 strongly support 
the fragmentation illustrated in Fig. 6.6 and hence support 
the proposed structural formula Fig. 6.5. The result for the 
ion at m/z 128 indicates that the molecular formula
C6H10N02 is the correct one of ttie two suSgested in Fig.
6.6. However, the proposed ion for m/z 70 (CLH,NO) is
3 4
only the sixth best fit for the actual mass found, the best 
fit being C^HgN.
6.3.5 GC/MS Analysis of N-nitrosoiminodiisopropanoic acid 
dimethyl ester
The mass spectrum obtained from N-nitrosoiminodiisopropanoic 
acid dimethyl ester (Fig. 6.7) was the same as that obtained 
from nitrosated alanylalanine indicating that the two 
compounds are the same.
6.3.6 Re-examination of nitrosated gastric juice by gas
chromatography
The chromatograms obtained from the GC/TEA of a methylated 
extract of nitrosated gastric juice, of the methyl esters of 
nitrosated dipeptides, and of the methyl esters of 
N-nitrosamino acids are compared in Fig. 6.8. Components of
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Fig. 6.8 GC/TEA of Nitrosated Gastric Juice after 
methylation (A) compared with those of Nitrosated Dipeptides 
(B) and N-nitrosoaminoacids (C)
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Table 6.3
High resolution mass spectral determination of selected ions 
produced during the fragmentation of nitrosated methylated 
alanylalanine
Nearest Fits Expected ion
Mass found Molecular Formula M.W. Molecular Formula M.W.
218.091 c 9h 10n 6°
c 8n 14n2°5
218.092
218.090 C8H14N2°5 218.090
188.091 c6h 12n4°3
c8h 14no4
188.091
188.092 C8H14NO4 188.092
159.076 C4H9N5O2
C6H11N2O3
159.076
159.077 c6HllN203
128.070 C4H8N4O
c6H10NO2
128.070
128.071
C5H8N2O2
C6Hi0N02
128.059
128.071
70.067 c4h8n
C5H1O
70.066
70.078
C3H4NO 70.029
the nitrosated gastric juice which can be tentatively 
identified due to coincident retention times are NPRO,
ALA-GLY, ALA-ALA, ALA-LEU, ALA-SER, ALA-PRO and ALA-PHE, the 
retention times obtained differing from those of authentic 
compounds by less than 3%.
6.4 Discussion
If as proposed in Section 6.1 the N-nitroso compounds present 
in nitrosated gastric juice are mainly derived from peptides 
and amino-acids, the precursors would arise from the digestion
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of proteins. This hypothesis has been confirmed by the 
similarity of the GC/TEA analysis of the methylated extracts 
of nitrosated gastric juice and nitrosated egg albumen 
digest. Additional confirmation has been obtained from the 
GC/TEA analysis of nitrosated amino acids and dipeptides where 
several peak coincidences have been obtained.
Several pieces of experimental evidence however suggested that 
the N-nitroso compounds produced from peptides could not be 
nitrosamides of the general formula proposed in Fig. 6.3. For 
instance, the TEA responded well to the nitrosated peptides 
whereas it does not usually respond to N-nitrosamides (Section 
2.4.2). The nitrosated peptides were also found to be stable 
on treatment with strong aqueous solutions of potassium 
hydroxide and even to a saturated ethanolic solution of 
potassium hydroxide, to which nitrosamides are unstable.
These findings in conjunction with the mass spectral evidence 
obtained from nitrosated alanyl alanine and the apparently 
unlikely methylation by diazomethane of a hydroxyl group in 
nitrosated alanylalanine, suggested that the compounds were 
nitrosamines not nitrosamides. This hypothesis was confirmed 
by the finding that the nitrosamine, N-nitroso 
iminodiisopropanoic acid dimethyl ester gave the same mass 
spectrum as the methylated product of nitrosation of 
alanylalanine. This nitrosamine structure was entirely 
consistent with both the low and high resolution mass spectral 
data obtained for the methylated nitrosated alanylalanine
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(Fig. 6.9). The mechanism leading to the formation of 
N-nitrosoiminodialkanoic acids from dipeptides is uncertain 
although two possible routes can be proposed.
Firstly, Fig. 6.10 hydrolysis of the peptide bond could 
liberate free amino acids which after deamination would form 
the precursor secondary amine at low yield which could 
subsequently be nitrosated.
Secondly, Fig. 6.11 deamination of the primary amino group 
leads to the formation of an unstable three membered ring 
which breaks to yield the parent amine which is subsequently 
nitrosated.
The finding that the TEA positive products of nitrosation of 
dipeptides are the nitrosamines, N-nitrosoiminodialkanoic 
acids, does not preclude the simultaneous formation of 
N-nitrosamido compounds, as the TEA would not respond to such 
compounds if present in the reaction mixture. This fact is 
emphasised by the discrepancy in the yields of nitrosated 
product from dipeptides as measured by the Luminox method when 
compared with the yields measured by GC/TEA (Table 6.2). In 
all cases the yield measured by the Luminox method which does 
respond to nitrosamides was higher than that measured by 
GC/TEA, suggesting that more than one N-nitroso derivative, 
may have been formed from each dipeptide.
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Fig. 6.10 A Possible Route of Formation of
N-nitrosodiisopropanoic Acid from Alanyl alanine
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Fig. 6.11 A Possible Route for Formation of
N-nitrosopropanoic Acid from Alanyl alanine
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CHAPTER 7
Mutagenicity
The mutagenecity assays reported on the nitrosated 
alanylalanine and pure N-nitrosodiisopropanoic acid prepared 
in this chapter were carried out at the International Agency 
for Research into Cancer, Lyon, France, whereas the assays 
carried out on the N-nitrosothiazolidine-4-carboxylic acid 
were carried out at Glaxo Group Research Ltd., Ware, Herts.
Thanks are therefore extended to Dr H Bartsch of the IARC and 
to Dr L E Martin of Glaxo for arranging for these tests to be 
carried out.
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7. MUTAGENICITY
7.1 Introduction
The discovery of increased NTCA concentrations in the urine of 
volunteers taking Ranitidine (Section 5.3.3.2) suggested that 
the in vivo production of this N-nitroso compound could occur 
in the achlorhydric stomach. This discovery and in addition 
the observation that dipeptides can yield N-nitroso 
derivatives (Section 6.3.2) made it important to know whether 
such compounds if formed in vivo could be responsible for the 
induction of tumours. Consequently nitrosated alanylalanine 
and its known product, N-nitroso iminodiisopropanoic acid, and 
a pure preparation of N-nitrosothiazolidine-4-carboxylic acid 
were tested for mutagenic activity.
7.2 Methods
7.2.1 Mutagenicity of nitrosated alanylalanine and N-nitroso 
iminodiisopropanoic acid
The mutagenic properties of nitrosated alanylalanine and a 
pure sample N-nitrosoiminodiisopropanoic acid were studied in 
Salmonella tvphimurium strains using a preincubation assay.
The compounds were dissolved in 100 p.1 buffered saline 
(5 mmol/1 Sorensen phosphate buffer, pH 7.4) and 100 p.1 of an
g
overnight bacterial culture medium (approx 2-4 x 10 
bacteria) and mixed with medium containing 0 or 150 p.1 of a 
post mitochondrial (S9) fraction derived from the livers of 
Aroclor treated female BDVI rats, cofactors (2 p.mol NADP+,
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2.5 pmol glucose-6-phosphate), 4 pmol MgCl^ and 50 p.mol 
Sorensen phosphate buffer, pH 7.4 (made up to a total volume 
of 500 pi with 0.15 mol/1 KC1 in 5 ramol/1 Sorensen phosphate 
buffer, pH 7.4). The mixture was preincubated for 30 minutes 
at 37°C with shaking before addition of 2 ml of 
histidine-poor soft agar and plating. The revertant colonies 
were counted after 48 hours of incubation at 37°C.
7.2.2 Mutagenicity of N-nitrosothiazoladine-4-carboxylic 
acid (NTCA)
A freshly prepared methanolic solution of the analytically 
pure compound was evaluated for mutagenic activity using the 
following assays.
1. Salmonella/Microsome Assay (Ames et al., 1975)
Test strains: S.typhimurium TA 98, TA 1535, TA 100, TA 
1537.
2. Liquid Preincubation Modified Assay (Yahagi et al., 1977) 
Test strains: S.typhimurium TA 98, TA 1535, TA 100, TA 
1537.
3. Fluctuation Test (Gatehouse, 1978; Gatehouse & Delow, 
1979)
Test strains: E.coli WP 2, WP 2 uvr A (R46), 343/113 lys 
60 (R46).
Assays 1 and 3 were carried out in replicate in the presence 
and absence of a post-mitochondrial (S9) fraction (+ 
cofactors) derived from the livers of rats pretreated with
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phenobarbitone and (3-napthoflavone. Assay 2 was carried out 
only in the presence of S9-fraction.
The maximum test concentrations were 5000 [ig/plate for assays 
1 and 2 and 1000 [.ig/ml for assay 3. A range of positive 
control compounds including the nitrosamide, MNNG, and the 
nitrosamine, N-nitrosomorpholine, were readily detectable in 
one or more of these assays.
7.3 Results
7.3.1 Mutagenicity of Nitrosated alanylalanine extract
The results in Table 7.1 indicate that nitrosated 
alanylalanine is mutagenic in S.typhimurium TA 100 at 
0.1 mg/assay the number of revertants were more than 5-fold 
that of revertants occuring spontaneously. When assays were 
performed in the presence of the S9 preparation, no 
mutagenicity or toxicity were observed. This may be due to 
the binding of N-nitrosoalanylalanine (or its breakdown
products) to nucleophiles present in the S9 fraction and/or
* v
its (NADPH independant) enzyme inactivation.
As shown in table 7.2, nitrosated alanylalanine was only 
mutagenic and toxic in S.typhimurium strains carrying a deep 
rough mutation, i.e. TA 1535, TA 100, and TA 100 NR which 
causes loss of the lipopolysaccharide barrier that coats the 
surface of the bacteria. The high sensitivity of the TA 100 
strain as compared to TA 1535 indicates that most bacterial 
DNA adducts are not miscoding, but are repaired by an
error-prone post-replicative repair system, thus increasing 
mutagenicity and decreasing the toxic effect. Thus in the 
above tests nitrosated alanylalanine reacted similarly to 
methylmethane sulphate. Furthermore the lower sensitivity of 
TA 100 NR (nitroreductase-deficient strain) as compared to the 
proficient nitroreductase strain TA 100 suggests that 
bacterial nitroreductase may be involved in the activation of 
nitrosated alanylalanine into a DNA damaging agent.
Table 7.1
Mutagenic Activity of Nitrosated Alanylalanine in 
S.typhimurium TA 100 in the presence or absence of a metabolic
activation system
Compound mg/plate His+ revertants/platea
No S9 S9 S9
- cofactorsk + cofactors
0.0 159 72 146
0.1 850 69 149
0.2 962 89 160
0.3 711 85 161
0.5 0 (toxic)c 96 167
1.0 0 (toxic) not done 155
a - Mean values of 2 - 4 plates.
*4“
b - Cofactors of mono oxygenases (NADP , 
glucose-6-phosphate) were omitted, 
c - Toxicity was judged based on the appearance of a 
bacterial lawn on the plate.
Table 7.2
Direct Mutagenic Activity of Nitrosated Alanylalanine in 
Various Strains of Salmonella typhimurium
Compound mg/plate His+ rever tants/plate in S.typhimurium strains3
TA 1530 TA 1535 TA 100 TA 100 NR
0.0 20 15 144 159
0.1 16 84 850 365
0.2 24 0 (toxic)b 962 331
0.3 20 0 (toxic) 691 196
0.5 23 0 (toxic) 0 (toxic) 0 (toxic)
a - Mean value of 2 plates
b - Toxicity was judged based on the appearance of 
bacterial lawn on the plate
7.3.2 Mutagenicity of N-nitrosoiminodiisopropanoic acid
The pure preparation of N-nitrosoiminodiisopropanoic acid 
(Section 6.2.4) was found to be non-mutagenic in all 
S.typhimurium strains tested at any concentration with or 
without metabolic activation.
7.3.3 Mutagenicity of N-nitroso thiazolidine-4-carboxylic 
acid (NTCA)
The Ames tests were uniformly negative both in the presence 
and absence of the S9 preparation, although some toxicity was 
observed at the highest concentration in the absence of S9 
mix. The tests conducted using the Yagahi modification of the 
Ames test were also negative.
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In addition negative results were obtained in both the direct 
and indirect fluctuation tests, although these are 
particularly sensitive for the detection of mutagenic 
N-nitroso compounds.
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CHAPTER 8 
Discussion and Conclusions
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Humans have not been deliberately exposed to potentially 
carcinogenic N-nitroso compounds in the long term and 
therefore evidence of human carcinogenicity is difficult to 
obtain. Epidemiological studies are possible, however, and 
some of these have produced strong evidence for the 
involvement of N-nitroso compounds in cancer of the oesophagus 
(Yang, 1982), stomach (Correa et al., 1975), and bladder 
(Kakizoe et al., 1979), and recently the tobacco specific 
N-nitrosamines have been associated with buccal and gingival 
cancer in snuff dippers (Winn, 1984).
A potential source of N-nitroso compounds is food particularly 
in products that are treated with sodium nitrite as a 
preservative. However, the concentrations of N-nitroso 
compounds found in foods (Walker, 1981; Massey et al., 1984; 
Satoh et al., 1985) are low when compared with the amounts 
potentially formed in vivo from the precursors present in the 
diet (Section 3.3).
The diet contains a large range of potentially nitrosatable 
amino and amido compounds (Section 1.1.3.2) which when treated 
with sodium nitrite in excess or at concentrations simulating 
the gastric environment have been shown to yield significant 
amounts of N-nitroso compounds (Section 3.3). These results 
confirm the findings of Walters et al., (1974, 1979(b)) who 
demonstrated that normal foods contained potential precursors 
to volatile and non-volatile N-nitroso compounds when 
incubated with nitrite and human gastric juice. The amount of
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precursors of N-nitroso compounds available in the foods 
tested in the present study was in vast excess of the amount 
nitrosated under simulated in vivo conditions indicating that 
the supply of such precursors was unlikely to be a limiting 
factor in in vivo N-nitrosation. Not suprisingly therefore, 
samples of saliva, gastric juice, urine and prostatic fluid 
were all found to contain large amounts of nitrosatable 
nitrogen. Only a small proportion of the N-nitroso compounds 
formed from these precursors are the simple steam volatile 
N-nitrosamines emphasising the necessity to use a method of 
analysis capable of detecting the more complex non-volatile 
N-nitroso compounds in any study of in vivo N-nitrosation.
This analytical requirement however has been ignored in most 
earlier studies of in vivo N-nitrosation. A consideration of 
the properties of the non-volatile compounds formed from the 
deliberate N-nitrosation of physiological fluids (Section 3.3) 
suggested that a large proportion were the derivatives of 
amino-acids and peptides, but the majority of the compounds 
formed remain unidentified as they are not amenable to gas 
chromatography. Future studies might successfully use a 
modified version of the Luminox method (Section 2.4.1) as an 
HPLC detector to enable the separation and identification of 
high molecular weight and/or TEA unresponsive N-nitroso 
compounds.
The possibility that some of the products formed in 
physiological fluids could be the N-nitroso derivatives of 
peptides has been further investigated (Chapter 6).
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Dipeptides when treated with an excess of sodium nitrite 
generally gave a N-nitrosated product at yields of between 5 
and 10%. Some but not all of the material detected by the 
Luminox procedure (Section 2.4.1) for total N-nitroso 
compounds could be detected by GC/TEA (Section 2.4.2) and 
therefore there is a possibility that each dipeptide can 
produce more than one N-nitroso derivative. The main product 
obtained for the N-nitrosation of L-alanyl-L-alanine has been 
shown to be a TEA responsive N-nitrosamine (N-nitrosoimino 
diisopropanoic acid), and it is probable that the TEA positive 
material obtained from the nitrosation of the other dipeptides 
are also N-nitrosoiminodialkanoic acids, as the TEA would not 
be expected to respond efficiently to N-nitrosamido compounds 
formed from the nitrosation of the peptide bond. Such a 
hypothesis would explain the low yield obtained from L-alanyl- 
L-proline which cannot form the secondary amino group 
postulated in the mechanism of formation of the N-nitroso- 
iminodialkanoic acids. These results agree with the recent 
publication of Pollock and Outram (1982) who gave evidence 
that the products from a variety of dipeptides were the 
corresponding N-nitrosoiminodialkanoic acids.
The possibility that peptides could yield N-nitroso 
derivatives in vivo is important when the number of peptide 
bonds present in protein rich foods is considered. However, 
although the product of nitrosation of L-alanyl-L-alariine was 
shown to be mutagenic without metabolic activation, N-nitroso
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iminodiisopropanoic acid was not mutagenic. This suggests 
that the difference in the determinations carried out by 
GC/TEA and by the Luminox method may be due to unidentified 
mutagenic N-nitroso compounds present in the product of 
nitrosation of L-ananyl-L-alanine. Such compounds could be 
N-nitrosamides derived from nitrosation of the peptide bond, 
as these would be detected by the Luminox method but not by 
GC/TEA, and would be expected to be mutagenic without 
metabolic activation. Nevertheless, firm evidence for the 
existence of these compounds has not yet been obtained, and 
would require the development of a separation detection 
technique such as the HPLC/Luminox system mentioned earlier.
The main source of nitrosating agent for in vivo N-nitrosation 
is nitrite produced from the in vivo reduction of dietary 
nitrate. This reduction can occur in the mouth, the 
achlorhydric stomach and the infected urinary tract. The 
major source of nitrite for the healthy individual is 
therefore the saliva.
The great individual variation in salivary nitrite 
concentrations reported by several workers was borne out by 
these studies (Section 4.3), and on the basis of the small 
number of volunteers involved were found to be independent of 
sex. Okabe (1973) found nitrite concentrations ranging from 
0.0014 to 2.9 mmol/1 in the saliva of 200 Japanese subjects 
while values of 0.0014 to 0.43 mmol/1 with an average of 0.097 
mmol/1 were obtained by Spiegelhalder et al., (1976), who 
concluded that differences in dental hygiene could not be the
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only cause for the large variation observed. In the present 
study of the ingestion of nitrate at concentrations in excess 
of the limit recommended by WHO for continuous use (Section
4.3.1), raised salivary nitrite concentrations were observed 
but the size of the increase varied considerably between 
individuals with the variation not being independant on sex. 
This finding agrees with that of Tannenbaum et al., (1976) who
used celery juice as the nitrate source. Similar results were
also observed by Spiegelhalder et al., (1976) and other 
workers who used nitrate-rich vegetables and vegetable juices, 
thus the nitrite concentration in the saliva appears to be 
related to the amount of nitrate in the diet and drinking 
water, the dietary origin being relatively unimportant. 
Spiegelhalder et al., (1976) found that the average increase 
in salivary nitrite concentration relative to nitrate intake 
in vegetables was 20mg NO^/l per 100 mg N0^. In the
present study consumption of the highest concentration of
nitrate gave similar results producing increases in salivary 
nitrite one hour later of 7.9 to 47.5 mg NO^/l per lOOmg 
N0^ with a mean of 23.2 mg NO^/l per lOOmg 
NO^. Spiegelhalder et al., (1976) also observed a 
threshold input of nitrate in vegetables of the order of 54 mg 
NO^ below which the salivary nitrite concentration was 
unaltered. This was certainly not the case in the present 
study where significant increases in salivary nitrite 
concentration were observed after consumption of a drink (250 
ml) containing 11.3 mg NO^ (N)/l which is equivalent to 
the ingestion of only 12.5 mg N0^ (Section 4.3).
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The size of the increase in the concentration of salivary 
nitrite is probably more important in terms of the production 
of N-nitroso compounds than total nitrite production since the 
rate of N-nitrosation of a secondary amine is generally 
proportional to the square of the nitrite concentration.
The variations in the capacity of subjects to convert nitrate 
ingested in water to nitrite were striking (Section 4.3). The 
relationship of this capacity to the rate of fall in salivary 
nitrite concentration preceding nitrate intake adds weight to 
the concept of the participation of the individuals’ oral 
microflora in the reduction (Tannenbaum et al., 1976). This 
supposition assumes that the overnight intakes of nitrate by 
the volunteers were grossly similar, a situation which could 
not be completely controlled, and that individuals did not 
differ widely in their storage of nitrate in vivo in the 
manner proposed by Tannenbaum et al., (1978). Nevertheless it 
is evident that the proportion of the small group of 
volunteers showing the greatest rates of fall in resting 
salivary nitrite concentrations were best able to convert 
water-borne nitrate into salivary nitrite.
Stephany and Schuller (1980) estimate that the average 
conversion of nitrate to nitrite by the oral microflora is
6.3 mol%/24 hr. Thus the majority of the dietary nitrate 
intake is available for reduction elsewhere in the body. The 
normal healthy stomach is too acidic to support viable 
bacteria. However, at a pH of greater than 4.5 to 5.0 
bacterial colonisation occurs enabling the bacterial reduction
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of nitrate to nitrite. An increase in total and nitrate 
reducing bacteria in gastric hypochlorhydria is thus 
associated with higher nitrite concentrations (Ruddell et al., 
1976; Tannenbaum et al., 1979). These results were confirmed 
in the present study with a significant association being 
found between nitrate reductase positive organisms and raised 
gastric pH produced by age, disease, surgery or receptor 
blockade (Chapter 5).
After pentagastrin stimulation of HC1 secretion in the stomach 
of fasting humans, the concentration of gastric thiocyanate, 
which is considered to be of salivary origin fell 
significantly whereas the nitrite concentration in the stomach 
remained unchanged (Ruddell et al., 1977). In addition, low 
concentrations of nitrite in urine free from bacterial 
infection have been demonstrated in this study. These low 
levels of nitrite may represent the concentration of a body 
pool of nitrite which is constantly being maintained by 
transport of nitrite in the blood. The finding that nitrite 
can survive in the blood at low concentration in spite of the 
ready oxidation of nitrite by oxyhaemoblobin emphasises that 
in vivo N-nitrosation may occur at any site. In addition the 
concentrations of nitrite found in normal urine and blood 
suggest a body pool of nitrite of between 100 and 200p. moles 
(Section 4.4).
There have been many experiments to show that feeding 
nitrosatable amines and nitrite to laboratory animals can 
produce the corresponding N-nitrosamine in the stomach and the
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associated malignant tumours (Section 1.1.5.3). However, in 
most of these experiments unrealistic concentrations of 
nitrite have been used. In any experiment to determine 
whether in vivo N-nitrosation can occur in the stomach, the 
nitrite concentration is critical, since the rate of 
N-nitrosation of secondary amines depends on the square of the 
nitrite concentration and that of the tertiary amines on the 
cube of the nitrite concentration. Thus the use of large 
nitrite concentrations will lead to exaggerated reaction rates 
and yields of N-nitroso compounds. In addition competition 
for the nitrite ion by reactive nucleophiles other than amino 
compounds could reduce low concentrations of nitrite to 
negligible proportions. Using low concentrations of nitrite 
(0.3 mmol/1) it has been possible to show that N-nitroso 
compounds could be produced from codfish, cheese, tobacco 
smoke condensate and a tricyclic antidepressant in a simulated 
gastric medium (Section 3.3) although this was only a fraction 
of the amount produced with an excess of nitrosating agent. 
Although the normal fasting gastric juice (pH 1.4) 
contains even lower concentrations of nitrite (c 2(j,mol/l) 
(Ruddell et al., 1976), even a slight change in gastric pH to 
2.7 ("hypochlorhydric normals") led to an increase in nitrite 
concentration to 25.6 p.mol/1 probably due to a lesser 
proportion of the nitrite entering the stomach from the saliva 
undergoing disproportionation at the higher pH. An increase 
in gastric pH following consumption of a typical meal also 
raised gastric nitrite concentrations from 14 (j.mol/1 at pH 2.2 
to 0.3 mmol/1 at pH 4.7 (Walters et al., 1979). The increase
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in nitrite concentration in this case however was attributed 
to the nitrite which was present in the meal at a 
concentration of 0.83 mmol/1 being distributed throughout the 
stomach contents. Many of the gastric juice samples analysed 
in the present study were from patients with consistently high 
gastric pH, rather than merely transient hypochlorhydria.
Such achlorhydria allows the growth of bacteria in the stomach 
and was found in old patients whose mucosa secreted less acid, 
patients with pernicious anaemia, patients who had undergone 
surgery to reduce acid secretion and in patients treated for 
gastrointestinal disorders by receptor blockade (Section 
5.3). In all cases the resultant raised gastric pH was found 
to be significantly associated with raised gastric nitrite 
concentrations, and with the growth of nitrate 
reductase-positive organisms.
It is probable, therefore, that in cases or persistant 
achlorhydria the main source of gastric nitrite which often 
exceeded 0.2 mmol/1 was probably not the saliva but from the 
intragastrie microbial reduction of dietary nitrate.
In vitro the N-nitrosation of secondary amines occurs most 
readily at a pH of about 3.5 and that of secondary amides 
continues to increase in rate with fall of pH. In contrast 
this study has demonstrated a highly significant relationship 
between gastric pH and the concentration of N-nitroso 
compounds with the latter rising progressively with pH from a 
geometric mean of 0.10 p.mol/1 at pH 1.0-1.5 to a mean of
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1.2 mol/1 at pH 6.5-9.0 (Section 5.3). This apparent 
discordance between in vivo and in vitro studies can be 
explained by the fact that as mentioned above, high gastric pH 
is associated with an increased growth of nitrate 
reductase-positive micro-organisms which in turn leads to 
increased gastric nitrite concentrations. In addition 
ultrafiltratable and thermostable bacterial factors can 
stimulate nitrosation at pH values higher than those at which 
uncatalysed chemical nitrosation occurs (Collins-Thompson et 
al., 1968). Thus the reason for the high concentrations of 
N-nitrosamines found at high gastric pH would appear to be the 
presence of nitrate-reducing bacteria which increase the 
concentration of nitrosating agent and assist in the 
nitrosation process.
This supports the hypothesis of Hill et al., (1973) by 
stressing the role of nitrate reducing organisms in 
N-nitrosation in vivo. Such a mechanism can clearly be seen 
in the results obtained for proximal gastric vagotomy (PGV) 
patients when compared with patients who had undergone a 
truncal vagotomy and pyloroplasty (TVP) (Section 5.3).
Although mean gastric pH was not very different from normal in 
either group of patients, TVP is associated with enterogastric 
reflux which would cause transient periods of high gastric pH 
and also provide a source of nitrate reductase-positive 
organisms. Thus 50% of the samples from TVP patients were 
found to contain nitrate reducing bacteria as opposed to only 
12% of PGV patients while 21% of TVP patients had raised
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nitrite concentrations which were absent in PGV patients. 
Consequently TVP patients had mean intragastric concentration 
of N-nitroso compounds very similar to gastric carcinoma 
patients, whereas in PGV patients these concentrations were 
not significantly different from normal.
It is debatable whether N-nitroso compounds are causal in 
human gastric cancer, but in animals the simple volatile 
nitrosamines, N-nitrosodimethylamine, N-nitrosodiethylamine 
(Homburger et al., 1976), and N-nitrosamides (Sugimura and 
Fujimura 1976; Sugimura et al., 1970) have acted as 
carcinogens in the glandular stomach. In addition 
achlorhydria along with raised nitrite concentrations and 
increased growth of total and nitrate reducing bacteria have 
been found in patients with gastric cancer and in conditions 
predisposing to it such as pernicious anaemia (Ruddell et al., 
1976), chronic atrophic gastritis with intestinal metaplasia, 
and after gastric surgery (Ellis et al., 1979). In this study 
the finding that N-nitroso compounds rise with age and gastric 
pH agrees with some features of gastric cancers associated 
with gastric mucosa secreting less acid and the incidence of 
which increases with age. In addition, a direct relationship 
was found between conditions associated with a higher than 
normal incidence of gastric cancer and significantly raised 
concentrations of N-nitroso compound concentrations of the 
same order as those found in gastric cancer patients. The 
potential danger of this is obvious especially since 
experimentally carcinogenesis following the application of
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N-nitroso compounds is accelerated if the gastric mucosa is 
damaged (Fujita et al., 1979). Also faecal bacteria have been 
shown markedly to increase the effectiveness of the 
carcinogenic N-methyl-N’-nitro- N-nitrosoguanidine; 
concentrations of 100 p.g/ml in drinking water given to germ 
free rats produced tumours in only 17% of the animals whereas 
in normal rats the same dose produced tumours in 91% (Sumi and 
Miyakawa, 1979). Thus a major pathway can be envisaged 
linking intragastric N-nitrosation with gastric cancer (Fig. 
8.1).
It is noteworthy that experiments on the nitrosation of 
gastric juices have shown that conditions leading to 
enterogastric reflux not only lead to the changes in 
iptragastric pH, nitrite concentration, microflora, and 
concentrations of N-nitroso compounds already discussed but 
also provide an additional source of nitrosatable precursors. 
Nitrosated gastric juice containing bile contained many more 
TEA positive peaks than did the product of a similar 
nitrosation of a pentagastrin stimulated gastric juice sample.
Since 1976 when the acid inhibitory H2-blocking drug 
Cimetidine was introduced, the management of peptic ulceration 
has been transformed. Millions of people worldwide now take 
Cimetidine or Ranitidine (a more recently introduced 
H2-receptor blocker) for dyspepsia whether an ulcer has been 
confirmed or not. In order to reduce ulcer recurrence 
indefinite maintenance treatment with Cimetidine also has been 
advocated (Alexander-Williams, 1979). Cimetidine treatment
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Fig. 8.1 Pathway linking intragastric N-nitrosation with 
gastric cancer
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has been shown to raise gastric pH above 4-5 during 39-50% of 
each 24 hours (Walt et al., 1981; McCloy and Baron, 1981), and 
in consequence can increase intragastric levels of faecal type 
bacteria and nitrite concentration (Deane et al., 1980;
Ruddell et al., 1980; Bartholomew et al., 1980). Not 
suprisingly, therefore in this study Cimetidine induced 
achlorhydria was significantly associated with increased 
gastric concentrations of N-nitroso compounds, in some cases 
up to a hundred times the normal concentration (Section 
5.3.1.6). For example of the 74 duodenal ulcer patients 
studied during Cimetidine treatment, 13 had concentrations of 
N-nitroso compounds and 25 had pH levels that either equalled 
or exceeded the mean levels found in 23 patients with gastric 
carcinoma. A similar relationship between Cimetidine 
treatment, increased gastric pH, growth of total and 
nitrate-reducing bacteria, raised nitrite and N-nitroso 
compound concentrations has been found by Stockbrugger et al., 
(1982). A study of the effects of Cimetidine in the stomachs 
of eight healthy men produced different results (Milton 
Thompson et al., 1982). Although 24 hour hydrogen ion 
concentrations were decreased significantly the gastric pH was 
rarely above pH 4 and as a result bacterial counts of
lO'Vml were only rarely observed. Consequently in these 
individuals no evidence was obtained for a relationship 
between gastric pH and concentration of N-nitroso compounds. 
However, the concentrations of N-nitroso compounds reported 
were very much higher than in the present study with one 
sample containing 40.5 jj,mol/l. These higher concentrations 
were probably partly due to the method of
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analysis used being less specific than the method used in the 
present study and partly due to the fact that the samples were 
obtained from non-fasted subjects. Milton Thompson used a 
modification of the Luminox method in which the gastric juice 
sample was injected without prior extraction directly into 
refluxing ethyl acetate containing the HBr/Acetic acid 
denitrosation reagent. Such an abbreviated proceedure would 
liberate nitric oxide from pseudonitrosites, S-nitroso 
compounds and nitrate in addition to any N-nitroso compounds 
present. Consequently interfering substances such as the 
pseudonitrosites and S-nitroso compounds present in food or 
formed in vivo could mask any differences in intragastric 
N-nitrosation. The major difference between these two 
conflicting studies would appear to be however, the difference 
in the effectiveness of Cimetidine at reducing gastric 
acidity. Whereas in the experiment reported in this thesis 
the gastric pH was increased significantly to allow bacterial 
colonisation and hence gastric nitrite concentrations often 
exceeded 0.2 mmol/1; Milton Thompson et al., found that 
gastric pH was rarely greater than pH 4, that bacterial and 
overgrowth did not occur and hence that the nitrite 
concentration in 95% of samples was less than 10 (j.mol/1 with 
the maximum concentration recorded being only 90.9p. mol/1.
The differences in the effectiveness of Cimetidine in these 
two studies may be due to the fact that the subjects used by 
Milton Thompson et al., were healthy young sailors whereas in 
the present study patients with gastroduodenal conditions were 
used in whom the intragastric environment is rather different.
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Indirect evidence for the in vivo formation of N-nitroso 
compounds in the hypochlorhydric stomach has also been 
obtained in this study by measurement of N-nitroso amino acids 
in the urine of volunteers taking the powerful H2-receptor 
blocker Ranitidine (Section 5.3.3.3). Although the gastric pH 
was not monitored in this experiment it was probably above pH 
4-5 for a large proportion of each 24 hours (Walt et al.,
1981) enabling the growth of bacteria in the stomach 
contents. Despite the raised pH and thus unfavourable 
conditions for chemical N-nitrosation, N-nitrosoproline 
excretion did not show any significant change during 
Ranitidine treatment, however, the excretion of 
N-nitrosothiazolidine-4-carboxylic acid increased 
significantly, indicating that the conditions occurring in the 
hypochlorhydric stomach provided with an adequate source of 
nitrosating agent (nitrate) are more suitable for the 
production of some N-nitroso compounds than the normal acidic 
stomach. In contrast, Bartsch et al., (1982) found that the 
excretion of N-nitrosoproline tended to be highest when the 
gastric pH was around pH 2-2.5; thus patients with conditions 
resulting in high gastric pH excreted relatively low amounts 
of N-nitrosoproline. This result is in marked contrast to the 
in vivo nitrosation mechanism proposed in this thesis (Fig.
8.1) which at first sight would predict that the highest 
concentrations of N-nitrosoproline would be excreted by 
patients with high gastric pH accompanied by bacterial 
overgrowth. However, this result can be explained in terms of 
the proposed mechanism when one considers that the method
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devised by Ohshima and Bartsch (1981) for the estimation of 
the endogenous nitrosation of proline used in the present 
study and in that of Bartsch et al., (1982) requires the 
single dose administration of a large amount of nitrate 
( > 200mg NO^) which is in excess of the average per 
capita daily nitrate intake (Table 4.4). Such a large dose of 
nitrate would result in far higher than normal concentrations 
of salivary nitrite entering the stomach of healthy 
individuals. In fact the mean concentration of salivary 
nitrite one hour after the nitrate dose would probably be in 
excess of 45 mg NO^/l compared with a normal resting 
concentration of < lOmg NO^/1. As the rate of 
nitrosation of proline is proportional to the square of the 
nitrite concentration such a high dose would therefore result 
in a 20-fold increase in the intragastric rate of nitrosation 
of proline, whereas a typical high nitrate meal containing 100 
mg N0^ would result in only a 4-fold increase in rate.
Such a large increase in reaction rate may in turn lead to 
abnormally high yields of N-nitroso compound in a dynamic 
system such as the stomach. Of course such a large dose of 
nitrate would also lead to high concentrations of nitrite in 
the colonised achlorhydric stomach which would be even higher 
due to intragastric bacterial reduction of the nitrate. 
However, there is little doubt that proline would undergo 
nitrosation more rapidly in the acidic stomach than in the 
achlorhydric stomach. Thus in the experiments of Bartsch et 
al., (1982), a large dose of nitrate provided a higher than 
normal intragastric concentration of nitrite in the acidic 
stomach of healthy individuals; the ^suiting high yield of
N-nitroso proline was more than sufficient to mask any 
increase in formation of N-nitrosoproline caused by the high 
nitrite concentrations in the chemically unfavourable 
achlorhydric colonised stomach. Conversely, the measurements 
of intragastric concentrations of total N-nitroso compounds 
made in the present study were made in fasting patients 
(Section 5.3) in whom the intragastric concentrations of 
nitrite increased from virtually nothing in the acidic stomach 
to a maximum in the neutral colonised stomach. Thus although 
the acidic stomach is more favourable for N-nitrosation, the 
low intragastric concentrations of nitrite resulted in 
reaction rates far slower than in the experiments of Bartsch 
et al., (1983) and in conjunction with the lower absolute 
amounts of nitrite available resulted in low yields of 
N-nitroso compounds. Conversely the higher concentrations and 
absolute amounts of nitrite in the achlorhydric stomach 
resulted in high yields of N-nitroso compounds despite the far 
slower reaction rates at high pH. The different results 
obtained by Bartsch et al., (1983) and in this study therefore 
emphasise the fact that the amount of in vivo N-nitrosation 
occurring at any site is related not only to the
physiochemical factors affecting the rate of reaction such as
pH, but also the the supply of nitrosating agent. In this 
context, it is noteworthy that healthy individuals who were 
efficient at reducing nitrate in the saliva excreted more
N-nitroso compounds in the urine than did healthy individuals
who were poor nitrate .reducers (Section 5.4). In addition 
different precursor amino and amido compounds will require
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different physiochemical conditions for N-nitrosation. Thus 
although proline is not easily nitrosated in the achlorhydric 
stomach this does not preclude the possibility of the 
formation of high concentrations of other N-nitroso compounds 
as the observations on the formation of 
N-nitroso-thiazolidine-4-carboxylic acid adequately 
demonstrate.
Regardless of the conditions within the stomach N-nitrosation 
could not occur without a nitrosating agent. It is probable 
that the most important intragastric nitrosating agents are 
formed from nitrite. Therefore any reduction in intragastric 
concentrations of nitrite should reduce the formation of 
N-nitroso compounds. Since the nitrite is derived from 
nitrate which would be virtually impossible to remove from the 
diet the only courses open to reduce gastric nitrite 
concentrations are to prevent the endogenous reduction of 
nitrate, or to remove the nitrite once formed, by reaction 
with nitrite scavengers. The latter course of action would 
appear to be the more feasible and in this context ascorbic 
acid and -tocopherol have been widely advocated for the 
reduction of intragastric N-nitrosation. Qhshima et al., 
(1981) demonstrated that the endogenous formation of 
N-nitrosoproline, which is assumed to occur in the stomach, 
could be completely inhibited by ingestion of 1 g of ascorbic 
acid and by about 50% with 500mg of ortocopherol. Likewise in 
the present study a significant reduction in mean intragastric 
N-nitroso compound concentrations was seen in hypochlorhydric 
patients whilst taking 4 g of vitamin C per day (Section
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5.3.1.8). This reduction was particularly noteworthy in 
patients who had undergone a partial gastrectomy. 
Epidemiological data from England, Columbia, Chile, Japan, 
Denmark, Hungary and Italy suggest that a high nitrate intake 
from food and/or water is characteristic of populations with a 
high risk of developing gastric cancer (Hill et al., 1973; 
Cuello et al., 1976; Zaldivar 1977; Haenzel et al., 1976; 
Jensen 1982; Juhasz et al., 1980; Amadori, 1980). In addition 
an inverse association between gastric cancer and consumption 
of fresh fruit and vegetables has also been reported, despite 
the fact that vegetables are a significant source of nitrate 
(Hirayama, 1981). Although direct measurements of Vitamin C 
were not made by Hirayama it is likely that low dietary 
intakes of Vitamin C may be important in enhancing the cancer 
risk as a reduction in its nitrite scavenging activity would 
allow the development of increased intragastric nitrite 
concentrations and consequent formation of N-nitroso 
compounds. If the results obtained in the present study of 
Vitamin C treated hypochlorhydric subjects is confirmed, large 
scale long term studies would be justified to establish 
whether Vitamin C might be useful in protecting individuals 
with a high risk of in vivo formation of N-nitroso 
compounds,as recently advocated by Tannenbaum 1983. Such 
individuals would include these with pernicious anaemia, those 
on long term H2-receptor blockade, and patients who have 
undergone vagotomy or partial gastrectomy.
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Although the majority of in vivo studies have only considered 
N-nitrosation in the acidic stomach, the observation that 
N-nitrosation can occur in the chemically adverse conditions 
of the hypochlorhydric stomach demonstrates the possibility 
that N-nitrosation could occur anywhere in the body that is 
provided with an adequate supply of nitrosating agent. 
Consequently some workers have demonstrated substantial 
amounts of N-nitroso compounds in urines from people with 
infected urinary tracts (Hicks et al., 1978; Brooks et al., 
1972; Eisenbrand et al., 1976). There seems little doubt that 
the reason for these high levels of N-nitroso compounds in 
infected urinary tracts is once again the presence of nitrate 
reducing bacteria. In the present study only very low 
concentrations of nitrite and N-nitroso compounds were found 
in the urine of healthy individuals. The nitrite levels were 
so low (2.5 jimol/1) that it was likely that the majority of 
the N-nitroso compounds excreted were N-nitrosoamino acids 
produced in the stomach. In patients with urinary tract 
infections however it is likely that urinary nitrite 
concentrations would be sufficiently high to allow a 
significant amount of N-nitrosation to occur in the near 
neutral conditions found in the bladder and urinary tract.
Thus in vivo formation of N-nitroso compounds can occur 
wherever there is an adequate supply of nitrosating agent.
The major source of nitrosating agent being the enzymatic 
reduction of dietary nitrate to nitrite by bacteria found in 
the mouth or sometimes in the stomach or bladder. However, 
despite the considerable variation in the amount of nitrite
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produced from nitrate in the saliva of healthy individuals the 
concentration of nitrite found in their gastric juice is 
generally very low and consequently despite the favourable 
gastric pH for N-nitrosation, the concentration of N-nitroso 
compounds is also very low. Nitrite concentrations are 
however much higher in the stomachs of subjects with 
persistant achlorhydria accompanied by colonisation with 
nitrate reducing bacteria, and consequently despite the 
unfavourable pH for N-nitrosation high concentrations of 
N-nitroso compounds are found. These high concentrations can 
be reduced however, by treatment with large doses of the 
nitrite scavenger, Vitamin C. Although the identity and 
carcinogenicity of the N-nitroso compounds formed are unknown 
the highest concentrations are found in patients who are 
considered to have a high risk of developing gastric cancer.
It would be prudent, therefore, to avoid wherever possible 
treatments which lead to persistant gastric achlorhydria such 
as partial gastrectomy or long term treatment with H2 receptor 
blockers, or if such treatment is unavoidable to recommend the 
consumption of high doses of vitamin C. In addition although 
consumption of nitrate at present dietary levels in Britain 
does not appear to produce a significant hazard to healthy 
individuals consumption of large doses of nitrate have been 
shown to significantly increase the in vivo formation of 
N-nitroso proline and have been linked to gastric cancer 
mortality. Considerable concern should therefore be attached 
to the progressive increase in the general level of nitrate in 
the environment and its accumulation in vegetables and 
drinking water.
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Determination of Nitrite at Low Level without Prior Extraction
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Bestimmung eines niedrigen Nitrit-Niveaus 
vorherige Extraktion
ohne
Zusammenfassung. Es wurde eine Methode fur die Be­
stimmung eines niedrigen Nitrit-Niveaus entwickelt, 
die ohne vorherige Extraktion direkt auf Nahrungs- 
mittel oder andere trockene Materialien anwendbar 
ist. Es wird das durch Einwirkung von Essigsaure aus 
Nitrit abgespaltene Stickstoffoxyd mit Hilfe eines 
Chemoluminescenz-Analysators bestimmt. Die Nach- 
weisgrenze liegt bei ungefahr 0,02 pg, indem die Varia- 
tionskoeffizienten unter Anwendung von 0,1 bezie- 
hungsweise 0,05 pg Natriumnitrit 5,7 und 8,2% be- 
tragen. Die Reaktion des Chemoluminescenz-Analy­
sators ist in Gegenwart von mehr als 0,5 ml Wasser im 
Bestimmungssystem herabgesetzt, es sei denn, daB 
Bromwasserstoff in Essigsaure angewendet wird an- 
statt Essigsaure allein; dies wurde, jedoch, neben der 
Stickstoffoxydbildung aus N-Nitrosoverbindungen 
noch zu Stickstoffoxydbildung aus Nitrit fiihren. Die 
Anwendung der Methode fur die direkte Bestimmung 
von Nitrit in einer gefriergetrockneten Kabeljau- 
fleischprobe ergab einen Gehalt von 0,25 mg Natrium- 
nitirit per kg, der mit 0,050 mg per kg des ungetrock- 
neten Originalmaterials Equivalent ist.
Summary. A method has been devised for the determi­
nation of nitrite at low level that is directly applicable 
to food or other dried matrices without prior extrac­
tion. Nitric oxide released from nitrite through the 
action of acetic acid is determined using a chemilumi- 
nescence analyser. The limit of detection is approxi­
mately 0.02 pg, the coefficients of variation being 5.7 
and 8.2% using 0.1 and 0.05 pg of sodium nitrite, 
respectively.
The chemiluminescence analyser response is dim­
inished when water in excess of 0.5 ml is present in the 
assay system unless hydrogen bromide in acetic acid is 
used instead of acetic acid alone. The application of
the method to the direct determination of nitrite in 
freeze-dried cod fish has indicated a content of 0.25 mg 
N aN 0 2 per kg, equivalent to 0.050 mg per kg of the 
original undried material.
Whilst nitrate is distributed widely at comparatively 
high concentrations in water supplies, vegetables and 
the environment in general, nitrite is not usually found 
at anything like the same concentrations, although 
bacterial and plant enzymes capable of reducing ni­
trate to nitrite are widespread. In addition to the fur­
ther breakdown of nitrite to elemental nitrogen or am­
monia, nitrite can react with phenols, thiols, amines, 
etc. in a biological matrix. Nevertheless, the quantities 
of nitrite required stoichiometrically for the produc­
tion from a secondary or tertiary amine or amide of a 
nitrosamine or nitrosamide in amounts considered to 
be of potential epidemiological importance is very 
small. Volatile nitrosamines have been detected by gas 
chromatography coupled with high-resolution mass 
spectrometry in fish samples in which no nitrite was 
detected by conventional means [1].
The methods available for the determination of 
nitrite have been reviewed by Usher and Telling [2]. 
Many rely upon modifications of the Griess [3] reac­
tion involving the spectrophotometric evaluation of 
an azo-dye formed on coupling a diazonium salt with 
an aromatic amine or phenol. Others involve the oxi­
dation of nitrite to nitrate by, for instance, potassium 
permanganate, followed by the determination of the 
latter. This can be accomplished by the nitration of a 
phenol to a coloured C-nitro derivative or by its re­
duction to nitrite or ammonia; obviously no distinc­
tion from nitrate itself is possible by these means.
A number of recent developments have made use 
of unexpectedly diverse procedures for the determina­
tion of nitrite. These have included enthalpimetry dur­
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ing the reaction of nitrite with sulphamic acid [4], 
differential pulse polarography [5] using the reaction 
between the nitrite ion and diphenylamine at low pH 
and gas chromatography with a selective nitrogen det­
ector [6] following the preparation of a steam-volatile 
C-nitro compound. Sub-nanogram levels of nitrite have 
also been determined fluorimetrically using 5-amino- 
fluorescein [7], but oxidants and reductants tend to 
interfere, and the differentiation of the emission spec­
tra from the reagent and its product of reaction with 
nitrite is relatively complicated.
- All procedures to date have required the prelimi­
nary extraction of nitrite contained in a food or other 
matrix prior to its determination and thus have in­
volved its dilution during the procedure so as to re­
duce any retention on the solid under examination to 
a minimum. Nicholas and Fox [8] have investigated 
the effects on the determinatioil of nitrite in meat 
products of parameters such as the dilution of the 
extracts, and have noted interference with the Griess 
reaction on the part of reducing agents in such foods.
Chemiluminescent emissions at the far end of the 
visible region are generally less numerous than those 
at shorter wavelengths [9]. That resulting from the 
deactivation of excited nitrogen dioxide formed by the 
reaction of nitric oxide with ozone does, however, oc­
cur principally in the near-infrared region. Using a 
photomultiplier tube shielded with a red filter cutting 
off transmissions below about 600 nm, therefore, a 
sensitive and selective method is available for the de­
termination of nitric oxide. Nitric oxide can be re­
leased from nitrite by acidification, and thus this pro­
cedure permits the determination of the latter at low 
levels directly on a food or other matrix without the 
necessity for its prior extraction.
Materials and Methods
Nitrite assay using a chemiluminescence analyser. Aliquots of food 
(usually 10 g), or of sodium nitrite itself dissolved in a small volume 
of water, were placed in a 250 ml three-necked flask containing 
30 ml of 1,2-dichloroethane and heated by a thermostatically con­
trolled heating mantle. One limb of the flask was attached to a 
reservoir of nitrogen at atmospheric pressure and another to a re­
flux condenser. Once the solvent was refluxing, 0.1 ml of glacial 
acetic acid or of a 15% [m/v] solution of hydrogen bromide in the 
same solvent was injected into the flask through a septum in the 
third neck. As a result of reduced pressure produced in the analyser 
reaction chamber, the volatile decomposition products were drawn 
out of the reaction flask through the reflux condenser in a stream of 
nitrogen from the gas reservoir at a rate of approximately 400 ml 
per minute. Volatile acidic products were removed from the stream 
of nitrogen by passage through two traps containing 6M-sodium 
hydroxide before entry into a British Oxygen Luminox 101A  Chem­
iluminescence Analyser with a reaction-chamber constructed of 
PTFE. The photomultiplier tube was refrigerated for maximum sta­
bility at the lowest concentrations of nitric oxide. The ranges of the 
instrument covered the values from Oto 0.1, 0.3, 1.0, 3.0, 10, 30, and 
100 v.p.m. At the range chosen, the output was applied to a 100 mv
chart-recorder, the duration of the response following the addition 
of acetic acid being usually of the order of 4-5 min. The responses of 
individual amounts of nitrite were calculated from the integrated 
areas under the recorder peaks in combination with the relevant 
range factor. Due to its high sensitivity towards nitric ocide, the 
maximum range of this instrument would be exceeded using about 
50 pg of nitrite. Where necessary, this limitation could be overcome ' 
by by-passing a known proportion of the nitric oxide produced or 
by reducing the amount of food or other matrix examined.
Results
The addition of acetic acid to sodium nitrite sus­
pended in refluxing 1,2-dichloroethane in an atmo­
sphere of nitrogen is accompanied by the evolution of 
gas, which produces a response in a chemilumines­
cence analyser designed to determine nitric oxide in 
the gas phase, as is illustrated by Fig. 1. A rectilinear 
response has been obtained between the amount of 
nitrite added and the chemiluminescence analyser re­
sponse up to at least 5 pg. The limit of detection of 
sodium nitrite by this method, estimated at three times 
the signal noise, was approximately 0.02 pg. In re­
peated determinations using 0.1 and 0.05 pg of sodium 
nitrite, the coefficients of variation were 5.7 and 8.2%, 
respectively. In comparison with the quantity of ni­
tric oxide released during the denitrosation of N-ni- 
trososarcosine by hydrogen bromide, approximately 
two moles of sodium nitrite gave rise to one mole of 
nitric oxide on treatment with acetic acid.
The inclusion of water during the process of acidi­
fication has been found to broaden the chemilumines­
cence analyser peaks. When decomposing nitrite with 
0.1 ml of glacial acetic acid, no significant change in 
the integrated area under the nitric oxide peak oc­
curred up to an addition of approximately 0.5 ml of 
water. Further additions of water did reduce some­
what the chemiluminescence analyser response, there 
being an approximately 20% reduction following the 
inclusion of 1.0 ml of water. No improvement was ef­
fected by increasing the volume of acetic acid used to
1.0 ml, nor through its combined use with acetic anhy­
dride to remove water present, but the chemilumines­
cence analyser response remained unchanged follow­
ing acidification with 0.1 ml of hydrogen bromide in 
glacial acetic acid up to at least an addition of water of;
4.0 ml, equivalent to 40% water in a 10 g sample of 
food, etc. The response peaks obtained using hydro­
gen bromide were consistently sharper than those 
from acetic acid alone, but they would include also a 
nitric oxide contribution from any N-nitroso com­
pound present [9]. —
The addition of acetic acid to an alkyl nitrite such 
as isopentyl nitrite in refluxing 1,2-dichloroethane re­
sulted similarly in the evolution of nitric oxide. The 
duration of the response following the addition of
0.1 ml of acetic acid was greater than that from inor-
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Fig.l. Response of chemiluminescence analyser to 5.0 pg of sodium 
nitrite
2 min
Fig.2. Response of chemiluminescence analyser to freeze-dried cod 
fish
ganic nitrite, taking approximately ten minutes for ni­
tric oxide evolution to cease, but this could be short­
ened by increasing the addition of the acid to a volume 
of 0.5 ml.
Figure 2 illustrates the application of the proce­
dure to the determination of nitrite in freeze-dried cod 
fish. Following the addition of glacial acetic acid to 
the matrix in refluxing 1,2-dichloroethane, a chemilu­
minescence analyser response was obtained equivalent 
to 0.25 mg of sodium nitrite per kg of the freeze-dried 
fish and to approximately 0.050 mg per kg of the origi­
nal undried material.
Discussion
Nicholas and Fox [8] have reviewed some of the dif­
ferent procedures advocated for the extraction of ni­
trite from foods, etc., and have suggested that the more 
drastic methods involve also the release of additional 
nitrite from labile by-products such as S-nitrosothiols. 
Under the conditions adopted for the procedure de­
scribed in this paper, S-nitroso-2-methylpropane-2- 
thiol is decomposed to yield nitric oxide in the reflux­
ing solvent alone, in which nitrite itself is stable. Upon 
this basis, therefore, inorganic nitrite can be differen­
tiated using a chemiluminescence analyser from its 
breakdown products of this type.
Furthermore, the necessity for the extraction of 
nitrite before its determination by the alternative ear­
lier procedures introduces a number of other disad­
vantages. Of necessity, a dilution is involved to ensure 
the adequate contact of the extraction medium with 
the substrate, and this reduces the over-all sensitivity 
of the methods. Secondly, nitrite may be lost through 
its interaction in solution at acid pH with other food 
components, such as ascorbate or thiols. On the other 
hand, nitrite is lost in contact with foods [10], and any 
removal of water before its determination using the 
chemiluminescence analyser could result in its partial 
decomposition, depending in extent upon the pH of 
the system. However, the ability to determine it di­
rectly in situ  in a food matrix does avoid the necessity 
for a process of extraction that is never absolutely 
complete.
Assuming that the nitrite contained in 10 g of a 
food or other matrix containing moisture can be ex­
tracted as completely as possible into a total water 
volume of approximately 25 ml, its limit of detection 
by the spectrophotometry of an azo-dye in cells of 
path-length 4.0 cm is of the order of 0.5 pg, equivalent 
to a concentration in the original substrate of 50 pg 
per kg. This compares with a detection limit of ap­
proximately 0.02 pg of sodium nitrite in a 10 g sample 
using the chemiluminescence analyser, equivalent to a 
concentration of 2.0 pg per kg in the freeze-dried ma­
trix, and thus to an even lower concentration if the 
material concerned contains appreciable amounts of 
water removed in freeze-drying. Furthermore, consid­
erably larger aliquots of foods, etc., than 10 g could be 
employed without modification to the latter tech­
nique, whereas an increase in sample size using a spec- 
trophotometric procedure would generally require a 
greater volume of extracting solvent with further dilu­
tion of the nitrite present.
The inclusion of water in the chemiluminescence 
analyser assay system will lead to the loss of acetic 
acid from the 1,2-dichloroethane phase, and could ac­
count therefore for the broader peaks of the nitric 
oxide output in its presence. It is surprising, therefore, 
that the situation is not reversed by the addition of 
further acetic acid when water is present. This may be 
due to the appreciable solubility of water in the acetic
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acid — 1,2-dichloroethane mixtures formed, leading 
to a reduced efficiency of release of nitric oxide from 
nitrite. Thus, the method devised is most suitable for 
the determination of nitrite in relatively dry materials 
but the response from any wet sample could be moni­
tored through the subsequent injection of a standard 
aliquot of nitrite in a minimum volume of water.
Low levels of volatile nitrosamines have been re­
ported [ l ] in  fish in which no nitrite could be detected 
by spectrophotometric means. It is now apparent that 
this precursor to such N-nitroso compounds can be 
available in such commodities at levels sufficient for 
their production on a stoichiometric basis.
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Abstract— Drugs of differing structures and pharmacological actions have been incubated at 37°C and 
pH 2.0 under conditions simulating those within the normal fasting stomach. The nitrite concentration 
(25 fiM) was kept as constant as possible for 3 hr in an attempt to mimic its in vivo replenishment from 
the saliva. The extents of A-nitrosation varied widely, but were less than those observed by Gillatt et al. 
{Fd Chem. Toxic. 1984, 22, 269) using the W H O  Nitrosation Assay Procedure, in which the initial nitrite 
concentration is 40 mM, 1600 times greater, and the pH (3.0) is close to the optimum for the A-nitrosation 
of secondary amines. The highest yield of A-nitroso compound was obtained with the benzathine salt of 
penicillin G  whereas some drugs, including hydrochlorothiazide and chlorthalidone, produced no 
detectable A-nitroso derivative. The degree of A-nitrosation was consistently reduced when the initial 
nitrite concentration of 25 fiM was not replenished during the incubations, underlining the importance of 
simulating the continuous supply of nitrite from the saliva. In all instances, the reactions of the drugs with 
nitrous acid were inhibited and, in most cases, completely prevented by the presence of ascorbic acid 
(125 mg).
INTRODUCTION
Concern over the possible formation o f A-nitroso  
compounds in man and his environment stems from 
their carcinogenicity in experimental animals. For 
instance, A-nitrosodiethylamine (N D EA ) is carcino­
genic in forty species o f animals, including higher 
primates (Bogovski & Bogovski, 1981; Schmahl & 
Scherf, 1985). Moreover, far less N D E A  is required 
for tumour induction when the carcinogen is admin­
istered in frequent small doses mimicking human 
exposure than when larger, less frequent doses are 
used (Druckrey, 1967) although the incubation 
period is increased commensurately. Furthermore, 
small changes in the chemical structure o f an A -  
nitrosamine can lead to considerable variation in its 
carcinogenic potency and site o f action. For example, 
A-nitrosomethylethylamine is primarily a liver car­
cinogen, whereas A-nitrosomethyl-«-propylamine in­
duces tumours mainly in the oesophagus (Lijinsky, 
1981). In addition, in the induction o f  tumours in 
50% o f exposed BH rats, N D E A  is approximately 14 
times as potent as A-nitrosodi-n-propylamine (Li­
jinsky, 1978; Wishnok, 1978). Finally, the precursors 
o f A-nitroso compounds, namely amines, amides and 
other nitrogen-containing groups and nitrosating 
agents, are widely distributed throughout the envi­
ronment.
Numerous drugs contain potentially nitrosatable
Abbreviations: 6-APO = 6-aminopcnicillanic acid; N A P  = 
Nitrosation Assay Procedure (WHO); N D E A  = A- 
nitrosodiethylamine; N D M A  = A-nitrosodimethylamine.
groups, such as amines, amides, hydrazides and 
carbamates. Many o f these have been subjected to 
nitrosation (Gillatt, Hart, Walters & Reed, 1984) 
under the conditions o f the Nitrosation Assay Pro­
cedure or N A P test (Coulston & Dunne, 1980) with 
a 4:1 molar excess o f  nitrite. M ost o f  the drugs 
subjected to the N A P test were converted into their 
A-nitroso derivatives to varying extents, the greatest 
yields being generally obtained from drugs containing 
secondary rather than tertiary amino groups. N o ­
table exceptions, however, were the analgesic amino- 
pyrine and the antibiotic minocycline, both o f  which 
produced large amounts o f A-nitrosodimethylamine 
(N D M A ).
This paper evaluates the extents to which a selec­
tion o f  drugs from those previously subjected to the 
N A P  test are converted to A-nitroso derivatives 
under conditions closely simulating those within the 
normal fasting human stomach. The drugs were 
selected to cover a wide range o f reactivities towards 
nitrous acid and included some that did not A -  
nitrosate in the N A P test. Their structures included 
primary, secondary and tertiary amines, secondary 
and tertiary amides and hydrazides. The nitrite con­
centration (25 / im )  used was considered to be repre­
sentative o f the upper end o f the range in the normal 
acidic fasting stomach, and was maintained through­
out the incubations in vitro in order to simulate its 
replenishment from the saliva in vivo. Finally, the 
concentration o f thiocyanate, a powerful catalyst o f  
secondary amine nitrosation at low pH values 
(Boyland & Walker, 1974), was 1.5 m M . This is 
typical o f  the gastric juice o f a smoker (Walters, 
Dyke, Saxby & Walker, 1976).
849
850 P. N. Gillatt et al.
EXPERIMENTAL
Caution— M ost N -nitroso compounds are carcinogenic 
to experimental animals and should be handled with 
great care
Sources o f  drugs. The sources o f  the drugs tested 
were as recorded by Gillatt et al. (1984).
Simulated gastric juice. Four adult doses of each 
drug were dissolved or suspended in simulated gastric 
juice (200 ml) giving a distribution of one dose/50 ml, 
a volume typical of the normal stomach. The com­
position of the simulated gastric juice (Long, King & 
Sperry, 1961) was based on a 0.05 m-KCI-HCI sys­
tem, buffered to pH 2.0, and contained total chloride 
at a concentration of 125 mM as well as sodium 
(70 mM), potassium (50 mM), D-glucose (2.2 mM), pep­
sin (0.14 mM) and lactic acid (1.1 mM). In addition, 
thiocyanate (1.5 mM) and catechin (0.14mM) were 
added to represent the nitrosation catalysts normally 
found in gastric juice, and ascorbic acid was added 
when required to a concentration of 125 mg per dose 
of drug.
Incubation and extraction procedure. Incubations 
were carried out at 37°C over 1 and 3 hr with 
continuous shaking and protected from light. Under 
these conditions and in the absence o f  any drug, the 
initial nitrite concentration o f 25 p M  decayed ex­
ponentially in the simulated gastric juice, with a 
decay curve represented by the equation:
[N O f ] =  3.86 e - ° 03t (min) nmol
A  system was therefore developed to maintain the 
nitrite concentration at approximately 25 pM,  with­
out any drug present, by the dropwise addition o f  a 
sodium nitrite solution. When a drug was present, 
however, the dropwise addition o f nitrite was not 
sufficient to maintain the initial nitrite concentration. 
Therefore on ten occasions during the incubations, 
the nitrite concentration was determined rapidly with 
a chemiluminescence analyser, using a modified pro­
cedure o f Cox (1980), and additional, larger, amounts 
o f nitrite were added to return the concentration to 
25 p M.  Blank determinations o f  A-nitroso com ­
pounds were made omitting the drugs, to account for 
the small amount o f A-nitrosation o f the gastric juice 
itself. Residual nitrite was destroyed at the end o f  
each incubation by the addition o f  excess sulphamic 
acid, prior to repeated extraction with ethyl acetate. 
Negligible amounts o f A-nitroso compounds were 
found to remain in the aqueous phases. N o evidence 
o f  nitrite remaining after the sulphamic acid treat­
ment was noted when the A-nitroso compounds were 
determined.
As no concentration procedure was involved in the 
work up o f the sample extracts, no artefactual for­
mation o f  A-nitroso compounds similar to that 
found by Raisfeld-Danse & Chen (1983) in the pres­
ence o f organic nitrites would have occurred. 
Furthermore, similar sulphamic acid treatment o f  a 
solution o f morpholine containing nitrite at concen­
trations o f  1.0 and 10 mM did not lead to the 
formation o f any A-nitrosomorpholine.
Determination o f  N-nitroso derivatives. A -Nitroso  
compounds formed during the incubations simu­
lating gastric conditions were determined by the 
group selective procedure o f Walters, Downes,
Edwards & Smith (1978). All types o f A-nitroso  
compounds tested have been found to respond to this 
procedure, which is capable o f differentiating them 
from most o f the other types o f compounds, such as 
aromatic C-nitroso compounds, that can be formed 
by reaction with nitrous acid. It was essential to use 
the full sequential procedure rather than an abbrevi­
ated one (Smith, Walters & Reed, 1983) because in 
some cases, such as with chlordiazepoxide and ni­
alamide, thermolabile compounds were formed and 
broke down to produce nitric oxide in the refluxing 
solvent alone. The degrees o f  nitrosation calculated 
on the basis o f  the amounts o f  nitrite added to 
maintain a concentration o f  25 p u  were reproducible 
to within ±  5%, but determinations based on the 
conversion o f drugs into their A-nitroso derivatives—  
generally much smaller values— were repeatable to 
within 20%. All determinations were carried out at 
least in duplicate.
RESULTS
The amounts o f  A-nitroso compounds formed 
when a number o f  drugs were incubated under simu­
lated gastric conditions for 3 hr are presented in 
descending order in Table 1. The absolute amounts 
obtained using the maximum recommended dose o f  
each drug (M artindale, 1982) at a nitrite concen­
tration maintained at approximately 25 p u  through­
out a 3-hr period at 37°C varied widely. A -Nitroso  
derivatives were not detected in the incubations of  
eight drugs, namely chlorthalidone, diphenylpyraline, 
hydrochlorothiazide, nialamide, phenytoin pindolol, 
procaine and streptomycin. The extents o f A - 
nitrosation o f secondary and tertiary amines are less 
readily distinguishable under simulated gastric condi­
tions than in the N A P test (Gillatt et al. 1984).
Table 1 also shows the percentage yields o f A - 
nitroso derivatives based upon the amount o f  drug 
used and upon the total amount o f nitrite that had to 
be added over the 3-hr incubation period to maintain 
the concentration at 25 p M,  assuming that each 
product contained one A-nitroso group per molecule.
The amounts o f  A-nitroso compounds formed 
during 3-hr incubations were consistently greater (by 
a factor o f 3-4) than those produced after 1 hr. Some 
o f the drugs were also incubated with an initial nitrite 
concentration o f  25 pM which was allowed to decay 
without replenishment during the 3-hr incubation at 
37°C. In Table 2 the percentage yields o f A-nitroso 
derivatives obtained without nitrite replenishment are 
compared with those obtained with replenishment, 
on the basis o f  both the amount o f drug and the 
nitrite used. Since the concentrations o f drugs and 
other reactive components o f the simulated gastric 
juice were in large excess o f the added nitrite, they can 
be assumed to have remained constant throughout 
the incubations. It would be expected, therefore, that 
while these concentrations, along -with the pH and 
temperature, remained constant, the relative propor­
tions o f the nitrite lost by reaction with the drug, by 
reaction with other groups and by disproportionation 
would remain approximately the same whether nitrite 
was replenished or not. However, the total yields o f 
A-nitroso compounds were increased markedly, usu­
ally by a factor o f about ten, when the nitrite level
L • i
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Table 1. Conversion o f drugs to A-nitrosoderivatives under simulated gastric conditions
Drug
Type o f 
compound
Dose
(mg)
Extent o f A-nitrosation
Nitroso 
compounds 
% o f drug % of N O f formed 
converted converted (nmol)
Penicillin G, 
benzathine salt
sec/tert amide, 
sec amine 250 0.85 27 4700
Penicillin G, 
sodium salt sec/tert amide 250 0.55 45 3900
Penicillin V, 
potassium salt sec/tert amide 250 0.51 43 3300
Cloxacillin, 
sodium salt sec/tert amide 250 0.21 14 1200
Ampicillin sec/tert amide, 
prim ary amine 250 0.057 4.0 420
Aminopyrine tert amine 600 0.013 8.0 340
Phenylephrine sec amine 60 0.042 0.58 140
Etham butol sec amine 400 0.005 0.39 100
Synephrine sec amine 60 0.026 1.3 93
Penicillin G, 
procaine sec/tert amide 250 0.016 0.47 67
Cyclizine tert amine 50 0.031 0.95 58
Ephedrine sec amine 60 0.016 0.53 58
Imipramine tert amine 75 0.020 0.26 54
Iproniazid hydrazide 40 0.023 0.71 51
6-Amino penicillanic 
acid
prim ary amine, 
tert amide 50* 0.018 0.35 41
Chlortetracycline tert amine 250 0.007 0.26 36
Tetracycline tert amine 250 0.007 0.35 36
Piperazine sec amine 1000 0.0003 0.20 35
Clomipramine tert amine 50 0.017 0.37 27 ■
Oxytetracycline tert amine 250 0.005 0.25 26
Epinephrine sec amine 60 0.008 0.43 25
Timolol sec amine, 
tert amine 30 0.035 0.31 - 25
Phenylpropanolamine prim ary amine 40 0.010 0.28 ... 25
Minocycline tert amine 50 0.021 0.28 23
Clonidine sec amine 5 0.15 0.29 ; 19
M aprotiline sec amine 25 0.020 0.26 18
Propranolol sec amine 30 0.015 1.0 18
Nortriptyline sec amine 25 0.012 0.21 17
Chlorpromazine tert amine 100 0.005 0.22 16
Hydroxyzine tert amine 25 0.026 0.17 14
Atenolol — sec amine 30 0.012 0.22 13
Phenylbutazone tert amide 125 0.003 0.21 13
Clomiphene tert amine 60 0.008 0.16 12
Chlordiazepoxide sec amine 30 0.011 0.22 11
Erythromycin tert amine 250 0.003 0.11 10
Promethazine tert amine 25 0.011 0.19 9.7
M etroprolol sec amine 30 0.01 0.15 7.8
Chlorpheniramine tert amine 5 0.01 0.22 1
*Amount used in study.
was maintained at a constant value. This emphasizes 
the necessity o f  simulating its replenishment from the 
saliva.
Marked inhibition o f  drug A-nitrosation occurred 
in the presence o f ascorbic acid, no formation o f the 
A-nitroso derivatives being detectable in most cases 
when 125 mg vitamin C/dose o f  drug was present. 
With penicillins G and V, synephrine and amino- 
pyrine, a small amount o f A-nitroso derivative was 
demonstrated after 3 hr at 37°C in the presence o f  
vitamin C, but the amounts were very greatly reduced 
compared with those observed in the absence o f  the 
vitamin.
DISCUSSION
The W HO NAP test has been recommended 
(Coulston & Dunne, 1980) as a means o f ranking 
drugs in relation to their susceptibilities to A - 
nitrosation under standardized conditions. It is car­
ried out at pH 3.0, close to the optimum for the
A-nitrosation o f secondary amines (Mirvish, 1975). 
Secondary amines generally form greater amounts o f 
A-nitrosamines by reaction with nitrous acid than do 
primary or tertiary amines. At pH 3, amines are not 
fully protonated, and secondary amines will react 
with nitrous acid to produce A-nitrosamines after loss 
o f a proton. However, tertiary amines will react to 
produce an immonium salt (Smith & Loeppky, 1967) 
which can react with water to form a carbonyl 
compound and a secondary amine by nitrosative 
cleavage. The secondary amine produced can then 
react to form an A-nitrosaminev It is apparent, 
therefore, that the more complex reaction mechanism  
will tend to impair the production o f  an A -  
nitrosamine from a tertiary amine. Exceptions to this 
are the tertiary amines aminopyrine and minocycline, 
both o f which react very readily to form N D M A . In 
the case o f  aminopyrine this is probably because the 
reaction proceeds via the formation o f  a pseudo- 
nitrosite (Mirvish, 1975).
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Table 2. Conversion o f drugs to A-nitroso derivatives under simulated gastric conditions in which the nitrite 
concentration o f 25 fiM is either maintained or allowed to decay during the incubations
Extent o f A -nitrosation
N 0 2 concn maintained N 0 2 concn not maintained
Drug
Dose
(mg)
% o f drug 
converted
% of N 0 2-  
converted
% o f drug 
converted
% o f N 0 2-  
converted
Penicillin G, 
sodium salt 250 0.55 45 . 0.057 51
Penicillin G, 
benzathine salt 250 0.85 27 0.12 27
Penicillin V, 
potassium salt 250 0.51 43 0.039 20
Cloxacillin 250 0.21 13 0.018 7.4
Ampicillin 250 0.057 4.0 0.0070 4.0
Aminopyrine 600 0.013 8.0 0.0015 2.5
Synephrine 60 0.026 1.3 0.0058 2.1
Iproniazid 40 0.023 0.71 0.0042 0.94
Phenylephrine 60 0.042 0.58 0.0024 0.82
Timolol 30 0.030 0.31 0.0011 0.59
Cyclizine 50 0.031 0.95 0.0020 0.44
Ethambutol 400 0.005 0.39 0.0004 0.43
Propranolol 30 0.015 1.0 0.0066 0.43
Clomipramine 50 0.017 0.37 0.0035 0.38
Phenylpropanolamine 50 0.010 0.34 0.0016 0.34
Erythromycin 250 0.003 0.11 0.0012 0.30
Clomiphene 60 0.008 0.16 0.0004 0.27
Atenolol 30 0.012 0.22 0.0030 0.26
M aprotiline 25 0.020 0.26 0.0030 0.26
6-Aminopenicillanic
acid 50* 0.018 0.35 0.0015 0.26
Imipramine 75 0.020 0.26 0.0003 0.26
Chlorpromazine 100 0.005 0.22 0.0002 0.23
Nortriptyline 25 0.012 0.21 0.0007 0.22
Promethazine 25 0.011 0.19 0.0007 0.16
♦Amount used in study.
The objective throughout these studies has been to 
evaluate the extent to which a typical oral dose o f  a 
drug is likely to be A-nitrosated within the fasting 
human stomach. The nitrite level adopted for the 
N A P  test, 40 mM, is much too high to simulate gastric 
conditions. Other workers have approached more 
closely the range o f  nitrite concentrations found in 
the acidic stomach. For instance, Ziebarth & 
Teichmann (1980) incubated drugs at pH 2.0 with
0.64 mM-nitrite. In reality, the nitrite concentration in 
the acidic stomach would be even lower. For exam­
ple, Raisfeld-Danse & Chen (1983) detected nitrite in 
only two out o f 22 human fasting gastric juices, with 
a maximum concentration o f  3.2 n m. However, ni­
trite has been found more consistently by other 
workers (Ruddell, Bone, Hill et al. 1976). Schlag, 
Bockler, Meyer & Belohlavek (1979) also reported 
that nitrite was present consistently in the stomach o f  
normal individuals, in a range o f concentrations 
approaching 10 fxM, which has been proposed as the 
minimum for the formation o f detectable A - 
nitrosopropranolol (Chen & Raisfeld-Danse, 1983). 
Recent studies (P. L. R. Smith & C. L. Walters, 
unpublished results, 1984) have indicated that the 
nitrite concentration in fasting human gastric juice 
can be as high as 25 / im . Nitrite occurs in saliva as a 
result o f the microbiological reduction o f nitrate 
ingested in vegetables and water. Whilst the 
background level in saliva usually ranges from 
approximately 100 to 150 / im  (Tannenbaum, Sinskey, 
Weisman & Bishop, 1974), its concentration can
approach 2.0 m M  after the ingestion o f a meal con­
taining vegetables (Walters, Carr, Dyke et al. 1979).
Swallowing therefore can produce transiently in 
the stomach a relatively high localized concentration 
o f nitrite, prior to its dilution and decay through 
disproportionation and reaction. The nitrite concen­
tration was therefore maintained in these studies as 
close as possible to 25 /am, to simulate its replen­
ishment from the saliva. A  pH o f  2.0 was selected, as 
this simulates the fasting gastric pH more closely than 
the pH 3.0 used in the N A P test, and the optimum pH 
for the A-nitrosation o f  dimethylamine in human 
gastric juice in the presence o f  thiocyanate is about 
2.5 (Lane & Bailey, 1973). Similarly, the extent o f  
A-nitrosation o f propranolol in the presence o f thio­
cyanate was greater at pH 1.0 than at pH 3.0. The 
reverse was true without thiocyanate (Raisfeld-Danse 
& Chen, 1983).'
Under the simulated gastric conditions used, the 
yields o f A-nitroso compounds varied from drug to 
drug, whether calculated on the amount o f drug or on 
the nitrite used. O f 46 drugs tested, 38 gave evidence 
o f A-nitrosation. Several o f  the other eight contain 
functional groups capable o f reacting with nitrous 
acid in such a way as to remove nitrite from the 
system and hence inhibit A-nitrosation. For example, 
hydrochlorothiazide and chlorthalidone (Fig. 1) both 
contain primary sulphonamides which can react irre­
versibly with nitrous acid. Procaine (Fig. 1), either as 
its hydrochloride or its salt with benzylpenicillin, 
contains a primary aromatic amino group. Such
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NHUSO
(a) (b)
S 0 2 NH2
h2 N— ^  b— COOCH 2 CH2 N (CH 2CH3)2
°6H5 V N
^  NH
(d)
(c)
CcH
/“ V  f
C H 3 ~  \ _ y 0CH
6 5
CcH<
(e)
Fig. 1. Structures of drugs that did not produce detectable N-nitroso derivatives when reacted with nitrite 
under simulated gastric conditions: (a) hydrochlorothiazide; (b) chlorthalidone; (c) procaine; (d)
phenytoin; (e) diphenylpyraline.
amines are known to react with nitrous acid via 
diazotization, probably in a manner similar to that o f  
primary sulphonamides. In this way, nitrous acid 
would be removed irreversibly from the simulated 
gastric juice, without forming A-nitroso compounds.
Other factors that may prevent or depress the 
formation o f  A-nitroso derivatives with some drugs 
include the conjugation o f aromatic systems with a 
potentially nitrosatable secondary amine, in which 
the nucleophilicity o f the nitrogen atom is reduced by 
delocalization o f electron density away from the 
nitrogen. This may occur in chlordiazepoxide. Steric 
hindrance imposed by large functional groups, such 
as phenyls, on the approach o f the nitrosating agents 
could reduce A-nitrosation, as was apparent with 
phenytoin (Fig. 1). The increased protonation o f  
amines as the pH is lowered will generally lead to a 
decrease in the reactivity o f  amines towards the 
nitrosating agents. In the case o f  piperazine, a rela­
tively small amount o f A-nitroso compound was 
formed under simulated gastric conditions, possibly 
because the parent compound is a strong base which 
will be principally in the ionized form at the pH  
representing the fasting stomach.
The greatest yields o f  A-nitroso compounds were 
obtained from the alkali metal and benzathine salts 
o f penicillin G and V, followed by the penicillin 
derivatives cloxacillin and ampicillin (Fig. 2), while 
penicillin G as the procaine salt and the parent 
compound, 6-aminopenicillanic acid (6-APA), gave 
lower yields. The penicillins contain a secondary and 
a tertiary amido group, the latter as part o f  a 
/?-lactam ring. A-nitrosation could occur at both 
sites, but it is likely that the strained ft-lactam ring 
undergoes acidic hydrolysis to produce a carboxylic 
acid and a secondary amine which could then react 
to produce an A-nitrosamine (Fig. 3). The formation 
o f an A-nitroso derivative o f desthiobenzylpenicillin 
was first reported in 1949 by Peck & Folkers. The 
lower yield o f  the A-nitroso derivative o f cloxacillin
is probably due to the steric hindrance imposed by 
the isoxazole ring (Fig. 2) which, because o f  its 
aromatic character, would not be expected to un­
dergo A-nitrosation. In ampicillin, the primary ali­
phatic amine (Fig. 2) can react with nitrous acid and 
thus inhibit A-nitrosation at the hydrolysed /Mactam  
ring when the availability o f nitrite is the limiting 
factor. Similar arguments can be advanced for the 
reduced A-nitrosation o f  procaine penicillin G and 
6-APA.
RNH CH,
CH,
J— N--
0 C02 H
(a) R = C6H 5C —
0
(b) R = C6H 5OCH2C —
0
(c) R s C6H 5CHC —
I
NH-
(d) R =
Fig. 2. Structures of 6-aminopenicillanic acid (R = H) and 
its derivatives: (a) benzylpenicillin (penicillin G);
(b) phenoxymethylpenicillin (penicillin V); (c) ampicillin; 
(d) cloxacillin.
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H
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RCONH
CH
HO'
NO
Fig. 3. Possible mechanism for the formation of A- 
riitrosamines following hydrolysis of 6-aminopenicillanic 
acid and derivatives.
The identity o f nitrite as the limiting factor in these 
reactions was underlined by the A-nitrosation o f 
aminopyrine, which is known to yield large amounts 
o f N D M A  (Eisenbrand, Spiegelhalder, Kann et al. 
1979) but was certainly constrained under the simu­
lated gastric conditions by the limited availability o f 
nitrite relative to the dose o f  the drug (600 mg). 
Because o f  the limitation imposed by the nitrite 
concentration, the difference between the extents o f  
A-nitrosation o f  secondary and tertiary amines was 
less marked under simulated gastric conditions than 
with the NAP test. Nevertheless, secondary amines 
generally converted more nitrite to A-nitroso  
compound(s).
In incubations in which the nitrite concentration 
was not maintained, the amount o f  nitrite added was 
usually some ten times lower than in the simulated 
gastric incubations (in which the nitrite concentration 
had to be replenished ten times to maintain its 
concentration) and the yields o f  A-nitroso derivatives 
were also lower, as was to be expected. The propor­
tion o f  nitrite converted to A-nitroso compound(s) 
was similar under both procedures. However, mainte­
nance o f  the nitrite concentration is o f importance in 
the evaluation o f  the absolute amounts o f  A-nitroso 
compounds produced. Thus, the tetracyclines gave no 
detectable A-nitroso compounds under conditions in 
which the nitrite concentration was not maintained, 
indicating that they can act as nitrite scavengers, but 
when the nitrite concentration was maintained at 
25 fiM, A-nitrosation was found to occur.
The addition o f vitamin C to the simulated gastric 
juice at a level o f 125 mg/dose o f drug inhibited 
A-nitrosation in all but penicillin G and V, syne­
phrine and aminopyrine, the drugs that appeared to
react most readily with nitrous acid under the various 
conditions used.
Since both inhibitors and catalysts o f  A -  
nitrosation can occur physiologically, nitrosation 
studies on drugs o f  particular importance, such as the 
penicillins, should be extended to a range o f fasting 
gastric juices to investigate significant variations in 
the yield o f  A-nitroso derivatives. A t the same time, 
attempts should be made to determine the amounts 
o f ascorbic acid required to prevent, as completely as 
possible, the A-nitrosation o f  such drugs.
Preliminary experiments using pentagastrin-
stimulated gastric juice have given results similar to 
those reported here, in terms o f  the proportion o f  
nitrite converted to A-nitroso derivatives o f  drugs. In 
addition, products o f  the reaction o f  penicillin G with 
nitrite under N A P test conditions have proved to be 
mutagenic to Salmonella typhimurium TA100 without 
metabolic activation, in preliminary studies under­
taken by Dr H. Bartsch & S. C. Malaveille o f  the 
International Agency for Research on Cancer, Lyon, 
France (unpublished data, 1985).
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The Influence of Enterogastric Reflux on Gastric Juice 
Bacterial Growth, Nitrite, and N-Nitroso Compound 
Concentrations following Gastric Surgery
P. I. REED, P. L. R. SMITH, K. S U M M E R S ,  K. HAINES,
B. A. BURGESS, F. R. H O U S E  &  C. L. W A L T E R S
Depts. of Medicine and Microbiology, Wexham Park Hospital, Slough, Berkshire,
and Leatherhead Food Research Association, Leatherhead, Surrey,
and Dept, of Pharmacology, Guy’s Hospital Medical School, London, England
Reed PI, Smith PLR, Summers K, Haines K, Burgess BA, House FR, Walters CL. 
The influence of enterogastric reflux on gastric juice bacterial growth, nitrite, and 
N-nitroso compound concentrations following gastric surgery. Scand J Gastroenterol 
1984, 19(suppl 92), 232-234.
Detailed analyses were carried out in 207 fasting gastric juice samples obtained at 
endoscopy or with a nasogastric tube from 50 patients with partial gastrectomy, 43 
with vagotomy, 20 with gastric carcinoma and 50 controls. Significantly higher mean 
pH, nitrite and N-nitroso compound (N-NO) concentrations and nitrate-reducing 
bacterial cultures were noted following partial gastrectomy compared with normal 
controls and comparable to findings in gastric cancer. A  highly significant relationship 
(p <  1(T6) was also demonstrated between pH and N-NO concentrations, highest 
levels of which were seen following Billroth II gastrectomy, significantly higher 
(p = 0.02) than Billroth I, whereas the only change observed following proximal 
gastric vagotomy was a nearly threefold rise in N-NO compared with normal controls. 
However, vagotomy and pyloroplasty produced gastric juice changes comparable to 
those seen with gastrectomy and gastric carcinoma. Thus, the most marked changes 
were observed following surgical procedures involving increased enterogastric reflux 
and these findings lend further support to the possible involvement of N-nitroso 
compounds in the development of gastric cancer following both Billroth I and II 
gastrectomy and vagotomy with pyloroplasty.
K ey words: Gastric bacterial overgrowth; hypochlorhydria; nitrite; N-nitroso com­
pounds; partial gastrectomy; vagotomy
P. 1. Reed, M .D ., F .R .C .P ., Gastrointestinal Unit, Wexham Park H ospital, Slough, 
Berkshire SL2 4H L, England
Partial gastrectomy for benign peptic ulcer carries nitroso bile acid conjugates which react like
a risk of gastric stump carcinoma formation (1). simple N-nitrosamides (3). It is possible that a
Suggestive causative factors include chronic risk of gastric cancer formation also exists follow-
atrophic gastritis with intestinal metaplasia and ing vagotom y and drainage (4). Having previously
persistent enterogastric reflux resulting in pro- demonstrated a highly significant correlation  
gressive hypochlorhydria and mucosal changes, between increased fasting gastric juice pH , NO:
particularly in the pre-anastomotic region of the and N -N O  concentrations, and growth of
gastric remnant (2), with possible mutagenic nitrate-reducing bacteria in gastroduodenal
effects due not only to N-nitroso compounds disease, including gastric cancer (5), we now pres-
(N -N O ), formed by intragastric bacterial conver- ent results of studies showing the effects o f partial
sion of nitrate to nitrite ( N 0 2), but also to N- gastrectomy and vagotomy on these parameters.
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Table I. Details of patients who underwent gastric surgery (PGV = proximal gastric vagotomy; TVP = truncal
vagotomy and pyloroplasty)
Patients Age (years)
Total M F Range Mean Smokers
Controls 50 24 26 16-60 29.5 23 (46%)
Partial gastrectomy
Billroth I 16 9 7 57-74 65.3 9 (64%)
Billroth II 34 25 9 40-88 64.0 21 (66%)
Carcinoma stomach 20 12 8 54-89 73.2 11 (55%)
Vagotomy
P G V 17 11 6 19-62 46.8 11 (79%)
TVP 26 20 6 27-78 48.7 13 (57%)
M A TER IALS A N D  M ETH O D S
A n endoscopic survey was carried out in 93 
patients with partial gastrectomy and vagotomy 
for benign peptic ulcer, performed 1-40 years 
previously, comparing the data with that from 20 
gastric carcinoma cases and 50 healthy normal 
controls. Patient details are presented in Table
I. A  total of 207 specimens of gastric juice, 
obtained after an overnight fast, were cultured 
for total and nitrate-reducing bacteria, and pH, 
N 0 2 and total extractable N -N O  levels (6) were 
measured. The data were analysed employing the 
Royal Statistical Society’s Glim Package; London 
1977.
RESULTS (Table II)
Mean pH  levels were highest following gastrec­
tomy, more so than in gastric cancer, in each 
being significantly higher than in normal controls. 
Raised N O 2 levels and positive nitrate-reducing 
bacterial cultures were obtained in nearly two- 
thirds of samples from gastrectomy and cancer 
patients but only in 6% of controls. A  highly 
significant relationship (p <  10-6) was demon­
strated between pH and N -N O , with highest mean 
N-NO levels in Billroth II, significantly more than 
in Billroth I gastrectomy (p =  0.02) and very 
similar to levels in gastric cancer. Following prox­
imal gastric vagotom y the mean pH was 1.8 and 
the only other abnormal finding was a nearly 
threefold rise in N-NO concentration compared 
with controls. In contrast, in patients with truncal 
vagotomy and pyloroplasty, with a higher mean 
pH at 2 .9 , 57% of samples grew nitrate-reducing 
bacteria and N -NO  rose to levels recorded with 
gastrectomy and gastric cancer.
Table II. Effect of gastric surgery on the intragastric environment
Gastric juice specimens
Subject
n n
Mean
PH %  t N 0 2
%  NOj-reducing 
Bact. cultures
Geometric mean 
N-NO conc. 
(pmol/1) P
Normal controls 50 50 2.9 6 6 0.07±
Partial gastrectomy
Billroth I 16 19 5.7 47 53 0.86± <  10~h
Billroth II 34 60 4.9 50 66 1.31± = 0.02
Carcinoma stomach 20 26 4.1 59 56 1.04±
Vagotomy
P G V 17 18 1.8 0 12 0.16±
TVP 26 26 2.9 21 57 0.94± < \0~K
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D ISCU SSIO N
While the developm ent of gastric stump carci­
noma following partial gastrectomy is now well 
established the exact mechanism has not been  
fully worked out. Gastrectomy results in the loss 
of the pyloric reflux barrier and subsequently 
reflux gastritis is very com m on, being related to 
high gastric concentrations o f duodenal contents, 
including bile acids and lysolecithin, the latter 
known to have cytotoxic properties. It is also 
recognised that bacterial colonisation of the gas­
tric remnant occurs almost universally following 
partial gastrectomy (7). Certain o f the nitrate- 
reducing bacteria, including E. Coli, streptococ­
cus faecalis and bacteroides, also have the ability 
to degrade bile acids. While secondary bile acids 
such as lithocholic and deoxycholic acids have 
been shown to be co-carcinogens in chemically 
induced colorectal carcinoma in animals and have 
also been implicated in human cancer in the same 
organs, D om ellof et al. (2) have produced some 
evidence that such secondary bile acids might also 
be produced in the human stomach following 
partial gastrectomy. The irritative effect of bile 
acids and lysolecithin is thought to lead to pro­
gressive destruction of the gastric mucosa with 
atrophy (8). Similar, but less marked, changes 
have also been observed by Schumpelick et al. 
(9) following vagotomy and pyloroplasty. Sauk- 
konen et al. (10) demonstrated progressive gastric 
intestinal metaplasia and epithelial atypia with 
advancing mean age and length of time following 
gastric surgery and Mortensen et al. (11) showed 
an increase in gastric juice nitrite and bacterial 
overgrowth in patients with obvious dysplasia 
postgastrectomy.
The results from the present study support and 
reinforce these various findings as they show that 
gastric operations which are followed by entero­
gastric reflux result in highly abnormal changes 
in the gastric environment including pH elevation,
colonisation by nitrate-reducing organisms and 
increased nitrite and N-nitroso compound pro­
duction. Although the role o f N -N O  in gastric 
carcinogenesis has not been settled (12), never­
theless the findings from this study lend further 
support to their possible involvem ent in gastric 
cancer formation following partial gastrectomy, 
both Billroth I and II, and vagotom y with 
pyloroplasty.
A CK NO W LEDG EM ENTS
We thank the Staff in the Endoscopy U nit for 
their assistance and PLRS and CLW wish to thank 
the Cancer Research Campaign for their financial 
support.
R E F E R E N C E S
1. Eberlein TJ, Lorenzo FV, Webster M W .  Ann Surg 
1978, 187, 251-256
2. Domellof L, Reddy SB, Weisburger JH. A m  J Surg 
1980, 140, 291-295
3. Piacek-Llanes BG, Shuker DEG, Tannenbaum SR. 
In: Bartsch H, O ’Neill LK, Castegnaro M, Okada 
M, eds. N-nitroso compounds: occurrence and bio­
logical effects. IARC Scientific Publication No. 41, 
Lyon, 1982,123-129
4. Ellis DJ, Kingston RD, Brookes VS. Waterhouse 
JAH. Br J Surg 1979, 66, 117-119
5. Reed PI, Smith PLR, Haines K, House FR. Walters 
CL. Lancet 1981, 2, 550-552
6. Walters CL, Downes MJ, Edwards M W K ,  Smith 
PLR. Analyst 1978, 103, 1127-1133
7. Enander L-K, Nilsson F, Ryder, A-C, Schwan A. 
Scand J Gastroenterol 1982, 17, 117-119
8. Orchard R, Reynolds K, Fox B, Andrews A, Par­
kins RA, Johnson AG. Gut 1977, 18, 457-461
9. Schumpelick V, Garbrecht A, Begemann F. In: 
Baron JH, Alexander-Williams J, Allgower M, 
Muller C, Spencer J. Vagotomy in modern surgical 
practice. Excerpta Medica, Amsterdam, 1982, 
275-283
10. Saukkonen M, Sipponen P, Varis K, Siurala M. 
Hepatogastroenterol 1980, 27, 48-56
11. Mortensen NJMcC, Savage A, Jones SM, Hill MJ, 
Marshall RJ. Gut 1981, 22 A  891
12. Tannenbaum SR. Lancet 1983, 1, 629-632
- - H
TH E LANCET, SEPTEMBER 1 2 ,1 9 8 1 553
EFFECT OF CIMETIDINE ON GASTRIC JUICE 
N-NITROSAMINE CONCENTRATION
P. I. R e e d  P. L. R. S m ith
K . H a in e s  F . R. H o u s e
C. L. W a l t e r s
Gastrointestinal Unit, Wexham Park Hospital, Slough, Berkshire;
Biochemistry Section, Leatherhead Food Research Association, 
Leatherhead, Surrey; and Department of Pharmacology,
Guy's Hospital Medical School, London SE1
S u m m a ry  Total extractable N-nitroso compounds, 
^  pH, and nitrite levels were measured in, 
and microorganisms were cultured from, the fasting 
gastric juice o f 140 patients taking the H2-receptor antagonist 
cimetidine and from 267 subjects, including 50 healthy 
volunteers, not taking cimetidine. Significantly higher mean 
N-nitrosamine concentrations and pH levels were 
demonstrated in the cimetidine-treated patients; 
N-nitrosamine concentration increased with pH. In 30 
patients studied, cimetidine treatment significantly increased 
gastric pH and N-nitrosamine concentrations, while in 23 
patients withdrawal o f cimetidine treatment resulted in a 
significant reduction o f pH but not o f N-nitrosamine 
concentrations. The gastric juice nitrite level was often raised 
and nitrate-reducing bacteria cultured were similar to those 
associated with other causes o f hypochlorhydria. These 
results demonstrate for the first time a relation between 
gastric juice Nmitrosamine concentration, pH, and 
cimetidine treatment, and the findings are discussed in 
relation to gastric cancer induction.
Introduction
T h e  introduction of the acid inhibitory H2-blocking drug 
cimetidine in 1976 has transformed the management o f 
peptic ulceration and millions o f people worldwide now take 
cimetidine for dyspepsia whether an ulcer has been 
confirmed or not. Also, to reduce ulcer recurrence indefinite 
maintenance treatment with cimetidine is now being 
advocated.1 We have demonstrated a relation between 
conditions predisposing to persistent hypochlorhydria or 
achlorhydria and N-nitrosamine concentration.2 The aim of 
this study was to examine the effects o f  cimetidine on gastric 
juice N-nitrosamine concentration.
Patients and Methods
Gastric juice was routinely obtained at endoscopy after an 
overnight fast of at least 12 h from patients with various 
gastroduodenal conditions, many of whom had been on cimetidine 
treatment in daily doses of 0 • 2 to 1 * 6 g for periods of 1 week to 45 
months. Patients on cimetidine were also asked to take a 200 mg 
tablet, usually 1-4 h before endoscopy. Asymptomatic volunteers 
without a history of gastroduodenal disease acted as normal 
controls.2 They did not have endoscopies and gastric juice was 
obtained by intubation. Each specimen was then processed as 
previously described for pH, nitrite, bacterial culture with special 
reference to nitrate-reducing bacteria,2 and measurement of total 
extractable volatile and non-volatile N-nitrosamines.3 In every 
patient careful note was made of endoscopic findings, cigarette 
consumption, and drug intake, especially of cimetidine and 
antacids.
370 subjects were studied; 216 specimens of gastric juice were 
obtained from 140 patients who were on cimetidine treatment and 
301 specimens were taken from 267 subjects not taking cimetidine, 
including 50 healthy volunteers and 37 patients later given 
cimetidine and subsequently sampled (table I and fig. 2). The 
diagnostic group details are listed in table II.
TABLE I—PATIENTS STUDIED D U RING C IM ETID IN E TR EA TM EN T
No. of patients Age range (yr)
No. of gastric 
juice samples
Male 103 18-80 156
Female 37 21-81 60
Total 140 216
Controls 50 18-51 50
TABLE II—GROUPS TREATED W ITH  CIM ETID IN E
Patients Samples
Group (n= 140). (n=216)
Post-vagotomy 15 22
Post-partial gastrectomy 4 5
Duodenal ulcer 74 122
Atrophic gastritis 5 5
Gastric ulcer 24 40
Reflux oesophagitis 7 8
Miscellaneous: dyspepsia/ 11 14
normal mucosa on endoscopy
The data were analysed using the G L I M  package (Royal 
Statistical Society, London: 1977).
,„v< .
Results
p H  an d  N -nitrosam ines
We found a significant relation between pH and 
N-nitrosamine concentration in the cimetidine-treated 
patients (fig. 1). N-nitrosamine levels rose progressively with 
pH from a mean level of 0 • 11 pmol/1 at pH range 1-1 • 5 to a 
mean o f  T  66 pmol/1 at pH 6* 5 -9  (p<10-6), compared with 
0-10 pmol/1 and 1 • 20 pmol/1, respectively, in individuals not 
so treated (p<10-6). As was expected, significantly higher pH 
levels were noted during cimetidine treatment (mean increase 
o f O’5 pH units; p = 0-0025). The mean N-nitrosamine 
concentration was 0-42 log units higher (p = 0-021) in the 
cimetidine-treated patients than in those not so treated in the 
same diagnostic groups, with higher concentrations seen in 
cimetidine takers in each o f  these groups (fig. 
2)—significantly so in those with duodenal ulcers (1-04 log 
units higher; p = 0-0083). The respective slopes for the 
regression (b) of N-nitrosamine concentration on pH are 0 • 47 
in the untreated and 0 -49 in the cimetidine-treated individuals
^  1 0 -
No of \
spotimen* Untreated 91 
T rea ted  5
9 mean pH
Fig. 1— Relation between gastric pH and N-nitrosamine 
concentration in cimetidine-treated and untreated patients.
Left hand columns indicate untreated and right hand columns indicate 
cimetidine-treated patients. Vertical bars indicate 95% confidence limits and 
base of histogram represents pH range.
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Fig. 2— Gastric pH and N-nitrosamine concentrations in different 
diagnostic groups.
Comparison between untreated and cimetidine-treated patients. The open 
circles on the right of the figure represent untreated groups for comparison. 
N =norm al controls, D U = duodenal ulcer, O e= Oesophagitis, V=vagotomy, 
G=chronic gastritis, GU=gastric ulcer, PG =partial gastrectomy, 
Ca=carcinoma of stomach, PA = pernicious anaemia.
(SE±0*03, not significant). Thus, increased N-nitrosamine 
concentrations noted during cimetidine treatment occurred 
in association with a pH rise.
S e r ia l S tudies
We assessed the effect o f  cimetidine treatment on 53 
patients studied serially. In 30 patients the pre-treatment 
state was compared with that after 3 to 9 weeks o f cimetidine 
treatment with daily doses o f from 0 • 8 to 1 • 6 g—usually 1 g. 
22 patients had higher pH levels during treatment, while in 3 
patients the levels remained unchanged and in 5 they were 
lower. The increases occurred irrespective o f the primary 
diagnosis. Both pH (mean pH rise from 2*3 to 4-1; 
p = 0*00048) and N-nitrosamine concentrations (geometric 
mean increase from 0 • 08 to 0 • 47 pmol/1; p = 1 ■ 9 x 10'6) rose 
significantly during cimetidine treatment (fig. 3).
23 patients had gastric juice sampled during cimetidine 
treatment and again at a variable time after stopping 
cimetidine. The treatment periods were between 1 and 48 
weeks and patients were off the drug from 1 to 40 weeks 
before sampling. As expected, treatment withdrawal resulted 
in a significant fall in pH (from 3*4 to 2*3; p =0*0082), but 
the fall in N-nitrosamine concentration (geometric mean 
reduction from 0*30 to 0*16 pmol/1) was not significant. 
Indeed, in 7 out o f 23 patients a rise in N-nitrosamine 
concentration was noted together with an increased pH in 4 o f  
them, even though the drug had been withdrawn at various 
times up to 34 weeks before (fig. 4).
N itr i te  a n d  B acteria
Although the gastric juice nitrite concentration rose and 
growth o f  nitrate-reducing bacteria increased more often in 
cimetidine takers, the trends were no different from those 
expected in patients with other causes o f hypochlorhydria.
S m okin g
Significantly different N-nitrosamine concentrations were 
noted in smokers from only two groups on cimetidine 
treatment. Levels were higher than those o f non-smokers in 
patients who had had vagotomies (2*37 log units; p =0 • 031)
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Fig. 3— Gastric pH and N-nitrosamine concentrations before and 
during cimetidine treatment.
and, surprisingly, lower in the 41 smokers with duodenal 
ulcers (1 • 3 log units; p =0  • 0023), even though in this group 
overall (n = 74) the N-nitrosamine concentrations were 
significantly higher during cimetidine treatment (1*04 log 
units; p = 0*0083).
Sex
No significant differences in N-nitrosamine concentrations 
were seen between the sexes during cimetidine treatment.
Discussion
The gastric juice o f hypochlorhydric or achlorhydric 
patients contains nitrate-reducing bacteria in significant 
quantity4,5 together with adequate amounts o f nitrosatable 
amines6 so that N-nitrosamines can be formed.7 A cimetidine- 
induced rise in gastric pH can increase intragastric levels o f  
faecal-type bacteria8'10 and nitrite concentration.8'11 This is 
not surprising since 24-hour studies12,13 have shown that 
cimetidine treatment will raise gastric pH above 4 -5  during 
39-50%  o f the 24 hours. In our study cimetidine treatment 
was associated with significantly raised N-nitrosamine 
concentrations—in some cases up to a hundred times normal. 
O f the 74 patients with duodenal ulcer on cimetidine 
treatment, for example, 13 had N-nitrosamine concentrations 
and 25 had pH levels that either equalled or exceeded the 
mean levels found in 23 patients with gastric 
carcinoma—results confirmed by the serial studies o f  
cimetidine takers already described.
We can envisage at least one major pathway whereby 
cimetidine could increase the risk o f gastric cancer in man 
(fig. 5). In one experimental study the growth o f faecal
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bacteria markedly increased the' effectiveness o f carcino­
genic N-nitroso compounds; N-methyl-N'-nitro-N-nitroso- 
guanidine (MNNG), 100 pg/ml in drinking water given to 
germfree rats, produced tumours in only 17%, but, given in 
the same dose to normal rats, produced tumours in 91%.14
Our tests were done on fasting gastric juice, thus we 
underestimated the total amount o f N-nitrosamines that 
could be formed from nitrate and amines in a normal diet. 
Cimetidine itself can be readily nitrosated in vitro at low pH  
to N-nitrosocimetidine15,16 which is a powerful mutagen in 
vitro17-18 as well as in vivo.19 Furthermore, the gastric juice of 
cimetidine-treated patients has been shown to be 
mutagenic.20 It is not known whether in man cimetidine is 
converted to N-nitrosocimetidine during treatment since a 
sufficiently sensitive analytical procedure is not yet available.
Patients with a damaged gastric mucosa produced by, for 
example, chronic gastritis, gastric surgery, or chronic gastric 
irritation due to bile reflux, have an increased susceptibility 
to gastric cancer.21 It is noteworthy that the carcinomas 
which develop in the presence o f a damaged gastric mucosa 
often arise in the prepyloric or pre-anastomotic regions of the 
stomach. Gastric cancers produced experimentally in 
animals by N-nitroso compounds, notably M NNG , also first 
develop in the prepyloric region.22 Rats given high doses of 
another H2-receptor antagonist, tiotidine, a compound 
similar to cimetidine in chemical structure, had 
intraepithelial dysplasia and adenocarcinomas in the pyloric 
region of the stomach.23 Most patients treated with 
cimetidine in whom adenocarcinomas o f the stomach 
subsequently developed had tumours in the prepyloric region
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• o f  the antrum.24'28 These findings support the view that 
enhancement o f a predisposition to cancer is seen in the 
gastric mucosa when there is a raised gastric pH.
It has been claimed that cimetidine treatment is as good as 
or better than vagotomy29 with the added advantage that 
treatment can be stopped, yet N-nitrosamine levels are 
similarly raised after both H2-blockade with cimetidine and 
after vagotomy. Thus, the implications for the continued 
long-term health o f the intragastric environment must cause 
concern. The effects o f continued mucosal exposure to high 
- N-nitrosamine concentrations is considered by some to be a 
cancer hazard.30 At least one clinical report21 postulates an 
increased risk o f gastric cancer after vagotomy, but this awaits 
confirmation. For long-term cimetidine treatment the 
toxicological data from the drug developers for rat31 and 
dog32 exposure at high concentrations appear reassuring but 
disagree with current clinical experience24'28 and with the 
data in this report. It is clear that H2-blockade effectively 
suppresses acid secretion but also increases N-nitrosamine 
concentrations, which, in a number o f patients in this study, 
were raised for a long time after stopping treatment.
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Hypothesis
THE RED-CELL IMMUNE SYSTEM
Isr a e l  S ie g e l  T ia n  L in  L iu *
N o r b e r t  G l e ic h e r
Division of Reproductive Immunology, Department of Obstetrics and 
Gynecology, Mount Sinai Hospital Medical Center of Chicago and 
Rush Medical College
S u m m a ry  It is suggested that red cells have an immune
function as well as a respiratory one. 
Adherence o f red cells to antigen-antibody-complement 
complexes (red-cell immune adherence) has been observed in 
primates and in rabbits and may represent a basic immune 
phenomenon that is common to at least all mammals. It is 
estimated that 95% o f C3b receptors in the human circulation 
are located on red cells and that an antigen-antibody- 
complement complex has a 500-1000 times greater chance o f  
being removed from the circulation by a red cell than by a 
white cell. That red cells also adhere to autologous >  
thymocytes and T  cells suggests that they may act as 
intermediaries bringing antigens and T  cells together.
INTRO D U CTIO N
T h e  functional division o f blood cells has traditionally 
followed a strict “colour line”. White cells are thought to be 
concerned mainly with immune and defence mechanisms, 
whereas red cells are generally thought to be highly 
specialised haemoglobin-containing cells with a main 
function as carriers o f respiratory gases. We postulate that, in 
addition to their respiratory role, the red cells are an essential 
component o f the immune system.
*Visiting scholar from Chung Shan Medical College, Kwongchow, People’s 
Republic of China.
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This immunocyte function o f the red cell can account for a 
growing number o f facts which are difficult to understand if  
the function of the red cell is assumed to be solely respiratory.
RED-CELL IM M UNE ADHERENCE
Red cells adhere to antigen-antibody-complement 
complexes1 through surface receptors which recognise C3b 
or C4b complement components.2 This “immune 
adherence”3 is also seen in a variety of lymphoid cell types 
and platelets. We believe that red-cell immune adherence 
(RCIA)4,5 represents one factor o f a red-cell immune system.
RCIA was formerly thought to occur in primates only, but 
we have now demonstrated it in non-primates.6 We used 
modifications o f standard RCIA assay procedures4,5 with a 
mixture (total volume 0*3 ml) containing the components 
(except thymocytes) described in column 1 o f table I. A slide 
was prepared as described in the table, and 200 red cells were 
counted at random. The percentage o f rabbit red cells that 
formed aggregates o f a least three cells was then calculated
(fig- !)•
Significant RCIA was seen in 9 o f 23 rabbits tested. When 
the RCIA o f 5 'rabbits was tested for a second time 14-30 days 
after the first RCIA determination, 3 previously RCIA- 
positive rabbits had become RCIA negative. Further 
experiments revealed that the lack o f RCIA activity in the 
RCIA-negative rabbits was due to a heat-labile inhibiting 
factor in their sera.6 Those sera served as a source of  
complement in the assay system. The inhibiting factor was 
demonstrated by showing that the presence o f serum from 
RCIA-negative rabbits in previously positive reaction 
mixtures diminished RCIA (table II). The inhibiting effect 
could be completely abolished by exposure o f sera containing 
inhibiting factor to 58 °C for 30 min. We were able to 
demonstrate significantly more RCIA-inhibiting factors in 
adult rabbits than in newborn rabbits (p<0-0005).6 
Variations in RCIA-inhibiting factor in different rabbits and 
the changes o f RCIA-inhibiting factor observed in the same 
rabbit at different periods (fig. 1) suggest the presence of 
physiological mechanisms controlling the synthesis o f the
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GASTRIC JUICE N-NITROSAMINES IN HEALTH 
AND GASTRODUODENAL DISEASE
P. I. R e e d  P. L. R . S m i t h  -
K .  H a i n e s  F .  R .  H o u s e
C. L. W a l t e r s
Gastrointestinal Unit, Wexham Park Hospital, Slough, Berkshire;
Biochemistry Section, Leatherhead Food Research Association, 
Leatherhead, Surrey; and Department of Pharmacology,
Guy’s Hospital Medical School, London SE1
S u m m a r y  The concentrations of total extractable 
N-nitroso compounds, pH, and nitrite levels 
were measured in fasting gastric juice, which was also 
cultured for bacteria, from 50 healthy volunteers and 217 
patients with common upper gastrointestinal complaints. 
The concentrations of N-nitroso compounds and p H  levels 
rose significantly with age. Sex and cigarette smoking had no 
significant effect. There was a positive correlation between 
p H  and N-nitroso concentration, and between p H  and an 
increase in the concentration of nitrites. A  significant relation 
was demonstrated between raised N-nitroso and nitrite levels 
and growth of nitrate reductase-positive microorganisms. 
These results demonstrate for the first time in man the 
interrelations of N-nitrosamine concentration, pH, gastric 
juice nitrite, and nitrate-reducing bacteria. The findings are 
considered in relation to the risks of development of gastric 
cancer in man.
Introduction
N-NITROSO compounds are powerful carcinogens formed 
when amines and amides react with nitrite.1 Their formation 
has been demonstrated in gastric juice of animals2 and man.3 
Gastric cancer is commoner in areas where drinking water 
contains much nitrate,4,5 and bacteria which reduce nitrate to 
nitrite, as well as increased nitrite concentrations, are often 
found in the hypochlorhydric stomach.6,7 W e  have therefore 
measured the nitrite content, the concentration of nitrate- 
reducing bacteria, and the intragastric p H  of gastric juice 
from patients with gastric abnormalities and from healthy 
controls, and have compared these findings with intragastric 
N-nitrosamine concentrations. Results in patients treated 
with the gastric secretory antagonist cimetidine are reported 
separately.8
Patients and Methods
Gastric juice was obtained at endoscopy from patients with 
conditions including duodenal ulcer, gastric ulcer, atrophic 
gastritis, pernicious anaemia, gastric carcinoma, dyspepsia with 
normal endoscopic result, and reflux oesophagitis. Also included 
were patients who had undergone vagotomy or partial gastrectomy. 
Subjects without symptoms or a history of gastrointestinal disease 
acted as controls. The samples were collected after an overnight fast 
of at least 12 h; this would reduce significant variation in amine 
precursor levels derived from food. Before each examination the 
endoscope and its aspiration channel and polyethylene tubing, 
through which each sample was obtained, were sterilised with 
activated glutaraldehyde and then rinsed with water. Every effort 
was made to avoid contamination of gastric juice with saliva. 
Immediately after collection part of the sample was cultured for 
aerobic and anaerobic microorganisms,9 and its nitrate-reducing 
activity was assessed.10 The pH of the rest of the sample was 
measured and the juice was tested for the presence of nitrite with an 
Ames ‘N-Labstix’ test tape. Sulphamic acid (50 mg/10 ml juice) was 
added to stabilise the system by removal of residual nitrite, and the 
specimens were rapidly frozen. Thus, N-nitroso compounds from
acidic and hypochlorhydric gastric juices were stored under the 
same conditions below pH 2. The ethyl acetate extraction of most 
specimens was done within a few days, the concentration of total 
volatile and non-volatile N-nitrosamines being measured by the 
method of Walters et al.11 Since the pH achieved was below the 
optimum for stabilisation of N-nitrosamides it is unlikely that the 
total original concentration would have been measured. The 
endoscopic findings, cigarette consumption, and drug intake were 
noted for each patient.
301 specimens of gastric juice were obtained from 267 untreated 
subjects (table i) including 50 healthy volunteers without a history
TABLE I—PATIENTS STU DIED
Patients* No. Age range (yr) No. specimens
Male 136 18-81 186
Female 81 18-87 115
Total 217 301
‘ Includes 50 controls (24 men and 26 women) in age range 18-60 from whom 
50 specimens were taken.
of gastrointestinal symptoms and taking no drugs which might 
affect the gastric juice, and including 37 patients before starting 
cimetidine treatment who subsequently had gastric juice samples 
analysed. The details of the diagnostic categories are listed in table
II. In every specimen pH and N-nitrosamine concentrations were 
measured but 41 specimens were not cultured for microorganisms 
owing to insufficient sample..
TABLE II—DIAGNOSTIC GROUPS
Group*
Patients
(n=217)
Specimens 
(n = 251)
Duodenal ulcer 70 77
Vagotomy 24 26
Partial gastrectomy 14 16
Atrophic gastritis 13 14
Gastric ulcer. 33 52
Pernicious anaemia 16 17
Carcinoma of stomach 23 23
Reflux oesophagitis 10 12
Miscellaneous—dyspepsia:
endoscopy normal 14 14
‘ Excluding 50 controls.
The data were analysed using the Royal Statistical Society’s 
G L I M  package: London, 1977. The variables examined included 
age, sex, smoking habit, presence of nitrite, pH, N-nitrosamine 
concentration, and bacteriological data. To eliminate the risk of 
false associations owing to the small numbers in some groups, only 
first order and a few genuine selected second order interactions were 
examined. Exploration of the residuals from the fit indicated that a 
natural logarithmic transformation of N-nitrosamine concentration 
was appropriate to obtain an approximately normal distribution. 
This was used throughout the analysis and regression coefficients 
should be interpreted with this in mind.
Results
Age
N-nitrosamine concentrations rose progressively with age 
in both sexes even after accounting for the influence of pH. 
The ages of the 50 controls ranged between 18 and 60 years 
and N-nitrosamine levels ranged from 0-02 to 1 • 1 ^ mol/1. In 
all patients (n = 217) N-nitrosamine concentrations rose 
significantly with age. The age range was from 18 to 87 years 
and N-nitrosamine levels ranged from 0 • 01 to 40 pmol 1. The 
regression coefficient (b) of N-nitrosamine on age v. a . 0-02
(p = 0-56 x 10“*). In the sam e patients the rise in iM;tric p H
.  to
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with age was also significant (pH range 1 • 0 -9  • 0; b =0 • 031;
p < 1 0 '6).
Sex
N-nitrosamine levels were significantly higher in males 
(0-44 log units; p =0*0036) taking into account all factors.
Smoking
Cigarette smoking had no significant effect on either 
N-nitrosamine or nitrite concentrations.
p H
Overall, we found a significant relation between pH and 
N-nitrosamine concentration after allowing for age, sex, 
smoking, presence o f nitrite, and their interactions (fig. 1).
e 20
108
pH range
Fig . 1—R elation  betw een g astric  pH  a n d  N -n itrosam ine  concen­
tra tio n .
301 samples. Vertical bars indicate 95% confidence limits and base of 
histogram represents pH  range.
N-nitrosamine concentrations rose progressively with pH  
from a geometric mean o f 0 • 10 /imol/1 at pH 1 • 0 -1  • 5 to a 
mean o f  1 *20 /imol/1 at pH 6 *5-9*0 (b= 0*44; p<10"6). A 
significant correlation was seen in several conditions 
including duodenal ulcer (b = 0*51; p = 0*91 x  10"6), post­
vagotomy (b=0*61;p = 0 * 4 0 x l 0-4), gastric ulcer (b = 0 • 36; 
p = 0*76x 10“5), gastric cancer (b=0*54; p = 0*0061), and 
pernicious anaemia (b = 0*62; p =0*0052). Furthermore, 
conditions known to be associated with reduced gastric 
acidity and raised pH showed correspondingly higher 
N-nitrosamine levels (fig. 2).
Nitrite
Fresh gastric juice was tested for the presence o f nitrite by a 
semi-quantitative method with a colour code indicating either 
an absence o f nitrite or concentrations which were either low 
(0*01 mmol/1) or high (>0*2 mmol/1). Mean N-nitrosamine 
concentrations were higher at both low and high nitrite 
concentrations—0*52 log units, p=0*043, and 0*89 log 
units, p =0*021, respectively.
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Fig . 2—G astric  pH  a n d  N -n itro sam ine  concen tra tions in  un trea ted
groups.
N=norm al controls, D U = duodenal ulcer, Oes=oesophagitis, 
V=vagotomy, Gas=chronic gastritis, GU=gastric ulcer, PG = partial 
gastrectomy, Care= carcinoma of stomach, and PA “ pernicious anaemia.
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A significant relation was also demonstrated between a rise 
in pH and an increase in nitrite levels (p< 10~6).
Bacteriological results
The gastric juice in man is normally sterile, but bacterial 
flora which are either swallowed with saliva or enter from the 
intestine can be cultured when the gastric juice pH rises. 
Bacteria from the gut, notably coliforms, enterococci, and 
gram-positive cocci, can break down nitrate to nitrite and 
we found a significant relation between the growth o f  
T such organisms and N-nitrosamine concentrations 
(p = 0*31 x  10-5). Nitrate reductase-positive organisms were 
also significantly associated with raised pH (p = 0*028).
Discussion
There are two main groups o f N-nitroso compound; 
N-nitrosamines form one group and N-nitrosamides such as 
the guanidines and ureturanes from the other. The 
N-nitrosamines are stable compounds which require 
biological activation to become carcinogenic, whereas the 
others are considered to be labile, particularly at alkaline pH, 
and do not require metabolic activation for methylation of 
nucleic acids.
N-nitrosamines are formed when secondary, tertiary, and 
even primary amines react with nitrate or nitrogen oxides 
under either acidic, neutral or, alkaline conditions, depend­
ing upon the precursors and presence o f catalysts. Catalysts 
and stimulators o f physiological importance include chloride, 
bromide, thiocyanate, and microorganisms. Thiocyanate, 
which can accelerate the rate o f nitrosation o f secondary 
amines several hundred fold at acid pH ,12 is present in 
saliva, and particularly in saliva o f smokers.13 However, it 
does not catalyse formation o f N-nitrosamides. Other sub­
stances, such as vitamins C and E, generally inhibit 
nitrosation.
In vitro, the nitrosation o f  a secondary amine occurs most 
readily at a pH around 3*5 and that o f a secondary amide 
continues to increase in rate with fall o f pH .14 Man is exposed 
to N-nitrosamines through ingestion, inhalation, dermal 
contact, and formation in vivo. Although preformed volatile 
N-nitrosamines are present in nitrite-cured meats, in some 
cheeses, fish, and many beers, the formation o f such
*' - 
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compounds in the gastrointestinal tract in vivo is probably 
the main source o f  human exposure, since far more nitrite 
arises from salivary nitrate than is ingested.15 Many bacteria 
can reduce nitrate, which is widespread in foods and 
saliva,16‘18 to nitrite. An increase in nitrate-reducing bacteria 
in gastric hypochlorhydria is associated with higher nitrite 
concentrations.6,19 Ultrafiltrable and thermostable bacterial 
factors can stimulate nitrosation at pH values unconducive to 
chemical action alone.20 Most N-nitrosamines in the fasting 
gastrointestinal tract are probably synthesised there.
The epidemiological evidence associating N-nitroso 
compounds with human cancer is strong for sites such as 
oesophagus,21 stomach,4 and bladder.22 Most o f  the more 
than 200 N-nitroso compounds which have been tested for 
their carcinogenicity have been shown to produce tumours in 
up to 22 animal species studied, ranging from fish to higher 
primates.23 Tumours have also been produced in a number o f  
organs including the stomach. In animals, the simple volatile 
N-nitrosamines, N-nitrosodimethylamine, N-nitroso- 
diethylamine,24 and N-nitrosamides25,26 have acted as 
carcinogens in the glandular stomach.
It is debatable whether N-nitroso compounds are causal in 
human gastric cancer. For any study, a valid, reproducible, 
and acceptable method o f measuring as many N-nitroso 
compounds as possible in biological fluids is necessary. The 
stabilisation o f these compounds as well as the avoidance o f  
their formation in vitro after collection is also important. 
Sulphamic acid for this purpose ha^ rapidly removed all 
nitrite and has not been responsible for the synthesis o f  
N-nitroso compounds. However, the pH achieved with 
sulphamic acid in this study « 2  • 0) would have precluded the 
extraction o f  basic N-nitroso compounds from gastric juice. 
This suggests that the total concentration o f N-nitroso 
compounds in the gastric juice was greater than that given in 
our results.
Raised nitrite levels are found in the achlorhydric 
stomach6,7 along with an increased growth o f total and 
nitrate-reducing bacteria. Such conditions have been found 
in gastric cancer and in conditions predisposing to it such as 
pernicious anaemia,19 chronic atrophic gastritis with 
intestinal metaplasia, and after gastric surgery.27 Schlag et 
al.28 showed that the pH rise after Billroth II gastrectomy is 
accompanied by a significant rise in gastric juice N-nitroso 
compound concentration. Our finding that N-nitrosamine 
levels rise with age and gastric pH agrees with some features 
o f gastric cancer, which occurs in a mucosa secreting less acid 
and the incidence o f which increases with age.
We found that raised N-nitrosamine levels were associated 
with significantly more nitrate-reducing bacteria in the 
gastric juice. This supports the hypothesis o f Hill et al.5 by 
stressing the role o f nitrate-reducing organisms in nitrosation 
in vivo.29 Furthermore, Tannenbaum et al.7 reported finding 
high concentrations o f nitrite in the gastric juice o f patients 
who had histologically proven precanperous lesions o f the 
stomach and were living in an area o f Colombia associated 
with a high risk o f gastric cancer. We have demonstrated a 
direct relation in man between conditions associated with or 
conducive to gastric cancer and significantly raised 
concentrations o f N-nitroso compounds. Patients in several 
groups (pernicious anaemia, atrophic gastritis, partial 
gastrectomy, and vagotomy) had N-nitrosamine levels o f the 
same order as were found in patients with gastric carcinoma. 
The potential danger o f  this is obvious, especially since, 
experimentally, carcinogenesis after the application o f
N-nitroso compounds is accelerated if  the gastric mucosa is 
damaged.30
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Determination of a Non-volatile A/-Nitrosamine 
on a Food Matrix
C. L. Walters, M. J. D ow nes, M. W. Edwards* and P. L. R. Smith
B ritish  Food M an u factu rin g  In du stries Research A ssocia tion , R an dalls Road, Leatherhead, Surrey, K T'22 T R Y
A  method devised for the determination of IV-nitrososarcosine, in which the 
N -nitrosamine in solution is denitrosated with hydrogen bromide to form 
volatile products that are rapidly removed and determined in a chemi- 
luminescence analyser, has been applied successfully to the same compound 
on powdered corn flakes. Differentiation of IV-nitrososarcosine and a number 
of other IV-nitrosamines and jV-nitrosamides from inorganic nitrite was 
achieved by decomposing the nitrite with acetic acid prior to the denitrosa- 
tion of the IV-nitroso compounds. In the presence of a secondary-amine 
receptor limited nitrosation can occur during the process of differentiation 
but this can be prevented through the use of ascorbyl palmitate. In 
differentiating between large amounts of nitrite and m u c h  lower levels of 
IV-nitrososarcosine on corn flakes, using a chemiluminescence analyser, the 
duration of the response from the nitrite can be shortened by freeze-drying 
the food matrix in the presence of ascorbic acid. The spectrophotometric 
determination of IV-nitrososarcosine as nitrosyl bromide released into solution 
by the action of hydrogen bromide was hindered by the presence of powdered 
corn flakes.
Keywords: N -N itroso  compound determ ination; N-nitrososarcosine determination ; 
food an a lysis; chemiluminescence analyser
While volatile IV-nitrosamines can be separated readily from a biological matrix by distilla­
tion in steam, no similar separation procedure applicable to all non-volatile IV-nitrosamines 
is available, some compounds of this type may be associated with the components of the 
matrix itself and therefore extraction procedures would be inefficient. As most IV-nitroso 
compounds are carcinogenic to experimental animals, it would be advantageous to have 
available a direct method for the determination of IV-nitrosamines and IV-nitrosamides on a 
biological or other matrix without the necessity for prior extraction. In some situations, 
moreover, the identities of the precursors of the IV-nitroso compounds involved are unknown 
and a method of screening for total non-volatile IV-nitrosamines and IV-nitrosamides would 
be valuable.
A method has been devised1 in which the volatile products of denitrosation of a non­
volatile IV-nitroso compound such as IV-nitrososarcosine can be determined by using a 
chemiluminescence analyser designed to respond selectively to nitrogen oxide. The most 
suitable denitrosating agent for this purpose was hydrogen bromide, the use of which was 
first proposed by Eisenbrand and Preussmann.2 In solution in acetic acid the release by 
this reagent of nitrosyl bromide, detected as inorganic nitrite, was restricted to IV-nitroso 
compounds.3 Nitrite itself, or an alkyl nitrite, also gave a response, which could be 
differentiated from that due to IV-nitroso compounds by means of a control determination 
in the absence of the denitrosating agent; some IV-nitrosamines derived from weakly basic 
secondary amines are, however, hydrolysed in aqueous solution without the use of hydrogen 
bromide. Further, nitrosyl bromide is a very reactive compound, which would be expected 
to react in solution with unsaturated and other compounds extracted concurrently from a 
biological or other matrix. Its reactivity is probably responsible for the low recoveries 
obtained for IV-nitroso compounds added to foods or extracts of foods when assayed by the 
method of Eisenbrand and Preussmann,2 which is excellent for the determination of such 
compounds in simple solution.
For these reasons, conditions have been chosen such that nitrosyl bromide arising from the 
denitrosation of IV-nitroso compounds is liberated and dispersed rapidly as nitrogen oxide,
* Present address: IPC Industrial Press, Dorset House, Stamford Street, London, S.E.l.
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for determination in a chemiluminescence analyser. Further, the addition of acetic acid 
prior to that of hydrogen bromide results in the evolution of nitrogen oxide from any nitrite 
present, thereby differentiating this nitrogen oxide from the gas produced from the denitrosa­
tion of IV-nitroso compounds, and providing a measure of the availability of metal or alkyl 
nitrites in the system.
This method1 has been extended to the determination of IV-nitrososarcosine on a food 
matrix in order to determine whether the release of nitrogen oxide by use of hydrogen bromide 
is impaired in this situation. In addition, the proposed method has been found to be equally 
applicable to IV-nitroso derivatives of other amines representing a wide range of basicities. 
Finally, it has proved possible to differentiate between nitrite and IV-nitrososarcosine 
impregnated on a food matrix when the nitrite is present in large excess.
IV-Nitrososarcosine was chosen in these studies as a typical non-volatile IV-nitrosamine 
likely to be formed in a biological matrix. Alternative procedures for its determination 
after extraction have been devised by Iwaoka and Tannenbaum,4 who employed photo- 
hydrolytic detection of the compound as inorganic nitrite, and by Eisenbrand et al.,5 who 
made use of single-ion mass fragmentography after trimethylsilylation.
Experimental
Caution— IV-Nitroso compounds axe highly carcinogenic and strictly controlled procedures should be
adopted for all aspects of experimental work involving their use.
Method of Assay of IV-Nitrososarcosine by Using a Chemiluminescence Analyser
This procedure was carried out in the manner described by Downes et al.,1 but with modifica­
tions. In particular, the traps immersed in ice and acetone saturated with carbon dioxide 
were replaced with two traps containing 6 n  sodium hydroxide solution. The converter 
was omitted. A 0.5-ml volume of a 15% m jV  solution of hydrogen bromide in glacial acetic 
acid was used for denitrosation and, as before, the responses of individual amounts of 
IV-nitrososarcosine were calculated from the integrated areas under the recorder peaks in 
combination with the relevant range factor.
Method of Assay of IV-Nitrososarcosine by Determination of Nitrosyl Bromide 
Released in Solution
Samples of powdered corn flakes (10 g) on which various amounts of IV-nitrososarcosine 
had been distributed as uniformly as possible were each suspended for 15 min at room 
temperature in 25 ml of glacial acetic acid containing 3.0% m (V  of hydrogen bromide. 
After sedimentation of the solid by centrifugation, 0.5 ml of 5.0% m jV  sulphanilamide in 
hydrochloric acid (1 +  3) was added to aliquots of the supernatants followed after 3 min by 
0.5 ml of 0.1% IV-l-naphthylethylenediamine dihydrochloride solution. The resulting pink 
colours were allowed to develop for 15 min at room temperature prior to the determination of 
the absorbances at 545 nm, using as controls preparations obtained in the same way but in the 
absence of the denitrosating agent hydrogen bromide. Control experiments were also carried 
out without the addition of IV-l-naphthylethylenediamine dihydrochloride in order to cover 
any changes in the spectra due to treatment of extracted pigments with hydrogen bromide.
Freeze-drying of Powdered Corn Flakes Impregnated with Nitrite and Ascorbic 
Acid
Slurries of powdered com flakes in aqueous solutions containing the requisite amount of 
sodium nitrite were distributed as evenly as possible around the surface of a round-bottomed 
flask and dried by lyophilisation in the frozen condition. From additions of sodium nitrite 
of 200mgkg“1 dry mass, recoveries of 15-20 mg kg-1 were obtained after freeze-drying; 
similar losses of nitrite in contact with food under refrigerated storage were noted by Shank 
and Newberne.6
Determination of Nitrite
The method of the Draft International Standard ISO/DIS 29.18.2 was employed.
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Results
Determination of JV-Nitrososarcosine on a Food Matrix by Using a Chemi­
luminescence Analyser
Fig. 1 illustrates the response of the chemiluminescence analyser to the volatile products 
of the denitrosation with hydrogen bromide of 2.0 fig  of iV-nitrososarcosine applied to 10 g 
of powdered corn flakes, using the procedure of Downes et al.1 As with iV-nitrososarcosine 
at the microgram level in simple solution, the detection of volatile products giving a response 
in the analyser was rapid, with little background noise although the pen did not return 
exactly to its original position.
2 min
Time
Fig. 1. Response of 
chemiluminescence analy­
ser to 2.0 fig of iV-nitroso- 
sarcosine on 10 g of pow­
dered corn flakes.
An essentially linear relationship was obtained between the response of the chemi­
luminescence analyser and the amount of iV-nitrosamine over at least the range of 2-80 fig  
of iY-nitrososarcosine. When the relationship was examined in greater detail at the lower 
end of the concentration range, a small intercept was noted on the response axis that was 
due to small responses obtained from unspiked corn flakes treated with hydrogen bromide 
in glacial acetic acid in refluxing 1,2-dichloroethane. The mean value obtained for 10 g of 
corn flakes without the addition of iV-nitrososarcosine was equivalent to 0.49 fig  of iV-nitro- 
sosarcosine, with a standard deviation of 0.0707 fig. Thus, the mean value plus three times 
the standard deviation gives a value of 0.7 fig  of iV-nitrososarcosine, which can be taken as 
the limit of detection under these conditions.
Determination of JV-Nitrososarcosine on a Food Matrix by Denitrosation to form 
Nitrite in Solution
Table I presents the recoveries of various amounts of iV-nitrososarcosine on powdered 
corn flakes suspended in glacial acetic acid when determined as the inorganic nitrite liberated 
following denitrosation with hydrogen bromide. No response at all was detected for added 
amounts of iV-nitrososarcosine of less than 50 fig, which is equivalent to a concentration in 
the food of 5.0 mg kg-1.
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R e c o v e r y  o f  IV-n i t r o s o s a r c o s i n e  a d d e d  t o  p o w d e r e d  c o r n  f l a k e s  w h e n
DETERMINED AS INORGANIC NITRITE FOLLOWING DENITROSATION IN  SOLUTION
Concentration of 
Amount of IV-nitrososarcosine
iV-nitrososarcosine added to food/ Recovery of added 
added/ / ig m g  kg-1 nitrosamine, %
1.0 0.1 0
10 1.0 0
23 2.3 . 0
34 3.4 0
41 4.1 0
50 5.0 13
100 10 21
200 20 38
500 50 73
Repeatability and Reproducibility of Determinations Involving the Use of a 
Chemiluminescence Analyser
Nine 10-g samples of powdered corn flakes each, with 22 jag of added IV-nitrososarcosine 
were analysed during 1 d by one operator with foreknowledge of the amount added, using the 
method of Downes et al.1 The results obtained were in the range 15.4-19.3 jtxg of IV-nitrososar­
cosine, the mean value being 17.52 jag, the standard deviation 1.53 jag and the coefficient of 
variation 8.7%. In comparison with the values reported for IV-nitrososarcosine in solution, 
the repeatability for this compound on the food matrix was less good and the mean recovery 
was slightly reduced.
Repeated determinations, using equal aliquots of a stock solution, of IV-nitrososarcosine 
on 10-g samples of powdered com flakes, were carried out on 1 a by two operators, neither 
of whom was aware of the concentration chosen, and the results are presented in Table II; 
the amount of IV-nitrosamine used for each determination was 2.0 fig. The difference 
observed between the mean values obtained by the two operators was not statistically 
significant.
T a b l e  II
R e p r o d u c i b i l i t y  o f  d e t e r m i n a t i o n  o f  e q u a l  a l i q u o t s  o f  IV-n i t r o s o s a r c o s i n e
ON POWDERED CORN FLAKES BETWEEN TWO OPERATORS USING THE 
CHEMILUMINESCENCE ANALYSER ON THE SAME DAY
iV-Nitrososarcosine detected/^g
/ * ,
Operator 1 Operator 2
1.58, 1.58, 1.98, 1.66, 2.08, 1.96,
1.73,1.87 2.42,2.22
Mean .. .. .. 1.75 2.07
Standard deviation .. 0.170 0.285
Coefficient of variation .. 9-7% 13.8%
t = 0.775 for 8 degrees of freedom.
Application of the Chemiluminescence Analyser Procedure to Other N-Nitroso 
Compounds
In  addition to IV-nitrososarcosine, other IV-nitrosamines, such as IV-nitrosodimethylamine 
and IV-nitrosodiphenylamine, gave volatile products following denitrosation with hydrogen 
bromide that were detectable by using a chemiluminescence analyser, as also did the IV- 
nitrosamides IV-nitroso-IV-methylurea, -IV-ethylurea and -IV-methylurethane.
Further, the procedure developed for the differentiation of IV-nitrososarcosine and nitrite1 
has been extended successfully to these further IV-nitrosamines and IV-nitrosamides. Thus, 
the IV-nitroso derivative of the weakly basic amine diphenylamine was sufficiently stable in 
the presence of acetic acid alone to permit the dispersal of nitrogen oxide from nitrite prior
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to that from the denitrosation of N-nitrosodiphenylamine using hydrogen bromide in the 
same solvent. During the differentiation process, however, a small extent of nitrosation 
of secondary amines present was noted. This is illustrated by Fig. 2, which shows the 
chemiluminescence analyser response due to nitrogen oxide liberated from nitrite following 
the addition of acetic acid and the additional peak after the inclusion of hydrogen bromide, 
which occurred only when morpholine or another receptor amine was included. The extent 
of conversion of this secondary amine of intermediate basicity into its N -nitroso derivative 
ranged from 0.70% at a molar ratio of nitrite to morpholine of 20:1 to a mean value of 
1.9% with a corresponding ratio of 1.2:1. However, the inclusion of 60 /xmol of ascorbyl 
palmitate to a concentration of 2.0 m M  prevented completely the nitrosation of 1.8 /xmol 
of diphenylamine by 0.14 mmol of nitrite following the addition of acetic acid under the test 
conditions.
As in practice it may be necessary to distinguish between N -nitroso compounds and 
nitrite in a food or other matrix with the latter present at much higher concentrations than 
those of iV-nitrosamines or iV-nitrosamides, the procedure developed for the differentiation 
in solution1 has been extended to iV-nitrososarcosine on powdered corn flakes impregnated 
with sodium nitrite. However, corn flakes freeze-dried following the addition of 200 mg 
of sodium nitrite per kilogram dry mass resulted in the evolution of large amounts of nitrogen 
oxide following treatment with acetic acid, which took about 60 min to disperse sufficiently 
to permit the determination of IV-nitroso compounds also added but at the microgram level. 
Nevertheless, the treatment of a food matrix containing 200 mg kg-1 of sodium nitrite with 
a 0.1% aqueous solution of ascorbic acid not only reduced the nitrite content further during 
the freeze-drying process but also shortened the time required to complete the breakdown 
of nitrite to at most 10 min prior to the determination of the iV-nitrosamine at high sensi­
tivity. Fig. 3 illustrates the ability to differentiate in this manner between 2.7 /xg of 
iV-nitrososarcosine and nitrite added originally to a concentration of 200 mg kg-1 to 
powdered corn flakes.
2 min
Time
Fig. 2. Responses of che- 
xniluminescence analyser to 
19.6 fig of sodium nitrite and 
500 fig of morpholine.
-o 2 min
Time
Fig. 3. Responses of 
chemiluminescence analy­
ser to 10 g of powdered 
corn flakes freeze-dried 
with 2.0 m g  of sodium 
nitrite and spiked with 
2.7 fig of JV-nitrososarco- 
sine.
Discussion
The choice of powdered corn flakes as a matrix in which to determine a non-volatile 
N-nitrosamine was prompted by the relative freedom from water of this commodity and its 
composition, which includes several of the major types of food components, and in no way 
implies the possible occurrence of such compounds in practice.
The method of Eisenbrand and Preussmann2 is entirely suitable for the determination of 
IV-nitrososarcosine in simple solution in many non-polar solvents such as 1,2-dichloroethane. 
In view of the reactivity of nitrosyl bromide liberated during the denitrosation process,
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however, it is not surprising that its recovery was far from complete in the presence of 
powdered corn flakes. Further, the sensitivity of this procedure is diminished by the 
comparatively large volumes of acetic acid containing hydrogen bromide required to ensure 
contact between the denitrosating agent and the food matrix. In many instances, the 
concentrations of inorganic nitrite, alkyl nitrites, etc., would be greatly in excess of that of 
any IV-nitroso compounds present. In such circumstances, it would be extremely difficult 
using this procedure to provide an exactly similar aliquot of a food or other matrix to take 
account of the relatively high background levels of inorganic nitrite itself and other com­
pounds, such as the S-nitrosothiols, which are likely to break down to nitrite.
On the other hand, it is apparent that the method devised for the determination of 
IV-nitrososarcosine in solution by using a chemiluminescence analyser is directly applicable 
to this compound when supported on the food matrix chosen without prior extraction, in 
which circumstances it can also be differentiated from inorganic nitrite. This improvement 
- over the method in which nitrosyl bromide is determined as nitrite in solution probably 
arises from the rapid dispersal of this denitrosation product as nitrogen oxide from the food 
matrix in a stream of nitrogen with a flow-rate of about 400 ml min-1. The dehalogenation 
of the nitrosyl bromide formed is indicated by the survival of the volatile denitrosation 
products following passage through the alkali traps currently interposed between the reaction 
vessel and the chemiluminescence analyser.
Not surprisingly, the coefficients of variation obtained under these circumstances were 
greater than those resulting from the determination of IV-nitrososarcosine in simple solution. 
Nevertheless, they remained reasonable for the direct determination of this nitrosamine at 
the microgram level on a matrix without prior extraction and clean-up, and the possibility 
remains of using larger samples in effecting even better replication at lower levels of spiking. 
Further, this procedure has permitted the differentiation from inorganic nitrite of IV-nitroso- 
diphenylamine and therefore appears to be applicable to IV-nitroso derivatives of weakly 
basic secondary amines in its presence, unlike the method involving denitrosation in solution.
Ascorbic acid is considered to be a nitrite scavenger and thereby to inhibit the nitrosation 
of secondary and tertiary amines in simple solution,7 in foods8 and in vivo9 when animals are 
fed concurrently nitrite and a nitrosatable amine. It has not, however, been found to 
decompose pre-formed IV-nitrosamines but in a limited number of circumstances its use has 
stimulated n i t r o s a t i o n . 1 0 -1!  I n  cured meat systems, for instance, the use of ascorbate has 
resulted in the incorporation of more nitrogen-15 from isotopically labelled nitrite into 
water-soluble components.12 In these studies, it has proved useful in reducing the extended 
duration of the response of the chemiluminescence analyser due to residual nitrite and 
probably other compounds derived from it within the food matrix. However, ascorbic acid 
is not very soluble in 1,2-dichloroethane and therefore it has not been particularly useful in 
restricting the small extent of irrelevant nitrosation observed during the differentiation of 
nitrite and an IV-nitroso compound in the presence of a secondary amine. Ascorbyl 
palmitate, which has also been found to inhibit strongly the rate of nitrosation of sarcosine 
in solution,13 is more soluble in the solvent system employed and has proved to be effective 
in suppressing irrelevant nitrosation in this instance.
The financial support of the US National Cancer Institute, Contract No. N01-CP-43337, 
is gratefully acknowledged.
References
1. Downes, M. J., Edwards, M. W., Elsey, T. S., and Walters, C. L., A n a lys t, 1976, 101, 742.
2. Eisenbrand, G., and Preussmann, R., A rzneim ittel-F orsch ., 1970, 20, 1513.
3. Johnson, E. M., and Walters, C. L., A n a ly t. L ett., 1971, 4, 383.
4. Iwaoka, W., and Tannenbaum, S. R., in “Environmental IV-Nitroso Compounds, Analysis and
Formation,” I A R C  Scientific P ublications, No. 14, International Agency for Research on Cancer,
Lyon, 1976, p. 5L
5. Eisenbrand, G., Janzowski, C., and Preussmann, R., J . Chrom at., 1975, 115, 602.
6. Shank, R. C., and Newberne, P. M., F d Cosmet. T oxic., 1976, 14, 1.
7. Mirvish, S. S., Wallcave, L., Eagen, M., and Shubik, P ., Science, N .Y . , 1972, 177, 65.
8. Fiddler, W., Pensabene, T. W., Piotrowski, E. G., Doerr, R. C., and Wasserman, A. E., J .  F d  Sci.,
1973, 38, 1084.
9. Kamm, J. J., Dashman, T., Conney, A. G., and Burns, J. J., Proc. N a tn . A cad . Sci. U .S .A ., 1973,
70, 747.
November, 1978 NON-VOLATILE IV-NITROSAMINE ON A FOOD MATRIX 1133
10. Sen, N. P., and Donaldson, B., "AT-Nitroso Compounds in the Environment,” IA R C  Scien tific
Publications, No. 9, International Agency for Research on Cancer, Lyon, 1974, p. 103.
11. Walters, C. L., Edwards, M. W., Elsey, T. S., and Martin, M., Z . Lebensm ittelunters. u . -F orsch.,
1976, 162, 377.
12. Woolford, G., and Cassens, R. G., /. F d  S ci., 1977, 42, 586.
13. Walters, C. L., and Manning, K., Z . Lebensm ittelunters. u . -F orsch., 1977, 165, 21.
Received A p r i l 13th, 1978 
Accepted J u n e 5th, 1978
i"
Reprinted from Banbury Report 12: Nitrosamines and Human Cancer 
© 1982 Cold Spring Harbor Laboratory
Endogenous Amines in Human Gastric Juice
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As long ago as 1931 , Martin determ ined that the nonprotein nitrogen content o f  
normal gastric juice ranged betw een 20-48  m g/100  m l, equivalent to  a concen­
tration o f  14-34 m m oles 1 for com pounds containing one nitrogen atom  
(Martin 1931). In simple achlorhydria and in pernicious anemia (PA) the 
corresponding ranges were 30-90 mg and 60-150  mg nonprotein n itrogen/100  
ml gastric juice. These values w ould, o f  course, include nonnitrosatable com ­
pounds such as the majority o f  the amino acids.
As reported in H eathcote and Washington (1 9 6 5 ), Washington compared 
the amino acid com positions o f  pooled  normal human gastric juice with the 
mean values obtained for individual samples o f  juice from PA patients. In­
creases were observed in the concentrations o f  all amino acids quoted in the PA  
samples, the ratios o f  the mean PA  levels to  those w ithin the normal pooled  
gastric juice ranging from 1 .4-13.5 . O f the potentially nitrosatable amino acids, 
arginine was observed in both normal and PA gastric juice.at levels o f  1.3 and 4 .7  
m g/100  ml respectively, equivalent to  concentrations o f  0 .0 9 0  and 0 .33  m m oles 
1 . The corresponding values for proline were 0.3 and 1.3 m g/100  ml (0 .0 2 6
nd 0.11 m m oles 1 respectively). O f the four quantitative studies reviewed by 
Heathcote and Washington (1 9 6 5 )  which compared the levels o f  am ino acids in
JUlces Wlth ^ o s e  in nor™ l  subjects, tw o recorded a threefold increase in the 
concentration o f  total am ino acids in the pathological condition. The third by  
Hiller and B ischof (1 9 5 3 ) gave individual concentrations which were about one 
hundred times less than the values reported for normal gastric juice by other 
workers and must, therefore, be treated w ith reserve. The m ost recent investi­
gation reviewed by Heathcote and Washington (1 9 6 5 ) showed an increase o f  
between four and five times the concentration o f  amino acids in PA gastric juice  
over the normal values. However, the volum e o f  fasting juice in the stom ach  
o f  the normal subject m ay be fifteen times that o f  the PA patient and hence it is 
likely that the overall amounts o f  som e amino acids are greater in normal juices.
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It has been established by Ruddell et al. (1 9 7 8 ) that the nitrite levels in 
achlorhydric gastric juice associated w ith gastric cancer or obtained from a 
significant proportion o f  normal subjects w ithout identifiable gastroduodenal 
lesions (Ruddell et al. 1976 ) or in PA  (Ruddell et al. 1978) were significantly 
greater than those in normal acidic fasting gastric juice as were also the counts 
o f  both total and nitrate-reducing bacteria. A  similar relationship was established  
by Tannenbaum et al. (1 9 7 9 ) in hypochlorhydric patients from a region at high  
risk for gastric cancer and Schlag et al. (1 9 8 1 ) in patients subjected to  Billroth  
I and II partial resections. Thus, in considering the form ation o f  V -nitroso  
com pounds in relation to  the possible induction o f  gastric cancer it is imperative 
to  determine the nitrosatable amines and amides w ith  w hich the nitrite could  
interact.
METHODS
Determ ination of /V-nitroso Compounds as a Group
This was carried out in the manner o f  Walters et al. (1 9 7 8 ) in w hich nitric oxide 
is obtained in sequence from heat labile com pounds such as S-nitrosothiols and 
pseudonitrosites, then from inorganic and alkyl nitrites and finally from V - 
nitrosam ines, -amides, -guanidines, -urethanes, and -sulfonam ides. For the 
differentiation o f  V -nitroso com pounds from other com pounds potentially  
formed from nitrite it is therefore vital to  release nitric oxide from the latter 
before the addition o f  hydrogen bromide to determ ine V -nitrosam ines,-am ides, 
etc. If this precaution is n ot adopted, it is likely that labile com pounds releasing 
nitric oxide in refluxing ethyl acetate w ill be m istaken for V -nitroso com pounds.
D eterm ination of Individual /V-nitroso Compounds
V olatile V -nitrosam ines were determ ined by gas chromatography (GC) w ith a 
Thermal Energy Analyzer (TEA) as detector in the manner essentially that o f  
Fine e t al. (1 9 7 5 ). Similarly the m ethylated products o f  gastric juices w ith  
and w ithout deliberate nitrosation were separated by GC on a colum n o f  0 V  
225  on Chromosorb B w ith detection o f  the eluted V -nitroso com pounds using a 
TEA. The temperature program usually involved 7 m inutes at 140°C increasing 
thereafter by 2°C /m inute to  2 3 0 °C w ith argon as the carrier gas at a flow  rate 
o f  4 0  m l/m in- 1 .
Nitrosation of Gastric Juice and Peptides
The conversion o f  com ponents o f  gastric juices and synthetic dipeptides into  
their V -nitroso derivatives was accomplished by treatm ent w ith nitrous acid 
(5-15 g I - 1 ) formed from sodium nitrite in dilute sulphuric acid at pH 2 .0  at 
4°C  for periods ranging from 12-72 hours. Before extraction o f  V-nitroso
Amines in Gastric Juice / 447
com pounds into ethyl acetate, the residual nitrous acid was removed from the 
products o f  nitrosation by treatm ent w ith  sulfamic acid in excess.
RESULTS 
Amines and Other Nitrosatable Com pounds in Gastric Juice
Simple volatile V-nitrosam ines can be obtained from the nitrosative cleavage o f  
com plex tertiary amines substituted w ith a dialkylam ino group. Therefore, in 
studying the availability o f  precursors to  V -nitroso com pounds gastric juices 
have been subjected to  nitrosation under optimal conditions and the products 
fractionated and studied as V-nitrosam ines and V-nitrosamides.
The deliberate treatm ent o f  pooled acidic gastric juice w ith nitrous acid at 
pH 2 .0  in the presence o f  thiocyanate has been found to  produce only very 
small quantities o f  the conventional volatile V-nitrosam ines. The predominant 
com pounds o f  this type detected by GC w ith a TEA as detector were V-nitroso- 
dim ethylam ine (NDM A) and -pyrrolidine at concentrations approxim ating to  
0 .05  and 0 .005  jumoles I -1  respectively. However, much greater quantities o f  
com pounds responding as V-nitrosam ines and (or) -amides, -guanidines, and 
-urethanes in the procedure o f  Walters et al. (1 9 7 8 ) could be extracted into ethyl 
acetate from the products o f  nitrosation o f  a pooled gastric juice in w hich excess 
nitrous acid had been removed using sulfamic acid. In this manner, levels o f  
putative V -nitroso com pounds have been obtained equivalent to  approxim ately 
0 .2  m m oles l ” 1 in the original gastric ju ice. The assay adopted responds to  all 
types o f  V-nitroso com pounds tested and differentiates them from the great 
majority o f  other com pounds potentially derived from nitrite in a biological 
matrix w ith the exception  o f  nitrolic acids and S-nitrothiols. In addition, the 
products o f  the treatment o f  gastric juices w ith nitrous acid gave positive 
responses to the procedure o f  Eisenbrand and Preussmann (19 7 0 ). A fter  
m ethylation w ith diazom ethane, m oreover, approxim ately 40% o f  the nitrosated 
gastric com ponents could be converted in to  a form (s) which was amenable to  
GC during w hich at least 20  distinct peaks were observed w ith the TEA as de­
tector in the manner o f  J .R . A. P ollock  (pers. com m .).
A similar pattern o f  TEA-positive peaks was observed in GC from the 
m ethylated products o f  the nitrosation o f  an enzym ic hydrolysate o f  the protein  
ovalbumin. In consequence, a number o f  dipeptides were treated w ith nitrous 
acid at pH 2 .0 . Excess nitrous acid was removed using sulfamic acid prior to  the 
extraction o f  nitrosated products in to  ethyl acetate. The extents o f  nitrosation  
o f  the dipeptides under standardized conditions were generally low  ( <  5% o f  
theoretical for the amide linkage alone) except where a secondary amino group 
was present, as in prolylalanine, w hen determ ined by the m ethod o f  Walters et 
al. (1 9 7 8 ); this procedure is capable o f  differentiating V -nitroso from any C- 
nitroso or C-nitro com pounds form ed where phenyl residues are available. 
After m ethylation, w ith diazom ethane, each product could be run in GC and
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detected by either the TEA or a mass spectrometer (MS). Only in the case o f  
the product o f  nitrosation o f  alanylalanine, however, was a m olecular ion ob­
served at a mass/charge (m /z) ratio o f  2 1 8 . This and the predominant fragment 
ions were exam ined by GC coupled w ith high resolution (7000 -8000 ) (MS), 
through the courtesy o f  Dr. P. Farmer, o f  MRC T oxicology U nit, Carshalton, 
Surrey, England. The precise m /z value found was 2 1 8 .0 9 1 , the nearest empirical 
formulae being C9H 10N 6 O (m /s = 21 8 .0 9 2 ), w hich w ould be m ost unlikely to  
be formed from alanylalanine, and C8H14N 20 s  (m /z = 2 18 .090 ). A major 
fragment ion occurred at m /z  = 188.091 (C6H 12N 4 0 3 or C8H 14N 0 4 ), w hich is 
consistent w ith the loss o f  NO from C8H 14N 2 0 5 . Other major fragment ions 
occurred at m /z = 159 .076  (presumably loss o f  -C O O CH 3 from C8H 14N 2Os )  
and m /z = 128 .070  (presumably loss o f  NO and -HCOOCH3).
Mutagenicity of the Product of Nitrosation of Alanylalanine
Through the courtesy o f  Dr. H. Bartsch, o f  the International Agency for 
Research on Cancer, L yon, France, the m utagenicity o f  the product o f  nitrosa­
tion o f  alanylalanine has been studied.
M utagenicity was established in Salm onella typhim urium  T A 100 w ithout 
metabolic activation; at the level o f  0.1 mg/assay, the number o f  revertants 
occurring was more than fivefold that o f  revertants occurring spontaneously. 
The high sensitivity D f the T A 100 strain as compared w ith the T A 1535 indicates 
that m ost bacterial D N A  adducts were n ot miscoding, but were repaired by an 
error-prone post-replicative repair system , thus increasing m utagenicity and 
decreasing the toxic effect. Furthermore, the lower sensitivity o f  the T A 100N R  
strain, w hich is deficient in nitroreductase activity, as compared w ith the pro­
ficient nitroreductase T A 100 strain suggests that bacterial nitroreductase may be 
involved in the activation o f  the nitrosated alanylalanine into a D NA  damaging 
agent.
DISCUSSION
The fact that tertiary amines can react w ith nitrous acid is well illustrated by the 
facility w ith w hich NDMA is released by nitrosative cleavage from the analgesic 
aminopyrine (Lijinsky and Greenblatt 1972); similarly, nicotine can give rise on  
nitrosation to A -nitrosonornicotine. In assessing, therefore, the nitrosatable 
amines and amides occurring in human gastric juice it is necessary to include 
tertiary amine precursors. This can be achieved m ost readily by nitrosation  
under optim um  conditions follow ed by the analysis o f  the resultant A-nitroso  
com pounds.
Thus from these studies it w ould appear that the availability o f  precursors 
to  NDM A in pooled human gastric juice is small. Nevertheless, dim ethylam ine
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itse lf has been shown to  be present in fasting gastric juice in a study by S P . 
Bordello and P.I. Reed (pers. com m .) and also Reed et al. (1 9 8 1 ). Considerable 
variations in contents were seen in samples from normal controls w ith low  pH 
( <  5) and high pH (>  5 ) as well as in fasting gastric juices from PA and h ypo­
gammaglobulinemia patients, the mean values being 0 .2 6 , 0 .3 0 , 0 .22  and 0 .30  
m m oles I -1  respectively. Trimethylamine was generally absent from or at low  
concentration in control gastric juice o f  both low  and high pH but occurred 
in alm ost all gastric juices from PA and hypogamm aglobulinemia patients 
with levels o f  0 .35 and 0 .29  m m oles I -1 respectively in the last tw o groups. 
The mean pH values for PA and hypogamm aglobulinemia gastric juices were 
7.3 and 8.1 respectively as compared w ith 1.9 and 7 .6 for normal and achlor- 
hydric controls.
The value found for total A -nitroso com pounds extractable from normal 
acidic human gastric juices after nitrosation, namely 0 .2  m m oles l - 1 , compares 
with that o f  0 .026  m m oles l -1  quoted for proline levels by H eathcote and 
Washington (1 9 6 5 ). The other nitrosatable amino acid reported in this source, 
namely arginine, w ould presumably not be extracted into an organic solvent 
from an acidified aqueous phase either before or after reaction with nitrous 
acid. The concentrations o f  a-am ino nitrogen in normal gastric juice in a number 
o f  studies reviewed by H eathcote and Washington (1 9 6 5 ) varied w idely. Never­
theless, the mean value o f  3 .4  m m oles l - 1 , calculated on the basis o f  one nitro­
gen atom per m olecule, is more than adequate to cover that found for 
nitrosatable precursors in normal gastric ju ice, although the majority o f  con­
tributors to  the a-am ino content are presumably non-nitrosatable am ino acids. 
H eathcote and Washington (1 9 6 5 ) also reported the presence o f  a number o f  
peptides in this biological fluid but no details were provided o f  their molecular 
weights or concentrations.
It is reported in an accom panying com m unication (R eed et al., this 
volum e) that the availability o f  A -nitroso com pounds in gastric juice increases 
with pH along with the nitrite concentration. This result w ould be expected  also 
on the basis o f  the reported increase in nonprotein nitrogen in the hypochlor- 
hydric gastric juices typical o f  PA (H eathcote and Washington 1965). Further­
more, the increase in total viable bacterial counts with pH w ould predispose to  
the form ation o f  amines by such processes as decarboxylation or cyclization o f  
am ino acids. Nevertheless, it has similarly been reported that the volum e o f  
gastric juice produced in PA can be fifteen times less than that secreted by a 
normal individual in w hich case the difference in absolute am ounts o f  nitrosat­
able precursor may n ot be borne out.
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COMMENTS
WEISBURGER: Dr. Walters, I think it is im portant to realize that there are
tw o kinds o f  gastric cancers, the intestinal type and the diffuse type. As 
it turns out, Dr. M unoz and others (M unoz et al. 1968), have related the 
PA blood group to the diffuse kind. We don’t really know  whether nitros- 
amines or what sort o f  nitroso com pounds are involved in its etiology, 
and we need to look  at this as a different sort.
WALTERS: Y es.
WEISBURGER: A nd, i f  I might also com m ent on Richard P eto ’s response to
Hoffm ann, relating the nitrate association w ith gastric cancer disease risk. 
Here again, we must be careful to  discriminate betw een these very m ulti­
factorial elem ents that relate to  any given disease risk or subclass. For 
exam ple, Armijo et al. (1 9 8 1 ) have shown that a high-risk population ex­
creted less nitrate in the urine than the low-risk population. That is at 
variance w ith the hypothesis proposed by Dr. Correa and Dr. Tannen- 
baum. But it has to  do w ith their nitrate com ing from vegetables, and 
that is not related, because the vegetables have their built-in antidote, 
namely Vitam in C, as Richard P eto correctly said.
It is very com plex. Unless w e put the w hole thing together in these 
multifactorial diseases, we are going to  get hopelessly lo st, especially if  
we are studying the wrong disease.
CORREA: You said that in PA the tumors are practically all in the intestinal
tract. They do have this blood group A  collection , but that is som ething  
different.
WALTERS: Well, that isn’t clear y e t, the w ay I read the literature.
HECHT: Y ou said you  get a lo t more TEA-positive peaks after you  m ethylate
your extract; is that correct?
WALTERS: That is in gas chromatography.
SEN: D o you m ethylate it w ith diazomethane?
WALTERS: Yes.
HECHT: How do you generate the diazomethane?
WALTERS: From D iazald®, I believe.
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HECHT: Isn’t that a nitroso com pound?
WALTERS: It is. It is a nitrososulfonam ide.
HECHT: So could that be som ehow  producing som e o f  your TEA positives?
WALTERS: N o, you  distill over the diazom ethane. But the possibility is there.
HECHT: Is there a possibility o f  transnitrosation during your m ethylation?
WALTERS: N o, because you  produce the diazom ethane by distillation.
HECHT: Okay. Y ou distill the diazomethane?
WALTERS: Y es. R eally, that w ould n ot give you  a nitrosating agent that was
volatile in GC. Diazald® is not volatile in GC.
HECHT: N o. I was thinking o f  transnitrosation.
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that a substantial reduction, for example, in the interference of magnesium chloride on lead can 
be obtained when probe atomisation is used instead of tube wall atomisation. The development 
of an automatic system for the study of probe atomisation will allow an assessment of such inter­
ference effects free from the errors associated with manual operation.
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of Pye Unicam Ltd. and B. Lersmacher of Philips Research Laboratories. Financial support from 
the Pye Foundation (for D.L.) and the SERC (for J.M. and W.C.) is gratefully acknowledged. 
The authors also thank B. Welz of Perkin-Elmer Bodenseewerk for the loan of the HGA 500 and 
S. Slavin of Perkin-Elmer, Ridgefield, USA, for the loan of the PE 5000 system.
References
1. Slavin, W ., Manning, D. C., and Carnick, G. R., A t. Spectrosc., 1981, 2, 137.
2. Slavin, W ., and Manning, D. C., Spectrochim . A c ta , P a rt B ,  1980, 35, 701.
3. L ’vov, B. V., Spectrochim . A c ta , P a r t B ,  1978, 33, 153.
4. Hendry, J. B. M., Fell, G. S., and Ottaway, J. M., to be published.
5. Manning, D. C., Slavin, W ., and Myres, S., A n a l. Chem., 1979, 51, 2375.
6. L ’vov, B. V., and Pelieva, L. A., Zh. A n a l. K h im ., 1978, 33, 1572.
7. Giri, S. K., Littlejohn, D., and Ottaway, J. M., A n a lys t, 1982, 107, 1095.
8. Slavin, W ., and Manning, D. C., Spectrochim . A cta , P a rt B ,  1982, 37, 955.
9. Manning, D. C., and Slavin, W ., A n a l. Chim . A cta , 1980, 118, 301.
10. Massman, H., Spectrochim . A cta , P a rt B ,  1968, 23, 215.
11. Lersmacher, B., Ger. Offen., 2949275 (Cl.GOINZI/03), June 25th, 1981.
Received M a y  6th, 19S3
D a v id  L itt le john  
J o h n  M a rsh a l l  
J o h n  Carroll  
W illiam  C o r m a c k  
J o h n  M . O t t a w a y
D e p a r tm e n t o f  P u r e  a n d  A p p l ie d  C h e m is try , 
U n iv e r s i ty  o f  S tra th c lyd e ,
C a th ed ra l S tree t,
G lasgow , G1 1 X L
Importance of Selectivity in the Determ ination of /V-Nitroso 
Compounds as a Group
K e yw o rd s'. N -N itro so  c o m p o u n d s; d e n itro sa tio n ;  n i t r i t e ; n itra te ', n itrogen  
ox ide
Most A-nitrosamines tested have proved to be carcinogenic in experimental animals, often at very 
low concentrations. It is vital, therefore, to be able to determine such compounds with the best 
possible selectivity and sensitivity. The considerable number of nitrosatable precursors precludes 
the evaluation of all A-nitroso compounds individually in a large number of biological samples. 
Thus, it is desirable to be able to monitor the level of such compounds as a group in order to pin­
point any sources of concern and interest.
A  procedure has been developed1 for the determination of iV-nitroso compounds as a group and 
to differentiate them as completely as possible from other compounds potentially derived from 
nitrite. It involves the selective and sequential release of nitrogen oxide, initially from c o m ­
pounds that are labile in refluxing ethyl acetate, then following the addition of acetic acid and 
subsequently from Ar-nitrosamines and Ar-nitrosamides. The denitrosation of Ar-nitroso c o m ­
pounds is achieved using hydrogen bromide, as originally used by Eisenbrand and Preussmann,2 
but conditions are chosen so that the product is nitrogen oxide rather than nitrosyl bromide. 
The latter is very reactive and can be lost in the presence of co-extracted phenols, amines, etc.1 
The use of hydrogen bromide is more selective than the pyrolytic release of nitrogen oxide employed 
in the Thermal Energy Analyzer,3 but nevertheless it can bring about evolution of nitrogen oxide 
also from S-nitrothiols and nitrolic acids.4 Any nitrogen oxide released is conveyed in a stream 
of nitrogen for its selective and sensitive determination using a chemiluminescence analyser.
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Thus the criteria upon which the determination of N-nitroso compounds is based require that 
they do not release nitrogen oxide in refluxing ethyl acetate either before or after the addition of 
acetic acid, but that they are denitrosated to nitrogen oxide using hydrogen bromide under the 
conditions of the test.
Nitrite is a very reactive entity and is lost, in part at least, in contact with a biological fluid, 
such as gastric juice, either by disproportionation to form nitrate and nitrogen oxide and/or by 
reaction with the components of the system involved. The extent of the loss is dependent mainly 
on the p H  and the temperature involved. Gastric juice, for instance, is capable of reacting with 
much larger amounts of nitrite than would be required for the formation of even the comparatively 
high levels of N-nitrosamines reported to be in this secretion.5 Most biological systems contain 
tyrosine and other phenols which can give rise to C-nitroso or C-nitro derivatives and S-nitroso- 
thiols can be formed from sulphydryl compounds such as cysteine or reduced glutathione. Thus, 
the procedure developed by Walters et a l .1 is designed to ensure that the evolution of nitrogen 
oxide from labile compounds, such as the S-nitrosothiols, in refluxing ethyl acetate has been 
completed before the addition of acetic acid to decompose any nitrite present. Again, the release 
of nitrogen oxide from nitrite following the addition of acetic acid is allowed to cease before the 
inclusion of hydrogen bromide to denitrosate the N-nitroso compounds in extract under examina­
tion.
Alternative versions of this procedure have been proposed. In that of Drescher and Frank,8 
for instance, it is not possible to make sequential additions of the necessary reagents and hence 
nitrite is removed initially from immiscible extracts by extraction into water, which is recognised 
to result in losses of polar N-nitrosamines. More recently, Bavin et a l l treated samples of gastric 
juice with hydrazine at p H  4 to remove any nitrite present. They then injected the product 
directly without extraction into refluxing ethyl acetate containing hydrogen bromide, the nitrogen 
oxide evolved being considered to provide a measure of N-nitroso compounds present. The 
advantage of this procedure is its speed, which, however, has been gained at the expense of its 
selectivity, as other interfering compounds would not have been eliminated previously.
Experimental
T w o  types of compound derived from nitrite but not containing an N-nitroso group, namely the 
S-nitrosothiol S-nitroso-N-acetyl-2,2-dimethylcysteine and the pseudonitrosite l-nitro-2-nitroso- 
cyclohexane, were treated individually with hydrazine sulphate buffered at p H  4.0 with a 
phthalate buffer according to Bavin et a l l Aliquots of the treated solutions, each at a concentra­
tion of approximately 0.25 m M ,  were subsequently injected into refluxing ethyl acetate containing
0.1 m  hydrogen bromide under oxygen-free nitrogen. Nitrogen oxide formed was detected using 
a British Oxygen Luminox 101A  chemiluminescence analyser.
Results and Discussion
Large evolutions of nitrogen oxide were obtained when either the hydrazine-treated S-nitroso­
thiol or pseudonitrosite was injected into ethyl acetate to which had been added hydrogen bromide 
in glacial acetic acid. Thus, compounds of this type would be confused with Ar-nitroso compounds 
under the conditions of the abbreviated procedure as it provides no separate opportunity for the 
release of nitrogen oxide from heat-labile compounds. Of the compounds potentially derived 
from nitrite studied by Walters et a l . ,1 it has already been reported8 that evolutions of nitrogen 
oxide ranging from 2 to 108% of the theoretical are obtained if the sequential procedure is not 
employed. Thus, the higher levels of N-nitroso compounds reported to be present5 in gastric 
juice when determined by the abbreviated procedure could have been due, in part at least, to 
greater levels of other contaminants even if the molar release of nitrogen oxide by each was less 
than theoretical. Further, nitrate, which occurs in all biological systems, gives a very small, but 
significant, release of nitrogen oxide when treated with hydrogen bromide under nitrogen.® Thus, 
a selective extraction of N-nitroso compounds is required to prevent potential interference when 
nitrate is present at relatively high concentrations.
The necessity for the sequential and selective decomposition of compounds to nitrogen oxide in 
evaluating N-nitrosamines and N-nitrosamides in a biological secretion is illustrated in Fig. 1. A  
much greater yield of nitrogen oxide was obtained initially (A), which was derived from heat- 
labile compounds in the bile extract, than was released on subsequent treatment with hydrogen
M, vi
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Fig. 1. Evolution of nitrogen oxide from extract of 
human bile in refluxing ethyl acetate (A) before and (B) 
after the addition of hydrogen bromide in acetic acid.
bromide (B) from putative iV-nitroso compounds. Thus, if the abbreviated procedure had been 
employed, the response ascribed to ALnitroso compounds would have been increased vastly to 
include contributions from nitrogen oxide itself and from labile compounds of types other than 
iV-nitrosamines and IV-nitrosamides. It is therefore of vital importance to ensure that evolution 
of nitrogen oxide from all other compounds has ceased before the determination of AT-nitrosamines 
and Af-nitrosamides by denitrosation. If this precaution is not observed, grossly erroneous 
values for the contents of ALnitroso compounds m a y  be obtained.
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The Transport of Nitrite in the Blood
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O f the total daily intake o f  nitrite by the average U.S. resident, White (1975) estimated 
that as much as 68 % arose from the microbiological reduction in the mouth o f nitrate 
ingested in vegetables, water supplies etc. Alt-tough the range o f  concentrations o f  
nitrite found in the saliva from fasting humans has been considerable, a number o f  wor­
kers have been able to demonstrate significant increases a short interval after the inges­
tion o f  nitrate-rich vegetables or their juices (Stephany & Schuller, 1975; Spiegelhalder 
e t al., 1976; Tannenbaum e t al., 1976; Harada et al., 1975; Ishiwata et al., 1975).
After pentagastrin stimulation o f  HC1 secretion in the stomach from fasting humans, 
the concentration o f  gastric thiocyanate, which is considered to be o f  salivary origin, 
fell significantly, whereas the nitrite concentration in the stomach remained unchanged 
(Ruddell e t al., 1977). This could have been due to an alternative source o f  supply o f  
nitrite to the stom ach or to the maintenance o f  a low constant residual concentration from  
the interaction o f  salivary nitrite with phenols, amines, thiols etc. in its acidic milieu.
A lthough nitrite readily unuergoes a coupled oxidation with oxyhaemoglobin to  
form  nitrate and methaemoglobin, its initial reaction, which is dependent on the nitrite 
and H + concentrations, is slow (Rodkey, 1976). Once methaemoglobin is formed, 
however, a second faster reaction ensues between oxyhaemoglobin and the nitrite salt 
o f  m ethaem oglobin which is directly dependent on the concentration o f  oxyhaem oglobin  
and on the square o f  that o f  methaemoglobin. Methaemoglobinaemia can result in this 
manner from nitrite produced microbiologicalJy from nitrate in the colonized achlor- 
Kydric stom ach o f  the young infant.
The change in nitrite concentration with time in citraled oig blood at 3 T C  has been 
studied after its'addition to various concentrations. O f an initial concentration of 60//M, 
for instance, 5 0 %  o f  the nitrite could be recovered after 12min, equivalent to about 25 
com plete circulations o f  the vascular system, and lower concentrations would survive 
for several hours. In general, the oxidation o f  1 mol o f nitrate by oxyhaem oglobin is 
accom panied by the formation o f  1 m ol o f  nitrate.
When pig blood was deproteinized directly after slaughter, nitrite was determined to  
be present in the supernatants to the extent o f  1 .0-1 .5 //mol/1. After 2 h storage o f w hole  
citrated blood at room  temperature, the nitrite contents had decreased to values o f  
0.7-0.9//m ol/1.
In spite o f  the ready oxidation o f  nitrite by oxyhaem oglobin, therefore, nitrite can  
survive in blood for periods greatly in excess o f  the time required for circulation within  
the vascular system o f  about 30s. Thus it is probable that nitrite can be transported in the  
circulation system o f  the blood and is therefore capable o f  distribution to  or from the 
stom ach by diffusion or active transport.
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NITRITE SOURCES AND NITROSAMINE 
FORMATION IN VITRO AND IN VIVO*
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Abstract— The ingestion by normal adults of a meal including vegetables rich in nitrate led to a rapid 
increase in the salivary nitrite concentration. This was followed by a fall towards the fasting nitrite levels, 
although the concentration in the saliva remained elevated for as long as 21 hr. Using foods as sources of 
nitrosatable amines, studies have been made both in vitro and in vivo on the formation of N-nitroso 
compounds under the conditions encountered in the human stomach, with special reference to the 
different thiocyanate concentrations in smokers and non-smokers. The nitrite level and pH of gastric 
contents increased markedly following the consumption of a meal containing nitrite, reaching maxima 
within about 45 min and then returning towards fasting levels. N-Nitrosopiperidine (NPIP) and N-nitroso- 
pyrrolidine were the major volatile nitrosamines produced when foods were incubated with nitrite 
under acid conditions in vitro. At the nitrite concentrations likely to occur in the stomach, nitrosamine 
formation was reduced and was significantly lower in the absence of thiocyanate than in its presence at 
levels of 0-2-3 mM. Trace amounts of NPIP were detected occasionally in the gastric contents of volun­
teers after ingestion of homogenized foods containing nitrite. Both volatile and non-volatile N-nitroso 
compounds were obtained from a tobacco-smoke condensate following incubations in vitro simulating 
those likely to occur within the human stomach. Under the same conditions, N-nitrosation occurred in 
incubations containing the antidepressant nortriptyline, but this was greatly reduced in the presence of 
ascorbic acid.
IN TRO D U C TIO N
The nitrite concentrations in the saliva of a group 
of randomly selected individuals were found by Spie­
gelhalder, Eisenbrand & Preussmann (1976) to range 
from 0-14 ftM to 0-43 mM, with an average value of 
0-097 mM. Okabe (1973) reported even wider vari­
ations in a group of 200 Japanese subjects. Neverthe­
less, salivary nitrite levels have been found to increase 
significantly following the ingestion of nitrate-rich 
vegetables or their juices (Harada, Ishiwata, Naka­
mura, Tanimura &  Ishidate, 1975; Ishiwata, Bori- 
boon, Nakamura, Harada, Tanimura & Ishidate, 
,1975; Okabe, 1973; Spiegelhalder et al. 19?6; Ste- 
phany & Schuller, 1975; Tannenbaum, Weisman & 
Fett, 1976). In general, the increase in nitrite concen­
tration in the saliva correlated directly with the sali­
vary nitrate content, although Spiegelhalder et al. 
(1976) observed a threshold intake of nitrate of about 
54 mg, below which the salivary concentrations of 
nitrate and nitrite remained unchanged.
In the long-term feeding of nitrite and morpholine 
to rats, Shank & Newberne (1976) found that the 
nitrite concentration in the diet had a greater effect 
than the amine level on the formation of N-nitroso- 
morpholine and thereby on tumour induction, but
*Presented in part at the Fourth IARC Working Confer­
ence on Environmental N-Nitroso Compounds— Ana­
lysis and Formation, held in Tallinn, Estonian SSR, in 
October 1975.
Telling, Hoar,' Caswell & Collings (1976) concluded 
that the concentration of dimethylamine or pyrroli­
dine in the diet had a greater influence on the forma­
tion of the corresponding nitrosamines in the rat 
stomach than did the level of nitrite in the drinking- 
water. The latter authors found no nitrosamine for­
mation with amine levels of 100 ppm, although Shank 
& Newberne (1976) reported that levels of nitrite and 
the amine as low as 5 ppm were carcinogenic in a 
small proportion of treated rats.
In studies on the availability in foods of precursors 
of N-nitroso compounds, Walters, Newton, Parke & 
Walker (1974) detected four volatile nitrosamines, 
N-nitrosodimethylamine (NDMA), -diethylamine 
(NDEA), -pyrrolidine (NPYR) and -piperidine 
(NPIP), arising from the nitrosation of milk products. 
The nitrosatability of a secondary amine depends 
markedly on its basicity. The rate of nitrosation of 
piperazine (pKa 5-57) is, for instance, no less than 
185,000 times faster than that of piperidine (pKa 11*2) 
under comparable conditions and at the optimum pH  
(Mirvish, 1975).
The series of in vivo and in vitro studies reported 
here were designed to relate these earlier findings to 
the normal patterns of food consumption by man and 
to assess, under conditions reflecting as closely as 
possible the actual situation in the consumer, the 
probable exposure to N-nitroso compounds resulting 
in vivo from dietary nitrite or nitrate. Changes in the 
nitrite concentration of human saliva as a result of  
ingestion of a meal consisting principally of salad veg­
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etables were determined, therefore. A further study 
examined the interactions of normal foodstuffs (as dis­
tinct from individual amines of unknown significance 
to the diet) during their retention in the human 
stomach. The possible influence of smoking and drugs 
on the in vivo formation of nitrosamines was also 
examined, in relation both to the provision of nitros­
atable precursors and, in the former case, to the effect 
on levels of thiocyanate, a potent catalyst of second­
ary amine nitrosation (Boyland & Walker, 1974). 
Since tests involving tobacco-smoke condensates and 
drugs were not possible in man, in vitro conditions 
simulating those within the human stomach were 
used for this work. The nitrite level adopted was ap­
proximately the maximum detected in the stomach 
following ingestion o f a meal containing nitrite, whilst 
the concentration of thiocyanate corresponded to the 
mean gastric level found in smokers.
EXPERIMENTAL
Effect o f dietary nitrate on salivary nitrite levels. 
Each of a group of nine volunteers consumed nitrate- 
rich meals consisting of lettuce, beetroot, carrot, 
celery and radish to a total K N 0 3 content of 
90-115 mg (0-90-1-15 mmol), supplemented by cheese, 
bread and butter and an apple; water was provided 
ad lib. The test meals were taken on 3 days alternating 
with control days when no dietary regime was imple­
mented, but the other foods and liquids taken were 
standardized as far as possible to avoid nitrate-rich 
components. Throughout the 5 days, samples of saliva 
of at least 3 ml were collected in beakers at regular 
intervals from the volunteers, following self-stimu­
lated salivation, and were processed shortly after­
wards.
Effect o f dietary nitrite and gastric nitrite levels. 
Using Ryle’s nasal tubes, samples of gastric juice were 
recovered from six student volunteers before and after 
consumption of a meal consisting of a fried egg (40 g), 
bread (32 g), butter (16 g), cheese (22 g), biscuits (17 g), 
milk (200 ml) and luncheon meat (80 g), the latter hav­
ing been produced at BFMIRA without added 
nitrate. The calculated overall concentration of nitrite 
in. the whole meal, excluding milk, was 0-83 mM.
Determination o f thiocyanate levels. Samples of 
saliva were taken at intervals from 30 volunteers (15 
smokers and 15 non-smokers) and samples of fasting 
gastric juice from 26 volunteers (six smokers and 20 
non-smokers) for the determination of thiocyanate 
levels, by the method of Johnson (1916).
Determination o f  phenols. The level of total phenols 
were determined in gastric-juice samples taken at 
various intervals from one smoker and four non- 
smokers, using the Folin & Ciocalteu (1927) reagent.
Nitrosation o f food amines in vitro. Using an MSE 
Atomix, meals similar to that used in the preceding 
experiment (including fried egg, bread, butter, cheese, 
biscuits, milk and luncheon meat) were homogenized 
in human gastric juice, the overall nitrite concen­
trations of the homogenates being adjusted to 
0-46 mM (32 ppm as N a N 0 2). After adjustment of the 
pH to 2-0 the homogenates were incubated for 3 hr at 
37°C. In addition, various individual foods were hom­
ogenized separately and incubated with a 0-1 5-m con­
centration of nitrous acid. The whole-meal homo-
genate was also used to determine the effect of 
thiocyanate on nitrosamine formation. Any volatile 
nitrosamines formed were separated by distillation 
under reduced pressure by a method based on that of 
Telling, Bryce, Hoar, Osborne & Welti (1974).
Nitrosation o f smoke condensate and nortriptyline 
hydrochloride in vitro. A tobacco smoke condensate 
was added to an HC1-KC1 buffer of pH 2-0 to give 
a concentration of l-0g/100m l. This was nitrosated 
under exhaustive and simulated gastric conditions, 
the nitrite concentrations being adjusted to either 
014  m or 0-3 mM. Subsequently, incubations at 37°G 
were continued for 3 hr with agitation. Similarly, the 
antidepressant nortriptyline hydrochloride (3-(3- 
methylaminopropylidene)-1,2,4,5-dibenzocyclohepta- 
1,4-diene hydrochloride) at a concentration of 45-5 mg/ 
100 ml was nitrosated under simulated gastric condi­
tions in human gastric juice previously cleared by 
centrifugation and adjusted to pH 2-0, using an initial 
nitrite concentration of 0-3 mM. Any extractable N- 
nitroso compounds formed during the incubations 
were separated by repeated extraction into 1,2-di- 
chloroethane.
Incubation o f foods in vivo. Oral tubes of approxi­
mately 5-mm bore permitted both the entry and sub­
sequent recovery of slurries of meals into and from 
the stomachs of volunteers after requisite time inter­
vals. Experiments made with food slurries prepared 
with the addition of phenol red, a dye that is not 
absorbed from the stomach, indicated high recoveries 
(80-90%) of the food slurries by this method. The 
homogenates of meals consisting of egg, milk and lun­
cheon meat with nitrite contents ranging from 0-46 to 
0-77 mM (32-53 ppm) were of a consistency to permit 
passage along the oral tubes. After recovery of the 
slurries following residence within the human 
stomach, any volatile nitrosamines formed were 
separated by the technique used for the products of in 
vitro nitrosation.
Analytical methods
Determination o f nitrite. After deproteinization with 
Carrez reagents (Adriaanse & Robbers, 1969) pre­
pared free of nitrite, determinations were made by a 
method based on that of Shinn (1941).
Concentration and estimation o f volatile nitros­
amines. Volatile nitrosamines contained in distillates 
of in vivo or in vitro incubations were extracted into 
dichloromethane after addition of sodium chloride to 
the aqueous phase to give a concentration of 10% 
w/v. After careful concentration of the extracts in a 
Kuderna Danish evaporator placed in a water-bath 
thermostatically controlled at 55°C and subsequent 
transfer into hexane, individual volatile nitrosamines 
were detected and determined by gas chromatography 
using as a detector a high resolution Hitachi RMU7L 
mass spectrometer in the manner of Crathorne, 
Edwards, Jones, Walters & Woolford (1975). Volatile 
nitrosamines formed in incubations with smoke con­
densates were concentrated similarly and determined 
by a combined gas chromatograph-thermal energy 
analyser (Thermo Electron Corporation, Waltham, 
MA, USA).
Determination o f  extractable N-nitroso compounds. 
These compounds as a group were determined by the 
method o f Downes, Edwards, Elsey & Walters (1976)
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Fig. 1. Mean salivary nitrite levels before and after consumption (over the period W) of a salad-type
meal containing 115 mg nitrate as K N 0 3 (▲--- ▲) and on days when nitrate consumption was low
(A  A).
using a chemiluminescence analyser. Differentiation 
from any inorganic or alkyl nitrites and S-nitroso- 
thiols was accomplished through the use of acetic acid 
alone prior to the denitrosation of any iV-nitroso 
compounds present, using hydrogen bromide in acetic 
acid.
RESULTS
Effect o f dietary nitrate on salivary nitrite levels
In a group of normal volunteers, who showed a 
wide variation in initial salivary nitrite levels 
(mean +  SEM of 013 +  0 0457 mM), consumption of 
salad-type meals rich in nitrate (90-115 mg or
0-90-1-15 mmol as K N 0 3) was followed by a rapid 
rise in salivary nitrite levels (Fig. 1). Peak nitrite con­
centrations (1*77 ±  0-283 mM) were reached about 
2 hr after completion of the meal, the differences 
between the peak and the basal values being highly 
significant. Approximately 21 hr after the test meal, 
on the intervening control days, the nitrite levels still 
showed a slight increase, although this decreased 
further during the following 2-5 hr. Individual vari­
ation in the salivary nitrite levels was generally small 
on the control days, when nitrate-rich dietary com­
ponents were avoided as far as possible.
Effect o f dietary nitrite on gastric nitrite levels
Following ingestion of a meal containing nitrite at 
an overall level of 0-83 mM, a rapid rise in mean pH 
and in gastric levels of nitrite took place, with maxi­
mum values for both occurring approximately 40 min 
after commencement of the meal (Fig. 2). Thereafter, 
the pH started to fall towards the average fasting 
value and there was a sharp decrease in the mean 
gastric nitrite level from about 60 min. The nitrite 
concentration in the fasting gastric juice of the sub­
jects was 14 +  8-17 /a i (mean ±  SEM).
Fasting levels o f thiocyanate and phenols
The concentrations of thiocyanate in both the 
saliva and gastric juice of smokers were on average 
three or four times higher than those of non-smokers.
In both groups, levels were lower in the gastric con- 
. tents (0-48 ±  0 076 (n =  20) and 1-49 ±  0 094 mM (n =  
6), respectively, for non-smokers and smokers) than in 
the saliva (1-82 ±  0-183 (n =  15) and 5-45 ±  0190  
(n =  15) respectively) presumably, due to dilution by 
gastric juice. The difference between the thiocyanate 
levels in the saliva of smokers and non-smokers was 
maintained in repeated determinations throughout a 
day (Fig. 3).
In a limited study of the concentration of total 
phenols in gastric juice, analysis of 19 samples from 
four non-smokers gave values in the fasting gastric 
juice ranging from 1-2 to 4-3 mM, as phenol, with an 
average value of 2-06 mM. The corresponding range 
for five determinations on samples from a smoker was
1-5-3-5 mM, with an average o f 2:64 mM. Thus on the 
basis of the small number of observations made, no 
significant difference was apparent between the two 
groups.
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Fig. 2. Mean gastric nitfite concentrations (A A) and
pH values (A A) following consumption (over the
period H) of a meal containing 0-83 mM nitrite (58 ppm as 
N a N 0 2).
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Fig. 3. Variation of salivary thiocyanate concentrations
with time, over a working day, in three smokers (•--- •)
and three non-smokers (0---O).
Nitrosation o f amines in vitro
Nitrosation o f  food amines. The predominant vola­
tile nitrosamines arising from the deliberate nitros­
ation of foods, particularly those of dairy origin, by 
means of a high concentration of nitrous acid (0-15 m) 
were N PIP and NPYR. The maximum levels of each 
detected by gas chromatography coupled with high- 
resolution mass spectrometry were 83 and 42 mg/kg, 
respectively.
Table 1 illustrates the extent to which increasing 
the concentration of thiocyanate above that found in 
the fasting gastric juice of a smoker affects the average 
formation of N PIP  and NPYR by a whole-meal 
slurry containing an overall nitrite concentration of 
0-46 mM and incubated for 3 hr at pH 2-0 and 37°C. A 
significant difference (P  <  0 05 by Student’s t test) was 
noted between the formation of N PIP in the absence 
of thiocyanate and that in its presence at any level, 
but no significant variation was apparent within the 
range of thiocyanate concentrations tested (0-2- 
3 0 mM). NPYR production was very small through­
out and no significant variations were noted.
The formation of N PIP and NPYR was determined 
also in slurries of meals consisting of luncheon meat, 
egg and milk (as used in in vivo studies) incubated for 
up to 3 hr at 37°C and pH 2-0. Nitrite was present to 
an overall concentration of 043  mM and thiocyanate 
was added to 1*2 mM. The formation of N PIP to a 
mean value of 6-7 mg/kg was apparent after incuba­
tion for 15 min and did not increase further when 
incubation was prolonged for up to 3 hr. NPYR forma­
tion was extremely small, ranging between 0-2 and
0-3 mg/kg.
Nitrosation o f nortriptyline. The initial realistic 
nitrite concentration adopted (0-3 mM) fell rapidly 
within the first 30 min at 37°G and pH 2 0 to approxi­
mately 0 1 2  mM. Continued incubation resulted in 
concentrations o f 0 07 ,0  0 4 ,0  03 and 0 02 mM after 60, 
90, 120 and 180 min respectively. The residual nitrite
Table 1. Effect o f  thiocyanate concentration on mean form a­
tion o f  volatile nitrosamines from food  amines following incu­
bation with 0-46 mM nitrite at pH 2-0 and 37 "C
Thiocyanate
Formation of volatile nitrosamines 
(/ig/kg food)
(mM) N P Y R NPIP
0 00 80
0-2 20 36
0-6 10 30
1-2 10 34
30 10 51
N P Y R  = N-Nitrosopyrrolidine 
NPIP = N-Nitrosopiperidine
w as rem oved  w ith  45 m M -sulpham ic acid  before  
extraction  o f  an y  N -n itro so  com p ou n d s.
• N-Nitroso compounds were formed in the presence 
and absence of nortriptyline hydrochloride, the ad­
ditional extractable N-nitroso compounds attribu­
table to the drug amounting to 31 /ig as N-nitroso- 
nortriptyline, only a small proportion of the total 
5 dose. The inclusion of ascorbic acid at a concen­
tration of 5-0 mM in the incubations reduced the ad­
ditional nitrosation by 75%.
Nitrosation of amines in a tobacco-smoke conden­
sate. Exhaustive nitrosation of the condensate yielded 
880pg extractable N-nitroso compounds (as NPYR)/g 
condensate. This compared with an initial content of
1-2 pg (as NPYR)/g in the untreated smoke conden­
sate. Of the N-nitroso compounds formed, 17% could 
be separated by distillation under reduced pressure 
from a solution of 10% w/v sodium chloride in the 
manner of Telling et al. (1974), the remaining 83% 
being non-volatile. The volatile nitrosamines, equival­
ent to 150/ig (as NPYR)/g smoke condensate were 
characterized, by gas chromatography coupled with 
the thermal energy analyser, as NDM A (35%) and 
NPYR (53%), with 12% being either lost or unac­
counted for as a simple volatile compound.
The reduced nitrite concentration in the simulated 
gastric nitrosations led to only small recoveries of N- 
nitroso compounds extractable into dichloromethane. 
Of the total production of N-nitroso compounds 
(12/ig/g tobacco-smoke condensate expressed as 
NPYR), only about 10% was found in the fraction 
that distilled in steam under reduced pressure, with 
approximately 70% remaining non-volatile. Thus, 
20% of the. N-nitroso compounds produced at the 
lower nitrite concentration were either not recovered 
from the distillation process or were lost, presumably 
as a result of their lability.
Nitrosation o f food amines in vivo
N o N PIP was detected in slurries recovered on 
three separate occasions from the stomach of a 
smoker and a non-smoker 15 min after introduction 
of a homogenate of luncheon meat, egg and milk with 
an overall nitrite concentration of 0-46 mM. However, 
when similar homogenates with a mean nitrite con­
centration of 0-51 mM were retained in the human 
stomach for 30 min, N PIP was detected three times in 
the stomach contents from the smoker (at concen­
trations of 0-52, 0-27 and 0-54 /ig/kg) and once in that
J
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from the non-smoker (0-36 /tg/kg) in seven tests on 
each subject. N o N PIP was detected in the samples 
from either the smoker or non-smoker on the one 
occasion when it was possible to extend the time of 
incubation in the stomach to 60 min. N o other vola­
tile nitrosamines of the simple dialkyl type were iden­
tified in any of the samples.
Since the use of an oral tube for the introduction of 
the samples into the stomach and their removal from 
it might have reduced the availability of thiocyanate 
from the saliva, meals containing 0-49-0-64 mM 
(34-44 ppm) nitrite were eaten whole and as much as 
possible was recovered via the oral tube. Only 
40-50% of the intake was recovered in this manner, 
compared with a mean recovery of 85% of the com­
minuted form, and neither N PIP  nor NPYR was 
detected in any of the six samples analysed following- 
recovery after both 30 and 60 min in the stomach.
DISCUSSION
The great individual variation in salivary nitrite 
concentrations reported by several workers was borne 
out by these studies. Okabe (1973) found nitrite levels 
ranging from 0-0014 to 2-9 mM in the saliva of 200 
Japanese subjects, while values in the range 
0-00014-0-43 mM, with an average of 0 097 mM, were 
obtained by Spiegelhalder et al. (1976), who con­
cluded that differences in dental hygiene could not be 
the only cause for the large variations observed. The 
studies reported here provide a measure of the extent 
and duration of the rise in salivary nitrite concen­
tration resulting from the consumption of a salad- 
type meal that could well be chosen by members of 
the general public.
In comparison with the levels observed on control 
days when the volunteers consumed other meals 
generally low in nitrate, the increases in salivary 
nitrite shortly after the ingestion of salads were highly 
significant. At the peak salivary nitrite concentration, 
the conversion factor obtained, namely an average in­
crease of 98 ppm sodium nitrite in the saliva for each 
100 mg potassium nitrate ingested was in reasonable 
agreement with the mean value of approximately 
140 ppm N aN O 2/100m g K N 0 3 calculated from the 
data of Tannenbaum et al. (1976), whilst the conver­
sion found by Spiegelhalder et al. (1977) was 20 ppm 
N aN O 2/100m g K N 0 3. Assuming a flow of saliva of 
50 ml/hr, it is estimated that about 20 mg sodium 
nitrite would enter the stomach within 4-5  hr, after 
the ingestion of a nitrate-rich salad meal of the type 
described here. This compares with a value of ap­
proximately 40 mg nitrite resulting within the same 
period from the drinking of red-beet juice containing 
four times as much nitrate (Spiegelhalder et al. 1976), 
which suggests that nitrate contained in lettuce, beets 
etc. is extracted and utilized at least as readily as that 
swallowed in solution in an extract. The peak salivary 
concentration of nitrite occurred between 50 and 
250 min after the commencement of the salad-type 
meals. Over a period of 30 min around the time of the 
observed peak nitrite concentration, a saliva flow of 
50 ml/hr would introduce into the stomach approxi­
mately 3 mg sodium nitrite. Judging by the further in 
vivo studies conducted, the pH by that time could 
have already decreased towards the low fasting value
of the stomach as a result of hydrochloric acid se­
cretion to overcome the buffering action of the meal. 
This situation differs from that of the consumption of 
a meal containing nitrite itself, in which case the gas­
tric nitrite concentration increases gradually, presum­
ably as a result of its distribution amongst the 
stomach contents, and then reacts with phenolic, 
amino, sulphydryl and other groups over a short 
period as the pH falls as a result of hydrochloric acid 
secretion. The maximum level of nitrite observed in 
the stomach following its ingestion in a meal was in 
keeping with its distribution from the food through­
out the stomach contents (about 1 litre in volume), 
suggesting that losses by absorption or by passage 
into the duodenum were small. In keeping with these 
results, positive indications of the formation of N PIP  
in vivo were not obtained with residence times of less 
than 30 min, by which time gastric pH values would 
presumably have been lowered by the renewed se­
cretion of hydrochloric acid into the stomach.
The difference between the thiocyanate levels in the 
saliva of smokers and non-smokers observed by 
Densen, Davidow, Bass & Jones (1967) was confirmed 
and was also found in the gastric juice obtained from 
such groups, although the actual concentrations were 
lower in the gastric juice than in the saliva. Neverthe­
less, thiocyanate levels in the gastric juice of both 
smokers and non-smokers fell within the range con­
sidered by Boyland & Walker (1974) to be significant 
as a factor in the stimulation of the nitrosation of 
secondary amines at pH 3-0 and below. Phenols of 
various types have been considered either to inhibit 
(Challis, 1973) or to stimulate (Challis & Bartlett, 
1975; Davis & McWeeny, 1977; Walker, Pignatelli & 
Castegnaro, 1975) the formation of nitrosamines from 
a secondary amine. Since, however, their levels in fast­
ing gastric juice showed no difference between 
smokers and non-smokers, neither effect on nitros­
ation is more likely to occur in one group than in the 
other.
The NPIP and NPYR formed in foods in contact 
with nitrite may well not be the bases themselves but 
derivatives such as piperine, which can occur in pep­
pers. Certainly the formation of these volatile nitros­
amines from spices treated with nitrite is well authen­
ticated (Gough & Goodhead, 1975; Sen, Miles. 
Donaldson, Panalaks & Iyengar, 1973) and the con­
version of piperine to N PIP has been demonstrated 
by Lijinsky, Conrad & Van de Bogart (1972). At a 
nitrite concentration likely to be close to the maxi­
mum that could be produced in the stomach by diet­
ary means, the formation of N PIP within a realistic 
residence time in that organ was approximately 10% 
of that produced during drastic nitrosation and was 
stimulated considerably in the presence of thio­
cyanate. Formation of NPYR, on the other hand, 
represented only a small proportion of the total pro­
duced under drastic nitrosation conditions, even when 
stimulated by thiocyanate, and this suggests that dif­
ferent pathways are operative in the production of 
these two volatile nitrosamines. At low pH values and 
nitrite concentrations, for instance, the nitrous acid 
route of nitrosation, in which the reaction rate is pro­
portional directly to both the nitrite and hydrogen 
ion concentrations, is favoured (Mirvish, Sams & 
Hecht, 1977).
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The reaction of the analgesics propoxyphene and 
norpropoxyphene with nitrous acid has been used for 
their simultaneous determination (Serfontein & de 
Villiers, 1976). At a nitrite concentration that could be 
achieved within the human stomach, nitrosation of 
the drug nortriptyline was apparent, although it in­
volved only a small percentage of the total dose. To 
date, the possible carcinogenicity of N-nitrosonor- 
tryptyline has not been investigated. Nevertheless, its 
potential yield arising from in vivo nitrosation of the 
maximum recommended dose of nortriptyline is likely 
to be far greater than the amount of volatile nitros­
amines ingested in the average British diet. The pro­
nounced inhibitory action of ascorbic acid on the 
nitrosation of nortriptyline under conditions simulat­
ing those within the human stomach is encouraging in 
relation to the use of combined formulations designed 
to reduce or prevent nitrosamine formation in vivo.
The most likely major component of the non-vola­
tile fraction of N-nitroso compounds produced by 
nitrosation of a tobacco-smoke condensate is N-nitro- 
sonornicotine, arising from the nicotine present (Hoff­
mann, Hecht, Ornaf, Wynder & Tso, 1976). Currently, 
little if any information is available on the amount of 
nicotine entering the stomach of a smoker, although a 
quantity will be contained in swallowed saliva. Prob­
ably, therefore, the most important point brought out 
by this part of these studies is the much smaller 
amount of N-nitroso compound found in the un­
treated condensate itself compared with that pro­
duced in the presence of nitrite under simulated in 
vivo conditions.
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Abstract— The increase in salivary nitrite concentration caused by drinking Q-50mg nitrate was 
measured in eight volunteers (over the subsequent 4-6 hr). The magnitude of the increase was dependent 
on the amount of nitrate consumed and varied between individual volunteers. Significant increases were 
not usually obtained with nitrate intakes of less than 10 mg. Four of the volunteers had a low relatively 
constant resting salivary nitrite concentration whereas the remaining four subjects showed much greater 
variations in nitrite concentration before the nitrate drink. A  correlation was obtained between the 
increase in salivary nitrite concentration after drinking 50 mg nitrate and the rate of fall of the resting 
nitrite concentration during the period preceding consumption of the nitrate drink.
IN TRO D U C TIO N
The importance of environmental factors in the 
aetiology of gastric cancer has been suggested by geo­
graphical variations in its incidence (Pfeiffer, Fodor & 
Canning, 1973; Wynder, Kmet, Dungal & Segi, 1963). 
In particular, the nitrate contents of water supplies 
have been reported to be elevated in areas of high risk 
both in Colombia (Correa, Haenszel, Cuello, Tannen­
baum & Archer, 1975) and in England (Hill, Hawks- 
worth & Tattersall, 1973). This finding has directed 
attention towards the possibility of in vivo formation 
of N-nitroso compounds since amines are widely dis­
tributed in the environment.
The saliva of fasting humans contains inorganic 
nitrite, at concentrations that vary considerably 
between individuals and this can react with amines to 
form N-nitroso compounds in vivo (Harada, Ishiwata, 
Nakamura, Tanimura & Ishidate, 1975). Parotid duct 
saliva was found to be free of nitrite (Tannenbaum, 
Sinskey, Weisman & Bishop, 1974) and therefore oral 
bacteria may be implicated in its production from 
nitrate. The ingestion of vegetables or their juices rich 
in nitrate leads to enhanced nitrate concentrations in 
the mouth and thereby to increases in salivary nitrite 
which can persist for some hours (Stephany & 
Schuller, 1975; Spiegelhelder, Eisenbrand & Preuss- 
mann, 1976; Tannenbaum, Weisman & Fett, 1976). 
Tannenbaum et al. (1976) were able to reduce mark­
edly the conversion of nitrate to nitrite in the saliva of 
volunteers through the application of antiseptic 
mouth washes.
Until recent years, the main concern about nitrate 
in water supplies centred on its reduction to nitrite by 
bacteria within the colonized achlorhydric stomach of 
the young infant. Foetal haemoglobin is particularly 
susceptible to oxidation by absorbed nitrite, with the 
production of methaemoglobin, which is inactive in 
the transport of oxygen from the lungs to the tissues. 
In addition, the erythrocytes of the young infant can 
be deficient in methaemoglobin reductase, an enzyme 
which reduces the oxidized haem pigment to its active 
ferrous form. Furthermore, the young infant con­
sumes a large proportion of its food in a liquid form 
in water and thus the intake of nitrate from this 
source may be high in relation to blood volume. For­
tunately, methaemoglobinaemia resulting from the 
conversion of dietary nitrate to nitrite can be readily 
reversed by transfusion with an electron transporting 
agent such as methylene blue or a reducing ageqt 
such as ascorbic acid. Nevertheless, fatalities of young 
infants have occurred in areas of high-nitrate drinking 
water and, for this reason, the World Health Organiz­
ation has recommended a limit on its concentration 
for continuous use of 11-3 mg/litre as nitrate nitrogen 
(WHO, 1977). However, the possibility of an epide­
miological link between nitrate in drinking water and 
gastric cancer has highlighted the potential impor­
tance of nitrite produced in the saliva as a precursor 
to carcinogenic nitrosamines and nitrosamides. In ex­
perimental animals, for instance, N-nitrosamides have 
proved to be active gastric carcinogens (Sugimura & 
Fujimura, 1967; Sugimura, Fujimura & Baba, 1970). 
For this reason, a study has been initiated to deter­
mine the effects on salivary nitrite concentrations of 
the ingestion by a group of volunteers of nitrate in 
drinking water at levels up to and in excess of the 
WHO recommended limit. Considerable care has 
been taken to minimize the effects of nitrate from 
other dietary sources on the nitrite responses 
observed.
EXPERIM ENTAL
Studies o f nitrite levels in the saliva o f volunteers. 
The intake of nitrate overnight by a group of volun­
teers w'as restricted as far as possible by the use of 
distilled water for beverages and by avoidance of 
foods recognized to contain high nitrate concen­
trations. Samples of saliva (3-4 ml) were collected 
from the volunteers over the course of a few minutes 
at intervals of 30-45 min before and after the con­
sumption of nitrate in 250 ml distilled water within 
5 min. The salivary nitrite response to the intake of 
water without and with the addition of nitrate was
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evaluated on at least three occasions for each concen­
tration.
Nitrite determinations were made directly on the 
salivas without further preparation by a method 
.based on that of Shinn (1941) using as blanks further 
aliquots of each saliva after treatment with 0-5% sul- 
phamic acid to take account of any colour in the 
samples.
Determinations o f nitrate in whole meals. Meals were 
weighed and homogenized in an M.S.E. Atomix with 
500 ml distilled water. After heating the homogenates 
for 1 hr on a steam bath they were cooled, centrifuged 
and the supernatants filtered. Determinations of 
nitrate in the supernatants as nitrite were made after 
its reduction with spongy cadmium prepared accord­
ing to Follett & Ratcliff (1963).
RESULTS
Variations in resting salivary nitrite levels
Figure 1 illustrates the appreciable differences ob­
served between the early morning levels of nitrite in 
the saliva of six volunteers who ate breakfasts of their 
own choice. In three of the volunteers, the salivary 
nitrite concentrations were maintained at relatively 
constant low levels throughout the morning. Three of 
the other subjects with higher initial values showed a 
general fall in nitrite concentration during the morn­
ing. At least four of the volunteers showed a rise in 
salivary nitrite concentration in the afternoon, prob­
ably as a result of nitrate consumed in the lunchtime 
meal, which was not restricted in any way.
Figure 2 shows the salivary nitrite levels of two 
volunteers throughout three days. Volunteer A, who 
normally consumes only a very light lunch, showed 
low levels of nitrite throughout without obvious re­
sponses during the post-lunch period. In view of the 
rises in salivary nitrite levels observed during the
afternoons in some volunteers, the nitrate levels of 
some of the meals available to the volunteers were 
determined and are shown in Table 1; these included 
a selection of those which would have been consumed 
by the volunteers at mid-day. The consumption of 
these meals w'ould lead to an intake of nitrate com­
parable with or in excess of the amounts to be studied 
in drinking water. For this reason, the observations 
on the latter were restricted to the pre-lunch period, 
the nitrate intake overnight being restricted as far as 
possible through, for instance, the use of distilled 
water for drinking purposes and the avoidance of 
foods particularly rich in nitrate such as spinach or 
beets.
Responses of salivary nitrite to intake o f nitrate in 
drinking water
Nitrate in distilled water was consumed by eight 
volunteers at approximately 10.30 a.m. on at least 
three occasions for ,each level of intake. Figure 3 
shows the responses in salivary nitrite concentration 
to the ingestion by a male volunteer of the highest 
level of nitrate (50 mg nitrate) on five occasions. In 
general, low (below 5 mg/litre as nitrite) relatively 
constant nitrite levels were observed in this volunteer 
when other sources of nitrate were avoided as far as 
possible prior to challenge with nitrate in drinking 
water. In each case, elevated salivary nitrite levels 
- resulted from the intake of nitrate in water, the in­
crease being relatively constant in four out of the five 
instances. On the fifth occasion, a much smaller in­
crease in nitrite concentration resulted for no obvious 
reason. When the observations were extended beyond 
the morning period and a mid-day meal was omitted, 
secondary smaller peaks were apparent.
Figure 4 shows the mean increases up to the high­
est salivary nitrite level recorded in all eight volun­
teers prior to the mid-day meal and following the
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Fig. 1. Salivary nitrite levels of six volunteers during a day on unrestricted diets.
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Table 1. N itrate contents o f  meals available to volunteers
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Meal
Weight
(g)
Nitrate 
concentration 
(mg N O  3 "/kg)
Total
nitrate
(mgNOj")
Main course
H a m  vci-au-vents, potatoes.
beans 324 98 37
Chicken and ham pie, potatoes.
mixed vegetables 317 39 12
Plaice, chipped potatoes, peas 305 48 14
Steak and kidney pie, potatoes,
carrots 310 39 12
Sliced beef, potatoes, mixed
vegetables, Yorkshire pudding 301 47 14
Beef cutlet, chipped potatoes 234 99 23
Dessert
Ice-cream roll 98 32 30
Plum crumble and custard 291 18 5-2
Apple turnover 188 40 7-4
consumption of various amounts of water-borne 
nitrate. Up to a nitrate intake of about 10m gN O 3_, 
the variations between individuals in the increases in 
the salivary nitrite level were unlikely to be significant 
in most cases. Above this nitrate concentration, how­
ever, the increases in salivary nitrite levels were more 
obvious but varied considerably between volunteers. 
Of the two females included in the group, one showed 
a large increase in salivary nitrite concentration with 
increasing levels of nitrate in the drinking water 
whilst the other showed a far more gradual increase.
On the basis of the small numbers of volunteers 
involved, therefore, it is unlikely that sex has contri­
buted to the considerable variations observed in the 
responses to water-borne nitrate.
It was noted that four of the eight volunteers 
selected had a low and relatively constant resting sali­
vary nitrite concentration during the early morning 
period up to the time of ingestion of the water-borne 
nitrate. The salivary nitrite level of the remaining four 
subjects all showed much greater falls during the pre­
drink period. A plot of the mean increase in salivary
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Fig. 2. Salivary nitrite levels in volunteers A (--- ) and B (----) during three days on unrestricted diets.
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Fig. 5. Relationship of the increase in salivary nitrite con­
centration over 1 hr produced by the consumption of 
5 0 m g N O 3~ ion to the fall in resting salivary nitrite con­
centration before consumption of nitrate. Volunteers who 
were less efficient at converting nitrate to nitrite ( + ); 
volunteers who were more efficient (x ).
nitrite concentration following the consumption of 
50 mg water-borne nitrate by all volunteers against 
the mean change of resting salivary nitrite in each 
before the intake of nitrate comprised essentially a 
straight line (Fig. 5), the coefficient of correlation for 
the relationship being 0-89. The values for the four 
volunteers less ‘efficient’ in converting nitrate to 
nitrite form a cluster while those for the more ‘effi­
cient’ volunteers are far more dispersed.
DISCUSSION
The ingestion of nitrate at concentrations in excess 
of the limit recommended by WHO for continuous 
use led to elevated levels of nitrite in the saliva but the 
size of the increase varied considerably between indi­
viduals. This finding accords with that of Tannen­
baum et al. (1976) who used celery juice as the nitrate 
source. As observed by Spiegelhalder et al. (1976) and 
other workers who used nitrate-rich vegetables and 
vegetable juices, the nitrite concentration in the saliva 
is also related to the amount of nitrate in the diet 
when that nitrate is given in water. Spiegelhalder et al. 
found that the average increase in salivary nitrite con­
centration relative to nitrate intake in vegetables was 
20 m gN O j/litre per 100m gN O 3 ; this figure was 
exceeded by some volunteers consuming nitrate in 
water whilst the response of others was appreciably 
smaller. Spiegelhalder et al. (1976) also observed a 
threshold input of potassium nitrate in vegetables of 
the order of 54 mg below which the salivary nitrite 
concentration was unaltered but this was certainly
not the case in all volunteers consuming nitrate in 
water. Evidence was obtained, however, of second 
smaller peaks of nitrite concentration resulting from 
the ingestion of nitrate, in keeping with the obser­
vations of Spiegelhalder et al. (1976) when they used 
much larger quantities of nitrate in vegetables or their 
juices. They ascribed the secondary and following 
peaks to absorption of nitrite swallowed in the saliva 
from the stomach into the blood stream where it was 
re-oxidized by oxyhaemoglobin to nitrate. Thus the 
nitrate formed was secreted by the salivary glands and 
reduced once more after a delay by the oral micro­
flora.
The size of the increase in salivary nitrite concen­
tration is probably more important in terms of the 
production of N-nitroso compounds than total nitrite 
production since the rate of nitrosation of a second­
ary amine is generally proportional to the square of 
the nitrite concentration. The variations in the 
capacity of subjects to convert nitrate ingested in 
water to nitrite were striking. The relationship of this 
capacity to the rate of fall in salivary nitrite concen­
tration preceding nitrate intake adds weight to the 
concept of the participation of the individual’s oral 
microflora in the reduction (Tannenbaum et al. 1976). 
This supposition assumes that the overnight intakes 
of nitrate by the volunteers were grossly similar, a 
situation which could not be completely controlled, 
and that individuals did not vary greatly their storage 
of nitrate in vivo, in the manner proposed by Tannen­
baum et al. (1978). Nevertheless it is evident that the 
proportion of the small group of volunteers showing 
the greatest rates of fall in resting salivary nitrite con­
centrations were best able to convert water-borne 
nitrate into salivary nitrite.
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